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Background: In 2018, 2.5 million newborns died; mainly from prematurity, infections, and intrapartum 
events. Preventing these deaths requires health systems to provide routine and emergency care at 
birth, and quality inpatient care for small and sick newborns. Despite high potential impact, inpatient 
newborn care is not consistently measured.  
Methods: For this PhD, I conducted a bottleneck analysis using data from 12 national workshops 
regarding delivery of inpatient newborn care in low- and middle-income countries (LMIC). Using WHO 
guidelines, grey literature and expert consultation, I mapped the components required to deliver 
inpatient care and reviewed these against three health facility assessment tools. Finally, I carried out 
an online survey to elicit global practitioner opinions regarding levels of newborn care, paralleling 
those used for monitoring emergency obstetric care in LMIC.  
Results: In 12 high-burden countries in sub-Saharan Africa and Asia, health financing and workforce 
were identified as the greatest bottlenecks to scaling up quality inpatient care, followed by community 
ownership. My review identified 654 components required to deliver inpatient care. These are 
inconsistently measured by existing health facility assessments. The 262 survey respondents agreed 
on 12 interventions to comprise a package of care for small and sick newborns; selected levels of care 
varied by clinical background and experience in LMIC.  
Conclusion: Inpatient newborn care faces multiple health system challenges, particularly to ensure 
funding and skilled staffing. Standard facility numbers and staffing ratios by defined levels of care are 
important for countries to benchmark service delivery progress. Due to the large number of 
components required for delivering quality care, newborn “signal functions” could be selected by level 
of care to parallel emergency obstetric care indicators. Improved measurement of service readiness 
requires sustained focus on interoperability of routine measurement systems, and further research to 
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Chapter 1. Introduction 
In 2018, an estimated 2.5 million babies died during their first 28 days after birth1(1). The main causes 
of death included direct complications of prematurity (35%), infections (23%), and intrapartum 
complications leading to birth injury (24%) (1-3). Most of these deaths occurred in low- and middle-
income countries (LMIC). Many lives could be saved – and morbidity prevented – through a health 
systems approach (4), with identification of those at high risk and timely provision of quality inpatient 
care (5, 6). 
All mothers and newborns require quality care at birth, with emergency obstetric and newborn care 
for those that need it. Routine newborn care (providing cleanliness, thermal care and support for 
breastfeeding) is essential for all babies, while timely resuscitation may additionally be required for 
up to 10% of babies at birth (7, 8). These packages of care are already well described in 
implementation guidelines and integrated into global and national monitoring systems.  
Many low birth weight (LBW) newborns, which include both preterm infants, and those born small for 
gestational age, along with essential newborn care, will require additional support to feed and to 
maintain their temperature. In addition, preterm newborns face increased risks of respiratory 
problems, infections, and jaundice (9, 10). Even amongst those born at full term, significant numbers 
of newborns face complications including, systemic infections, neonatal encephalopathy, severe 
jaundice, and congenital disorders, with high mortality risk in the absence of care. Many of these 
babies will require inpatient (facility-based) care for them to survive and to minimise chances of 
developing future morbidities and/or long-term disability.  
For this PhD, “small and sick newborns” refers to all newborn babies who are 1) preterm and/or LBW 
and/or 2) face life threatening illness and require inpatient care to survive. The care that small and 
sick newborns require is not a single intervention, but a package made up of multiple interventions, 
including ongoing provision of warmth, hygiene, nutrition, respiratory support, and detection and 
management of complications, such as infections and jaundice. Unlike other packages along the care 
continuum, such as emergency obstetric care and essential newborn care, inpatient care of small and 
sick newborns is not currently routinely defined and tracked as part of LMIC monitoring systems.  
In LMIC, access and availability of quality inpatient care for small and sick newborns remains a major 
challenge. Providing such services requires significant health system capacity and the associated 
monitoring systems to identify gaps in access, availability, coverage and quality of care. For health 
 
1 UN-IGME updates estimates of child mortality each year. Throughout the life course of this PhD, estimated newborn 
deaths have reduced from 2.8 million in 2014 to 2.5 million in 2018 (the most recent estimates are from 2018). In earlier 
published material, earlier mortality estimates may have been used.  
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system planning and accountability purposes, there is a need to improve dimensions of measurement 
of inpatient care for small and sick newborns, starting with service readiness. 
At the start of the Sustainable Development Goal (SDG) era, the WHO envisions a world where every 
pregnant woman and newborn receives quality care throughout pregnancy, childbirth and the 
postnatal period (11). These sentiments are echoed in the Every Newborn Action Plan (ENAP) (6) and 
Ending Preventable Maternal Mortality (EPMM) (12). Every Newborn was launched in 2014, followed 
by EPMM in 2015; both aim to achieve equitable and high-quality coverage of care for all women and 
newborns through links with other global and national plans, and measurement and accountability 
frameworks (6, 13). The next phase from 2016-2030 described in the Global Strategy for Women’s 
Children’s and Adolescent’s health, should target multiple dimensions of quality of care to further 
reduce the burden of not just preventable mortality, but morbidity into the (SDG) era so that 
newborns not only survive, but go on to thrive (14). Such a vision cannot be achieved without a focus 
on the continuum of care for mothers and newborns, and importantly including inpatient care for 
small and sick newborns, which has to date been overlooked.  
1.1 Aims and objectives 
The overall aim of this PhD is to identify the challenges to delivering inpatient care in LMIC health 
systems, describe the health system components required to deliver inpatient care, and explore how 
measurement of service readiness for inpatient care can be integrated into existing maternal and 
newborn measurement systems.  The thesis will use both a conceptual and practical approach to 
consider health systems and measurement frameworks and tools. Learning from this work is intended 
to help inform the refinement of existing measurement tools. In addition, it aims to contribute to the 
development of new approaches such that LMIC can systematically track readiness to deliver quality 
inpatient care services for small and sick newborns. 
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This overall aim will be addressed by five key objectives, covering two main themes; 
Theme A: Delivering quality inpatient care services for small and sick newborns 
This theme identifies the health system structures and challenges to delivering quality inpatient care 
for small and sick newborns  
Theme B: Measurement of service readiness for care of small and sick newborns 
This theme explores how measuring service readiness for small and sick newborn can be integrated 
into existing and evolving measurement systems. 
Theme A 
Objective 1: To describe the package of inpatient care for small and sick newborns and determine the 
existing health system challenges impeding scale up in 12 high burden countries by health system 
building block 
Objective 2: To create a standardised matrix of the structural components required to deliver inpatient 
care for small and sick newborns 
Theme B 
Objective 3: To review the capacity of existing health facility assessment tools to capture service 
readiness for small and sick newborns 
Objective 4: Carry out and analyse a global survey to elicit expert opinion on a list of newborn 
interventions to different levels of care to determine newborn signal functions  
Theme A and B 
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6 Existing tools to 
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1.2 Outline of thesis 
This thesis is a hybrid of chapters and research papers. There are four published research papers; one 
presented as a background chapter and three as results chapters. One of the published papers is split 
over two results chapters as it addressed two distinct objectives.  
This first chapter introduces the thesis, outlines the overall aim and objectives and the research 
questions and themes. There is no unifying methods chapter because the study design and methods 
used to address each objective differ. Detailed methods for each study are presented in individual 
chapters to avoid repetition.  
Chapter 2 is the background to the research thesis. To provide context, it presents existing 
epidemiological data on small and sick newborns and delineates some of the terminologies and 
definitions used in the thesis. It describes the importance of service readiness as a prerequisite for 
quality of care, what we know about measuring service readiness and how it complements other areas 
of measurement for maternal and newborn health.  
Chapter 3 presents the first of the four papers titled “Count Every Newborn: a measurement 
improvement roadmap” (15). The chapter provides an introductory description of how the research 
in this thesis fits into the broader Every Newborn measurement improvement roadmap by addressing 
an identified research need. This paper articulates the global Every Newborn metrics project and the 
details of the Every Newborn measurement improvement roadmap. 
Chapter 4 presents the second published research paper titled “Inpatient care of small and sick 
newborns: a multi-country analysis of health system bottlenecks and potential solutions” (16). This 
paper addresses objective one of the PhD thesis. Firstly, it describes the package of inpatient care for 
small and sick newborns within the context of the health system. Using the WHO health system 
building blocks as a framework, this paper assesses the existing health system challenges impeding 
the scale up of inpatient care for small and sick newborns in 12 high burden countries using secondary 
data collected with a “bottleneck” analysis tool. This paper uses quantitative and qualitative methods 
to analyse the data, combined with literature review.   
Chapters 5 and 6 present the third published research paper entitled “Service readiness for inpatient 
care of small and sick newborns: What do we need and what can we measure now?” (17) The paper 
is split into two chapters for this thesis as it addresses two different thesis objectives.  
Chapter 5 presents the results of a grey literature review of existing international guidelines and 
resources on inpatient care of small and sick newborns. To address objective two of this PhD, it applies 
the Donabedian framework (19) as a construct to create and populate a matrix of the service readiness 
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structural components (infrastructure, equipment, drugs, providers and guidelines) required to 
deliver a package of inpatient care interventions for small and sick newborns.  
Chapter 6 presents part of the same published research paper (17) to address the fourth objective of 
this thesis. It reviews the matrix presented in chapter 5 against three multi-country health facility 
survey tools to determine gaps in these existing measurement tools to capture service readiness for 
inpatient care of small and sick newborns.    
Chapter 7 presents the final published research paper titled “Categorising interventions to levels of 
inpatient care for small and sick newborns: Findings from a global survey”(18). It addresses the fifth 
objective of the thesis that identifies potential signal functions and levels of care for small and sick 
newborns to parallel existing obstetric signal functions. The paper presents the results of a 
quantitative analysis of a global survey on signal functions and levels of inpatient care for small and 
sick newborns. It discusses findings from the survey in the context of existing EmONC signal functions 
and levels of care.  
Finally, Chapter 8 synthesises the main findings and discusses internal consistency of the results and 
their combined implications for measurement of small and sick newborn care within existing and 
evolving measurement systems. This chapter also discusses future policy, programme and research 
priorities for this topic, and puts the focus back into the context of the broader agenda for newborn 
health and measurement of quality of care in the SDG era.  
1.3 Role of candidate in Every Newborn metrics project 
I developed the idea for this PhD research during and following an Every Newborn Action Plan metrics 
workshop hosted by WHO in Ferney-Voltaire. The idea for the PhD research was conceived with my 
supervisor, Joy Lawn and co-supervisor Hannah Blencowe as part of the Every Newborn metrics 
project. Initially, I took the lead role in a task team to develop metrics for kangaroo mother care (KMC) 
and then began the analysis of bottleneck data on inpatient care of small and sick newborns, which 
led to development of the research on service readiness. Thereon, I took the lead in the CIFF funded 
Every Newborn metrics team in developing the research and technical side of the workstream on care 
for small and sick newborns and service readiness. All work was carried out from my base at the LSHTM 
with additional travel to conferences and workshops. A summary of my contribution to each research 
activity and element included in this thesis is provided in Appendix A. 
1.4 Ethics 
Permissions for the national consultations for the bottleneck analyses for chapter 4 was granted to 
UNICEF by national Ministries of Health; the tools were then utilised in a series of national 
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consultations supported by the Every Newborn Steering Group between July 1st and December 31st, 
2013. Where required, ethics for other work for this thesis was obtained from the London School of 
Hygiene and Tropical Medicine (LSHTM) ethics committee and is described in further detail in 
individual chapters.  
1.5 Funding 
This research was carried out as part of a full-time research fellow role at LSHTM from 2014 to 2019; 
most of this time was funded by Children’s Investment Fund Foundation (CIFF) through a grant entitled 
“Transforming Newborn Measurement”. Save the Children’s Saving Newborn Lives Project provided 
funding for initial background work. The bottleneck data collection in countries was funded by the Bill 
& Melinda Gates Foundation through a grant to the US Fund for UNICEF (Grant ID: OPP  OPP1094117). 
Additional funding for the bottleneck analysis was received from USAID (Grant ID GHA-G-00-07-00007) 
through UNICEF. Work for the service readiness matrix and some of the time for the work on the 
global survey were funded by Save the Children’s Saving Newborn Lives programme. 
24 
 
Chapter 2. Background 
At the end of the Millennium Development Goals (MDGs) the global health community celebrated 21 
million extra lives saved between 2000-2015 (20). Survival gains were especially apparent for children, 
in part thanks to collective investment in immunisation and preventive disease-specific focused 
community programmes and reductions in deaths from HIV/AIDS, malaria, and tuberculosis (21-23). 
Despite a doubling of donor funding to reproductive, maternal, newborn and child health (RMNCH) 
programmes (24), progress for maternal and newborn survival was much slower, and newborn deaths 
saw the smallest proportional declines. For children aged 1-59 months, there was a 3.4% average 
annual rate of reduction (ARR) in mortality between 1990-2012 compared to an ARR of only 2.0% for 
newborns (21). Deaths in the newborn period (the first 28 days of life) emerged as nearly half (44%) 
of all the under-five deaths globally (20, 21, 25).  
According to recent estimates, 2.5 million neonatal deaths occurred in 2018 (1); the majority (97%) of 
deaths were in lower-middle incomes countries with 75% of these in sub-Saharan Africa and South 
Asia (21). Ten countries, all LMIC, accounted for around two-thirds of all neonatal deaths globally, and 
three countries (India, Pakistan and Nigeria) accounted for almost half of all neonatal deaths 
worldwide (21). Estimates of the burden of neonatal morbidities also drew attention to 19 million 
newborns annually facing life-threatening conditions who require specific care and who are at high 
risk of long-term disabilities and poor health outcomes (21, 26). Disability following neonatal 
conditions is high, with rising numbers of disability in middle-income countries where rates of 
disability are nearly double those in high-income countries (21, 27).   
The SDG era saw in a shift in global health focus beyond survival alone and towards thriving, including 
human capital and well-being (28). Recognition that most of the death and disability that occurs due 
to newborn conditions occurs in LMIC and are preventable with known intervention packages 
prompted international action. At the 67th World Health Assembly in 2014, the ENAP was endorsed 
and launched, setting targets of ≤12 neonatal deaths per 1000 live births and ≤12 stillbirths per 1000 
total births by 2030 with eight specific milestones set at global and country level to 2020, many of 
which focused on measurement improvement (6). The Every Newborn impact framework (21), 
brought “Every Newborn” into the “Every Woman, Every Child” concept, broadening its goals to 
include ending preventable stillbirths and deaths for women, newborns and children, as well as 
improving child development and human capital.  
The Every Newborn Action Plan together with the Strategy for Ending Preventable Maternal Mortality 
(EPMM) provide a strong investment case for women’s and children’s health with clear actions and 
goals for maternal and newborn health post-2015 (6, 12). Effective intervention packages for 
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improving the survival and health of newborns form one component of integrated health services for 
reproductive, maternal, newborn, child and adolescent health (RMNCH). 
2.1 Situating inpatient care of small and sick newborns within the continuum of care 
for reproductive, maternal, newborn and child health   
The continuum of care for RMNCH, as shown in Figure 2.1, includes the main intervention packages 
for women and newborns during pregnancy and around the time of birth: 1) integrated pregnancy 
care (antenatal care)  2) quality care at birth, including emergency obstetric care and management of 
preterm labour (and prompt newborn resuscitation if needed) 3) essential newborn care and 
postnatal care for women and babies, including inpatient care for small and sick newborns. At each 
stage of the continuum, there is opportunity for identification of high risk and associated interventions 
to improve survival and longer-term outcomes (23). Inpatient care of small and sick newborns is 




Figure 2.1 Situating inpatient care for small and sick newborns within the continuum of care for reproductive, maternal, newborn and child health 
 
Figure adapted from Mason et al (2014): From evidence to action to deliver a healthy start for the next generation (23) 
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In the 2015 Every Newborn Lancet series, it was estimated that high coverage of currently available 
interventions along the continuum of care have the potential to save 3 million lives per year by 2025, 
which would include 162,000 women, 816,000 stillbirths, and 1.95 million newborn babies (4). 
Inpatient care for small and sick newborns was identified in this research as an intervention package 
for which high quality coverage could have some of the highest potential impact on newborn deaths, 
especially in LMIC where the greatest proportion and numbers of deaths occur (21, 23, 25). For 
example, care of small and sick newborns could avert over half a million (580,000) estimated newborn 
deaths per year by 2025, besides additional potential impact on disability and long-term well-being 
(4). Despite this, policy and health system analysis identified care of small and sick newborns as an 
area of the continuum of care that has been largely overlooked in LMIC health systems (23, 25, 29). 
Neglect of this package of care may well have been due to a widespread belief that caring for small 
and sick newborns is either unaffordable or unfeasible in LMIC health systems (25, 29).  
In high-income settings, the speciality of neonatology exists as an independent discipline. However 
this is not the case in many LMIC, and small and sick newborns can be “lost” between obstetric and 
paediatric services (25). The assumption that general maternal and child care “trickles down” to small 
and sick newborns without intentional investment and focus has proved to be erroneous, as 
demonstrated by the most recent epidemiological evidence (21, 23, 25). Skilled nurses or midwives, 
as well as doctors, are critical for care of small and sick newborns and training in only essential 
newborn care and resuscitation is insufficient to manage the diverse needs of small and sick newborns 
(29-31).  
The place of care for small and sick newborns also needs to be different.  Labour ward care has great 
potential impact for women and newborns through both routine and emergency care. However, care 
in the labour ward alone is insufficient for small and sick newborns, who require a separate place of 
care.  It is not sufficient for small and sick newborns to be cared for in postnatal wards or as part of 
general paediatrics (which is currently typical in many LMIC settings) they require a specific, dedicated 
space for ongoing inpatient care, usually referred to as a neonatal inpatient care ward or unit.  (32).  
The lack of focus and attention on inpatient care for small and sick newborns within the care 
continuum has been a hindrance to scale up in LMIC. Whilst packages of antenatal care, obstetric care 
and postnatal care have accompanying WHO global guidelines and standards, this is not the case for 
inpatient care of small and sick newborns. Monitoring systems and available data on the care that 
small and sick newborns receive are lacking, making programme planning and targeted actions to 
improve care challenging (15, 29).  
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2.2 Inpatient care for small and sick newborns: epidemiology and specific conditions 
For the purpose of this PhD,  “small and sick newborns” refers to all newborn babies who are 1) 
preterm and/or LBW  and/or 2) face life threatening illness and require inpatient care to survive. For 
this section, the general definitions/terms, aetiology, and epidemiology of the main conditions faced 
by newborns requiring inpatient care are described using the most recent available estimates. None 
of the conditions described in this section can be tackled with provision of inpatient care alone. As 
emphasised in the background, reducing newborn mortality and morbidity requires a health system 
approach along the continuum of care. This PhD, however, is focused on the inpatient care package. I 
therefore describe the clinical condition and then the implications for inpatient care for each of these 
conditions to highlight the large burden that will only be fully addressed with newborn inpatient care.  
2.2.1 Small size at birth 
Low birth weight (LBW) is an umbrella term for babies born weighing less than 2500g. LBW babies 
may be preterm or small for gestational age, or both; the degree of overlap between the two varying 
by setting. Small size at birth is a major risk factor contributing to more than 80% of the neonatal 
deaths and increasing risk of postnatal mortality (especially infection) and poor growth in childhood 
(33).  
2.2.1.1 Preterm 
Preterm birth is defined as all births before 37 completed weeks of gestation (or fewer than 259 days 
since the mother’s last menstruation) (34).  
Risk factors for preterm birth are multi-factorial with genetic, social, environmental, and physiological 
factors playing a role. Preterm birth can be spontaneous, or provider induced. With spontaneous 
preterm birth, the cause is unknown in up to half of cases (10). Maternal factors contribute to the risk 
of spontaneous preterm birth including multiple pregnancies, body mass index, ethnic group, young 
or advanced age, exposure to stress, excessive physical work, or exposure to infections (including 
malaria, sexually transmitted infections or urinary tract infections) and non-communicable disease 
(especially pregnancy related diabetes and hypertension) (9, 35-38). Provider-initiated preterm birth 
for a clinical indication occurs as a result of induced labour or elective caesarean-section (10); these 
births vary between countries and are affected by the quality of antenatal care and contextual factors, 
such as rates of caesarean-sections (many for non-clinical indications) (39). Spontaneous preterm birth 
overall is more common in boys than girls (9).  
Preterm births can be subdivided into three categories based on gestational age: late and moderate 
preterm (32 to <37 weeks), very preterm (28 to <32 weeks) or extremely preterm (<28 weeks) (9, 10). 
Identifying the gestation of a pregnancy is important to determine whether it is preterm or term, 
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which is informative for individual antenatal, intrapartum care and postnatal newborn care, as well as 
for health system planning at a population level. However, accurate assessment of gestational age is 
challenging, especially in lower-income settings where access to first trimester ultrasound (the gold 
standard for gestational age assessment) is limited (40). Other approaches to gestational age 
assessment include dating on reported last menstrual period (LMP) or clinical assessment of the 
newborn at birth. The former is limited by maternal recall and variation of in length of menstrual cycle 
and recent use of hormonal contraception, and the latter of variable accuracy depending on provider 
skill and experience in using clinical assessment tools (41). A further challenge is misclassification of 
extremely preterm births as miscarriages, which may vary between settings dependent on perceptions 
viability (9). The challenges in accurately assessing gestational age often results in poor and 
inconsistent reporting and recording at the facility level (9). The quality of data on preterm birth, 
therefore, is limited by the correct identification and consistent reporting of preterm births (9). 
The Global Burden of Disease study found that 3.1% (a total of 77 million) DALYs were attributed to 
preterm birth (21, 42). National estimates for preterm birth in 2010 were published for 184 countries 
showing a total of 14.9 million (12.3-18.1 million uncertainty range) preterm births, which equates to 
11.1% of all livebirths (10).  Estimates suggest that preterm birth rates range from about 5% of live 
births in European countries to up to 18% in African countries (9). Estimates show that most preterm 
births occur in the late and moderate preterm bracket (84%), which is important as mortality risk 
decreases with increasing  gestational age. However, even later preterm newborns face significant risk 
to their health, especially in more poorly resourced settings (9). Complications of prematurity are 
estimated to be the single largest cause of under-five child deaths overall, and a significant cause of 
long-term loss of human potential globally (2). 
Preterm birth greatly increases a baby’s risk of mortality and morbidity due to other causes, especially 
neonatal infections (43) (See section 2.1.2). Being born preterm is also a major risk factor for longer-
term health issues, including neurological conditions (cerebral palsy and learning difficulties), vision 
and hearing impairment and later non-communicable disease (2, 9). Of 13 million survivors of preterm 
birth in 2010, 345,000 (uncertainty range 269,000-420,000) were estimated to have moderate of 
severe neurodevelopmental impairment, and a further 567,400 (uncertainty range 445,000-732,000) 
estimated to have mild neurodevelopmental impairment (44).  
South Asia and sub-Saharan Africa account for an estimated 60% of the world’s preterm babies, and 
over three-quarters of the world’s newborn deaths are due to preterm birth complications (9, 10, 27). 
In settings with more reliable data, trend data suggests that preterm birth rates are increasing; 
countries with the largest numbers of preterm births include Brazil, the United States, India, and 
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China. (9). Explanations for this vary between settings, with some countries seeing changing obstetric 
practices and behaviours: higher maternal age, increasing infertility treatments (leading to higher 
rates of multiple births), or increases in preterm C-sections (10). In lower-income settings apparent 
increases in preterm birth rates may also be explained in part by higher rates of reporting with 
increased awareness of the issue (9, 10). However, there is uncertainty in these national estimates 
due to the limitations of correctly assessing preterm births, described above.  
2.2.1.2 Small for gestational age 
Birthweight less than the 10th centile for gestational age gender-specific reference population are 
referred to as small for gestational age (SGA). SGA babies may be either constitutionally small (in the 
lower tail of the growth curve) or pathologically growth restricted (or a combination of both) (45).  
For SGA babies, maternal stature and weight is an important factor and ethnic group and lower 
socioeconomic status have also been found to play a role (46). Specific risk factors for intrauterine 
growth restriction include maternal nutritional status, substance exposure (especially smoking) (47), 
as well as chronic (asthma, autoimmune) and/or maternal non-communicable disease (pre-eclampsia, 
hypertension) (48).  
The highest rates of SGA occur in South Asia where in 2010, an estimated 45% (uncertainty range 40.0-
49.7) of births were estimated to be SGA, compared to a global average of 27% (uncertainty range 
24.1-30.5) (45). In South Asian settings, growth restriction accounts for a high proportion of SGA births 
justifying the frequent use of SGA as a proxy for growth restriction in many such settings (33, 45). SGA 
babies were found to have nearly twice the risk of neonatal and post neonatal mortality when 
compared with infants born at an appropriate size for gestational age (≥10% birth weight for 
gestational age) (33).  
Quantifying the burden of SGA is challenging. For the 2010 estimates, US National Centre for Health 
Statistics data for 1991 was used (based on 313,4879 livebirths) (49). However, it is accepted that 
adopting a global reference population for birthweight may not be appropriate for all populations (45, 
50). 
2.2.1.3 Small size and implications for inpatient care 
Small babies, whether premature, growth restricted, or both, carry a considerably higher risk of 
mortality and morbidity in the neonatal period and childhood and are especially vulnerable to 
hypothermia, difficulty establishing feeding, hypoglycaemia, breathing difficulties (respiratory 
distress), infections and jaundice. Strategies and interventions that focus on prevention to reduce the 
numbers of small babies are needed, especially through family planning strategies (birth spacing), 
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treatment of infections (particularly malaria) during pregnancy (51). Nonetheless, rates of preterm 
births are rising in most settings (9, 10) and the cause of small size at birth is often not known (5). 
Direct complications of preterm birth, especially due to respiratory problems is the leading cause of 
death in all settings globally (2). In high income settings, the majority of the newborn deaths now 
occur in a sub-population of extremely preterm babies, often described as micro-preemies (<26 weeks 
gestation). However, in lower-income settings, the majority of preterm deaths still occur in late and 
moderate preterm (32- <37 weeks gestation) (10). Recent estimates show that up to half of preterm 
deaths could be averted through warmth, feeding support, infection prevention and treatment 
supported by kangaroo mother care (KMC); over 90% could be avoided with special and intensive 
newborn care including continuous positive airway pressure (CPAP) (4). Thus, preventing a large 
proportion of deaths in small babies globally is achievable but requires the provision of these known 
affordable interventions as part of an inpatient care package.  
2.2.2 Infections 
Serious bacterial infections, a major cause of newborn morbidity and mortality, include the clinical 
infection syndromes of sepsis, meningitis, and pneumonia (43, 52). Infections are usually described as 
early (within the first 3 days) or late onset (after the first 3 days until the end of the neonatal period). 
The former is commonly associated with vertical acquisition (during or related to birth or from the 
birth canal); the latter is usually acquired from external sources after birth (e.g. from the home or 
hospital environment) (53).  
There are multiple reasons for increased vulnerability to infection in the first 28 days of life, including 
immaturity of the immune system, potential exposure to micro-organisms in the birth canal and risk 
factors during the intrapartum and postpartum period, especially in resource poor environments (54). 
Maternal risk factors for newborn infections include prolonged rupture of membranes, preterm labour 
and maternal infections. Babies born in unhygienic conditions, with low birth weight (especially 
preterm) and/or that are fed substances other than breastmilk are known to be at greater risk of 
infections (54, 55), as well as those with unhygienic substances applied to the umbilical cord area after 
birth (8). Boys have been found to have higher risk of serious neonatal infections than girls (43, 52).  
When more advanced laboratory support is available, diagnosis of suspected infections is confirmed 
fully using microbiological investigations (e.g. analysis of microorganisms in blood and other body fluid 
and tissue) (43). Such advanced laboratory infrastructure is often lacking in lower-income settings. In 
addition, when babies are born outside the health facility, cases may go unrecorded. Therefore, both 
diagnosis and reporting of neonatal infections in LMICs is challenging, often relying on clinical 
algorithms which detect possible infections with greater sensitivity than specificity (56).  
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Serious bacterial infections account for approximately a third of the 2.5 million neonatal deaths 
globally (43). Serious bacterial infections in the neonatal period are an important contributor to the 
global burden of disease, accounting for about 3% of all DALYs, most of which are deaths (42, 52). The 
incidence of possible serious bacterial infection (PSBI) in 2012 was estimated at 7.6 per 100 live births 
(95% confidence interval 6·1–9·2%) (43, 52). In 2012 there were an estimated 6.9 million (uncertainty 
range 5.5-8.3 million) cases of PSBI requiring treatment (in liveborn babies ≥32 weeks gestation or 
≥1500g birthweight) in sub-Saharan Africa, South Asia and Latin America; 680,000 (460,000-920,000 
uncertainty range) of these were estimated to have led to neonatal deaths (43). The largest number 
of cases of PSBI in 2012 were estimated in South Asia at 3.5 million (uncertainty range 2.8-4.2 million), 
followed by sub-Saharan Africa at 2.6 million (uncertainty range 2.1-3.1 million) and then Latin 
America at 0.8 million (uncertainty range 0.7-1.0 million) (43). Despite higher numbers of PSBI in South 
Asia, it was estimated that case fatality risk in sub-Saharan Africa was higher – which may be explained 
by access to quality care or differing underlying causes and risk factors, such as higher preterm rates 
in Africa compared to Asia (43).  
Data on long-term morbidity of babies with severe neonatal infection are sparse, especially for 
disability in survivors, and estimation of rates of impairment following neonatal sepsis and pneumonia 
was not possible due to lack of data (52).  
2.2.2.1 Infections and implications for inpatient care 
Prevention of infection is of critical importance in reducing newborn death and long-term disability 
and multiple strategies are needed, including maternal vaccination, hygienic care at and around the 
time of birth and exclusive breastfeeding (43, 57). However, with estimated incidence of 7.6 cases of 
PSBI per 100 live births in 2012, inpatient care is also critical to reduce the resulting burden of death 
and disability (57, 58). The severity of bacterial infection in the newborn period, as well as the overlap 
with other major risk factors for neonatal death and disability (particularly small size) means most 
newborns with infections cannot be treated in the community and will require a period of inpatient 
care. In hospital settings, WHO recommends treatment with injectable antibiotics for 7-10 days with 
supportive care (58). Microbiological investigations (blood culture and lumbar puncture for suspected 
infections) are a core component of inpatient care, alongside antibiotic stewardship and strict 
infection control procedures, to prevent both nosocomial infections and development of antimicrobial 
resistance, which are growing public health issues (53).  
2.2.3 Intrapartum-related events and neonatal encephalopathy 
“Birth asphyxia” is a term that was previously used to describe impaired oxygen delivery and 
decreased blood flow to the fetus in the perinatal period, most frequently due to events during labour 
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(intrapartum). Clinically, “birth asphyxia” was used to describe babies that are not breathing at birth, 
who require resuscitation in the delivery room, or who show signs of brain injury (59).  However, there 
are a broad range of conditions that may present with this same clinical picture, which makes the 
diagnosis of birth asphyxia challenging. Because of this complexity, particularly in lower-income 
settings, there has been a shift in terminology, from using “birth asphyxia” to “intrapartum-related” 
complications or events to indicate the timing and subsequent injury due to hypoxia (60, 61).  The use 
of “intrapartum-related” events deliberately does not assume a causal relationship (60).  
Neonatal encephalopathy is a disorder of brain function, which develops in infants that survive 
intrapartum or severe hypoxic events at birth (16, 60). The more severe cases of encephalopathy can 
progress to seizures, lack of consciousness and apnoea. 
Risk factors for neonatal encephalopathy include primiparity, multiple births, lack of antenatal care, 
small or large for gestational age, induction and/or augmentation of labour and prolonged/obstructed 
or labour and perinatal infection (62, 63).  
Based on estimates of intrapartum related events, 1.15 million  (0.89-1.60 million uncertainty range) 
new cases of neonatal encephalopathy were associated with intrapartum related events in 2010; 96% 
of these were born in LMICs. An estimated 287,000 (181,000-440,000 uncertainty range) of these died 
(60). Of those babies that survived, 413,000 were diagnosed with neurodevelopmental impairment; 
233,000 (163,000-342,000 uncertainty range) with moderate to severe neurodevelopmental 
impairment and 181,000 (82,000-319,000 uncertainty range) with mild neurodevelopmental 
impairment (60). In 2010, intrapartum-related conditions are estimated to have accounted for 50.2 
million disability adjusted life years (DALYs) and 6.1 million years lived with disability (60). 
2.2.3.1 Intrapartum-related events and implications for inpatient care 
Quality obstetric care and effective neonatal resuscitation are of key importance in the prevention of 
death and disability related to intrapartum complications and subsequent injury to the brain (61). 
However, for those babies that survive intrapartum events and develop neonatal encephalopathy, 
many will go on to require inpatient care to treat symptoms (such as seizures), provide 
developmentally supportive care, establish feeding and minimise and manage long term sequelae. In 
advanced settings where neonatal intensive care is available, interventions such as brain cooling have 
been shown to be effective in treating neonatal encephalopathy (64), but it is still unclear how to 




Neonatal jaundice, characterised by high levels of serum bilirubin, is common, occurring in up to 85% 
of all live births (65). Whilst most cases are physiological and resolve spontaneously, unresolved and 
severe cases can result in acute bilirubin encephalopathy (kernicterus) or death.  
Preterm newborns and those with infections are at increased risk of jaundice, as well as those with 
blood group incompatibilities or genetic disorders, such as glucose-6 phosphate dehydrogenase 
(G6PD) deficiency (65, 66).  
Quantifying the burden of severe jaundice (serum bilirubin levels >25mg/dL)  is challenging, especially 
in LMICs where diagnosis with serum bilirubin levels is often delayed or not available (67).  
Based on figures published in 2013, an estimated 481,000 newborns were affected by extremely 
severe jaundice in 2010 (66). More recently, a meta-analysis of studies from 2010-2017 found an 
incidence of severe neonatal jaundice (defined as jaundice associated with acute bilirubin 
encephalopathy and/or exchange transfusions and/or jaundice related death) of 667.8 (95% 
confidence interval 603.4-738.5)  per 10,000 live births in the African region followed by 251.3 (95% 
confidence interval 132.0-473.2) per 10,000 live births in South East Asia; lower rates were found in 
Europe, Americas and Western Pacific (65).  
Acute bilirubin encephalopathy is a significant cause of death and long-term disability, including 
cerebral palsy, deafness, language and processing disorders and motor and speech delays (68). Follow 
up of cases of kernicterus, estimates published in 2013 found 64,100 (uncertainty range 36,000-
83,300)  cases of hearing loss, 62,100 (uncertainty range 35,200-81,800) cases of developmental delay 
and 35,500 (uncertainty range 15,000-155,500) cases of cerebral palsy (66). The burden of impairment 
following kernicterus disproportionally affects LMIC, especially sub-Saharan Africa and South Asia (65, 
66).  
2.2.4.1 Jaundice and implications for inpatient care 
Prevention, early diagnosis and inpatient care treatment can transform outcomes for babies with 
jaundice. This requires a combination of screening, diagnostics and treatment with phototherapy. 
Previous work has highlighted the critical importance of providing effective phototherapy in resource 
poor settings, where the burden of severe neonatal jaundice is the greatest and contribute 
significantly to the global burden of cerebral palsy, deafness and other auditory and language 
processing disorders (65). Cases of jaundice can be treated in LMIC with affordable and available 
diagnostic and phototherapy technologies as part of inpatient care; more extreme cases will require 
more intensive inpatient care, including exchange transfusions (68).  
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2.2.5 Congenital disorders 
According to WHO, congenital disorders (also referred to as birth defects) are any potential 
pathological conditions arising before birth; they are either evident at birth or become manifest later 
in life (69). Congenital disorders are highly diverse in their aetiology and outcomes and subsequently, 
epidemiological data is lacking in most settings (70); they can be grouped into congenital 
malformations/anomalies (such as neural tube defects, orofacial clefts and congenital heart disease) 
chromosomal disorders (such as Down syndrome and other trisomies) and inherited disorders (such 
as sickle cell and thalassemia). Risk factors for congenital disorders include genetic, societal, and 
environmental factors (e.g. infections, toxins, teratogens).  
In the absence of interventions, the birth prevalence of congenital disorders in any given population 
is relatively constant. Average baseline prevalence of congenital anomalies is estimated to be at least 
20 per 1000 and the baseline prevalence of congenital disorders is over 37 per 1000 (69). Actual 
prevalence, however, varies greatly depending on both preventative and treatment interventions. For 
example, meta-analysis suggests folic acid food fortification could reduce incidence of neural tube 
defects by 46% (95% confidence interval 37-54%), with a potentially higher effect using 
supplementation (71) (69).    
Cleft lip and palate, congenital heart anomalies, and neural tube defects account for an estimated 21.4 
million DALYs. An estimated 6% of global under 5 deaths are attributed to congenital anomalies, of 
which 92% occur in LMICs (72). 
2.2.5.1 Congenital conditions and implications for inpatient care 
If a fetus is diagnosed in utero to be affected by a congenital disorder, options include treatment 
during pregnancy, termination of pregnancy, planning for labour and postnatal care (often involving 
neonatal care). The inpatient care interventions mainly centre on identification and clinical 
management, including supportive care for both affected child and wider family.  In some congenital 
anomalies, including orofacial cleft, neural tube defects and congenital heart disease surgical 
correction can improve both survive and quality of life (73). Often surgery cannot occur in the 
immediate neonatal period (and/or access to surgery is limited) therefore, for clinical management 
many of the core inpatient care package interventions apply, such as assisted feeding (often by 
intragastric tube) and supportive care, which can significantly impact mortality and longer term 
morbidity and functioning (70).  
2.3 Service readiness: a prerequisite for quality of care  
A significant change observed during the MDG era was a major shift in the proportion of births that 
occurred in facilities with a skilled birth attendant. Rates of facility births increased from 62% globally 
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in 2000 to 80% in 2015  (21). However, despite this shift in place of birth, maternal and newborn 
deaths did not decrease accordingly (74).  
A frequently cited explanation for why maternal and newborn mortality did not decrease as much as 
hoped is that there was insufficient attention and investment in the quality of intrapartum care (4, 11, 
21, 22, 75, 76). For example, in South Africa, more than 95% of births are facility-based, but NMR did 
not significantly shift by the close of the MDGs, most probably due to inadequate quality of care not 
only during pregnancy and childbirth, but during the postnatal period (77). Similarly, the evaluation of 
the conditional cash transfer Janani Suraksha Yojana program in India, focused on increasing skilled 
birth attendance, showed significant increases in facility deliveries but no change in NMR (78).  
2.3.1 What is quality of care 
Quality of care is a multidimensional concept defined by WHO as “the extent to which health services 
provided to individual and patient populations improve desired health outcomes” (p 1046) (11). There 
is no single definition or framework for quality, but many definitions for quality healthcare are based 
around the Institute of Medicine’s six dimensions, which call for quality healthcare to be safe, 
effective, patient-centred, timely, efficient and equitable (79).  
Defining quality healthcare differs from definitions of quality improvement, which involves 
interventional experiments or changes in practice designed to test a change over time (80, 81). Many 
of the models or frameworks for quality improvement in healthcare are borrowed or developed from 
the manufacturing industry (82, 83). They are designed to help understand the factors influencing 
outcomes or processes in a specific context or population (81). For example, Ishikawa or fishbone 
diagrams are graphic tools used to display the causes of a certain effect (or identified problem) and 
graphically display the relationship of more distal and proximal factors and their relationship to each 
other (84). Deming or Plan Do Study Act (PDSA) cycles, originally developed by Deming and Shewhart 
for use in manufacturing, are iterative and cyclical learning approaches that encourage process and 
culture change by measuring and testing changes in a complex system over time (82, 85-87). Also 
developed in the manufacturing industry, Lean and Six Sigma have been applied in conjunction to 
healthcare since 1990 (82, 85).  Lean focuses on waste reduction and six sigma on defect rates to 
reduce variability and standardise outcomes in a system (82, 85).  
Fundamental in measuring and translating concepts of quality to healthcare, the Donabedian model 
for measuring quality of care emerged in the 1970s (19). The Donabedian framework contains three 
measurement domains: the structures (e.g. infrastructure, equipment, health providers) and 
processes (e.g. actions performed by health professionals) that lead to health outcomes (what 
happens to the patients). It has now been used for decades to help academics, implementation 
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scientists and programme implementers operationalise and measure key concepts of quality in health 
care (19, 88-90).  
As part of a global health vision for quality of care beyond the MDG era and into the SDG era, the WHO 
developed a new framework for quality of care for maternal and newborn health care, conceptualising 
both the provision and experience of care as essential components of quality care (Figure 2.2). This 
framework builds on both the Donabedian model and the six WHO health system building blocks 
(leadership and governance, financing, essential medicines, information systems, workforce, service 
delivery) (11) using different domains which can be targeted to assess, improve and monitor care 
within the context of a health system. Identifying where problems are occurring can therefore help to 
point to interventions to improve quality (75).  
Figure 2.2 WHO framework for the quality of maternal and newborn health care  
Source: Adapted from Tuncalp et al (2015) Quality of care for pregnant women and newborns – the WHO vision (11) 
http://apps.who.int/iris/bitstream/handle/10665/249155/9789241511216-eng.pdf?sequence=1 
 
This thesis aims to describe the health system components required to deliver inpatient care using 
both the WHO health system building blocks and the Donabedian model; they provide frameworks to 
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describe the foundations of the health system required to build quality of care relevant to newborns.  
Measuring service readiness requires an understanding of the needs of health systems delivering 
inpatient care for small and sick newborns. The Donabedian framework is a practical model for 
operationalising service readiness and placing it within the broader context of RMNCH and the WHO 
vision for quality of care. The choice of the Donabedian model alongside the health system building 
blocks helps ensure that findings from this thesis are relevant and aligned with WHO vision of health 
care quality for maternal and newborn health, and helps contextualise findings within the SDG era.  
2.3.2 Importance of quality of care for small and sick newborns 
It was estimated in 2014 that addressing quality of care was an immediately feasible opportunity for 
newborns, and that addressing the quality of care gap could save 1.325 million newborns by 2020 (4). 
Some of the greatest effect could be achieved through a focus on small and sick newborns, which 
could prevent 600,000 newborn deaths per year by 2025 (4). This is largely achievable through focus 
on high coverage of quality of care in facilities, particularly district and sub-district level facilities in 
LMIC where some of the greatest gains can be made (4).  
It is not only survival that is gained through quality of care. Being born in either a low- or a middle-
income country greatly influences your chance not only of survival, but long-term health and 
development. In high-income settings where higher quality inpatient care is almost universally 
available, neonatal mortality is low (<5 per 1000 live births) and few full-term babies develop 
complications. Furthermore, for preterm babies, 95% survive free of disability, even those born at the 
lower thresholds of viability (21, 27). In middle-income settings, the risk of disability in babies born 
between 28-32 weeks is nearly double that in high-income countries (21, 27). This is not only related 
to access to care; a similar pattern was observed in higher-income settings as intensive care was 
introduced. Specialisation of neonatal staff alongside factors such as safe use of oxygen, 
developmentally supportive care, and management of pain, have been instrumental in improving the 
quality of neonatal care in higher income settings over the last few decades, and improving long term 
outcomes for neonatal survivors (5, 27). In LIC, disability following neonatal illness is less common 
because those with severe complications (<28 weeks) still die due to lack of essential and routine care 
at and around the time of birth (91). The existing data shows us that as we progress into the SDG era, 
health programmes will require specific focus on quality and safety to avoid a similar trajectory of 
rising rates of preventable disability as mortality rates decrease.  
2.3.2.1 Learning from retinopathy of prematurity 
The example of retinopathy of prematurity (ROP) is a useful illustration of the importance of quality 
of inpatient care for small and sick newborns (92-95). ROP is a condition characterised by abnormal 
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retinal vascular development, usually caused by unregulated use of high concentrations of oxygen 
without monitoring its effect on oxygen content of arterial blood (oxygen saturations). Oxygen is one 
of the most frequently used drugs to treat respiratory distress due to preterm birth in inpatient care 
units (96). In 2010, an estimated 184,700 preterm babies developed ROP during the neonatal period; 
53,800 progressed to potentially vision impairing disease, 20,000 of whom became blind or severely 
visually impaired (97). ROP is now a leading cause of childhood blindness worldwide (93, 97), yet is 
largely preventable with well-controlled oxygen levels, use of the appropriate devices and monitoring 
systems. Therefore, high rates of ROP, particularly in moderate and late preterm newborns, are 
directly related to the quality of care that they received (97, 98). If rates of intrapartum events are 
considered a key marker of the quality of obstetric care, rates of ROP are a similar marker of the quality 
of inpatient newborn care. 
The highest rates of ROP are found in middle-income settings, especially Asia, Latin America and 
increasing rates of ROP are seen in countries where neonatal care has been scaled up without due 
attention to the quality of care (95, 99). Lessons learned from the example of ROP demonstrate the 
need for simultaneous focus on preventing avoidable death and preventing disability through 
attention to quality and safety of inpatient care (27). Quality of care is the nexus between newborn 
survival and children thriving into adulthood. Significant gains to both survival and quality of life can 
be achieved through focused attention to safety and quality of care (4) and improved monitoring and 
data for babies requiring inpatient care. In the case of ROP, the provision of safe, monitored levels of 
oxygen in cases of respiratory distress during the period of neonatal inpatient care is a critical safety 
and quality issue with potentially long-term consequences for social and educational outcomes.   
2.3.3 What is service readiness and how is it measured? 
For health systems to function effectively they need a combination of inputs and processes, as well as 
coverage of care. As per the Donabedian quality of care framework, services are usually judged on 
their outcomes, but improved outcomes cannot be achieved without the key structures and processes 
in place (89). Assessing quality of care, therefore, requires measures of both structures and processes 
(19, 88, 89).  
Structures are the key characteristics of the health service and its providers – the health system inputs. 
Planning, resource allocation and day-to-day management of healthcare requires timely information 
on these inputs (equipment, supplies, infrastructure and human resources) (100). Processes refer to 
the actions carried out on patients in a health care institution. Process indicators are important to 
measure, but often more challenging to measure than structural inputs (76, 101) as there is greater 
variability in the performance of process measures than service inputs, which are more stable (102). 
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Outcome measures are essential as they assess the ultimate goal of the health system but reflect 
multiple factors beyond the health system itself (76) making it less easy to action change at a local 
level.  
Service readiness refers to the capacity of a health system to deliver the services offered (101). Service 
readiness is measured predominantly through service inputs – the equipment, supplies, 
infrastructure, and human resources. To ensure that services are ready, however, the structures not 
only need to be present, but maintained, re-stocked and updated (e.g., equipment requires 
maintenance, supplies require re-stocking, guidelines require updating) and staff continually trained 
and supervised. Therefore, elements of processes are also covered through service readiness 
measurement. Given the pivotal role of quality newborn care in affecting long term newborn 
outcomes, this PhD views the service readiness structures as a critical starting point to identify service 
delivery gaps and support scale up of quality care.  
To be immediately actionable, service readiness data is ideally readily available at a local level. 
However, national health information systems in LMIC may currently have limited capacity to collect 
this type of data. Data are particularly lacking in settings where access to neonatal inpatient care is 
the lowest and where facilities are most in need of targeted efforts to strengthen services and improve 
the quality of care. This means that many LMIC settings rely on national surveys to supplement their 
health information for measures of access, availability, and quality of care, including service readiness. 
Intermittent surveys - such as health facility assessments - are frequently used.  
There are many health facility assessment tools available, using multiple different methods and 
indicators to collect data.  Despite the variety of health facility assessments that exist to supplement 
general national health information gaps, there are relatively few studies of service readiness specific 
to inpatient care for small and sick newborns. A recent systematic review of health facility assessments 
found 10 different tools covering 41 different assessment domains (103). Broadly, however, health 
facility assessment tools have been found to tend towards assessments of services at the primary care 
or community level rather than secondary level services, limiting the number that capture information 
on inpatient care for small and sick newborns (103).  
2.3.4.1 Example of service readiness data for inpatient care of small and sick newborns  
A recent study in Kenya aimed to describe the provision and access to inpatient neonatal services 
within Nairobi City County health care system and examined the structural capacity of facilities to 
provide quality of care (104). The study found that larger facilities tended to score higher on structural 
capacity than smaller ones. Several items were missing from inpatient care units, including blood 
transfusion giving sets, Vitamin K and IV drugs. Thermometers, weighing scales and suction machines 
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were often shared between maternity or sick child services. Of 17 drugs required for small and sick 
newborns, a median of 88.9% (5.3-100%) were only available in stores (rather than immediately 
available). Pulse oximeters were only available in 24 out of 31 facilities. Incubator sharing was reported 
by 9 out of 31 facilities and was especially common in the larger volume public facilities. Only 12 out 
of 31 facilities had dedicated nursing staff for small and sick newborns with greater staff shortages on 
night shifts (104).  
While the study is not representative of the whole country and cannot be directly extrapolated to 
other settings, it is reasonable to assume that other settings may face similar challenges. The Nairobi 
study found that half of small and sick newborns are not able to access appropriate care (104), further 
emphasising the need for routine monitoring systems in place that can track health system readiness 
and availability of services to be able to improve dimensions of quality of care and plan appropriate 
distribution of services (104-106).  
2.4 Conclusions 
For this PhD, service readiness is framed both through the lens of WHO building blocks and the 
Donabedian framework. These frameworks are used as foundational constructs to identify and 
understand domains which can be targeted to track and monitor health system readiness for small 
and sick newborns within the context of the health system. Measuring service readiness for inpatient 
care requires an understanding of the structural components that comprise the package of inpatient 
care, which is lacking for small and sick newborns in comparison to other packages of interventions 
along the continuum of care. Rather than creating a parallel system, the overall aim of this PhD is to 
contribute a body of work that will help to guide and improve the measurement of service readiness 
for inpatient care for small and sick newborns. As part of this aim, this PhD considered small and sick 




Chapter 3: A measurement improvement roadmap  
3.1 Introduction  
Chapter 3 presents the first published research paper entitled “Count Every Newborn: A measurement 
improvement roadmap”. The chapter provides a description of how the research in this thesis fits into 
the broader Every Newborn measurement improvement roadmap to address an identified research 
need. This paper describes the broader context of the global Every Newborn Action Plan (ENAP) and 
the Every Newborn metrics measurement improvement roadmap. While the focus on this paper is 
largely on coverage measurement rather than service readiness, this work is included as part of the 
background section of this PhD to show how the candidate identified the need for and shaped the 
subsequent project on service readiness for small and sick newborns within the Every Newborn 
measurement improvement roadmap project.  
This work was published in BMC Pregnancy and Childbirth as an open access article in September 
2015. See Appendix M (15) for the published version of this article and copyright. The paper was part 
of a supplement of nine papers on scaling up high impact interventions and improving the quality of 
care for mothers and newborns at and around the time of birth This is one of the crosscutting papers 
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The Every Newborn Action Plan (ENAP), launched in 2014, aims to end preventable newborn deaths 
and stillbirths, with national targets of <12 neonatal deaths per 1000 live births and ≤12 stillbirths per 
1000 total births by 2030. This requires ambitious improvement of the data on care at birth and of 
small and sick newborns, particularly to track coverage, quality and equity.  
 
In a multistage process, a matrix of 70 indicators were assessed by the Every Newborn steering group. 
Indicators were graded based on their availability and importance to ENAP, resulting in 10 core and 
10 additional indicators. A consultation process was undertaken to assess the status of each ENAP 
core indicator definition, data availability and measurement feasibility. Coverage indicators for the 
specific ENAP treatment interventions were assigned task teams and given priority as they were 
identified as requiring the most technical work. Consultations were held throughout. 
 
ENAP published 10 core indicators plus 10 additional indicators. Three core impact indicators 
(neonatal mortality rate, maternal mortality ratio, stillbirth rate) are well defined, with future efforts 
needed to focus on improving data quantity and quality. Three core indicators on coverage of care for 
all mothers and newborns (intrapartum/skilled birth attendance, early postnatal care, essential 
newborn care) have defined contact points, but gaps exist in measuring content and quality of the 
interventions. Four core (antenatal corticosteroids, neonatal resuscitation, treatment of serious 
neonatal infections, kangaroo mother care) and one additional coverage indicator for newborns at 
risk or with complications (chlorhexidine cord cleansing) lack indicator definitions or data, especially 
for denominators (population in need). To address these gaps, feasible coverage indicator definitions 
are presented for validity testing. Measurable process indicators to help monitor health service 
readiness are also presented. A major measurement gap exists to monitor care of small and sick 
babies, yet signal functions could be tracked similarly to emergency obstetric care.  
 
The ENAP Measurement Improvement Roadmap (2015-2020) outlines tools to be developed (e.g., 
improved birth and death registration, audit, and minimum perinatal dataset) and actions to test, 
validate and institutionalise proposed coverage indicators. The roadmap presents a unique 
opportunity to strengthen routine health information systems, crosslinking these data with civil 
registration and vital statistics and population-based surveys. Real measurement change requires 
intentional transfer of leadership to countries with the greatest disease burden and will be achieved 
by working with centres of excellence and existing networks. 
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3.3 Background in the paper 
The close of the Millennium Development Goals (MDGs), with a halving of maternal mortality and 
under five child deaths, demonstrates that global targets are linked to national and global 
accountability and can drive change. Under-five deaths due to HIV/AIDS, malaria and measles (among 
others), have seen the greatest proportional declines (107). Where indicators for high impact, 
evidence-based interventions are carefully tracked, previous analysis has demonstrated that coverage 
tends to improve, largely due to focused policy attention, investment and informed planning, leading 
to better population health outcomes (25). Interventions for child health and causes of child death 
have had more programmatic data (coverage and process), collected more frequently, at a more 
granular level (e.g. district level, by various equity analyses groups), than for newborn health, where 
the data is of poorer quantity and quality, and has been collected with less frequency (21).  
 
As the MDGs transition to the Sustainable Development Goals (SDGs), there remains an unfinished 
agenda for 2.7 million neonatal deaths, for whom progress has been much slower than progress 
towards reducing the overall under 5 mortality rate. An estimated 2.6 million stillbirths were not 
counted at all in the MDGs (108). Well-functioning civil registration and vital statistics (CRVS) systems 
generate policy, ensure access to services and are associated with better health outcomes worldwide 
(109); counting births and deaths, especially the deaths around the time of birth, lies at the heart of 
post-2015 health monitoring, accountability and action (21). Tracking vital events and measuring 
coverage is also central to developing national health management information systems (HMIS), such 
as in the Measurement and Accountability for Results in Health (MA4Health) Roadmap (110), which 
aims to increase investment in national data systems and data use.  
 
The Every Newborn Action Plan (ENAP) (6) is a global multi-partner movement to end preventable 
maternal and newborn deaths and stillbirths. Through a series of consultations, multiple stakeholders 
(governments, United Nations (UN) agencies, donors, business communities, professional 
associations, academic and research institutions, global initiatives and civil society members) 
developed an impact framework and an action and measurement agenda for integration within 
national newborn health plans (21, 23). 
 
To reach 2030 national targets for neonatal mortality and stillbirth rates of ≤12 per 1000 births, high 
and equitable coverage of the evidence-based interventions identified by ENAP is needed (4). ENAP 
prioritises achieving universal coverage of these interventions particularly during childbirth and the 
first week of life. Yet many of these interventions are not systematically measured. One of the five 
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ENAP strategic objectives – to count every newborn (and birth) – underlines the need for improved 
data and accountability. The ENAP milestones, linked to a World Health Assembly resolution [7], have 
a particular focus on inputs required prior to 2020 and more than half refer to improving metrics for 
targeting and driving change (Figure 3.1). One such milestone is to develop a monitoring framework 
building on the Commission on Information and Accountability (COIA) for Women’s and Children’s 
Health (111) to track global progress post 2015 and align with country priorities and objectives.  
 





In support of Health Measurement and Accountability post-2015: A Common Roadmap WHO (2015) (110).  
ENAP: Every Newborn Action Plan; WHO: World Health Organization. 
 
The principal focus of this paper is based on the ENAP milestone to define and improve priority 
coverage indicators, as this was where the largest measurement gaps were identified. Many newborn 
care interventions lack standard indicator definitions and are not routinely monitored at national or 
global level, especially in low and middle-income countries (LMIC). We define a coverage indicator as 




service (numerator) out of a total population that should receive the intervention or service (the 
denominator). For the numerator, indicators rely on clear technical definitions of the service or 
intervention. Where there is difficulty capturing the population in need (the denominator) particularly 
for specific treatment interventions, some indicators (such as the caesarean-section rate) use total 
live births as the denominator to give a proxy. In such cases, where the aim is not for 100% coverage, 
the rate is then benchmarked against a target threshold.  
 
The coverage indicators prioritised by the Commission for Information and Accountability (COIA) 
mainly reflect contact points along the continuum of care, notably antenatal care, skilled birth 
attendance and postnatal care. Such coverage indicators capture contact with the health system or 
delivery of a specific intervention, but not always detailed, accurate information on the content or 
quality of the care delivered (112), although antenatal care now has a detailed content module within 
the Demographic and Health Survey (DHS) (113). In high-burden countries the main current data 
source is through household surveys. The most commonly employed household surveys are the 
United States Agency for International Development (USAID)-supported DHS (114) and the United 
Nations International Children’s Fund (UNICEF)-supported Multiple Indicator Cluster Survey (MICS) 
(115). However, coverage of many maternal and newborn interventions cannot feasibly and/or 
accurately be collected through household surveys. 
 
For health information collected through household surveys, the data quality usually depends on the 
validity of the mother’s report, often up to two to five years after the intervention occurred. There is 
evidence suggesting that maternal recall of events that occurred during labour is poor (113), especially 
if there were complications. In addition, how the question is asked can affect the accuracy of the 
response. For surveys, large sample sizes are needed to generate sufficient statistical power to assess 
social and demographic factors. Bryce et al (116) described some of the limitations of household 
surveys for measuring coverage of interventions, including the time, cost and limited validity 
(sensitivity and specificity) of many of the indicators.  
 
Health facility assessments (HFAs) are frequently used to complement HMIS, facility-based logistics 
and service delivery information systems. These provide information on staffing, equipment 
availability, spatial organisation, data collection capacity, and service readiness. A number of 
standardised HFA tools exist, the most commonly employed being the Service Availability and 
Readiness Assessment (SARA) (101), Service Provision Assessments (SPA) (117) and the Emergency 
Obstetric Care (EmOC) needs assessments (118). These allow health systems to report on a sample of 
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facilities that provide a certain service or have health workers trained in specific skills but are not 
routine reporting mechanisms. In addition, the WHO Health Access/Action International database has 
data on medication availability. Service availability and quality indicators provide complementary 
metrics to population coverage which can be used to ensure that services achieve adequate coverage 
and give due attention to the availability of care, and the readiness of facilities to deliver the safe and 
quality care that is fundamental to the Every Newborn movement.  
 
Since coverage of evidence-based care for mothers and newborns is often unknown, or data may be 
old or not locally available, this is a major “bottleneck”, impeding scale up of high-impact, evidence-
based interventions for newborns. Such data have been critical in accelerating progress in the 
implementation and scale-up of immunisation and HIV programmes through increased policy 
attention, focused investment of resources and accountability (116). Such data are crucial for 
informed planning, driving programme improvement and targeting underserved populations to 
reduce inequities.  
3.3.1 Objectives of the paper 
The objectives of this paper are to: 
1. Describe the systematic process used to select Every Newborn action plan indicators and 
present the core and additional indicators.  
2. Assess the status (technical definitions and data availability) of the Every Newborn action plan 
coverage indicators and identify actions needed to improve these for measurement at scale, 
particularly for coverage of the treatment interventions. 
3. Identify priorities for testing validity and feasibility, in order to institutionalise these metrics 




3.4.1 Selecting the core Every Newborn action plan and additional indicators 
A multi-stage process was carried out to identify a list of potential indicators and then prioritise a short 
list. This process involved a working group appointed by the ENAP management team who compiled 
a comprehensive list of indicators, drawing on existing databases such as COIA(111), UNICEF’s State 
of the World’s Children (SoWC) (119), Countdown to 2015 (120) and other World Health Organization 
(WHO) statistics and reports. Standardised, nationally representative survey tools currently in use 
(MICS, DHS, SPA, SARA and EmOC surveys) were considered as sources of data. In addition, possible 
indicators relating to common causes of neonatal death were included. This resulted in a matrix of 
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over 70 relevant indicators measuring impact (mortality and morbidity), outcome (coverage of care 
for all babies and coverage of treatment interventions), outputs (service quality, availability, demand, 
and the enabling environment) and inputs (human resources, essential medicines and supplies) (see 
Appendix B). The current status of definitions, measurability and data availability were reviewed for 
each of the proposed indicators.  
  
A systematic scoring process was applied to prioritise core indicators that could track the main focus 
of the action plan, particularly on quality of care at birth and the five strategic objectives. Each 
indicator was graded by its importance to the ENAP focus (A to C) and by current data availability (1 
to 3). A grade of A was given to indicators of highest relevance and match to the ENAP focus and a 
score of 1 was given to indicators with a common and consistent definition already measured in 
existing data sources. Scoring was completed by an expert working group and decided via group 
consensus with priority given to indicators in terms of their relevance to the ENAP focus, rather than 
data availability.   
 
Given the principle of accelerating impact, a decision was taken to focus on a shorter list of important 
indicators and ensure those would be made measurable, rather than to just select those that were 
already measurable. Hence, indicators were prioritised first based on their importance to the ENAP 
focus (category A) and then on data availability. Indicators in Category A ranged from those with 
definitions and existing data (availability 1) to those without standard definitions and existing data 
(availability 2 or 3). The latter were identified as having priority measurement gaps that needed to be 
addressed with a specific program of work.  
 
3.4.2 Assessing the status of the Every Newborn action plan coverage indicators and identify 
priorities to improve measurement at scale 
For each of five high impact interventions identified with the greatest measurement gap (red box in 
Figure 3.2), a Task Team was established. These included antenatal corticosteroids (ACS), newborn 
resuscitation, Kangaroo Mother Care (KMC), case management of serious neonatal infection and 
chlorhexidine cord cleansing. The Task Teams sought to represent both the maternal and newborn 
health communities and reflect multiple stakeholders, e.g. non-governmental organisations, UN 
organisations, professional associations, and research institutions; ensuring representation from 
LMIC. With the support of the Every Newborn metrics coordination group, Task Teams carried out a 
consultation process to define indicators based on a technical definition, suggest feasible indicators 
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that can be measured now through existing data collection platforms, and outline research priorities 
to test validity and feasibility for these coverage metrics for each area, including data collection tools.  
 
Figure 3.2 Every Newborn core and additional indicators 
Current 
Status 









1. Maternal mortality ratio  
2. Stillbirth rate Intrapartum stillbirth rate 
3. Neonatal mortality rate Low birth weight rate  
 Preterm birth rate 
Small for gestational age  
Neonatal morbidity rates 











Care for All 
Mothers and 
Newborns 
4. Skilled attendant at birth 
5. Early postnatal care for 
mothers and babies 
6. Essential newborn care 
(tracer is early 
breastfeeding) 
Antenatal Care  
 
 




















7. Antenatal corticosteroid 
use 
8. Neonatal resuscitation  
9. Kangaroo mother care 
Caesarean section rate  
 
10.Treatment of severe 
neonatal infections 




Quality of Care 
Emergency Obstetric Care 
Care of Small and Sick Newborns 
Every Mother Every Newborn Quality Initiative with 
measurable norms and standards 
 
Input: Counting 
Birth Registration Death registration, cause of 
death 
 
Shaded= Not currently routinely tracked at global level. 
Bold red= Indicator requiring additional testing to inform consistent measurement. 
Indicators to be disaggregated by equity such as urban/rural, income and education. 
Adapted from WHO and UNICEF, Every Newborn Action Plan. WHO, 2014. www.everynewborn.org and Mason et al. Lancet 
2014(23).  
 
WHO hosted a consultation at a meeting in Geneva, December 2014 to review the work of the Task 
Teams, and also gain inputs on the other core indicators. This meeting developed a draft plan to deliver 
on the ENAP metrics milestones including discussion on the specific actions needed to improve 
coverage indicators. Plans for improving measurement tools and tracking systems were also 
discussed; for example, perinatal audit tools, neonatal care registers and Civil Registration and Vital 
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Statistic (CRVS) improvements. The draft plan was then advanced by those at the meeting and through 
wider consultation.  
 
The priorities for testing validity and feasibility to institutionalise these metrics within large scale data 
collection platforms and the measurement improvement roadmap (Objective 3) are discussed in detail 
in the discussion section of this paper.  
 
3.5 Results 
3.5.1 Grading of Every Newborn action plan core and additional indicators 
Following the process described above, ENAP listed 10 core indicators (Figure 3.2). For the three 
impact indicators that already have agreed definitions (Figure 3.3), the priority is for improved quality 
and quantity of data. There is increasing consensus on the need to invest in CRVS and linked facility-
based tracking to improve reliability of impact indicators (21, 42, 108).  
 
The principal focus of this paper is on the coverage indicators, where the largest metrics gaps were 
identified. The coverage indicators fall into two groups: key contact points for care for all mothers and 
newborns (Figure 3.4), and specific treatment interventions (mainly for care for newborns at risk or 
with complications) (Figure 3.5 and Figure 3.6). For essential newborn care, early initiation of 
breastfeeding was identified as a tracer indicator, with exclusive breastfeeding up to 6 months as an 
additional indicator. Chlorhexidine cord cleansing was also added to the improvement agenda, given 
the gaps in coverage data.  
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Figure 3.3 Every Newborn core indicators regarding impact, with definitions and data sources 










Number of maternal deaths per year during pregnancy 
and childbirth or within 42 days of termination of 
pregnancy, irrespective of the duration and site of the 
pregnancy. Defined as a death from any cause related to 
or aggravated by pregnancy or its management 
(excluding accidental or incidental causes). 
Per 100,000 live 
births  
CRVS and registries 
(when high coverage 
and quality) or surveys 
or facility/HMIS and/or 
estimation modelling 
ICD10.  For more details see 
WHO/UNFPA/UNICEF 
estimates 2014 (121)  
2 Stillbirth rate 
For International Comparison: 
Number of babies per year with no signs of life born 
weighing at least 1000 grams or after 28 weeks gestation  
(ICD10 also recommends the inclusion of fetal deaths ≥22 
weeks or ≥500g).   
Per 1,000 total (live 
and stillborn) births  
ICD10**. See Lancet Stillbirth 
series 2011 Lawn et al for 




Number of live born infants per year dying before 28 
completed days of age. 
Per 1,000 live births  
ICD10. See Lancet Every 
newborn for discussion of 
reporting of definitions (21) 
 
Shaded= Not currently routinely tracked at global level. 
Bold= indicator requiring additional evaluation for consistent measurement.  
*The time period will normally be calculated per year. 





Figure 3.4. Every Newborn core indicators regarding coverage of care for all mothers and newborns, with definitions and data sources 
 






























Intrapartum care tracked 
by the contact point of 
skilled attendant at birth 
 
Number of women aged 15-49 years who were attended by skilled health 
personnel during their most recent live birth [MICS - 2 years preceding the 
survey] 
Number of live births assisted by a skilled provider (doctor, nurse midwife, and 
auxiliary nurse/midwife) [DHS - 5 years preceding the survey]  
Total number of women aged 
15-49 years with a live birth in 
the two years prior to the 
survey [MICS] or all live births 
within the last 5 years [DHS]  
Household surveys (e.g. 
DHS, MICS) or National 
facility data/Health 
management information 
system or district health 
information software 
5 
Early postnatal care 




Number of women aged 15-49 years who received a health check within 2 
days after delivery for the most recent live birth  [DHS & MICS - 2 years 
preceding the survey]  
Woman: 
Total number of women 15-49 
years with a live birth in the 
last 2 years [DHS & MICS] 
 
Newborn:  
Number of last live birth with a postnatal health check in the first 2 days after 
birth [DHS & MICS- 2 years preceding the survey]  
Newborn:                                                                    
Total number of last live births 
in the last 2 years [DHS & 
MICS] 
6 
Essential Newborn Care 
with Early Initiation of 
breastfeeding as Tracer 
indicator  
 
Number of live born infants (born in the 2 years preceding the survey) who are 
breastfed within first hour after birth [DHS, MICS]  
                                                                   
Total number of last live born 
infants [DHS & MICS] 
Exclusive breastfeeding 
to 6 months 
      
Number of living children (born in the 2 years preceding the survey) under 6 
months of age who are exclusively breastfed [MICS]  (MICS allows oral 
rehydration solution, vitamins, mineral supplements and medicines) 
 
Number of babies 0-5 months who are exclusively breastfed [DHS] 
(Both MICS and DHS questions focus on feeding behaviours within the last 24 
hours from the time of survey)  
Total number of living infants 








Figure 3.5. Every Newborn core indicators regarding coverage of care for newborns at risk or with complications, with definitions and data sources 
Core Numerator 
Denominator (options to be tested and compared especially when target 












































Process Indicator:  
The number countries with ACS on the 
essential drug list for the purpose of fetal 
lung maturation [As collected in the United 
Nations commodities commission data 
system & reported in Countdown] 
Number of countries with Essential Medicine List policy data 
 
Facility based: National 
facility-based data or 
facility survey (SARA, SPA 
etc.), potential in HMIS 
(initial focus of data 
collection in facilities 
WHO guidelines for these 
are mainly for facility 
treatment but for 
countries with major 
national scale up of 
community provision e.g. 
of severe neonatal 
infection case 
management, additional 
community tracking will 
be required. 
 
Household surveys: These 
treatment interventions 
are unlikely to be 
measurable in Household 
surveys based on sample 
size, and challenges with 
defining denominators 
especially for parental 
recognition and also in 
knowing or recalling 
details of numerator (e.g. 
Coverage indicator (needs validation):  
All women giving birth in facility who are  
<34 completed weeks and received one 
dose of ACS for being at risk of preterm 
birth (later testing focus on splitting by 
gestational age) 
a) Live births in the facility  
b) Total births in the facility (including stillbirths) 
c) Estimated births (live or total)  
d) Target population for coverage:  
i.e. live births in facility by gestational age in weeks, notably GA <34 




Process indicator:  
Number of facilities with a functional 
neonatal bag and two masks (size 0 and size 
1) in the labour and delivery service area  
[as defined in WHO QoC report and 
collected in SPA & SARA facility assessment 
tools] 
Total number of facilities with inpatient maternity services that are 
assessed  
Coverage indicator (needs validation):  
Number of newborns who were not 
breathing spontaneously/crying at birth for 
whom resuscitation actions (stimulation 
and/or bag and mask) were initiated  
a) Live births in the facility  
b) Total births in the facility (including stillbirths) 
c) Estimated births (live or total) 
d) Target population for coverage:  
i.e. total births in the facility not breathing spontaneously/crying but 
excluding macerated stillbirths (i.e. including fresh stillbirths as a 





Process indicator:  
Number of facilities in which a space is 
identified for KMC & where staff have 
received KMC training (< 2 years)  




Coverage indicator (needs validation work):  
Number of newborns initiated on facility 
based KMC  
a) Live births in the facility  
b) Total births in the facility (including stillbirths) 
c) Estimated births (live or total) 
d) Target population for coverage:  
i.e. total number of newborns with birthweight <2000g as target 
population for coverage or <2500g  
ACS injection vs. Oxytocin 
injection). 
KMC and treatment of 
neonatal infections may 
be feasible with further 








Number of facilities in which gentamicin is 
available at suitable peripheral level for 
treatment of severe neonatal infection  
[WHO QOC, collected by SPA and SARA] 
Number of facilities assessed 
Coverage indicator (needs validation work):  
Number of newborns that received at least 
one dose of antibiotic injection for PSBI in 
the facility 
a) Live births in the facility  
b) Total births in the facility (including stillbirths) 
c) Estimated births (live or total) 
d)  Target population for coverage:  
-newborns diagnosed with Possible Serious Bacterial        Infection 
(PSBI) as target population for coverage 
 
Blue coloured cells= not currently tracked and collated by United Nations. 
Bold italics= indicator needing further work to ensure availability of consistent data in routine information systems.  





Figure 3.6 Every Newborn core indicators regarding coverage of complications and extra care (specific treatment indicators), with definitions and data sources 
Core Numerator 
Denominator (Options to be tested and compared 
especially when target population for coverage is 





























































Chlorhexidine (CHX) cord 
cleansing 
Process Indicator: 
The number countries with CHX on the essential 
drug list for the purpose of cord cleansing  
[As collected in the United Nations (UN) 
commodities commission data system & 
reported in Countdown]  
 Countries with Essential Medicine List policy data 
As collected in the UN 
Commodities Commission & 
reported in Countdown to 
2015  
Coverage indicator (needs validation work): 
Number of newborns that received at least one 
dose of CHX (7.1%) to the cord on the first day 
after birth (within 24 hours of birth)  
Live births in surveyed population 
(or live births at home depending on national policy/data 
available) 
Potential to collect in 
household surveys (e.g. DHS, 
MICS) 
Caesarean Section Rate 
Number of women ages 15-49 with a live birth 
in the X years preceding survey delivered by 
caesarean section [Countdown, 2015] 
Women ages 15-49 with a live birth  
(also to evaluate option of per total births in facility per 
year (i.e. including stillbirths, macerated and fresh) given 
high rate of C-section amongst women with a stillbirth) 
National facility-based data, 






























 Emergency Obstetric care 
(EmOC) 
Number of facilities in area providing basic or 
comprehensive EmOC [Monitoring EmOC 
handbook, 2009] 
Population of area by 500000 [Monitoring EmOC 
handbook, 2009] 
(note recent recommendation to shift to denominator 
based on births not population)   
Facility based survey, or 
potentially from national 
facility-based data / HMIS 
Care of small and sick 
newborns 
Definitions and measurement approach to be 
determined 
(Similar approach to EmOC) 
Population to be defined  
(according to births) 
Facility based survey, or 
potentially from national 
facility-based data / HMIS 
Every Mother Every 
Newborn 
Other norms and standards to be defined 
(e.g. criteria related to structure, such as Water and Sanitation) 
 
Blue coloured cells= not currently tracked and collated by United Nations. 
Bold italics= indicator needing further work to ensure availability of consistent data in routine information systems.  
Red= service delivery package for which norms and standards will be defined and tracked.  




3.5.2 Status of Every Newborn action plan coverage indicators, and priorities to improve 
measurement at scale 
For each coverage indicator, we describe technical definitions, current data availability, improvements 
needed and steps to be taken. 
 
3.5.3 Coverage measurement of care of all mothers and newborns 
3.5.3.1 Intrapartum care 
Technical definition of package  
A package of support and healthcare around the time of birth integral to maintaining perinatal and 
maternal safety along the continuum of care (123) (124). Skilled birth attendance (SBA) is used as the 
contact point indicator to monitor coverage of this care. 
 
Indicator to track contact point 
A skilled birth attendant is described by the WHO as an accredited health professional (such as a 
midwife, doctor or nurse) educated and trained to proficiency in the skills needed to manage normal 
(uncomplicated) pregnancies, childbirth and the immediate postnatal period and in the identification, 
management and referral of complications in women and newborns (125). 
 
Current data availability 
SBA data are available mostly from DHS, MICS, and are reported in many UN documents and by the 
Countdown to 2015/2030 report (http://countdown2030.org/), which charts country progress 
towards meeting MDG goals and targets. However, no robust time series has been published for all 
countries for the MDG era to date, although SBA was the main indicator under MDG5 for maternal 
health. Of 75 countries participating in Countdown, all but 15 provide equity analysis in relation to the 
coverage of SBA (120) (countries who do not report equity compared with SBA coverage are: Angola, 
Botswana, Brazil, China, Djibouti, Equatorial Guinea, Eritrea, Korea, Mexico, Myanmar, Papua New 
Guinea, Solomon Islands, South Sudan, Sudan and Turkmenistan). These suggest SBA coverage has the 
widest equity gap for any contact point along the COIA continuum of care indicators (120). SPA also 
has a new optional observational module for labour and delivery care that has been applied in Kenya, 
Malawi and Bangladesh developed by the Maternal and Child Health Integrated Program (MCHIP) that 





What can we do to improve the data? 
While WHO’s definition of a SBA has a defined list of core midwifery skills (118), measurement of SBA 
is challenged by the variety of cadres included in the definition and the lack of consistency in training, 
skills and core functions across countries (126). Besides doctors, nurses and midwifes, there are 
several other country specific cadres of auxiliary midwifes, medical assistants and other health 
professionals that are included in the SBA category in many countries; these may also be subject to 
change over time, or across survey programmes. Current work towards standardising the professional 
remit of SBAs and foster more universal accountability mechanisms are being carried out by WHO, 
UNICEF and UNFPA and expert consultations will be held in late 2015 to discuss operational definitions 
and develop measurement guidance for survey programmes.  
 
In addition, SBA is an indicator of contact with the health system and does not provide information on 
the content or quality of care making it an incomplete and misleading proxy for quality of care at birth 
(113); additional information about equipment, provider skills, referral availability, content of care 
and other measures of quality are also required. Process indicators on facility readiness are collected 
by SPA, SARA and EmOC needs assessments (Figure 4) though the range of data collected varies 
between surveys and there is limited focus on newborn care. Current DHS and MICS survey tools do 
not collect extensive data on the content of care at time of birth (113); therefore, increasing the 
capacity and availability of routine facility level data is a priority for improvement.  
 
3.5.3.2. Early postnatal care 
Technical definition of package 
A package of healthcare provided to women and their newborn either at the facility or during 
consultation at home. For women who deliver at a health facility, WHO recommendations support 
inpatient care for at least 24 hours, and/or provision of care as early as possible and at least within 24 
hours for women and newborns who are born at home (127).  
 
Indicator to track contact point 
Early postnatal care is defined as a contact provided to a woman and her newborn during the 2 days 
(48 hours) following birth (whether in a facility or at home) (see Figure 4) and excludes immediate 
postpartum care (114).  
 
Current data availability  
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The early postnatal care contact point is measured in household surveys as two separate indicators (a 
postnatal health check for the newborn and a postnatal health check for the mother) tracking 
coverage of a first postnatal contact within 2 days of delivery. The questions used to derive this 
indicator have changed significantly over time and have been different between the DHS and MICS 
(115), however Phase 7 of DHS (114) now includes questions allowing computation of a comparable 
postnatal care indicator. 
 
What can we do to improve the data? 
Postnatal care is a package of services for women and babies, therefore, data on content and quality 
are required in addition to tracking the contact point. One critical question is to ensure the data can 
distinguish between intrapartum and postnatal care (128). In both DHS and MICS, this is being 
attempted through the use of question prompts to better describe the content of the postnatal check 
and recent revision of the DHS core questionnaire includes a question on the content of PNC checks. 
Supplementary data pertaining to the content of care, provider skill and other quality control 
measures is urgently required; a move away from intermittent survey-based data collection towards 
sustainable HMIS is essential in ensuring that effective management mechanisms can be facilitated 
and can support routine quality of care tracking.    
 
3.5.3.3 Essential newborn care 
Technical definition of package 
Preventive and supportive care required for all newborns including: warmth, cleanliness, 
breastfeeding, cord and eye-care, Vitamin K and immunisations (129-131). 
 
Indicator to track care  
Due to the strong evidence of a reduction in newborn mortality and morbidity with early initiation of 
breastfeeding, especially through decreased rates of infection (132-134), early initiation of 
breastfeeding was prioritised as a tracer indicator for essential newborn care, with exclusive 
breastfeeding at 6 months as a further marker (Figure 4). Indicators of other components such as skin-
to-skin care, may also be possible, and are recalled accurately by mothers (113). However, these data 
are not currently widely available, and further testing is required to ensure that routine skin-to-skin 
can be accurately distinguished from KMC by survey respondents.  
 
The WHO recommends the early initiation of breastfeeding within one hour of birth (135) and then 
exclusive breastfeeding for the first 6 months of life (136). To support this, babies should be placed 
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skin to skin with their mothers immediately following birth and offered help to breastfeed when 
needed (137). 
 
Current data availability  
MICS, DHS and other national household surveys collect data measuring coverage of the early 
initiation of breastfeeding (107, 138) and it is reported in Countdown and State of World’s Children 
(SoWC) (120). Both MICS and DHS contain measurement questions focusing on feeding behaviours 
within the last 24 hours from the time of survey. This approach allows for more accurate recall of the 
behaviour, however, does not capture breastfeeding practises across the infant time period and, 
therefore, the results may not reflect breastfeeding practises over time. 
 
What can we do to improve the data? 
A recent validation study reported that the early initiation of breastfeeding indicator had high 
sensitivity (0.82) but poor specificity (0.25), using a household survey instrument (113). Although the 
instrument used in the study posed a slightly different question than what is in DHS, this suggests a 
need for further testing and validation. Additional research to determine the impact of other essential 
newborn care practices would enable more informed and targeted behaviour change and associated 
measurement approaches.   
 
3.5.3.4 Antenatal corticosteroids 
Technical definition of intervention  
Currently, antenatal corticosteroid therapy (ACS) (24mg of intramuscular dexamethasone or 
betamethasone in divided doses over 24 hours) is recommended by WHO for all mothers at risk of 
imminent preterm birth (delivery before 34 completed weeks of gestation) when the mother is in a 
facility where accurate gestational age can be obtained, where there is no clinical evidence of maternal 
infection, and there are adequate levels of maternity care and special newborn care available (139) 
(WHO guidelines are currently being revised). These guidelines reflect changes after the Antenatal 
Corticosteroids Trial (ACT) which evaluated prescription of ACS at lower levels of the health system, 
with approximately half of births being a home, and found a risk of adverse outcomes especially 
amongst births after 34 completed weeks of gestation (140). This trial underlines the importance of 






Current coverage data availability  
Coverage data on provision of ACS for neonatal admissions are routinely collected within most high-
income countries (HIC), but are not consistently part of HMIS or standardised facility surveys. Since 
the intervention is used in health facilities (140), improved facility level data are a priority for capturing 
ACS coverage. Household surveys are unlikely to be a useful source for this information, as mothers 
may not accurately report ACS (with difficulties to differentiate between ACS and other drugs given at 
the time of labour). In addition, data may have low statistical power given the relatively small numbers 
in the population who receive ACS for fetal lung maturation (113).  
 
Process indicator to track now 
In many LMICs, where HMIS does not capture ACS coverage, a commodities-based process indicator 
can be measured for tracking in the short term; SARA and SPA includes the availability of 
dexamethasone within their facility checklist. WHO Health Access/Action International database also 
collect data on availability of dexamethasone and betamethasone in their existing pharmacy and 
facility audits (141). However, a denominator of all health facilities may not be fully accurate as not all 
facilities would meet WHO criteria for safe provision of ACS (see definition above), including provision 
of appropriate maternal and newborn care (107) (142). Countdown reports the number of countries 
whose national policy recommends antenatal corticosteroids for preterm labour (107). While this 
indicator is distal to coverage, it is available and helpful in tracking changes in policy context (Figure 
5).  
What can we do to improve the data? 
It is challenging to define a precise indicator that can capture both eligible women who should receive 
ACS and measure ACS provision. Recent evidence suggests use of ACS may be associated with a risk of 
adverse outcomes for babies whose gestational age is ≥34 completed weeks (140). A major challenge 
is defining the denominator of eligible mothers presenting in labour <34 weeks. In LMICs, the recall of 
LMP is often poor or inaccurate in settings with low rates of literacy and antenatal care. Access to 
ultrasonography is low and mothers frequently present for ANC late in pregnancy, when ultrasound 
dating is inaccurate. Thus, improved assessment of gestational age before and/or after birth, and 
documentation of gestational age in medical records, is an urgent priority in all settings irrespective 
of resource availability, along with improved tracking of safety and non-fatal outcomes. Studies are 
needed to validate different and feasible methods of ascertaining gestational age compared to 
accurate gestational age dating (early ultrasonography) in LMIC. Furthermore, methods require 




Thus, present capacity within most LMIC may only extend to crude coverage of ACS (e.g. all mothers 
who received 1 dose) and will not differentiate between those who received ACS before (true 
positives), or after (false positives) 34 weeks completed gestation. To capture such information, 
existing datasets from high- or middle-income countries may be analysed to facilitate the 
development and testing of a more refined indicator. Improved gestational age assessment and 
documentation is needed in all settings irrespective of resource availability, along with improved 
tracking of safety and non-fatal outcomes. 
 
Observation of facility births in a number of countries would allow for testing and validation of a 
number of options for the denominator (Figure 5). The measurement improvement roadmap aims to 
assess whether using these denominators is feasible in routine HMIS, and the extent to which 
proposed options for testing yield useful programmatic tracking information.  
 
As with many of the treatment intervention coverage indicators, the option of using all live births as a 
denominator will not give accurate population-representative treatment coverage in settings where 
reporting in HMIS is poor, such as settings with low facility births or a large private sector. In such 
contexts it may be worth considering estimated births within a facility catchment area as 
denominator, which is more challenging where populations are not well-defined or birth cohorts are 
uncertain. A denominator that is not restricted to the population in need, will require definition of 
target coverage levels. For ACS this target benchmark could potentially be defined by the recent 
estimates of national preterm birth rate (<34 weeks), which was shown to vary from around 4% to 
18% globally (9).  
 
3.5.3.5 Neonatal resuscitation 
Technical definition of intervention 
Basic neonatal resuscitation describes assessment and actions for every newborn at the time of birth, 
to assist in establishing breathing and circulation (143); it should be practised on all non-macerated 
newborns not breathing spontaneously following immediate drying in accordance with current WHO 
guidelines (144). Effective and safe resuscitation of these babies is highly time-sensitive and should be 
initiated within the first minute after birth. The actions include additional stimulation and positive 
pressure ventilation with bag and mask if clinically indicated following stimulation (145). The 





Current coverage data availability  
National coverage data are not currently available on neonatal resuscitation and the intervention lacks 
a standard measurable indicator. As with ACS, there are several known and suspected limitations of 
using household surveys to measure neonatal resuscitation coverage, including the likely inability of 
mothers to report accurately as they may not understand or know if their newborn was resuscitated 
at birth, and small numbers resulting in low statistical power (113, 146).  
 
Process indicator to measure now  
Data on the availability of a functional newborn size bag and mask in the delivery area of a health 
facility offering maternity services may be utilised as a service readiness indicator for neonatal 
resuscitation, as these data are easy to document and already available now for many countries (see 
Figure 5) (101, 117, 118). SPA and SARA capture the availability of at least one neonatal size bag and 
mask in the labour and delivery ward (SARA captures two sizes of masks) and neonatal resuscitation 
was added to the UN EmOC signal functions in 2009 with data collected as part of standard EmOC 
needs assessments supported by UNICEF. Since a neonatal-size bag and mask is on the UN essential 
commodities list, this equipment is also increasingly tracked in logistics management information 
systems (LMIS). This indicator has strong negative predictive value (a labour ward with no bag and 
mask cannot ensure adequate resuscitation when needed) and was recommended by the WHO 
consultation on quality of care (147). However, the presence of resuscitation equipment does not 
equate to appropriate and timely use of the neonatal bag and mask, and not all newborns who do not 
breathe at birth require positive pressure ventilation. Many newborns may respond to stimulation 
alone, and there is evidence demonstrating that the provision of resuscitation training is associated 
with a reduction in bag and mask use (148). Supplementary information regarding the presence of 
staff who have received newborn resuscitation training in the last two years is collected as part of the 
SARA and SPA surveys; however, these data may be difficult to compare depending on question 
framing (101, 117). 
 
What can we do to improve the data? 
One of the major challenges in capturing precise neonatal resuscitation coverage is the identification 
and accurate measurement of a denominator that reliably captures babies requiring resuscitation to 
establish breathing after birth. As with other treatment indicators, accurate identification of the target 
population depends on correct diagnosis and classification of the individuals in need by health care 
providers. Accurate classification of babies needing resuscitation is challenging in all settings due to 
variable diagnostic skills and experience of individual providers (7, 146). Independent of provider 
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competence, this would likely be difficult data to collect in routine systems; we can speculate that it 
is unlikely that any healthcare worker would record a case where a baby required resuscitation but 
did not receive it. As with ACS, the measurement improvement roadmap outlines the priority 
denominators for testing and the validation of observed compared with reported resuscitation 
practises. Appearance, Pulse, Grimace, Activity, Respiration (APGAR) scores were intended to assess 
the condition of the newborn after birth but are not useful for measuring of resuscitation for 
monitoring purposes as they are not reported until 1 minute of life, after the time within which 
resuscitation should be initiated. In addition, APGAR scores may not be predictive of outcome unless 
the score is very low at 5 minutes, and in busy labour wards the scores are often recorded after the 
event, if at all.  
 
There are further challenges associated with defining a numerator to track neonatal resuscitation 
coverage accurately and feasibly. An important principle in effective and safe neonatal resuscitation 
is careful assessment and stimulation of the newborn who does not start breathing spontaneously 
after routine drying, and only using bag and mask if needed in order to reduce inappropriate use of 
positive pressure ventilation (145, 149, 150). However, bag and mask use may be easier to recall and 
validate than distinguishing stimulation actions, such as back rubbing, from routine drying and 
wrapping. A study in Sweden found that neonatal resuscitation documentation was inadequate for 
reliable evaluation (151); documentation of resuscitation is unlikely to be more adequate in LMICs. 
Several countries such as Bangladesh, Nepal, and Tanzania, propose testing collection of routine 
information on newborn resuscitation by action step. Further analysis of such efforts is likely to be 
useful.     
 
Proposed testing includes comparison of health worker documentation of newborn resuscitation 
actions in facility records with observed or video recorded resuscitation care; some of this may be 
possible using existing videos from Nepal or birth records from Bangladesh. New work to observe 
births in health facilities across a number of countries would allow testing of the resuscitation 
denominator options (Figure 3.4) in line with the other treatment indicators, including various case 
definitions of babies who do not breathe at birth, or do not breathe after stimulation. A simpler 
denominator for resuscitation based on live births would require defined target levels. According to 
estimates (based on limited observational data) approximately 6-10% of newborns may require some 




3.6.3.6 Kangaroo mother care 
Technical definition of intervention 
A method of caring for LBW newborns (mostly preterm) is direct and continuous skin-to-skin contact, 
in the kangaroo position, with their mother (or guardian), with support for early and exclusive 
breastmilk feeding. The current evidence to achieve mortality reductions is KMC for clinically-stable 
newborns, weighing less than 2000g, initiated in a facility (153). WHO guidelines support that the 
infant is cared for in the kangaroo position for the equivalent number weeks it would have taken for 
the infant to reach full term (or as long as the baby will tolerate the position) accompanied with 
appropriate follow up after discharge (154).  
 
Current coverage data availability  
Limited data on KMC are available from facility-based surveys and HMIS for several countries, 
including Malawi, Dominican Republic, and El Salvador. Some middle-income countries, especially in 
Latin America, have detailed program data on KMC received, but there is no existing standardised 
coverage indicator definition. There may be differences between the level of facility in which KMC can 
be safely provided or initiated and the eligibility criteria for KMC, which creates difficulties in 
comparing data between settings. Measurement of KMC is not currently carried out by routine 
household survey platforms.   
 
Process indicator to measure now  
Given the immediate challenges for capturing coverage, a service-readiness indicator is proposed: the 
number of facilities in which a space is identified for KMC and where at least one staff member has 
received KMC training (SPA measures within the last 2 years) (see Figure 3.5). This measure is similar 
to that defined in a recent consultation by WHO on improving measurement on the quality of 
maternal, newborn and child health care in facilities (147) and is consistent with current SARA and SPA 
facility assessment tools (101, 117). 
 
What can we do to improve the data? 
It is possible to measure the number of newborns initiated on facility based KMC in a number of 
settings through HMIS or hospital admission records (e.g. El Salvador, Dominican Republic, Malawi, 
Tanzania). However, measuring a denominator of <2000g is challenging given that nearly half of all 
newborns globally are not weighed at birth. Where birthweight is recorded, there is a known tendency 
for digit preference and heaping, especially at 2500g and 2000g (155). The denominator could be 
measured as a rate per 100 or per 1000 live births, avoiding the difficulties of including weight in the 
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numerator and identifying babies in need for the denominator. However, this doesn’t measure 
whether babies were truly eligible or benefitted from KMC. Since KMC is an intervention that benefits 
predominantly preterm infants, the proportion of live births that could benefit from KMC will vary 
between settings (4 to 18%); identical rates may correspond to a different unmet need for KMC (9).  
 
Efforts to improve birthweight recording and gestational age assessment are integral to the scale-up 
and measurement of more precise indicators for KMC. Existing datasets from countries with 
established KMC programmes and accurate assessment of gestational age and birthweight should be 
used for testing the denominators and proposed numerator (Figure 3.5). Linked to the measurement 
improvement roadmap, developing and validating questions for household surveys is also important 
if the practice is widespread enough to ensure a sufficient sample size. Recent work in Colombia has 
shown that women can accurately and reliably recall KMC, even decades later (156).  
 
To develop the service readiness indicator, both the WHO quality of care report and the KMC 
Acceleration Group propose a measure of “operational” KMC (147), although this would need further 
work to identify and test its specific components. The operational indicator could be based on 
available “tracers”; for example, SPA currently collects data on allocated KMC space, infant weighing 
scales, thermometer, and whether staff has received training. Other items (feeding cups, NG tubes, 
job aids) or improvements to the questions on training and space could be added where more detailed 
assessments are being carried out. In Colombia, a manual of minimum, desirable and optimal 
standards for KMC has been developed (157), which could be adapted for different settings. 
 
3.5.3.7 Treatment of neonatal infection 
Technical definition of intervention  
The provision of antibiotics to newborns admitted for inpatient care with PSBI, in accordance with 
current WHO treatment guidelines (158, 159) and diagnostic algorithms (160). Case management can 
also be considered by levels of care: administration of oral antibiotics only, injectable antibiotics only, 
or full case management of neonatal infection (potentially second line antibiotic therapy, IV fluids, 
oxygen therapy, other supportive measures) (161). Recent trials of Simplified Antibiotic Therapy show 
that, where referral is not possible, treatment with the simpler regimes by lower level workers is 






Current coverage data availability  
Most LMICs do not collect or aggregate the number of newborns treated for PSBI in HMIS. Household 
surveys, including DHS and MICS, do not collect data on newborns treated for PSBI because these 
would likely be unreliable (given recall issues measuring incidence of pneumonia in children under five 
years) (163). This contrasts with HIC settings where HMIS data is routinely maintained with additional 
data points specific to monitoring antibiotic resistance.   
 
Process indicator to measure now  
Given challenges in measuring coverage of serious neonatal infection, a process indicator is proposed: 
the proportion of facilities in which gentamicin is available (at a suitable peripheral level) for treatment 
of serious neonatal infection (147). This is collected by both the SPA, SARA facility assessment tools 
(101, 117) and the WHO health action/access international database (141). However, as with 
resuscitation, the presence of the antibiotic in the facility does not directly measure correct use of 
antibiotics to treat newborns for PSBI or guarantee that the antibiotic is available in paediatric doses 
(164).  
 
What can we do to improve the data? 
The number of newborns treated with at least one dose of injectable antibiotic at a facility is proposed 
for validation and feasibility testing against a number of denominator options, including total live 
births, the number of newborns presenting with illness, or the number of newborns diagnosed with 
pSBI. As treatment regimens may vary between settings, the measurement improvement roadmap 
aims to assess multiple options for a numerator and explore the validity, feasibility and utility of using 
HMIS to collect this data. For measurement of the dose of any antibiotic, more details would be 
required at program and/or facility level (rather than from the coverage indicator); notably, which 
antibiotic(s) were used and whether the course was completed. It will be necessary to determine 
appropriate use of antibiotics, as over treatment may increase anti-microbial drug resistance. Routine, 
national systems are required to track all injectable antibiotic doses given, and those not given, with 
associated clinical outcomes. A recent review found that within facility based audits, the availability 
of data on neonatal specific formulations (lower concentration gentamicin, procaine benzylpenicillin) 
was scarce (164) and therefore, more data is needed regarding the availability of neonatal 
formulations and specific requirements for administration to newborns. At first level facilities, testing 
of the new WHO module on “where referral is not possible” with new simplified antibiotic regimens 
(165) will be possible in five countries (Democratic Republic of Congo, Bangladesh, Pakistan, Ethiopia 
and Nigeria). Process and quality indicators should also be improved at the facility level, for example, 
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gentamicin has a narrow therapeutic index and is associated with toxicity risks (158); therefore, 
monitoring its safe administration at program or facility level is an important marker of quality care. 
Specific data on neonatal administration of medicines (formulations, concentrations) could also help 
monitor safety and quality of care in facilities. In addition, where direct patient observations are 
carried out (as with SPA for the treatment of suspected pneumonia), this could be extended to the 
treatment of serious neonatal infection in facilities to ensure health worker compliance with 
integrated management of childhood illnesses (IMCI) guidelines (159).  
 
3.5.3.8 Chlorhexidine cord cleansing 
Technical definition of intervention 
Chlorhexidine (CHX) cord cleansing is the routine application of topical chlorhexidine digluconate 7.1% 
(solution or gel, delivering 4%) to the cord stump within the first 24 hours of life. The WHO currently 
recommends this intervention in settings with an NMR >30 per 1000 or for homebirths (166) (167).    
 
Current coverage data availability  
The recommended routine administration of CHX cord cleansing is a recent policy development (127). 
Data are not collected by most HMIS or as part of standardised household survey tools. Both SPA and 
SARA track the availability of CHX used for general disinfection in their commodity checklists (101, 
117). Monitoring use of 7.1% CHX for cord cleansing requires documentation of the presence of the 
specific concentration of CHX (7.1% formulation rather than any type of CHX product). Because of 
country-specific variations in policy for routine cord cleansing, documenting availability of 7.1% CHX 
in a health facility will only be of use in settings where programs that use chlorhexidine for umbilical 
cord cleansing exist. 
 
Process indicator to measure now  
Given the current challenges in measuring coverage, the inclusion of CHX 7.1% (solution or gel) within 
national essential drug lists for the purpose of cord cleansing has been identified as an interim process 
indicator (Figure 3.6). These data are collected by the RMNCH Trust (formerly UN Commodities 
Commission) and are reported by Countdown (107). As with ACS, this indicator is distal and is not a 
measure of coverage; however, it is an important enabling condition, data are currently available, and 
it would facilitate tracking of policy changes in the coming years.  
 
What can we do to improve the data? 
Household surveys can be used to measure CHX coverage, as carried out in Nepal (168), The number 
of newborns who had chlorhexidine applied to the cord stump within the first day of birth can be 
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evaluated against a denominator of live births in the survey population. DHS has incorporated an 
optional five question CHX module for countries with a national CHX for umbilical cord cleansing 
programme as part of its newborn module. In countries where CHX has been introduced at scale (e.g. 
Nepal, Bangladesh, and Nigeria), the CHX technical working group is recommending adding a follow-
up probe question specifically asking about CHX use.  
 
Refinement of both the numerator and denominator with rigorous assessment of sensitivity and 
validity will be beneficial. Showing the respondent a picture of the locally marketed CHX during a 
household interview might assist with recall, improve validity and will be tested as part of the 
measurement improvement roadmap. Due to variations in national policy on use of CHX within 
facilities, further testing is required to assess the sensitivity and specificity of household survey 
questions on CHX cord cleansing following birth within a facility, where cord cleansing may have 
occurred away from the mother or performed in her absence. Further validation will be undertaken 
to compare observed CHX use with reported practice. Depending on findings, longer-term efforts 
towards institutionalising CHX coverage questions within routine household survey platforms would 
be essential to achieve consistent coverage data. 
 
3.6 Discussion 
The Every Newborn movement is committed to supporting countries to reach a target of <12 neonatal 
deaths and stillbirths per 1000 births by 2030, also closely linked to ending preventable maternal 
deaths (6). The ENAP metrics process has highlighted major gaps and lack of tracking for newborn 
interventions at all levels of the health management information system. To date, insufficient 
technical work and investment has been dedicated to strengthening national data systems and to 
rigorous testing of coverage data. Both validation and feasibility testing using standard research 
protocols for rigorous testing are needed. The multistage ENAP metrics process identified 10 core 
indicators and a set of 10 additional indicators (Figure 3.2). Of the core ENAP indicators, five newborn-
specific interventions are high impact and central to ENAP, yet coverage information is not collected 
through existing measurement platforms with comparable data. Our findings highlight the priority 
actions required to improve ENAP indicators, especially coverage, and detail the technical and 
research priorities that will enable countries to collect and use the data in health sector review 





3.6.1 Measurement improvement roadmap 
The ENAP measurement improvement roadmap aims to build on existing national and global metrics 
work, particularly linking to maternal health metrics, whilst identifying and addressing key 
measurement gaps for the focus around care at birth and care of small and sick newborns (Figure 3.7). 
Through this process the measurement improvement roadmap aims to intentionally transfer data 
collection, management and analysis skills at a country level (Figure 3.8). 
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Figure 3.7. Measurement improvement roadmap for coverage indicators (including care of small and sick newborns) 
 
 
Refining of existing  contact point coverage indicators, plus more work on content of care, with triangulation of population-based and facility data
Refining of existing  contact point coverage indicators, plus more work on content of care, with triangulation of population-based and facility data
Refining of existing  contact point coverage indicators, plus more work on content of care, with triangulation of population-based and facility data























































































































































































































































Coverage: Test  numerator validity PPV etc and evaluate use of 
various candidate denominators 
Test  process & quality  metrics by WHO standards, 
feasibility testing in HMIS, refine metrics accordingly  
Integrated implementation  in HMIS & 
ongoing feasibility testing for mHealth tools 
Coverage: Test  numerator validity PPV etc. and evaluate use of 
various candidate denominators 
Test  process & quality  metrics by WHO standards, 
feasibility testing in HMIS, refine metrics accordingly  
Integrated implementation  in HMIS & 
ongoing feasibility testing for mHealth tools 
Assess validity of recall of KMC practice Define & test potential survey modules, sample size Pilot testing before inclusion in DHS/MICS
Focus on facility assessments that measure content and quality: 
provider skills, referral capacity, observed care, & community links
Increase quality & quantity of facility level data 
collected internally (eg HMIS) & externally (eg HFA)
Integrated implementation  in HMIS & 
feasibility evaluated, mHealth tools
Focus on facility assessments that measure content and quality: 
equipment, provider training and skills, & observed care
Increase quality & quantity of facility level data 
collected internally (eg HMIS) & externally (eg HFA)
Integrated implementation  in HMIS & 
feasibility evaluated, mHealth tools
Focus on facility assessments that measure content and quality: 
equipment, provider skills, referral capacity & observed care
Increase quality & quantity of facility level data 
collected internally (eg HMIS) & externally (eg HFA)
Integrated implementation  in HMIS & 
feasibility evaluated, mHealth tools
Coverage: Assess validity of cord care question in DHS /MICS, 
consider sample size  feasibility where policy for use is not national
Process & quality: test additional metrics. Test tools 
for feasibility with use at scale
Include in DHS/MICS core module 
dependent on testing
Coverage: Test  numerator validity PPV etc. and evaluate use of 
various candidate denominators 
Test  process & quality  metrics by WHO standards, 
feasibility testing in HMIS, refine metrics accordingly  
Integrated implementation  in HMIS & 
ongoing feasibility testing for mHealth tools 
Coverage: Test  numerator validity PPV etc. and evaluate use of 
various candidate denominators 
Test  process & quality  metrics by WHO standards, 
feasibility testing in HMIS, refine metrics accordingly  
Integrated implementation  in HMIS & 
ongoing feasibility testing for mHealth tools 
Core competencies defined and validated Facility assessment module developed and piloted 
Module linked to EmOC and routine  HMIS 
tracking and piloted in countries 
Not feasible  given survey recall or sample size 
Current WHO policy not for facility use
Not feasible  given survey recall or sample size 
Not feasible  given survey recall or sample size 
Not feasible  given survey recall or sample size 
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Figure 3.8. Every Newborn Measurement Improvement Roadmap 
What is the Every Newborn Action Plan measurement improvement roadmap?  
Given the world’s commitment to end preventable maternal, newborn, child deaths and stillbirths, the Every 
Newborn Action Plan (ENAP) measurement improvement roadmap is a five-year plan to improve, 
institutionalise and use ENAP metrics in programmes by the year 2020, to track and drive reduction of 
neonatal mortality and stillbirths to ≤12 per 1000 by 2030. This Roadmap is in support of the Measurement 
and Accountability for Health (MA4Health) Roadmap (110) to increase investment in national health 
management information systems. Strong national data systems that count births and deaths, and track 
coverage of interventions, are fundamental to influence policy, improve quality and delivery of equitable 
services for a healthy start in life.  
How has it been developed? 
During the development of ENAP, a systematic process listed 10 core indicators. In the implementation phase, 
ENAP metrics work is led by a coordination group with representation from multiple partners co-chaired by 
World Health Organization (WHO), and London School of Hygiene & Tropical Medicine (LSHTM), working with 
task teams linked to existing technical working groups (e.g. Newborn Indicator Technical Working Group, 
United Nations Commission on life saving commodities (UNCoLSC) technical working groups). The work 
involved technical mapping of indicators, and measurement gaps and questions. Following a WHO Technical 
meeting in Geneva, December 2014, the measurement improvement roadmap was refined through a 
consultation process between January and May 2015.  
 
What will this result in? 
The output is a multi-partner, 5-year ambitious plan to validate and institutionalise these metrics in national 
data collection platforms and global metrics architecture including accountability mechanisms. This will result 
in improved measurement of coverage, quality and equity as well as impact through the development, 
refinement and/or the improvement of the following tools, and approaches to cross link data at these three 
levels including use of innovative mHealth platforms:  
 
Civil and vital statistics 
o Birth certificates and increased coverage and quality of data, e.g. for birth weight.  
o Death certificates with improved perinatal data capture and International Classification of Disease 
(ICD) codes. 
 
Facility and HMIS 
o Perinatal mortality audit (linked to maternal audit, and death surveillance and response).  
o Minimum perinatal dataset with health management information systems (HMIS) collation for highly 
prioritised data points, possible in Demographic and Health information systems 2 (DHIS2). 
o Tracking of validated coverage indicators for quality of care at birth and care of small and sick 
newborns, (e.g. antenatal corticosteroids, resuscitation, kangaroo mother care, and treatment of 
neonatal infections). 
o Health facility assessment tools (with standardised process and quality indicators). 
 
Population based surveillance and surveys (Demographic and Health information systems/Multiple Indicator 
Cluster Surveys) 
o Mortality capture including recall, misclassification of stillbirth/neonatal death and pregnancy versus 
live birth 
o Verbal autopsy for stillbirths and neonatal deaths, with optional social autopsy 





To achieve institutionalisation, and intentionally shift technical leadership to high burden settings, the 
measurement improvement roadmap is linked to existing networks and country centres of excellence to 
ensure testing and use in many contexts. The process depends on national governments and multiple 
partners.  
 
NETWORK 1: For mortality data INDEPTH Network with more than 50 sites in Asia and Africa: 
o Population based pregnancy surveillance of birth, stillbirths and neonatal deaths  
o Opportunities to advance validation of pregnancy history modules, improved low birth weight 
assessment and verbal autopsy tools. 
 
NETWORK 2: For “Beyond Newborn Survival” data the All India Institute of Medical Sciences (AIIMS), the WHO 
collaborating centre for training and research in newborn care is well placed to be the institutional focus for:  
o Designing a simplified follow up schedule for at risk newborns, by varying levels of care, to screen for 
disability, retinopathy of prematurity (ROP) and to improve child developments,   
o Validate and test the feasibility of a minimum linked dataset for follow up.   
 
COUNTRY HUBS FOR TESTING: The validation work will start with a few countries with opportunities to then 
expand to other countries 
o Validation and feasibility testing for facility-based coverage data 
o Linked tools such as perinatal audit, minimum perinatal dataset, and simplified gestational age 
assessment. 
 
3.6.1.1 Impact indicators 
Impact indicators are fundamental to tracking progress for Every Newborn. Without impact data we 
cannot accurately measure progress towards goals to end preventable maternal and newborn deaths 
and stillbirths. Child mortality data have seen the most significant improvement progress over the last 
decade (169). For example, the UN Inter-agency Group for Child Mortality Estimation (UN-IGME) 
report more than tripling input data, mostly through surveys.  
 
ENAP milestones by 2020 include a number of tools to link facility-based minimum perinatal datasets 
with CRVS to increase birth/death registration (170) and birthweight capture, and in settings with a 
high proportion of home births, links to intermittent surveys or population surveillance may also be 
possible (Figure 3.1). Some countries are now implementing maternal death surveillance and response 
(171) and have begun to count maternal deaths in real time. A few countries are also incorporating 
perinatal death audits, which represents a key opportunity to expand use and quality of perinatal audit 
data (172). A major focus is needed for inclusion of stillbirth rates in reporting and accountability 
mechanisms, and especially increasing data on intrapartum stillbirths. Further opportunities have 
been identified in increasing the coverage and quality of CRVS and verbal autopsy to improve cause 
of death estimates for maternal, neonatal and stillbirths (173, 174). Substantial work is required on 
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the additional indicators measuring newborn morbidity, disability and child development, which are 
critical to validate and institutionalise particularly as countries scale up neonatal intensive care 
services (Figure 3.7). 
 
Improving measurement of gestational age is essential given that prematurity is the leading cause of 
newborn deaths and deaths in children under five (10). Preterm birth is also a major risk factor for 
deaths from infections and other morbidities (175). Gestational age is an essential part of clinical 
targeting of interventions to reduce morbidity and mortality and can be measured both during 
pregnancy (using methods ranging from the dating of LMP to using more resource intensive 
ultrasound scans) to clinical assessments of the newborn. The skill sets needed for the measurement 
approaches that are currently available are different. Estimating gestational age using first trimester 
ultrasound and the date of LMP is standard in most HIC, but these methods are not available for most 
women in LMIC. LMP recall is often poor or inaccurate in settings with low literacy. Universal access 
to ultrasonography is unlikely to be available to large numbers of women in LMIC in the shorter term, 
and/or mothers who present late in pregnancy, when ultrasound dating is inaccurate (+/- 3 weeks). 
Current work is looking at the potential for simplified tools for more accurate assessment of 
gestational age (176), including simplified clinical tools, and surrogate anthropometric measures that 
could be used by community health workers(177-179). Validation of new methods in cohorts with 
early accurate ultrasonography dating is a critical need. Feasible and innovative approaches need to 
be validated in different regions, populations and settings, across which their performance may vary.  
 
3.6.1.2 Coverage indicators 
The next five years demands an ambitious and systematic process for data improvement (through 
effective partnership) to address the gaps in newborn coverage indicators. Shared goals across the 
maternal and newborn health (MNH) community will facilitate metrics testing and help institutionalise 
capacity for systems to collect and use these data (Figure 1). In the short term, desk-based testing and 
validation of indicator definitions using existing datasets (from LMIC) is required. Additionally, these 
indicators need to be field-tested in a range of settings. The research process for validation of 
indicators involves collecting empirical data through direct observations of care in a facility and 
directly comparing this data with both health worker reports and maternal recall of events. Relatively 
large numbers of direct observations may be needed to ensure sufficient sample power for estimating 
sensitivity and specificity of the indicators using appropriate statistical tests. Initial testing sites have 
been identified as part of the measurement improvement roadmap (Figure 8). Once finalised, testing 
protocols will be made available to facilitate wide-scale testing across many different settings to yield 
comparable results. Where indicator definitions already exist and are being collected at scale, there is 
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potential to increase the quantity, quality and frequency of the data (Figure 4). Crosscutting work on 
increasing the availability, quality, and accuracy of birth weight and gestational age assessment (both 
in pregnancy and the neonatal period) is needed and will support the development of more precise 
indicators. It is anticipated that findings from these studies will inform refinements to the proposed 
indicators before institutionalisation into existing systems (Figure 7).  
 
Household surveys remain the primary data collection method to estimate coverage of contacts with 
the health system. The Population Council is carrying out ongoing work to assess the validity of current 
indicators measuring SBA (180). Such work provides invaluable evidence on the validity of maternal 
recall of interventions at the time of birth, with MICS using two-year recall and DHS now using the last 
birth within two years for some maternal and newborn indicators (although collects data for a five-
year retrospective period). Even where recall achieves higher specificity (such as location of birth or 
Caesarean-section), their infrequent cycles (currently averaging 5 years) and high cost (181) make 
population level surveys less sensitive for annual programme planning and timely decision-making 
(182). Previous efforts to improve measurement of many interventions have focused predominantly 
on household surveys (183) (128) (113), including recent validation studies from the Improving 
Coverage Measurement Group. Many of the challenges of measuring the treatment of pneumonia in 
children through household surveys, especially in identifying the true population of children with 
pneumonia for the denominator (163), are also applicable to measuring coverage of treatment of 
neonatal infections and other specific treatment interventions.  
 
The sample size required to generate point estimates of coverage of newborn interventions with 
sufficient precision through household surveys is often too high; even more so when attempting to 
consider equity and analyse by socioeconomic and demographic factors. For CHX cord cleansing in 
settings where policy is provision for all live births (127), data collection through a household survey 
such as DHS could be feasible. Other treatment indicators address subsets of newborns, and therefore, 
sample sizes and recall issues may make household surveys very challenging for coverage 
measurement. For measurement of treatment indicators, the results of the ENAP metrics process 
suggest a shift away from household surveys towards a focus on facility-based data collection tools 
where these interventions can be more feasibly and accurately measured, and a range of 









 Already collected 
 
* Feasible to collect  
 
X=Not likely to be feasible to collect (due to recall of numerator, denominator identification challenges, sample size issues) 
 
DHS: Demographic and Health Surveys, MICS: Multiple Indicator Cluster Surveys, HMIS: health management information systems, SPA: Service performance assessments, SARA: Service 




(For full indicator definitions, numerators and denominators see 
Table 1-3 and web appendix) 
Household Surveys Routine health 
information 
systems 
Health Facility Assessments  
 
DHS MICS HMIS SPA SARA EmOC 
Care for all mothers and newborn babies 
Skilled birth attendant at birth (SBA)       
Essential Newborn Care (immediate breastfeeding as 
tracer) 
   
  
 
Early postnatal care – for mother and baby    
  
 
Early and Exclusive breastfeeding       
Care for newborns at risk or with complications (specific treatment interventions) 
               Antenatal corticosteroid (ACS) X X *   * 
Newborn resuscitation X X *   * 
Kangaroo Mother Care (KMC) * * * * * * 
Management of severe neonatal infection X X *   * 
Chlorhexidine (where recommended) * *   *  
78 
 
For most of the treatment interventions, KMC, ACS, and currently most neonatal resuscitation and 
serious neonatal infection case management, policy recommendations are focused largely on facility-
based initiation or administration. This has meant that preliminary task team work has focused 
predominately on facility platforms (with the exception of CHX). Combined testing in a number of 
facilities of the range of treatment interventions would enable more efficient testing of a range of 
numerators and denominators for each intervention using the same datasets and help to harmonise 
and align indicators with national and facility-level needs. 
 
Where there is no denominator 
Task teams found denominators the most technically challenging issue for measurement of 
intervention indicators and have identified a list of denominator options for testing wherever possible. 
Where detailed datasets are available with complete and accurate birthweight and gestational age 
data (for example in higher or middle-income settings), these will be analysed to test and compare 
the simplified per 100 or per 1000 live births denominator to a more precise indicator option to 
ascertain correlation between risk and the more precise indicator and sensitivity to change over time.  
 
In view of contextual variation, such as varying preterm birth rates, or PSBI in different countries, there 
may be a need to define thresholds or upper and lower limits for indicator values. The proportion of 
C-section deliveries, for example, has been roughly benchmarked against a threshold of 5-15% in order 
to highlight where there is an unmet need (less than 5%) or to identify an excess number of C-sections 
(more than 15%) within a population (184-186); this threshold is not without controversy. Learning 
from such processes is important to set realistic, useful ranges for countries to monitor whether 
interventions are reaching a sufficient number of newborns within safe limits.  
 
Health management information systems 
Work towards sustainable, real-time, locally owned and used systems underlines the need for 
strengthening national HMIS (182). HMIS refers to health information collected and routinely reported 
from health facilities and districts (often from government or public sector facilities only) and are an 
ideal platform to influence as they are present in most settings, relatively inexpensive (compared with 
large scale representative household surveys) and largely driven by national decision makers. 
Electronic platforms are evolving to support data collection, management, analysis and report 
generation, linking to other systems including logistics management (rather than external agencies). 
The emphasis for strengthening HMIS needs to fall on improving the validity of HMIS indicators and 
increasing the use of this data for improving programme performance at the ground level. Many 
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settings are now using District Health Information Systems 2 (DHIS2) (187). DHIS 2 software has a field-
tested flexible data model with data entry forms for indicators and the ability to support data 
collection, management and analysis, including generating reports to monitor indicator trends over 
time and produce maps to visualise subnational variations for identification of inequities. There is 
potential for newborn treatment indicators (particularly KMC, ACS) to be included in HMIS/ LMIS, SPAs 
and other facility audits along with the supplies and equipment for ACS, neonatal resuscitation and 
PSBI treatment in settings where they do not already exist.  
 
Before recommending inclusion of indicators into any national data collection system, indicators will 
need testing for validity and then for feasibility and usefulness, as per the steps of the measurement 
improvement plan (see Figure 1 and Figure 7). Given the ongoing tension between demand for more 
information for decision making, versus the need to be parsimonious with the number of indicators 
to avoid overburdening frontline workers and information systems, prioritisation of the ENAP 
treatment indicators for inclusion in these systems should be country specific and consider relevance 
to national policy and health system needs. Overloading an HMIS system with data can limit its 
usefulness and negatively affect data quality. In addition to validity testing, consideration of national 
data needs, existing levels of facility, infrastructure, resources and technical capacity is essential 
before introducing new indicators into a national HMIS. Furthermore, data from HMIS may be more 
limited in settings where a large proportion of births take place in the community (e.g. Ethiopia), or 
where there is a large private sector (e.g. India). 
 
3.6.1.3 Input and process data for tracking content and quality of care 
Given the challenges in measuring coverage for several of the treatment interventions, appropriate 
process indicators were identified that can be measured immediately. For the purpose of this 
discussion, “process” data refers to any measurement of the presence of specific elements needed to 
deliver an intervention, such as supportive policy, trained staff, commodities, documentation or 
infrastructure. Process data are not a replacement for coverage data but ensure a standardised proxy 
can be used immediately. These data can be measured through a variety of platforms, including HMIS, 
routine audits and/or facility-based supervision checklists. Additionally, periodic or intermittent 
health facility assessments, such as SPA (117) and service readiness assessments, such as SARA (101) 
and EmOC needs assessments (118) monitor input and process indicators. As many of the indicators 
(impact and coverage) measured through household surveys require relatively long periods of time to 
see significant change following policy adjustments, facility level programmatic data is essential for 
measurement of more proximate factors in the facility that are more amenable to change in the 
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shorter term. Furthermore, facility surveys can provide external validation for self-reported data, such 
as those emerging from HMIS. Harmonisation of core modules for HFAs should include the priority 
ENAP process indicators to maximise their use and allow for comparison between surveys (Figure 3.9). 
However, the use of periodic health facility assessments is expensive and does not replace routine 
supervision or programme monitoring. 
 
Some task teams proposed indicators regarding existence of supporting policy at national level as a 
key measure of process. For example, the task teams for both ACS and CHX proposed a measure of 
the number of countries with ACS or CHX respectively on the essential drug list since their addition is 
recent (2013)(139), data are collected in the RMNCH Trust data system and reported in Countdown 
(Figures 3.5 and 3.6). Given that these interventions are at an earlier point in policy to programme 
change, these may be useful trackers for now but as programme implementation accelerates, the 
process indicator should be shifted to more proximal readiness indicators and coverage.  
 
The ENAP measurement improvement roadmap, in partnership with other tracking data 
harmonisation efforts, aims to test both simple and composite readiness indicators for newborn 
interventions, considering the presence of essential commodities, trained staff, and space.  
 
Care of small and sick babies 
There is a major gap in the definition of standards for the care of small and sick newborns; the 
provision of quality inpatient care for small and sick babies could have a significant impact on neonatal 
deaths (123). The UN EmOC indicators are based on process indicators referred to as “signal functions” 
for basic and comprehensive emergency obstetric care (118); currently only one signal function 
specifically relates to newborn care, but does not fully represent all interventions needed for 
emergency newborn care. New research supports the addition of signal functions specific to newborn 
care and strongly recommends that these indicators should be updated (188). Specific challenges and 
details on the levels of care are explained in greater detail elsewhere in the series (16) and ENAP 
recommends an ongoing process with the UN to define indicators for newborn care intervention 
packages by levels of care.  
 
As a milestone in ENAP and reiterated in EPMM, addressing quality of care at birth is critical; the Every 




3.6.2 Challenges and opportunities going forward 
Integrating maternal health and broader roadmaps for improving metrics 
It is essential to unite maternal and neonatal health communities towards a common metrics agenda 
with a convergence of global efforts to end preventable mortality and coordinated support to 
countries to assess progress meeting targets set within the SDGs, ENAP and the EPMM movement. 
These functions are the remit of the WHO, other UN agencies and academic partners, and can be 
aligned through the creation of an over-arching MNH reference group. This remit will also aim to link 
existing work and relevant convening groups, including those working on wider metrics systems 
change.   
 
Intentional development of leadership to assess, improve and use data 
In order to institutionalise the proposed metrics, there is a need to build leadership skills to assess and 
use data in high burden settings (Figure 3.8). These include INDEPTH Network’s Maternal and 
Newborn Working Group, which aims to improve population-based metrics, especially pregnancy 
tracking, mortality, cause of death and social autopsy, birthweight and gestational age. INDEPTH is a 
network of currently 52 health and demographic surveillance sites (HDSS) in twenty countries where 
a total population of 3.8 million people are tracked each year. The Maternal and Newborn Working 
Group is building the capacity of member sites to use standardised tools and to make data regularly 
available to the public. The All India Institute of Medical Sciences/WHO Collaborating Centre for 
Newborn Care is well placed to develop a simplified database for follow up of at risk neonates, track 
and minimise disability outcomes and maximise child development, especially preterm, for example 
preventing blindness from retinopathy of prematurity (97, 190). ENAP is identifying provisional 
country hubs for testing of proposed indicator numerators and denominators initially linked to focus 
countries for EMEN.   
 
3.7 Conclusion 
Major gaps have been identified in the measurement of core ENAP indicators to track the progress 
towards targets to end preventable deaths for women, stillbirths, newborns and children; key 
messages and action points are summarised in Figure 10. The quality and quantity of impact data must 
be improved, but coverage indicators need the most urgent work. Content and quality of care is the 
current priority for the three contact point indicators. For the treatment indicators, preliminary work 
to identify measurable denominators is required in preparation for the quality improvement agenda. 
The findings of this work underline the need for increasing prioritisation for strengthening and 
improving routine facility-based data, CRVS and national HMIS. This paper has laid out a systematic, 
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yet ambitious testing agenda – the ENAP Measurement Improvement Roadmap – to move towards 
use of these indicators at scale, which must be combined with an intentional transfer of technical 
leadership, especially to countries with the greatest disease burden. The strengthening of institutional 
capability to collect, analyse and convert data into action is essential. By 2020, the aim is to 
institutionalise the proposed metrics at scale across all countries. A roadmap that focuses on counting 
births, deaths and improves tracking of coverage and equity is central to support countries to build a 
strong national data system that can be used to inform policy and focus investment and resources 





Figure 3.10 Key messages for measurement improvement 
Key messages 
 
Every Newborn Action Plan published 10 core indicators with selected additional indicators 
following a systematic, multi-stage consultation process to assess 70 indicator options.  
 
• The impact indicators – neonatal mortality rate, stillbirth rate and maternal mortality ratio 
– have clear definitions, but there are gaps in data quantity and quality. 
 
• The coverage indicators for care of all mothers and newborns – intrapartum/skilled birth 
attendance, early postnatal care and essential newborn care – are based on clearly defined 
contact points, but still have major gaps in measuring package content and quality.  
 
• The coverage indicators for care for newborns at risk or with complications (specific 
treatment interventions) - antenatal corticosteroids, neonatal resuscitation, treatment of 
severe neonatal infection and kangaroo mother care, and an additional indicator, 
chlorhexidine cord cleansing - lack clear indicator definitions. Data on these treatment 
interventions is not currently tracked in routine systems or existing data collection 
platforms. Measurement of the denominator for these treatment intervention indicators 
is especially challenging.  
 
Key action points 
The Every Newborn Metrics group has devised the Measurement Improvement Roadmap in 
order to track progress of ENAP milestones so that every country can reach a target of ≤12 
neonatal deaths and stillbirths per 1000 births by 2030. This involves: 
 
• Development of measurement tools (perinatal death certificates, audit tools, minimum 
perinatal dataset, gestational age and birthweight metrics improvements), including a 
focus on strengthening routine health information systems, linking to CRVS and 
population-based surveys. 
 
• An ambitious plan to test validity of the Every Newborn coverage indicators, in selected 
facilities/settings, and feasibility of including in facility based HMIS, considering a range of 
options for denominators. 
 
• Intentional transfer of leadership for measurement, especially in those countries with the 
greatest disease burden, with links to existing networks (e.g. INDEPTH) for testing, 









Chapter 4. Inpatient care of small and sick newborns: a multi-country 
analysis of health system bottlenecks and potential solutions  
 
4.1 Introduction  
The paper presented in this chapter aims to address the first objective of this PhD and describes the 
package of inpatient care for small and sick newborns. Using the WHO health system building blocks 
as a framework, this paper assesses the existing health system challenges impeding the scale up of 
inpatient care for small and sick newborns in 12 high burden countries using secondary data collected 
with a “bottleneck” analysis tool.  
This paper was published in BMC Pregnancy and Childbirth in September 2015 as an open access 
article (16). See Appendix N for the published version of this article and copyright. The paper was part 
of a supplement of in-depth analyses, which focused on the specific challenges to scaling up high 
impact interventions and improving the quality of care for mothers and newborns around the time of 
birth. The nine papers in the series consist of one overview paper, six intervention package specific 
papers and two crosscutting papers. This is the 7th paper in the series focused specifically on inpatient 
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Preterm birth is the leading cause of child death worldwide. Small and sick newborns require timely, 
high-quality inpatient care to survive. This includes provision of warmth, feeding support, safe oxygen 
therapy and effective phototherapy with prevention and treatment of infections. Inpatient care for 
newborns requires dedicated ward space, staffed by health workers with specialist training and skills. 
Many of the estimated 2.8 million newborns that die every year do not have access to such specialised 
care.  
 
The bottleneck analysis tool was applied in 12 countries in Africa and Asia as part of the Every Newborn 
Action Plan process. Country workshops involved technical experts to complete the survey tool, which 
is designed to synthesise and grade health system “bottlenecks” (or factors that hinder the scale up) 
of maternal-newborn intervention packages. For this paper, we used quantitative and qualitative 
methods to analyse the bottleneck data, and combined these with literature review, to present 
priority bottlenecks and actions relevant to different health system building blocks for inpatient care 
of small and sick newborns.  
 
Inpatient care of small and sick newborns is an intervention package highlighted by all country 
workshop participants as having critical health system challenges. Health system building blocks with 
the highest graded (significant or major) bottlenecks were health workforce (10 out of 12 countries) 
and health financing (10 out of 12 countries), followed by community ownership and partnership (9 
out of 12 countries). Priority actions based on solution themes for these bottlenecks are discussed.  
 
Whilst major bottlenecks to the scale-up of quality inpatient newborn care are present, effective 
solutions exist. For all countries included, there is a critical need for a neonatal nursing cadre. Small 
and sick newborns require increased, sustained funding with specific insurance schemes to cover 
inpatient care and avoid catastrophic out-of-pocket payments. Core competencies, by level of care, 
should be defined for monitoring of newborn inpatient care, as with emergency obstetric care. Rather 
than fatalism that small and sick newborns will die, community interventions need to create demand 
for accessible, high-quality, family-centred inpatient care, including kangaroo mother care, so that 




4.3 Background to the paper 
Severely sick newborns, including those with infections, severe intrapartum insults, severe jaundice 
or those who are too small to maintain their body temperature or to breathe or to feed actively, will 
require inpatient care to survive. This paper forms part of a series on high quality maternal and 
newborn care and examines bottlenecks and solutions specific to the provision of newborn inpatient 
care for small and sick babies.  
 
The first 28 days of life is a vulnerable time for newborns, with an estimated 2.8 million babies dying 
during the first month of life worldwide in 2013 (191). The main causes of death include direct 
complications of prematurity (36%), intrapartum events (previously called birth asphyxia) (23%), and 
infections (23%) (21, 45). Nearly three-quarters of all neonatal deaths occur in the first week of life 
(21). The highest risk of death or serious morbidity occurs among the 10 million born at term with low 
birth weight (<2500g) (33) and the 15 million born preterm (before 37 completed weeks of gestation) 
each year (9). Many lives could be saved, and morbidity prevented, through a combined health 
systems approach (4) along the continuum of care, with identification of those at high risk and timely 
provision of quality inpatient and supportive care (5). Strengthening of existing facility-based systems 
for the care of vulnerable newborns is the most effective approach for saving newborn lives (192) and 





Figure 4.1. Inpatient care of small and sick babies, showing health system requirements by level of care 
 
Red text signifies tracer indicator for bottleneck tool analysis.  
*See Vesel et al (2015)(193) Kangaroo mother care, Enweronu-Laryea et al (2015)(8) Basic newborn care and resuscitation, and 
Simen-Kapeu et al (2015)(58) neonatal sepsis. 
 
 
Inpatient care is usually delivered across three levels (Figure 4.1) and refers to the facility-based care 
of newborns focused on both treatment and prevention of infection and further complications. 
Prevention includes protection from hypothermia (ensuring warmth) and hospital-acquired infection, 
as well as the provision of adequate nutrition (often with nasogastric or cup feeding), with the overall 
goal of establishing exclusive breastfeeding where possible. Treatment, where available, centres on 
the management of common neonatal conditions including respiratory distress syndrome (RDS), 
Neonatal Intensive 
Care
For babies including ventilation
Special Care














• A specific room or specially allocated corner of a warm facility, with specific 
areas for resuscitation, stabilisation and space for kangaroo mother care*
• Incubators/resuscitaires overhead heaters
People
• Specialised nursing and midwifery  staff 
• High nurse/midwife to newborn ratio e.g. 1:4 in United Kingdom
Equipment and
commodities
• Feeding support with nasogastric tubes and Intravenous fluids 
• Infection prevention and management, including antibiotics
• Some access to oxygen provision (with pulse oximetry),  and effective 
phototherapy for jaundice case management
Support 
system
• Space and support for mothers including place to express breast milk
Place • Basic facility or home birth with skilled attendance
People • Midwifery and nursing staff
Equipment and
commodities
• No specialised equipment (apart from bag and mask for resuscitation when 
required).
Support system
• Warmth, cleanliness and breastfeeding support
Place
• A special ward that includes neonatal  care facilities
• Incubators, resuscitaires
• Space for kangaroo mother care* and supporting breastfeeding
People
• Nurses with specialised neonatal skills
• High nurse-newborn ratio e.g. 1:1 in the UK
• At least one doctor with specialised neonatal training
Equipment and
commodities
In addition to special care equipment and commodities (see below)
• Availability of Continuous Positive Airway Pressure, Intermittent Positive 
Pressure  ventilation and monitoring equipment 
• Surfactant therapy for extremely premature newborns, if appropriate
Support 
system
• 24 hour laboratory support
• Transport and safe referral if needed







neonatal infections, hyperbilirubinaemia, feeding difficulties (5) and the prevention and treatment of 
retinopathy of prematurity (ROP)(97). Advanced treatment for other important conditions, such as 
necrotising enterocololitis (NEC), patent ductus arteriosis (PDA), correctable congenital anomalies and 
broncho-pulmonary dysplasia (BPD) may also be undertaken. Basic newborn care (providing 
cleanliness, warmth and support for breastfeeding) is essential for all babies, including timely 
resuscitation for up to 10% of babies that may require resuscitation at birth (7) and is covered 
elsewhere in this series (8). Inpatient care for small or sick babies includes two cornerstone 
components: KMC and sepsis case management, which are also considered elsewhere in this series 
(58, 193). While in a well-functioning health system all three levels of care will be available (Figure 
4.1), many small babies can be managed without provision of any higher level neonatal intensive care 
and can be looked after in special care units (5). Currently, however, over three quarters of babies 





Figure 4.2. Estimated coverage of neonatal care by region of the world and level of care  
 
*By Special Care Baby Unit, this is the highest level of care available (i.e. no Neonatal Intensive Care).  
 
Data source: Adapted from Beyond Newborn Survival: The Global Burden of Disease due to Neonatal Morbidity. Estimates of neonatal morbidities and disabilities at regional and global levels 




High quality inpatient care for sick neonates includes careful monitoring by trained health 
professionals with a sound understanding of the physiological and psychosocial needs of the small or 
sick newborn baby and their families. A recent DELPHI exercise estimated that optimal supportive care 
in a hospital Special Care Baby Unit (SCBU) could avert 70% of neonatal deaths due to preterm birth 
complications, and that 90% could be averted with availability of hospital Neonatal Intensive Care 
Units (NICUs) (4). Whilst coverage of these inpatient care packages is near universal in high-income 
settings, both the coverage and the quality of care available in middle-and low-income settings are 
highly variable (42). The provision of high-quality nursing and inpatient medical care of small and sick 
newborns not only saves lives but could also help to facilitate more rapid discharges from health 
facilities, leading to better short and long-term morbidity outcomes for these babies, including 
reduction of BPD and ROP. This need is reflected by the current burden of long-term disability in 
survivors following preterm birth being greatest in middle income countries, particularly where 
coverage of inpatient neonatal care has expanded without due attention to the quality of care 
provided (97). 
 
Inadequate care in facilities can be caused by a number of constraints usually related to health worker 
shortages and poorly equipped facilities, compounded by a lack of specific knowledge and 
competencies in dealing with small and sick newborns amongst existing clinicians and nursing staff 
(29). Facility-based neonatal care frequently remains under-prioritised and under-funded in many 
parts of the world, particularly in LMIC. Few standardised indicators exist to measure quality of 
newborn care in facilities and challenges remain to improve the metrics and core competencies (15). 
Inadequacies in supplies and safe use of medicines and equipment (including effective phototherapy 
and case management for sick neonates) are common problems despite the fact that evidence-based 
interventions exist that can be delivered in resource-constrained environments (194).  
 
The vision of providing quality care to sick newborns is part of a wider global movement – the UN 
Secretary General Global Strategy in 2010 (195) called for innovative approaches to provide quality 
care for mothers and newborns, using coordinated research and the formulation of accountability 
mechanisms through the Commission on Information and Accountability for Women’s and Children’s 
Health (COIA). Published in 2014, The Lancet Every Newborn Series 
(http://www.thelancet.com/series/everynewborn) demonstrated the progress that has been made, 
even in challenged settings, and outlined the urgent steps still needed to improve newborn survival. 
The Lancet papers proposed a package of integrated quality interventions (29, 189) – the Every 
Mother, Every Newborn (EMEN) initiative - that have been outlined in the ENAP alongside specific 
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actions and ambitious targets for newborn survival (6). This paper aims to interrogate country-level 
data on “bottlenecks” to quality care and to draw out innovative solutions, in order to aid the 
formulation of country led health plans and strengthen the capacity of health systems to respond to 
the needs of small and sick newborns.  
 
4.3.1 Objectives of the paper 
The objectives of this paper are to:  
o Use a 12-country analysis to explore health system bottlenecks affecting the scale-up of 
inpatient supportive care for small and sick newborns  
o Present the solutions to overcome the most significant bottlenecks including learning 
from the 12-country analyses, literature review and programme experience 




This study used quantitative and qualitative research methods to collect information, assess health 
system bottlenecks and identify solutions to scale up of maternal and newborn care interventions in 
12 countries: Afghanistan, Cameroon, Democratic Republic of Congo (DRC), Kenya, Malawi, Nigeria, 
Uganda, Bangladesh, India, Nepal, Pakistan and Vietnam.  
4.4.1 Data collection 
The maternal–newborn bottleneck analysis tool was developed to assist countries in the identification 
of bottlenecks to the scale up and provision of nine maternal and newborn health interventions across 
the seven health system building blocks as described previously (29, 189). The tool was utilised during 
a series of national consultations supported by the global Every Newborn Steering Group between July 
1st and December 31st, 2013. The workshops for each country included participants from national 
ministries of health, UN agencies, the private sector, non-governmental organisations (NGOs), 
professional bodies, academia, bilateral agencies and other stakeholders. For each workshop, a 
facilitator oriented on the tool coordinated the process and guided groups to reach consensus on the 
specific bottlenecks for each health system building block. This paper, seventh in the series, focuses 
on the provision of inpatient care of small and sick newborns.  
 
Tracer interventions were defined for each package to focus the workshop discussion. For the purpose 
of this bottleneck analysis, three interventions required for the treatment of common neonatal 
conditions were included as tracer items for the package of inpatient care: safe oxygen administration, 
95 
 
intragastric tube feeding (IGTF) and the provision of intravenous (IV) fluids (Figure 4.3). Oxygen 
therapy is a mainstay treatment for small and sick babies, with respiratory compromise commonly 
seen in RDS (following preterm birth, neonatal pneumonia and neonatal sepsis) and respiratory failure 
being an important mechanism in most neonatal deaths (21). Developmental immaturity of the 
preterm newborn (especially those born before 34 weeks gestation), or severe illness in a more 
mature neonate, may limit their ability to coordinate sucking and swallowing required for successful 
exclusive breastfeeding. In these instances, intragastric feeding is a commonly used low-tech 
intervention to deliver nutrition, using expressed breast milk where possible. In addition, many of the 
most small and sick newborns will require administration of IV fluids to prevent dehydration as a result 
of insensible water loss, and to manage the delicate fluid, electrolyte and glucose balance, especially 





Figure 4.3 Definitions of tracer indicators for inpatient care of small and sick newborn bottleneck 
analysis tool  
 
Safe oxygen administration 
Involves the use of an appropriate delivery mechanism with adequate monitoring to ensure 
that babies maintain appropriate oxygen levels. Common interfaces used are nasal 
prongs/cannula, head box, Continuous Positive Airway Pressure (CPAP) or in a small 
proportion of the most severe cases, mechanical ventilation. All babies require the 
monitoring of oxygen levels using pulse oximetry to ensure optimum and safe levels of 
oxygen are delivered to maximise survival and minimise potential damage (97, 197). There 
has been substantial debate around the optimal oxygenation levels for sick neonates. 
Hyperoxia may lead to brain injury and in premature neonates can lead to retinopathy of 
prematurity (ROP). The highest risk of ROP is in neonates born at <32 weeks, however ROP 
can occur in sick neonates born at up to 36 weeks gestational age where inadequate 
attention is given to safe oxygen delivery (198). Conversely, hypoxemia can lead to brain 
injury, renal failure, pulmonary hypertension and necrotising enterocolitis (NEC). As 
targeting lower O2 saturation levels (85-90%) decreases risk of ROP, but increases the risk 
of mortality, current recommendation is to target levels 90-95% - especially in very 
premature infants (199). Finally, oxygen administration relies on safe mechanisms for 
storage (including consideration of fire risk) and containers for its delivery (oxygen 
concentrators or blenders). 
 
Intragastric feeding 
Refers to the administration of milk feeds through a small plastic tube (196). The tube 
should be passed by a trained individual, usually a nurse, through the nose (naso-gastric) 
or mouth (oro-gastric) (collectively referred to as intragastric) directly into the stomach. For 
many infants, particularly very small and sick newborns, it will be undesirable to commence 
enteral feeds at the full volume needed to meet their nutritional needs. The immature gut 
and renal systems may have limited capacity to tolerate milk feeds and balance electrolytes 
– particularly sodium. Where full enteral feeding is not tolerated, intravenous fluids or total 
parenteral nutrition (TPN) may be considered, in settings where these are available. 
 
Safe administration of IV fluids 
Intravenous fluids are most commonly administered through venous cannulae inserted by 
trained medical or nursing staff. They require careful monitoring of the insertion site for 
signs of infection, as well as meticulous monitoring of fluid intake and output, including 
serum electrolytes, urine output and daily records of weight(196). Intravenous fluids should 
be administered with caution, complemented by enteral milk feeds where feasible. They 
should be discontinued as soon as possible as they do not provide adequate nutrition and 
small and sick infants are at high risk of NEC, broncho-pulmonary dysplasia and 





Safe implementation and monitoring of these interventions can be challenging, especially in low-
resource settings. The list of tracers is not exhaustive and other important interventions, notably, 
effective phototherapy for the treatment of hyperbilirubinemia (Figure 4.4), basic newborn care and 
resuscitation (8), KMC (193) and management of neonatal infections (58) are covered by other 
sections of the bottleneck analysis tool. 
 
Figure 4.4 Overcoming bottlenecks for the management of neonatal jaundice: diagnostics and 
devices 
 
Neonatal hyperbilirubinaemia is common, whilst most mild cases resolve spontaneously, 
failure to recognise and institute timely effective treatment for potentially severe disease 
can lead to bilirubin induced brain damage (kernicterus) and neonatal death. A systems-
based approach is crucial to prevent adverse outcomes (200). This will require innovative 
strategies and affordable technologies to bridge the existing social and access barriers in 
micro and macro-health environment (66) which may include: 
 
Improved identification and management of underlying causes: Rh haemolytic disease is 
an important established preventable cause of kernicterus, point-of-care Rh blood typing, 
minimally at the time of birth with unfettered targeted access to Rh immunoprophylaxis is 
critical for prevention. There is need for a panel of bilirubin tests for haemolysis and 
glucose-6-phoshate dehydrogenase deficiency.  
 
Overcoming Barriers to diagnosis: Icterometry is a low cost, simple, effective diagnostic 
tool. Coupled with jaundice education as part of postnatal care delivered by rural health-
care workers it improved care-seeking and a reduced bilirubin levels in a Vietnamese 
cluster-randomized study (201). In a community birthing facility in Brazil Screening, using 
an Ingram icterometer or transcutaneous bilirubin during the first day after birth, with 
promotion of breastfeeding and timely use of phototherapy was associated with very low 
(0.82%) readmission rates with none requiring exchange transfusions (202). 
 
Overcoming Intervention Barriers: Effective phototherapy implies its use as a “drug” at 
specific blue light wavelengths, emission spectrum in a precise (narrow) bandwidth to up 
to 80% of an infant’s body surface. The efficacy of longer-lasting LED lights that meet 
clinical and engineering expectations have been demonstrated in low- and middle-income 
settings (67, 203). These devices are also the most affordable and effective for at least 
one year of continuous use and are poised for implementation at both primary and 
secondary birthing facilities.  
 
Plans and Challenges are not just limited to development of novel screening and 
prevention technologies, improving access to healthcare, or monitoring global 
benchmarks of unacceptable neonatal morbidities. These need to be embedded in 





4.4.2 Data analysis methods  
Data received from each country were analysed and the graded health system building blocks were 
converted into heat maps (Figures 4.5 and 4.6). Bottlenecks for each health system building block were 
graded using one of the following options: not a bottleneck (=1), minor bottleneck (=2), significant 
bottleneck (=3), or very major bottleneck (=4) (Figure 4.5). We first present the number of countries 
from which workshops participants categorised health system bottlenecks as significant or very major, 
by mortality contexts (Neonatal Mortality Rate (NMR) <30 deaths per 1000 live births and NMR ≥30 
deaths per 1000 live births) and region (countries in Africa and countries in Asia) (Figure 4.4). We then 
developed a second heat map showing the specific grading of health system bottlenecks for each 
country (Figure 4.6).  
 
Context specific solutions to overcome challenges to scaling up inpatient care identified in all countries 
were categorised into thematic areas and then linked to the specific bottlenecks in the results section 
(Appendix D, Appendix E). We undertook a literature review to identify further case studies and 
evidence-based solutions for each defined thematic area (Appendix G). For more detailed analysis of 




Our analysis identified bottlenecks across seven health system building blocks relating to the inpatient 
supportive care of small and sick newborns. Twelve countries submitted their responses to the 
inpatient care of small and sick newborns bottleneck tool. Afghanistan, Cameroon, Democratic 
Republic of Congo (DRC), Kenya, Malawi, Nigeria, Uganda, Bangladesh, Nepal and Vietnam returned 
national level responses. Pakistan provided subnational data from all provinces, Gilgit-Baltisan, Azad 
Jammu and Kashmir, excluding two tribal territories. India returned subnational data from three 
states: Andhra Pradesh, Odisha and Rajasthan (Appendix F).  
DRC did not provide a grade for health service delivery and community ownership and partnership; 
and Malawi did not provide a grade for health information systems. In these cases, the country was 
removed from the sample for the quantitative grading of that building block, but included for all other 
building blocks; their examples of described bottlenecks were still included in the analysis and 
presented in the results. Afghanistan listed their bottlenecks and completed rating for all building 
blocks but did not propose any solutions.  
The solution themes are summarised by health system building block in Table 4.1. Care of small and 
sick newborns is a newborn intervention area highlighted by all country workshop participants as a 
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major challenge to health systems, especially when considered in comparison with other intervention 
areas studied in the workshop. Grading according to the number of countries that reported very major 
or significant health system bottlenecks for inpatient supportive care for small and sick newborns is 
shown in Figure 4.5. Overall, the health systems building blocks with the most frequently reported 
very major or significant bottlenecks were health financing (10 out of 12 countries), health workforce 
(10 out of 12 countries), followed by community participation (9 out of 11 countries), suggesting these 
may be priority areas within which to tackle barriers to the scale up of inpatient care for small and sick 
newborns. As expected, building blocks were rated more poorly in countries with higher NMR. African 
countries reported a higher number of major and significant bottlenecks, but Afghanistan had the 
highest level of very major bottlenecks and Malawi had the lowest graded bottlenecks, as shown in 








Solution Themes Proposed actions  
Leadership and 
Governance 





Review and disseminate 
guidelines 
• Active involvement of national advocates (professional bodies, 
academic, policy makers) for care of sick newborns 
 
• Increase number of special care units and spaces in facilities for 
newborns 
 
• Develop national policies and guidelines for referral systems, 







Innovative funding and 
removal of user fees 
• Increase and sustain funding for sick newborns, earmark funds 
within facilities caring for newborns 
 
• Expand existing maternal health schemes (end-user incentives, 
insurance schemes, voucher schemes) to cover inpatient care of 
newborns 
 
• Long term vision and health systems approach towards universal 














• Develop neonatal nursing cadre with agreed standards and 
benchmarks 
 
• Strategies to incentivise neonatal health workers  
 
• Develop job descriptions, appropriate remuneration and career 
development pathways for health workers caring for newborns 
 
• Scale up of simplified, skilled based training programmes on 
infection prevention, feeding, provision of warmth and family 
centred care for newborns 
 
• Maximising existing resources, including nurses, lower level 












• Update and implement the essential medical list to include 
oxygen 
 
• Inclusion of neonatal equipment and drugs in logistics systems 
 




Increase service delivery 




Quality improvement and 
assurance 
 
Improve working conditions 
• Special care baby units (or dedicated area) in every district 
hospital 
 
• Decentralisation of inpatient neonatal care, stable babies cared 
for in KMC units 
 
• Develop and harmonise quality assurance tools and carry out 
quality assessment of neonatal units 
 
• Provide supportive supervision and mentoring 
 
• Improve remuneration and incentives (see also, health 












integration of HMIS 
 
Development of indicator 
definitions, reporting 
systems, tools and 
Scale up audits and 
registers 




• Define and harmonise newborn indicators, especially care of sick 
newborns 
 
• Regular mortality audits in all special care and neonatal intensive 




Accessibility of information 
and community awareness  
 
 





• Sensitisation on importance of newborn inpatient care and 
entitlements to care 
 
• Use of community volunteers, local champions and leaders 
 
• Develop local transportation solutions for families, improve 
patient experience in facilities and develop family-centred 
guidelines  
 
• Male role models in the community, inclusive policies and 
frameworks in facilities 
 
• Education on maternal and newborn health targeted at men 
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Figure 4.5 Very major or significant health system bottlenecks for inpatient care of small and sick newborns  
 
 
NMR: Neonatal Mortality Rate 




































































8 out of 12 4 out of 7 4 out of 5 3 out of 6 5 out of 6
10 out of 12 6 out of 7 4 out of 5 5 out of 6 5 out of 6
10 out of 12 6 out of 7 4 out of 5 5 out of 6 5 out of 6 ≥75%
8 out of 12 4 out of 7 4 out of 5 3 out of 6 5 out of 6 25-74%
7 out of 11 3 out of 7 4 out of 4 4 out of 6 3 out of 5 <25%
8 out of 11 4 out of 6 4 out of 5 4 out of 6 4 out of 5
9 out of 11 5 out of 7 4 out of 4 5 out of 6 4 out of 5
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Part A: Heat map showing individual country grading of health system bottlenecks for inpatient care of small and sick 
newborns 
Part B: Table showing total number of countries grading significant or major for calculating priority building blocks 
DRC: Democratic Republic of the Congo.  
 
4.5.1 Leadership and governance bottlenecks and solutions  
The first building block, leadership and governance, was considered to have very major or significant 
bottlenecks across 5 of the African countries, and 3 of the Asian countries (Figure 4.5). Countries in 
both regions commonly identified a lack of national level advocates (including policy makers, key 
individuals within professional bodies, academics and national institutions) for advancement of quality 
care for newborns. At the governance level, country workshop participants highlighted lack of 
supportive policies for care of small and sick babies. Specifically, workshop participants noted that 
Africa Asia
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their existing policies were not inclusive of the key supportive and organisational policies for newborn 
care, such as well-defined, rational referral systems, discharge criteria and standardised levels of care 
at the district and peripheral level. Policy documents in circulation amongst senior officials were not 
always disseminated to the managers at lower levels of the health service and did not always 
incorporate guidelines with important components of special care for newborns, such as supportive 
policies, guidelines for breastfeeding and family-centred care (Appendix D).  
 
Solutions proposed by country teams centred on the need for targeted advocacy and political will. 
They focused on improving the organisational and supportive structures for sick newborns at the 
policy and governance level and building local champions. Country workshop teams proposed 
reviewing the existing organisational policies and guidelines at a central level and ensuring these were 
disseminated to all levels of the health system (Appendix E). 
 
4.5.2 Health financing bottlenecks and solutions 
Health financing bottlenecks were frequently graded as needing significant work for inpatient care of 
newborns – 10 out of all 12 country teams (Figure 4.5) graded it as very major or significant, with only 
Malawi and India perceiving there to be only minor bottlenecks (Figure 4.6). Revenue collection for 
newborn health, and competing calls for financing of other areas of healthcare, was clearly viewed as 
a barrier, and insufficient earmarked funds at the facility was impeding their ability to provide quality 
care to sick newborns. Participants specifically described a lack of designated funding for laboratory 
support and to purchase supplies such as blood components, antibiotics and other equipment for 
newborns, such as oxygen cylinders. The most frequently described health financing challenges 
pertain to prohibitive user-fees and insurance policies that do not cover inpatient care of newborns 
showing that families are frequently put at risk of severe financial hardship in the event of a baby 
being born small or sick (Appendix D).  
 
Country workshop participants proposed solutions including the need to increase amount of 
earmarked funding available for sick newborns and the need to mobilise and advocate for increased 
funding at the health system level. Participants also proposed more innovative funding mechanisms 
in order to remove the prohibitive user fees placed on care of sick newborns, either through more 
comprehensive health insurance, community-based finance or mutual health schemes (Appendix E). 
 
4.5.3 Health workforce bottlenecks and solutions 
Almost all countries identified the lack of trained personnel in neonatal care in quantity and quality 
(knowledge, training, skills) and 10 out of 12 graded these bottlenecks as significant (Figure 4.5), with 
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Afghanistan grading their bottlenecks as very major (Figure 4.6). Poor supervision and the need for 
specialist and refresher training in neonatal skills were overarching challenges. Countries described 
difficulties recruiting specialist staff to work in remote areas and staffing disparities between urban 
and rural areas; 8 countries specified that problems in the health workforce stemmed from the lack 
of competency-based training and refresher training for the health workforce managing small babies, 
especially at the lower levels of the health system. Regarding task shifting, some countries noted that 
often only physicians are authorised to carry out tasks that could be performed by lower level health 
workers, such as prescribing oxygen or antibiotics. Other countries indicated that job descriptions 
were not clear in roles and responsibilities for those providing care to sick newborns, which is 
particularly relevant for neonatal nurses. Country workshop participants underlined that the 
motivation for neonatal nurses and other professionals to provide high quality care to sick babies was 
low (Appendix D) and that incentives and remuneration were insufficient, leading to poor health 
worker attitudes, ineffective communication and poor compliance with infection control procedures.  
 
Participants recognised that to remove health workforce bottlenecks, detailed health worker mapping 
of those caring for sick newborns was needed to identify the resources available and where tasks could 
be rapidly shifted to make more rational use of the existing workforce. Workshop participants also 
proposed improving working conditions, motivation and skills through more structured pre-service 
and in-service training and more appropriate remuneration for neonatal skills, including rewarding 
those prepared to work in rural areas (Appendix E). 
 
4.5.4 Essential medical products and technologies bottlenecks and solutions 
The provision of essential medical projects and technologies was graded as having very major 
bottlenecks by a third of all country workshop participants (Figure 4.5). The Essential Medicine List 
(EML) was a commonly described bottleneck; participants noted that the EML lacked the commodities 
required for special care of newborns, such as oxygen and IV fluids and was not implemented at the 
national level. Many participants described general stock-outs of neonatal equipment, especially 
cannulas and drugs (specifically antibiotics) and lack of availability of specialist equipment, such as 
continuous positive airway pressure (CPAP) and portable radiographs. Participants reported that weak 
and inaccurate information systems underpinned this problem, limiting the ability of facilities to 
forecast the demand for oxygen, fluids and the maintenance supplies needed for provision of quality 
inpatient supportive care (Appendix D).  
 
Solutions to the essential medical products and technology bottlenecks started with a need to update 
the EML to reflect the essential commodities needed for sick newborns (oxygen, antibiotic and IV 
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fluids). Following this, workshop participants recognised a need for improving and building logistics 
management capacity to support the health system to manage inventories and prevent stock-outs 
(Appendix E). 
 
4.5.5 Health service delivery bottlenecks and solutions 
Service delivery was described as a challenge in all the countries with higher mortality contexts (Figure 
4.5). Workshop participants described the limited number of facilities available to provide any type of 
services or inpatient care for sick or low birth weight babies, particularly at lower levels of the system. 
Poor enabling environments, undersized and outdated buildings, and lack of resource capacity for 
both delivery of care and provision of family-centred supportive care for babies in the public sector 
were commonly described. Five countries highlighted the limited space in health facilities for the 
special care of sick newborns. This included potential space for mothers to stay with their baby or lack 
of nurseries or side rooms for sick babies. Other country workshop teams described quality 
improvement as a major challenge due to inadequate monitoring or lack of quality improvement tools, 
poor mentoring and supervision, and poor implementation of clinical guidance and cot-side care plans 
for all staff caring for newborns (Appendix D).  
 
Country workshop participants recognised that the number of facilities or, at least, dedicated spaces 
for sick newborns needed to be increased and that service delivery needed to be rationalised. In 
alignment with the health workforce bottlenecks, teams suggested that quality assurance tools, 
quality improvement strategies (including care protocols), and improved mentorship and supervision 
for those delivering care to newborns could help to improve service delivery (Appendix E).  
 
4.5.6 Health information system bottlenecks and solutions 
The lack of health information and standardised, well-defined indicators to measure interventions for 
sick newborns is a central issue being tackled within the ENAP (6). Most participants from higher 
mortality contexts graded it as a significant or very major bottleneck to the provision of quality care 
in facilities (Figure 4.5). Specific barriers to quality improvement in facilities included the absence of 
effective mortality audits in facilities, lack of both coverage and process indicators and registers on 
sick newborns with the existing data were not well managed. In other settings, participants recognised 
the need for strengthening and integration of newborn facility-based care indicators into their 
national HMIS (Appendix D).  
 
Country workshop participants stated a need for clear definitions for indicators and harmonising these 
indicators such that national HMIS can be strengthened and include select indicators for sick 
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newborns. This would require improved measurement tools, reporting systems and use of appropriate 
software. Participants highlighted a need for capacity building within health information to support 
the appropriate disaggregation, dissemination and reporting of sick newborn data. Teams also 
suggested scaling up regular mortality audits for neonatal units (Appendix E). 
 
4.5.7 Community ownership and partnership bottlenecks and solutions 
The community ownership and partnership building block were graded as having significant or very 
major bottlenecks in three-quarters of countries (Figure 4.5). Malawi was the only country for which 
workshop participants graded this building block as having no bottlenecks (Figure 4.6). Workshop 
participants specified a wide range of issues largely related to a lack of general information and 
awareness in communities about sick babies. Limited knowledge of the treatment processes and the 
severity of newborn illness, including poor awareness of the civil rights of babies born sick or low birth 
weight to access care, were highlighted. There were several access related problems reported, 
including poor referral and transport systems and inability to access facilities either due to cost or 
availability. For mothers in the community, participants described the lack of female decision-making 
power, loss of wages due to caring for a sick newborn and lack of privacy in facilities. Lack of 
involvement of men was mentioned by six countries partially related to poor awareness and 
engagement of the wider community on issues related to sick newborns (Appendix D).  
 
Solutions for community ownership were wide-ranging but were themed around improving the 
accessibility of information for carers and the services for small and sick newborns. Participants 
suggested a need for greater community awareness of the needs for sick and small newborns in order 
to improve demand, compliance and patient experience; specifically, encouraging male involvement 
and increased participation of the community in processes to improve family centred care in facilities 
(through development of materials, tapping into community groups and developing mutual health 





This paper has presented an analysis and synthesis of bottlenecks and solutions for one of six key 
intervention packages to reduce neonatal mortality worldwide reviewed in this series of papers; 
inpatient care for small and sick newborns. Previous analysis of the bottleneck data showed that 
amongst all intervention packages explored, inpatient care has some of the highest graded 
bottlenecks hindering scale-up (29), with very major or significant bottlenecks being reported across 
all health systems building blocks. Whilst inpatient care for the small and sick newborn forms part of 
the overall care along the continuum from pre-pregnancy to childhood, these findings are timely and 
this issue is new on the global agenda. Complications from preterm birth are now the leading cause 
of death in children under five (191). Previous experience from high income settings has shown that 
initial provision of low-tech supportive inpatient care and case management, followed by full high-
tech neonatal intensive care, has played an important role in reducing overall neonatal mortality (5); 
therefore, in order to further reduce the burden of death due to prematurity, strategies to provide 
comprehensive, high quality inpatient care for small and sick newborns must be developed. 
 
The methodology used in the bottleneck analyses employed a unique consultative and participatory 
approach to bring together a wide range of partners and players in newborn health. Rather than the 
top down approach employed by many research initiatives, this data collection and analysis 
methodology focused on eliciting information from ground-level field implementation, as perceived 
by stakeholders and experts in 12 countries with the highest burden of neonatal mortality. This has 
helped the data to capture context-specific challenges and has enabled participants to share their 
experiences and work together to identify innovative solutions. The grading process encouraged the 
workshop participants to reach consensus on the perceived challenges and generate a quantitative 
measure of the perceived bottlenecks to delivering care to this vulnerable sub-population. Rather than 
reporting on systematic reviews or results from randomised trials, this paper aims to facilitate 
programmatic learning through the South-to-South exchange. This paper has brought together a wide 
range of programmatic experience and technical expertise in neonatal care from across the globe to 
inform programme managers and policy makers in multiple settings facing a range of health system 
challenges in delivering high quality, facility-based care to small and sick newborns.  
 
Health systems seek to ensure that individuals in need of care receive high quality health services 
without the risk of financial catastrophe. This analysis identified three priority health systems building 
blocks with substantial barriers to implementation of facility-based care for small and sick newborns: 
health workforce and health financing followed by community ownership and partnership. Solution 
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themes, including examples from literature review and programme learning, are discussed in detail 
below.  
 
4.6.1 Health workforce priority actions 
A worldwide nursing shortage exists in both high and low resource settings (30, 204). For small and 
sick newborns this is not simply a shortage of qualified individuals; there is a critical human resource 
gap for a neonatal nursing cadre, with almost no neonatal nursing training programmes outside of HIC 
(Figure 4.7). Neonatal nurses are the backbone of newborn inpatient care, as both providers of 
frontline care to the newborns and their families, but also through extended roles such as the 
advanced neonatal nurse practitioners (ANNPs) (23, 205). To improve neonatal outcomes, particularly 
in those countries which account for the highest newborn death and morbidity rates, nurses need to 
be recruited and offered specialised training in how to care for small and sick newborns and be 
provided with ongoing resources to enable them to give consistent high-quality care. There are other 
factors at institutional and country level including inadequate allocation of resources for a health 
workforce, inadequate workforce planning, poor retention strategies, ineffective use of existing 





Figure 4.7 Neonatal nursing as part of national human resource planning 
Nurses caring for small and sick newborns are in a unique position to improve their chance 
of survival and ability to thrive. Despite the vital role for nurses in the care of a sick newborn, 
neonatal nursing is not an internationally recognised cadre.  
 
What is a neonatal nurse?  
The role of a neonatal nurse includes the provision of care for newborn infants born with a 
variety of problems ranging from prematurity, birth defects, infection, and surgical problems 
within an individualised, developmentally supportive and family-centred framework 
(http://www.nann.org). However, even across high income countries, there is no agreed 
definition for neonatal nurses, but it is a viewed as a highly skilled nursing speciality that 
requires years of hand-on experience and is usually attached to specific academic and 
clinical training schemes.  
 
Health workforce planning. How many neonatal nurses do we need? 
Currently, there is a global shortage of neonatal nurses (30). The survival of premature 
infants in facilities has been linked to the number of qualified neonatal nurses working per 
shift (207) and very sick or extremely premature newborns require higher staff to patient 
ratios than other areas of paediatric care. Intensive care newborns often require one-on-
one care and special care babies require a ratio of approximately 1 to 4  (204). There are a 
lack of international standards on the number of nurses needed or defined staffing ratios 
and benchmarks.  There are a small number of countries that provide specialised academic 
and formal training for nurses, most of which are high-income countries. As nurses 
constitute the largest component of the health care system, it is imperative that planning 
for neonatal nursing skills is incorporated into wider human resource and health workforce 
plans. International health workforce market analysis is needed to examine the impact of 
migration and retention of nursing workforce. Where neonatal nurses are trained, resources 
should also be directed to motivate retention including valuing their role, recognising 
ongoing training needs and protect them from rotation out into other sub-specialities (208). 
Individual countries can work towards improving quality and efficiency of care by more 
strategic and intentional delegation at the local and country levels. There is a need to review 
the efficiency of current workforce support at the local and country levels and review the 
current delivery of care.  
 
Qualifications  
Training in skills specific to the needs of the newborn is required, with corresponding 
accreditation. Accreditation is important to provide recognition and to promote increased 
responsibility as well as to assist with staff retention through increased job satisfaction, 
potentially higher salaries and the prevention of nursing staff rotation, which is common in 
many low- and middle-income settings.  
 
The development of special neonatal certificates, training courses and advanced neonatal 
nurse practitioners (ANNP) has gained traction, especially in high income settings, but not 
without challenges. For example, ANNPs have been shown to be effective, but some 
programmes report the sentiment that ANNPs feel they are substituting junior doctors 
rather than being valued as an alternative approach to high quality service provision for 
newborns (209), leading to low morale. In low- and middle-income countries, at the district 
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and community level, education and training of nurses working with newborn infants within 
community-hospital-community network systems with integration of community healthcare 
workers, and in some settings, use of volunteers is possible (30). Other options include 
organisation or co-ordination of overseas programs involving visits by experienced trained 
neonatal nurses to low resource settings to provide mentoring, education, and sharing of 
information with the ultimate goal of building in country capacity.  
 
All institutions can increase the basic quality and speciality of neonatal nursing programmes. 
These strategies require financial and political support and a shared vision for neonatal 
nursing and care between professional institutions. Better data capture on neonates in 
facilities, including follow up data, is urgently needed so that standards of practice and 
quality of care can be carefully evaluated (209). Extraction information on the nursing 
workforce is essential to describe who, where, and how neonatal nurses work (noting that 
many nurses are not permitted to provide such data without government or institutional 
approval). Further research is needed to examine neonatal nursing education and 
distribution of the workforce in relationship to neonatal outcomes. There is a global need to 
establish an international competency-based standards for neonatal nursing supported by 
appropriate regulatory processes and mechanisms (30) that support this vital cadre to 
improve neonatal survival and outcomes. 
 
ANNP: Advanced Neonatal Nurse Practitioner 
 
4.6.1.1 Skills-based/competency-based training 
Almost all countries in the workshop highlighted the lack of skills-based training programmes for 
health workers caring for small and sick babies. Qualitative work on the barriers to nurse education 
for those caring for sick newborns has found that educational programmes focusing on neonatal skills 
are often inconsistent, poorly structured, or may require long, off-site training courses making them 
inaccessible for large numbers of lower level hospitals or SCBUs (31). Survive and Thrive is a private 
and public partnership with the American Academy of Pediatrics and has developed educational 
programmes focused on newborns. Essential Care for Small Babies (ECSB) (210) is to be released in 
early 2015 and addresses skills such as nasogastric feeding and prevention of infection and skin-to-
skin care through a cooperative learning approach2. Learning techniques used by ECSB are skills-based 
and focused on small group work, using simulation methodology and role-play to practice technical 
and communication skills. Knowledge is tested through multiple-choice questions and Observed 
Structured Clinical Evaluations (OSCEs). Such pre-service and in-service training programmes are 
available and could be scaled-up within health worker training, even in lower resourced settings, as 
they do not rely on electricity supplies (being flip-chart based) and make use of low-cost simulation 
models. Well-designed programmes focused on neonatal clinical skills have been shown to be 
 
2 See the end of chapter for additional content on ECSB and simulation based training.  
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effective and improve health provider knowledge and practice (211), but will require supervision 
systems and regular refresher training to sustain and update skills (212).  
4.6.1.2 Task shifting 
The WHO’s recommendations on optimising the roles of health workers aim to address critical health 
workforce shortages that slow progress towards the health-related MDGs (213). A more rational 
distribution of tasks and responsibilities among cadres of health workers can significantly improve 
both access and cost-effectiveness – for example, by training and enabling ‘mid-level’ and ‘lay’ health 
workers to perform specific interventions otherwise provided only by cadres with longer (and 
sometimes more specialised) training. These recommendations are intended for health policy-makers, 
managers and other stakeholders at a regional, national and international level. WHO hopes that 
countries will adapt and implement them to meet local needs. The recommendations were developed 
through a formal, structured process including a thorough review of available evidence. Specific 
examples that have been taken up include nursing auxiliaries or health care assistants supporting and 
maintaining KMC. In Malawi, ward attendants have been involved in supporting KMC  and health 
surveillance assistants have been trained to promote facility-based care for sick newborns (214-216). 
ECSB training incorporates sharing tasks with mothers, when appropriate, for basic skills such as 
nasogastric feeding and providing basic care to a small baby looked after in a facility (217).  
 
4.6.1.3 Recruitment and retention 
Once health workers have the skills needed to care for small and sick babies, recruitment and 
retention strategies are needed to supervise and motivate, which is especially important for rural and 
hard to reach postings. Innovative recruitment and retention strategies have been implemented with 
success in some settings. Thailand has historically used a bonding system to improve recruitment of 
health workers for rural areas. Newly qualified health professionals, including doctors and cadres of 
nurses are required to spend a mandatory time period in rural postings. On completion, professional 
qualifications can be upgraded. Evidence suggests this has led to a substantial increase in the numbers 
of trained professionals in rural areas and is partially responsible for the impressive health gains in 
Thailand in the last 25 years (218, 219).  
 
In addition to task shifting there are other immediate, interim strategies that can be put in place. 
These could include improving conditions for the workforce through incentives (220) (financial, 
educational or other), relieving staff of other duties, improving daily working conditions (break areas, 
food vouchers, accommodation on-site or nearby) (221) and improving job satisfaction through 
structured supervision and mentoring efforts (212). Non-rotation of staff out of neonatal care is an 
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important strategy to prevent neonatal staff being shifted annually within the hospital from 
department to department or into other specialties (Figure 4.7). 
 
4.6.2 Health financing priority actions 
4.6.2.1.Budget allocation 
Whilst the health financing issues faced by many low-income countries (LIC) are due to the lack of 
financial resources for health and development overall, and are not unique to the newborn (222), 
those newborns requiring inpatient care are at greater risk due to their need for specialised facility-
based care. Newborns are relatively neglected in official development assistance (25) and specialised, 
intensive care is often perceived as prohibitively expensive. A strong economic case, including the 
relative burden of newborn mortality globally, and the argument for prevention of long-term 
morbidities, is required to advocate for the earmarking of funds specifically for developing and 
sustaining high quality inpatient newborn care. The issue of health financing is explored in greater 
detail in paper 1 of this series (189). 
 
4.6.2.2. Innovative funding and removal of user fees   
The birth of a small or a sick baby can be financially catastrophic for families. Shifting from a reliance 
on out-of-pocket payment to prepayment and risk pooling is a critical part of the health financing 
transition that most countries go through as they get richer (223). Limited risk pooling means that 
insurance and depth of coverage is a common problem for families. Removal of user fees in the public 
sector is a first step, but has associated risks and challenges and must be replaced by alternative health 
financing mechanisms that could include: social health insurance, community based health insurance 
and government supply side financing (224). The success of these schemes is dependent on the 
context within the countries where they are implemented. Rwanda’s community financing scheme is 
backed by compulsory government payments into the scheme and stringent pooling of donor funds 
(225). Provision of coverage for inpatient newborn care within insurance schemes or voucher and 
incentive systems is a neglected area, with often only delivery and basic newborn care being covered. 
Attention to successful schemes that already exist in countries could partially ameliorate the risk of 
financing catastrophe for families when a baby is born small or sick, rather than introducing new 
schemes for sick newborns that may further fragment health financing systems. Sick newborn care is 
frequently not covered by maternity packages or maternal health financing schemes (e.g. Nepal 
vouchers scheme), yet has potentially large expenses associated with it. Schemes using prospective 
case-based systems for inpatient care – as in Kyrgyzstan (218) could be adapted to give higher priority 
to newborn inpatient and special care. Further implementation research is needed for innovative 
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funding mechanisms to identify factors that may facilitate their success and provide recommendations 
for their implementation in different settings. 
 
4.6.3 Community ownership and partnership priority actions 
Whilst reported bottlenecks to high quality inpatient newborn care are similar across regions, 
individual communities differ in their geographical and socio-cultural structures and available 
resources. Enabling maximum effect through tailor-made solutions for a given community will require 
empowering solutions from a grassroots level.  
 
4.6.3.1 Community awareness 
Lack of demand for quality newborn inpatient care may reflect the fatalistic assumption that all small 
and sick babies will die (23). Across settings, country teams highlighted the lack of awareness in 
communities about sick newborns, the treatment processes and their civil rights to access health 
services. Most country teams reported a lack of awareness of the severity of newborn illness and 
knowledge that timely, high quality care can save newborn lives. In some contexts, such as India, there 
are specific care-seeking barriers for newborn girls. The workshops participants’ perceptions strongly 
suggest there is a lack of strategic, targeted health education on newborn health across settings and 
that sensitisation and local community education efforts are needed to reduce fatalism and increase 
care-seeking and demand. Mobilisation of communities using women’s community groups has been 
shown to have a positive effect on a range of maternal and newborn health outcomes, including the 
potential to reduce neonatal mortality in a number of settings (226-228). There is a clear role for 
community volunteers, local role models and community leaders to raise awareness on issues 
surrounding newborn health and the care of sick newborns.  
 
4.6.3.2 Improve care seeking and transport linkages 
Qualitative study of the local barriers and solutions for care-seeking in child health in Kenya, Nigeria 
and Niger highlighted important factors on perceived awareness and the subsequent demand for care 
(229). Lack of trust in health services, perceptions that treatment is ineffective and experience of poor 
quality of care were perceived as important in reducing demand for care. Health services that are out-
of-stock, negative experiences with health workers, or poor communication between staff and 
families, especially mothers, may be detrimental to the care of the newborn. Facilities may need to 
focus on community strategies to improve the patient experience in facilities, especially for mothers. 
It is critical for the mother to spend time with the sick newborn wherever possible, therefore, local 
hospital policy guidelines that encourage family-centred care and take into account the local and 
cultural family structure are vital for mothers to be able to participate in the care of their newborns. 
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Local transport systems are needed to facilitate access between the community and facility, especially 
when newborns are in the facility for long periods of time. Within the facility, involving mothers in 
care, in addition to the necessary support for breastfeeding and expressing milk, can play an important 
part in empowering mothers and securing the linkages between the family and inpatient care (215).  
 
4.6.3.3 Male involvement  
Half of the countries in the workshop specifically reported that there was a lack of male involvement 
in the care of sick newborns. Individual, family, community, societal and policy factors are previously 
identified barriers to male involvement during pregnancy and birth (230). Qualitative research 
suggests men often lament their lack of involvement or understanding of MNH issues (230, 231) – an 
area that is often seen as dominated exclusively by females. Empirical research confirms that for 
pregnancies that are wanted and where men are more educated, men are more likely to be involved 
in maternity-related care (232). The care of sick newborns is no different and tackling barriers to male 
involvement is an issue that spans the care continuum from family planning to the care of a sick 
newborn in a facility. Men often control family finances or have a stronger influence on decision-
making. Women may be removed from their usual schedules when their newborn is sick, leading to 
potential for neglect of other commitments (whether work or household related) and, therefore, may 
need additional support. Use of male role models in the community may help to facilitate this 
transition away from MNH being viewed as an exclusively female domain. Using lessons learned from 
Prevention of Mother To Child Transmission (PMTCT) research (231), interventions to increase male 
involvement in newborn care include addressing hospital policies and staff attitudes in facilities to 
allow for culturally sensitive, inclusive policies for men and families, such as special visiting hours and 
supporting fathers to participate in KMC (193).  
 
4.6.4 Other priority actions 
As highlighted in the analysis, very major or significant bottlenecks were reported across all building 
blocks. Solution themes for three of these building blocks have been discussed in detail above and 
more details on the country-specific bottlenecks for each health system building block are available in 
Appendix E. A few other bottlenecks described were especially relevant to inpatient care. For example, 
India and Pakistan stressed the shortfall in supply of oxygen due to demand and supply gaps. 
Improving oxygen systems within health facilities is key to enable widespread availability when 
required. Oxygen cylinders are still commonly used in many facilities in low and middle-income 
settings, however they are expensive, require filling up regularly and are difficult to transport. Where 
power supplies are reliable, oxygen concentrators can provide a consistent and inexpensive source of 
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oxygen. In view of the emerging epidemic of ROP (97), the use of oxygen in any setting should be 
carefully monitored using pulse oximetry and safe delivery mechanisms to ensure optimum and safe 
saturation levels (97, 197), as described in Figure 4.3. The safe and systematic use of oxygen, as with 
all drugs, needs to involve training and supervision of nurses, doctors, technicians, and administrators 
(96) and appropriate documentation is needed. Commonly prescribed antibiotics for small and sick 
newborns, such as gentamicin, which has potentially adverse effects related to dosage and interval 
(233) need particular attention to safety, especially where therapeutic drug monitoring is not possible 
(234). A number of country teams highlighted newborn inpatient care health information bottlenecks. 
A recent assessment of facility-based neonatal care in Kenya highlighted how poor data were 
potentially undermining the quality of practice (235), especially affecting the assessment of 
gestational age and symptoms of severe illness. At a national level, efforts are needed to strengthen 
the HMIS and to develop basic indicator definitions for monitoring inpatient care with core 
competencies and standards for small and sick newborns by levels of care (15). At the facility level, 
there is a clear need for improved documentation, registration and incorporating the use of regular 
mortality audits (172).  
 
4.7 Limitations 
The data generated from the workshop came from the subjective and consensus views of participating 
national stakeholders, including government representatives and experts. The quality and amount of 
information extracted from these workshops varied depending on the level of knowledge of 
participants about health system issues and facilitation. In addition, bottlenecks were reported as 
perceived bottlenecks relative to the other health system building blocks under exploration. There 
may be instances where known health system challenges or deficits based on robust quantitative data 
may be in conflict with the perceived bottleneck grading. This may be due to the method of grading 
relative to other health system building blocks, or that participants place higher subjective value on 
other areas of their health system. An additional explanation is that groups’ may view certain building 
block areas as easier challenges to overcome based on their knowledge of their setting and expertise 
in the specific newborn intervention being discussed. The tool is comprehensive and detailed, which 
is one of its strengths. However, it also may have caused some workshop fatigue, particularly towards 
the end of the workshop where teams discussed and recorded solutions. For example, for the 
inpatient care questionnaires, Afghanistan completed the bottleneck portion of the questionnaires, 
but did not submit any solutions. The analysis focused only on three tracer items: safe oxygen, IGTF 
and the provision of IV fluids. Other specific components of inpatient neonatal care may have different 
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bottlenecks and solutions, for example, identification of and effective phototherapy for neonatal 
hyperbilirubinemia (67) (Figure 4.4).   
4.8 Future agenda 
Improving inpatient newborn care will require a health systems approach and some countries are 
recognising this need. For example, the securing of political, professional and financial commitment 
in India has led to substantial increases in provision of quality inpatient newborn care (Figure 4.8). 
Previously, particularly in low-income settings, much investment has occurred in delivering public 
health and community-based interventions to improve newborn outcomes. This has led to important 
gains in outcomes, especially in settings with the highest neonatal mortality rates. However, as seen 
historically in high income countries, to reduce neonatal mortality further, attention is first required 
on improved supportive case management (which for the smallest and sickest newborns will require 
inpatient care) and then should be followed by the introduction and scale-up of neonatal intensive 




Figure 4.8 India’s health systems approach to improving inpatient care for small and sick newborns 
Rationale 
India, with an annual birth cohort of 26 million, accounts for highest number of stillbirths and neonatal deaths 
in the world. The neonatal mortality rate (NMR) of India in 2014 was 28 per 1000 live births, which means 
748,000 newborns die each year (191). The NMR in rural areas (33 per 1000 live births) in 2014 was twice 
that in urban areas (16 per 1000 live births) (236). The Government of India, through the launch of the 
National Rural Health Mission in 2005, has made significant efforts to promote institutional deliveries by 
providing conditional cash transfer under Janani Suraksha Yojna (JSY)* and provision of free transport and 
care for pregnant women to reduce out of pocket expenses under Janani Shish Suraksha Karyakram (JSSK)**. 
These efforts contributed to an increase to 73% institutional births in 2009 (237). Despite this progress, 
suboptimal quality of care during birth alongside a lack of specialised care for small and sick newborns 
remains a major challenge to newborn survival.  
Approach taken  
India has focused on strengthening facility-based newborn care through the establishment of special 
newborn care units (SNCUs) at district level and newborn stabilisation units (NBSUs) at block level. These are 
linked with home visits and referrals by 0.9 million Accredited Social Health Activist (ASHA) workers focusing 
on both home deliveries and community follow up of both newborns delivered in hospitals and those 
discharged from SNCUs. The National Health Mission budget for state and districts has a separate budget 
line for facility based newborn care with earmarked resources for facility-based care, including operational 
costs, human resources, drugs and provision for record keeping and data management. To address the access 
barriers and reduce out of pocket expenses, free health care for pregnant women and infants, including 
diagnostics, treatment and drugs, has been made an entitlement. In order to attract and retain workforce, 
states like Madhya Pradesh have successfully used walk-in interviews, performance-based incentives, 
difficult area allowances, enforcement of service bonds and flexibility in place of posting based on individual 
preference.  
Innovations: Education of health care professionals with evidence-based guidelines, using standardised tools, 
on-site job aids and skill building is a daunting task for such a large and diverse country. WHO Collaborating 
Centre at All India Institute of Medical Science (AIIMS) has designed smart phones as an innovative point of 
care tool for management of sick newborns and e-learning as a distance learning strategy for continuing 
education.  To aid the implementation of corrective actions for sick newborns, a real time online data 
monitoring system has been developed by UNICEF and will be scaled-up nationally to monitor performance 
of all SNCUs and tracking after discharge till one year. A national cell has been established to support capacity 
building, monitor data quality and to interpret data for policy and programmatic use.   
Looking Beyond survival Rashtriya Bal Suraksha Karyakram (RBSK)*** programme aims at identifying birth 
defects, disabilities and developmental delays with both community and facility screening, and provision of 
early intervention clinics at district level. 
Results 
All these efforts have resulted in operationalisation of 575 SNCUs and 1810 NBSUs, with states like Madhya 
Pradesh, Rajasthan, Andhra Pradesh, Tamil Nadu and Orissa achieving near universal coverage of SNCUs 
following prescribed standards at district level. However, there are still issues of inadequate human 
resources in these states with slower progress in Chattisgarh, Jharkhand, Bihar and Uttar Pradesh.  The 
monitoring system currently has 13 states with 350 SNCUs inputting online data and more than 650,000 
newborns are registered in the national database. The current inpatient mortality in existing SNCUs was 10% 
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in 2013-14 (238).  Whilst this is not due to health system changes alone, the NMR of India, which had been 
stagnant at 37 per 1000 from 2004 to 2006, has shown a 17% decline during 2008 to 2012 (236).  
Future directions  
There is a need is to accelerate coverage in states where progress is slow, and to focus on quality of care 
and improving long-term outcomes once scale-up has been achieved. To achieve this, the system needs to 
reduce the case load in SNCUs by expediting establishment of kangaroo mother care wards for care of 
stable preterm babies, address high mortality due to respiratory distress by up scaling coverage of 
antenatal steroids, use of continuous positive airway pressure (CPAP) across all SNCUs and continue to 
develop innovative approaches and tools for capacity building of the health workforce, including 
implementation research to evaluate progress. In view of high load of preterm and sick babies with risk 
factors for ROP, the provision of ROP screening and treatment needs to be implemented. The scale–up of 
the real-time data system for online monitoring will be completed by mid-2015 for the whole country 
making it the largest database for small and sick newborns globally.  All these issues have been emphasised 
under the India Newborn Action Plan (INAP)(239), which has set target for a single digit NMR by 2030. This 
will be achievable only with sustained work towards good coverage of quality interventions for newborns, 
including those that are small and sick. 
*Janani Suraksha Yojna (JSY): a conditional cash transfer to promote institutional delivery); **Janani Shishu Suraksha 
Karyakram (JSSK): reducing out of pocket expenses by making free health care an entitlement; ***Rashtriya Bal Suraksha 
Karyakram (RBSK): looks at developmental delays and disabilities, birth defects and deficiencies, covering age group of 0-18 
years of age. Other abbreviations: AIIMS: All India Institute of Medical Science; ASHA: Accredited Social Health Activist; 
CPAP: Continuous Positive Airway Pressure; India Newborn Action Plan (INAP); NMR: Neonatal Mortality Rate; NBSU: 
Newborn Stabilisation Units; ROP: Retinopathy of Prematurity; SNCU: Special Newborn Care Unit; UNICEF: United Nations 
International Children’s Emergency Fund; WHO: World Health Organization.  
Specific areas for action have been highlighted above, with many of these bottlenecks being critical to 
address to enable provision of quality inpatient newborn care (Figure 4.9). Interdisciplinary linkages 
and a focus on better quality data will help identify areas for improvement so that teams delivering 
care to small and sick newborns can plan and implement changes. Ongoing data monitoring helps the 
team recognise their improvement and identify specific areas to focus on in the future, so that the 
exercise is an ongoing cycle. The EMEN package (29) will be crucial to this process. 
4.9 Conclusions 
Whilst major bottlenecks to the scale-up of quality inpatient newborn care are present, in many cases, 
effective solutions exist. Currently, there is a large grass roots commitment to improving care around 
the time of birth to end preventable maternal and newborn deaths and stillbirths, and to improve 
health outcomes as part of the ENAP (6). Improving availability and quality of inpatient newborn care 
has been identified as an important area to achieve the aims of this plan, providing potential for 
political, professional, and financial support to develop and scale-up solutions to these bottlenecks. 
We must build on this momentum, using knowledge of what works to ensure action, so that every 
small and sick newborn baby has access to timely, high quality and family-centred inpatient care as 




Figure 4.9 Key messages and action points for inpatient care of small and sick newborns 
Key messages 
• Each year, there are an estimated 15 million preterm newborns, many of which do not 
have access to inpatient care when needed. Inpatient care for small and sick newborns 
includes the provision of warmth, feeding support, safe oxygen therapy and effective 
phototherapy, with prevention and treatment of infections. This requires dedicated 
ward space, staffed by health workers with specialist training and skills. 
 
• Bottlenecks to the scale up of inpatient care are reported across all health system 
building blocks; countries that graded their bottlenecks most severely were Uganda, 
Afghanistan, Nepal and Pakistan. 
 
• The health system bottlenecks graded highest by the 12 countries in the analysis were 
within health workforce and health financing, followed by community ownership and 
partnership. 
 
Key action points 
• Current health workforce effectiveness for inpatient newborn care could be 
improved through skills-based training for health workers, considering the potential 
for task shifting. There is a critical human resource gap for a neonatal nurse cadre, 
with almost no training programmes outside high income countries; this links to the 
current policy investment for midwives.  
 
• Rather than catastrophic out of pocket payments, addressing health financing 
bottlenecks for newborn inpatient care requires specific, planned and sustained 
funding at a national level. Small and sick newborns need appropriate insurance 
covering their care, similar to the mechanisms for emergency obstetric care.  
 
• Addressing community bottlenecks will require a shift in attitude away from the 
fatalistic assumption that all small newborns will die, towards increased awareness 
and demand for quality inpatient care. This should be accessible and family centred, 
using local resources, involving mothers through kangaroo mother care and long-





Continued from footnote 2. 
ECSB is not the only package of this type that focuses on simulation-based medical education. 
Simulation-based medical education has a long history; it was originally used in the military and 
aviation fields and then introduced to healthcare initially for training in trauma management before 
being adapted for obstetrics and care around the time of birth (240). Randomised controlled trials 
have shown simulation-based training to be superior to didactic and routine undergraduate training, 
particularly through encouraging teamwork and communication and helping students learn a more 
systematic approach to managing emergencies(240-243). Drawing on behavioural theory, studies also 
show it helps skill acquisition, performance and maintenance(243).  
ECSB was used as an example in this chapter due to its explicit focus on small and sick newborns, its 
simulation-based approach as a training programme and its paediatric rather than obstetric, 
focus(210). There are, however, numerous emergency obstetric care training programmes using skills 
and drills or simulation based approaches with newborn components and that have been used with 
success in a wide variety of LMIC settings. The Centre for Maternal and Newborn Health at Liverpool 
School of Tropical Medicine (CMNH-LSTM) EmONC training covers major areas of EmONC and causes 
of newborn death, including newborn resuscitation, treatment of newborn hypoglycaemia, 
hypothermia and infection(243). It is designed using low trainer to trainee ratios and incorporates 
simulation and interactive learning to encourage communication and teamwork. Other important 
examples of such training programmes include Essential Steps in Managing of Obstetric emergencies 
(ESMOE)(240) and PRONTO(241), however, both of these programmes are more focused on time of 
birth than specific care of small and sick newborns. The Pacific Emergency Maternal and Neonatal 
training manual contains sections on newborn resuscitation, preterm birth and newborn 
infection(244). Overall, such training programmes have been shown to result in significant 
improvements in healthcare provider competence and improvements in clinical skills(242). There is, 
however, an identified need for more rigorous operational research in this field looking at how such 
programmes are best scaled up, and whether they result in improved outcomes for mothers and 
babies(243). In addition, many obstetric training programmes may benefit from adding sections on 
care of small and sick newborns as additional modules for health providers caring for women and 






Chapter 5. Service readiness structures and domains for inpatient 
care interventions for small and sick newborns 
5.1 Introduction 
Delivery of interventions to small and sick newborns requires health facilities that are prepared, which 
is termed as “service readiness”. The underpinning principle to service readiness is based on 
traditional quality of care frameworks, such as that conceived by Donabedian (Figure 5.1). The 
framework refers to the structures (the necessary infrastructure, equipment, drugs, health providers 
and guidelines); and some of the processes (actions performed by health professionals with requisite 
training and skills) that are needed to provide a package of care (88, 89).  
 
Figure 5.1. Service readiness as part of the Donabedian Framework 
 
 
*Adapted from the Donabedian model for evaluating the quality of medical care (19, 88, 89)  
 
According to the Donabedian framework, when all of the components of the structural domain are in 
place, it allows for improvements in clinical processes, which in turn lead to improvements in patient 
outcomes (19, 88, 89). To achieve service readiness, the structures not only need to be present, but 
maintained, re-stocked and updated (e.g., equipment requires maintenance, supplies require re-
stocking, guidelines require updating) and staff continually trained and supervised. To deliver a quality 
package of care, therefore, requires strong health systems with the capacity to monitor and track 
service readiness and react appropriately to service needs (101, 245). 
 
Using a process described in Table 5.1, I adapted a list of evidence-based newborn interventions (8, 
16, 193, 246). All newborn interventions were included for this exercise, including essential newborn 
Structure Process Outcome
What are the characteristics of 
the service and its providers: 
Infrastructure, equipment, 
medicines, guidelines?
E.g. Is there a constant oxygen 
supply? Is there equipment to
give safe oxygen to small and 
sick newborns?
What is done to the patients in 
the institution?
E.g. Is oxygen regularly given to 
small and sick newborns? Are
health workers skilled in
delivering oxygen safely? 
What happens to the patients?
How many newborns die? 





care, based on the rationale that small and sick newborns will require these basic interventions in 
addition to inpatient care (16, 246).  
 
Table 5.1. Expert focus group on small and sick newborn care interventions 
Expert focus group on inpatient care interventions 
In April 2016, I convened a group of 14 newborn care technical experts at an Every Newborn 
metrics workshop for a focus group on the interventions and levels of inpatient care for small and 
sick newborns. Participants were purposively selected to represent different high and low 
mortality country contexts (Bangladesh, Colombia, India, Malawi, Nigeria, Peru, South Africa, 
Tanzania, United Kingdom and USA) and types of expertise (nurses, midwives, neonatologists, 
researchers and monitoring and evaluation specialists). The aim was to identify a shortlist of the 
key interventions for inpatient care of small and sick newborns to inform further discussion on 
newborn signal functions (see chapter 4 and chapter 7). The focus group discussion was structured 
on:  
• What are the inpatient newborn care interventions?  
• Which interventions should be provided at each health system level?  
Prior to the workshop, the participants were given background information on the purpose of the 
session and background reading, including: 
https://bmcpregnancychildbirth.biomedcentral.com/articles/supplements/volume-15-
supplement-2 . Acting as facilitator, I gave a short presentation to clarify the problem, and explain 
the purpose and structure of the discussion so that the group understood the task for discussion. 
 
Focus group process 
The focus group involved a two-hour discussion carefully facilitated to give each participant time 
to voice opinions and experience. Detailed notes were collected throughout the discussion by a 
named rapporteur (see appendix H). In the early stage of the discussion, participants found it was 
necessary to delineate inpatient care from routine and emergency care that occurs in the labour 
and delivery room. Participants agreed that routine care for all newborns should be available at 
all facilities where births occur and requires: 
• Thermal protection/warmth  
• Essential care for all newborns (draying, skin-to-skin, delayed cord clamping, hygienic cord 
care, Vitamin K and vaccinations) 
• Early initiation and support for exclusive breastfeeding 
• Neonatal resuscitation  
• Prevention of mother to child transmission for HIV positive mothers. 
 
The remainder of the discussion was focused on the inpatient care interventions. At the end of the 
session, each group participant was given the option to vote for up to (but no more than) eight 
inpatient care interventions split these between different levels as participants deemed 
appropriate. Votes were cast at the end of the session using colour coded markers on a wall chart 
to disseminate results. The wall chart results on inpatient care interventions for small and sick 
newborns and the extensive list discussed by the group are summarised appendix H. The final list 





Figure 5.2 Evidence-based newborn care interventions from routine care for all newborns to 
complex inpatient care for small and sick newborns 
 
*Specialised follow up of high-risk infants did not have specific structural requirements, therefore, is included on the list of 
interventions, but not on the final matrix. There are additional evidence-based interventions for newborns that should also 
be included in the antenatal period – antenatal corticosteroids and antibiotics for preterm premature rupture of 
membranes – and additional follow-up processes that would fall outside of inpatient newborn care and be linked to 
paediatric services.  
As described in chapter 2, Bhutta and colleagues estimated that high coverage of currently available 
interventions along the continuum of care have the potential to save 3 million lives per year by 2025 
(4). Inpatient care for small and sick newborns is an intervention package for which high quality 
coverage could have some of the highest potential impact on newborn deaths, especially in LMIC 
where the greatest proportion and numbers of deaths occur (21, 23, 25). Despite this, there are 
currently no set WHO standards or guidelines for the inpatient care for small and sick newborn 
package. This means that to understand the specific structures needed to deliver quality inpatient 
care, multiple sources of information need to be consulted. As shown in chapter 4, lack of standardised 
guidance and monitoring tools were highlighted as hindering service delivery for inpatient care for 
small and sick newborns. In view of this, the objectives of this chapter are to:  
• Construct a standardised service readiness matrix organised by the health system structural 
domain (infrastructure, equipment, drugs, providers, and guidelines)  
• Essential newborn care (drying, skin-to-skin contact of the 
newborn with the mother, delayed cord clamping, hygienic 
cord care, Vitamin K, eye care and vaccinations)
• Thermal protection
• Early initiation and support for exclusive breastfeeding
• Neonatal resuscitation 
• Prevention of mother to child transmission of HIV
• Kangaroo mother care
• Assisted feeding (including cup feeding, nasogastric feeding)
• Safe administration of oxygen
• Antibiotics for neonatal infection
• Intravenous fluids
• Management of hypoglycaemia
• Effective phototherapy
• Seizure management
• Treatment and screening for retinopathy of prematurity
• Blood transfusion
• Mechanical/assisted ventilation, including intubation
• Continuous positive airway pressure (CPAP)




















• Review existing global guidelines for content relevant to inpatient care for small and sick 
newborns  
• Populate the matrix with structural components relevant to inpatient care 
5.2 Methods 
5.2.1 Review existing global guidelines for content relevant to inpatient care for small and 
sick newborns  
I searched for existing published guidelines for all the newborn interventions, including relevant 
newborn and paediatric guidelines available on the WHO website. AS the WHO website does not have 
an advanced search function, all relevant maternal, newborn and child health guidelines were 
accessed, hand-searched, and relevant guidelines downloaded. Where no WHO guideline existed, I 
consulted relevant resources developed by UNICEF and other partners, including resources from 
international professional associations, such as the American Academy of Paediatrics and Royal 
College of Paediatrics and Child Health.  
 
Based on the journey of the small and sick newborn from birth to inpatient care unit, I organised the 
matrix by six areas: 1) labour and delivery room 2) place of care for small and sick newborns 3) 
pharmacy/medicines, 4) human resources/providers, 5) laboratory & blood bank and 6) transport 
service. I organised interventions by whether they occur in the labour and delivery room or the 
neonatal unit (or both). Human resources and pharmacy were allocated as a separate area given that 
providers and drugs will be needed in multiple places of care. Given that most of the guidelines 
reviewed included information or guidance on referral systems and the associated structural 
components, I included transport system as a separate “area”. Specialised follow up was considered 
a part of paediatric services, therefore, was not given a specific area of the matrix (as this would 
involve adding an entire paediatric section). Finally, given the wide variation in laboratory systems, I 
separated the laboratory and blood bank by capacity to perform certain tests and actions, rather than 
an itemised list of components or equipment. 
 
5.2.1.1 Populate the matrix with structural components relevant to inpatient care 
Following structuring of the matrix and selection of the resources, I was then able to populate the 
matrix with the specific components required to deliver the interventions for small and sick newborns. 
During the process of the guideline review, where items or structural requirements were mentioned 
in the guideline, these were marked on the relevant section the matrix. Clinical knowledge was applied 
when different terminologies were used to ascertain the most neutral and appropriate term for each 
of the structural items so that the list could be used in multiple settings. The matrix was then reviewed 
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and checked by several practicing clinicians (including neonatologists, paediatricians, and nurses) with 
experience in Nigeria, India, Ghana and Malawi, United Kingdom, United States.   
5.3 Results 
For this chapter, I reviewed 23 resource materials; see Table 5.2 for a list of the guidelines and 
resources used for this review. To ensure consistency with existing tools and other areas of care, I also 
reviewed the interagency list of medical devices for essential interventions for RMNCH (247), a master 
list created for newborn health in humanitarian settings by the Inter-Agency Working Group on 
Reproductive Health in Crises (IWAG), UNICEF and Save the Children (248) and the latest version of 
the WHO model essential drugs list (249).  
On the final matrix, I mapped a total of 654 service readiness items for inpatient care of small and sick 
newborns to provide the inpatient care interventions. This included a total 167 structural items in the 
labour and delivery room and 266 in the place for small and sick newborn care (or neonatal unit). I 
listed a total of 33 different potential providers, 114 essential newborn drugs and medicines. Within 
the specific “areas” of the matrix, where equipment items recurred (e.g., components required for 
more than one intervention such as linen, gauze, swabs, weighing scale) I included these under general 
items for either the labour and delivery room or place of care for small and sick newborns. The final 




Table 5.2 Resource materials and guidelines reviewed for newborn interventions 
Essential newborn care, thermal 
protection, early initiation and 
support for exclusive breastfeeding 
WHO essential newborn care course 2010 
WHO early essential newborn care: Clinical practice pocket 
guide 
2014 
Essential care for every baby 2015 
WHO Integrated management of pregnancy and childbirth: 
Pregnancy, Childbirth, Postpartum and Newborn Care: A 
guide for essential practice 
2015 
UNICEF: Baby Friendly Hospital Initiative (BFHI)  2012 
WHO Interagency list of priority medical devices for 
essential interventions for reproductive, maternal, newborn 
and child health 
2015 
Neonatal resuscitation WHO guidelines on basic newborn resuscitation 2012 
Helping Babies Breathe Resources 2017 
WHO guidelines on managing complications in pregnancy 
and childbirth 
2007 
WHO guidelines on managing newborn problems: a guide 
for doctors, nurses and midwives 
2003 
Prevention of mother to child 
transmission of HIV 
WHO guideline update on HIV and infant feeding 2016 
WHO guidelines on antiretroviral drugs for treating pregnant 
women and preventing HIV infection in infants 
2010 
Médecins sans Frontières: Neonatal Care Guidelines 2016 
Kangaroo mother care for premature 
babies, including follow up, 
alternative feeding (including cup 
feeding and nasogastric feeding) 
Essential care for small babies 2015 
WHO kangaroo mother care: A practical guide 2003 
WHO guidelines on optimal feeding of low birth-weight 
infants in low- and middle-income countries 
2011 
UNHCR operational guidelines on improving newborn health 
in refugee operations 
2014 
UNICEF toolkit for setting up special care newborn units, 
stabilisation units and newborn care corners 
No 
date 
WHO recommendations on interventions to improve 
preterm birth outcomes 
 
Injectable antibiotics for neonatal 
infections, hypoglycaemia 
management, effective phototherapy, 
seizure management, administration 
of oxygen 
WHO pocket book of hospital care for children 2013 
Save the children, UNICEF: Newborn care charts 2009 
Treatment and screening for 
Retinopathy of prematurity* 
Guidelines on screening and treatment for retinopathy of 
prematurity  (UK and India) 
2008 
  
Blood transfusion, Mechanical 
ventilation and continuous positive 
airway pressure (CPAP) 
WHO pocket book of hospital care for children 2013 






To the best of my knowledge, this is the first time that service readiness for inpatient care of small and 
sick newborns has been delineated and mapped by structural component. By mapping this 
information in a practical and usable matrix it can be used as a blueprint by implementers for 
programme planning or monitoring purposes; for example, to develop management checklists, budget 
templates or stock inventories. The matrix can be flexible depending on the needs of the service and 
the interventions or packages of care they intend to provide; those providing a limited service may 
only have the capacity to provide a selection of newborn interventions, such as resuscitation, assisted 
feeding and KMC. Overall, the matrix clearly defines the structures required for inpatient care as 
distinct to this package of care, rather than as a sub-set of obstetric or paediatric services.  
5.4.1 Strengths and limitations 
The facilitation of the focus group described in the introduction encouraged participants to account 
for the views that they held and covered different viewpoints in a short space of time. The process of 
the discussion was helpful for the researcher and participants alike to understand the complexity of 
the topic and to consider viewpoints from diverse contexts. The time-constraints and voting process 
also brought pragmatism and help to bring levels of consensus in a short timeframe. Interventions 
that were discussed and debated, but not included in the final list included: total parenteral nutrition 
(which formed an important part of the discussion but was not voted onto the final shortlist); 
surfactant therapy (which many felt was prohibitively expensive for many contexts); and head cooling 
(which participants expressed concerns about the feasibility and lack of evidence base for efficacy in 
LMIC contexts). As with any focus group approach, there may be some contamination of viewpoints 
and more vociferous participants may have influenced or shaped final views and voting choices (250). 
Time limitations meant that much time was focused on the interventions, with less time for discussion 
on the justification for levels of care or a wider consultation process.  
The matrix is limited by the availability of relevant, up-to-date guidelines that are currently published 
and available for the review for the specific interventions outlined in Figure 5.2. As can be seen in 
Table 5.2, some of the resources used are now over a decade old and require updating. As these 
guidelines are revised, the matrix will require updating.  
The matrix was particularly challenging to populate for the more complex interventions, which had 
fewer available, detailed guidelines and paediatric guidelines had to be used: for example, the WHO 
pocket book of hospital care for children (158) covers areas of sick newborn care, but does not provide 
the level of granularity and detail that would be required for more complex care. In some cases, for 
example, retinopathy of prematurity where there were no available global guidelines, recent 
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guidelines recommended by experts were selected for review. However, the guidelines may be more 
context specific and may have certain equipment or items that is differently named or used in different 
settings. For specialised follow up of high-risk infants, I could not delineate the structural requirements 
without adding a full paediatric section, which exceeded the scope of this exercise, which was focused 
on care for small and sick newborns at and around the time of birth. However, the intervention 
remains on the list for consistency with other areas of the thesis and its importance in linking to 
paediatric services and ongoing care.  
Finally, with the growing problem of nosocomial infection and antimicrobial resistance, improved 
antibiotic stewardship is reliant on accurate diagnostics and availability of microbiological 
investigations. Further investigation of the minimum laboratory structural requirements for inpatient 
care of small and sick newborns will be critical but exceeded the scope of this guideline review.  
5.5 Conclusions 
Mapping the health system structures required for delivering inpatient care and delineating these by 
health system domains allowed for the creation of a practical and usable matrix for small and sick 
newborn care. The matrix, which mapped 654 service readiness items for inpatient care of small and 
sick newborns, can be used by implementers for programme planning, depending on the needs of 
their health system and the interventions or packages of care they intend to provide at their service. 
For this PhD, the matrix quantifies and delineates the structural needs for inpatient care, which is a 
prerequisite for exploring measurement of service readiness needs. The matrix, however, is limited by 
the current availability of global guidelines for newborn care. Up to date WHO standards of care for 
inpatient care of small and sick newborns are urgently needed to inform service delivery and 





THEME B: Measurement of service readiness for care of small and sick 
newborns 
 




Chapter 6. Existing tools to measure service readiness for inpatient 
care of small and sick newborns: what can we measure now?  
 
6.1 Introduction  
This chapter presents the results of a review of health facility assessment tools which was carried out 
to address the fourth objective of this thesis to determine gaps in existing measurement tools to 
capture service readiness for inpatient care of small and sick newborns.    
This chapter and the matrix described in chapter 5 (and Appendix I) were written as a research paper 
entitled “Service readiness for inpatient care of small and sick newborns: What do we need and what 
can we measure now?”(17), which was published in Journal of Global Health as an open access article 
in June 2018. For the purpose of this PhD, I divided the paper into two chapters for this thesis as it 
addresses two different thesis objectives. This part of the paper takes the matrix described and 
presented in chapter 5 and reviews this against three multi-country health facility survey tools to 
determine gaps in existing measurement tools to capture service readiness for inpatient care of small 
and sick newborns.  
See Appendix O for the published version of this article. See http://www.jogh.org/contributors.htm 
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Each year an estimated 2.5 million newborns die, mainly from complications of prematurity, neonatal 
infections, and intrapartum events. Reducing these deaths requires high coverage of good quality care 
at birth, and inpatient care for small and sick newborns. In LMIC, standardised measurement of the 
readiness of facilities to provide emergency obstetric care has improved tracking of readiness to 
provide care at birth in recent years.  However, the focus has been mainly on obstetric care; service 
readiness for providing inpatient care of small and sick newborns is still not consistently measured or 
tracked.  
We reviewed existing international guidelines and resources to create a matrix of the structural 
characteristics (infrastructure, equipment, drugs, providers and guidelines) for service readiness to 
deliver a package of inpatient care interventions for small and sick newborns3. To identify gaps in 
existing measurement systems, we reviewed three multi-country health facility survey tools (the 
Service Availability and Readiness Assessment, the Service Provision Assessment and the Emergency 
Obstetric and Newborn Care Assessment) against our service readiness matrix.   
For service readiness to provide inpatient care for small and sick newborns, our matrix detailed over 
600 structural characteristics. Our review of the SPA, the SARA and the EmONC assessment tools 
identified several measurement omissions to capture information on key intervention areas, such as 
thermoregulation, feeding and respiratory support, treatment of specific complications (seizures, 
jaundice), and screening and follow up services, as well as specialised staff and service infrastructure.  
Our review delineates the required inputs to ensure readiness to provide inpatient care for small and 
sick newborns2. Based on these findings, we detail where questions need to be added to existing tools 
and describe how measurement systems can be adapted to reflect small and sick newborn 
interventions. Such work can inform investments in health system to end preventable newborn death 





3 Refer to chapter 5 
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6.3 Introduction to paper 
The first 28 days of life, the newborn period, represents the time of highest risk in the human lifecycle. 
In 2016, an estimated 2.6 million newborns died (2), mainly of complications of prematurity (35%), 
infections (23%), and intrapartum complications leading to birth injury (24%) (2, 3). Preventing deaths 
from these causes requires a combined health systems approach along the continuum of care (4). This 
approach should deliver routine newborn care for all babies (cleanliness, thermal care and support for 
breastfeeding), newborn resuscitation and PMTCT for all babies who need it (7, 8); and timely 
provision of quality inpatient care for babies born small and sick (5, 16). 
Many LBW newborns, especially preterm infants, and those born small for gestational age, require 
support to feed and maintain their temperature. In addition, preterm newborns face increased risks 
of respiratory problems, infections and jaundice (16). Even amongst those born at full term, significant 
numbers of newborns suffer from systemic infections, neonatal encephalopathy, pathological 
jaundice and congenital abnormalities, with high mortality risk in the absence of care (16). “Small and 
sick newborns”, therefore, includes all those babies who require inpatient (facility-based) care to 
survive. The care that small and sick newborns require is not an individual intervention, but a package 
made up of multiple interventions. Previous work has discussed the specific evidence-based 
interventions that comprise this package of care (4, 16, 246). 
Evidence from The Lancet Every Newborn Series (21) informed the design of the Every Newborn Action 
Plan, a multi-partner initiative launched in 2014, backed by a World Health Assembly Resolution. Every 
Newborn aims to end preventable newborn deaths and stillbirths, with national targets of ≤12 
neonatal deaths per 1000 live births and ≤12 stillbirths per 1000 total births by 2030 (6). To achieve 
these targets, Every Newborn partners acknowledge a need to improve the measurement of care at 
birth, and to better track coverage, quality, and equity of care for small and sick newborns around the 
time of birth (15). A dedicated sub-group – Every Newborn metrics - focuses on improving the 
measurement of interventions (15), and has a work stream focused on service readiness for inpatient 
care of small and sick newborns (246). 
Currently, national and facility-based health information systems in LMIC collect few data on service 
readiness for small and sick newborns (15, 21, 172), in contrast with child health programmes, notably 
immunisation, HIV and malaria (251). Data are sparse in sub-Saharan Africa and parts of Asia where 
access to care for small and sick newborns is the lowest, and where many facilities need targeted 
efforts to strengthen services (15, 16). 
Data from functional routine national HMIS and logistics management systems (LMIS) are able, in 
principle, to capture service readiness in a sustainable way, but the content and quality of data in 
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national HMIS are variable in practice. This means many LMIC depend on periodic evaluations, such 
as nationally representative facility surveys or censuses, as a key source of health information to 
monitor the readiness of the health system to provide facility-based care (15, 113, 116). These surveys 
or censuses are referred to as health facility assessments. 
The most common health facility assessment tools are the DHS Programme’s SPA (117), the WHO 
SARA (101), and the EmONC assessments, currently managed by Averting Maternal Death and 
Disability (AMDD) (118) in collaboration with UNFPA. The content of these tools with regards to 
service readiness specifically for inpatient care of small and sick newborns has not previously been 
systematically evaluated. 
Our overall aim was to review the current health facility assessment tools’ ability to capture service 
readiness for inpatient care of small and sick newborns. 
The specific objectives of this article are to: 
o Compare the components of a standardised matrix (chapter 5, Appendix I) against what is 
currently measured by widely used multi-country health facility survey tools (SPA, SARA, 
EmONC assessment) and identify gaps in measurement of the structural and process domains. 
o Synthesise these findings to provide recommendations on how to improve measurement of 
service readiness for inpatient care of small and sick newborns. 
6.4 Methods 
6.4.1 Comparing the components of this standardised matrix against widely used multi-
country health facility survey tools (SPA, SARA, EmONC assessment) and identifying gaps in 
measurement of structural and process domains 
We applied the Donabedian framework (19, 88, 89) as a construct to review health facility assessment 





Figure 6.1 The Donabedian Framework as a construct to review health facility assessment tools 
 
*Adapted from the Donabedian model for evaluating the quality of medical care (19, 88, 89)  
 
We obtained the latest versions of the SARA (version 2.2, revision July 2015) (101) and the SPA (revised 
2012) (117) from their websites. The EmONC assessment tool was being revised at the time of the 
study and we obtained the version undergoing field-testing from AMDD in July 2016. 
We reviewed the SARA core questionnaire tool, the SPA health facility inventory and health worker 
interview, and the latest versions of the relevant modules from the EmONC assessment, (Module 1: 
Identification of facility and infrastructure; Module 2: Human Resources; Module 3: Essential drugs, 
equipment and supplies; Module 5: EmONC interventions; and Module 7: Provider knowledge and 
competency for maternal & newborn care). 
We compared the content of each of the tools to the structural components in our matrix. To identify 
gaps in structural components we checked: 
• Does the tool measure the infrastructure, equipment, drugs, health providers and/or guidelines 
needed to provide the interventions? 
Many of the tools are also designed to also measure aspects of the process domain in the service 
readiness framework (Figure 6.1). Therefore, measurement of regular practice or training was 
considered as a proxy measurement of the process domain for service readiness (as it looks at what is 
regularly done to patients in the institution). For each of the 18 interventions included in the package 
of care (Figure 5.2), we also checked: 
• Does the tool measure whether staff are given any training to provide the intervention? 
Structure Process Outcome
What are the characteristics of 
the service and its providers: 
Infrastructure, equipment, 
medicines, guidelines?
E.g. Does the tool measure if 
there is an oxygen supply?
Facility inventory, health worker 
interview
What is done to the patients in 
the institution?
E.g. Does the tool measure when 
the service last gave oxygen to 
sick newborns?
Health worker interview, 
register review and/or clinical 
observations
What happens to the patients?
E.g. Does the tool measure how 
many newborns die? Does the 
tool measure how many 
newborns are discharged alive?




• Does the tool measure if the intervention is regularly performed? 
The first author (SM), completed the review of each tool. The review of the health facility assessment 
tools was verified by a representative of the lead agency for the EmONC assessment and the SPA to 
ensure the findings were consistent with the most recent versions of the tool. 
6.5 Results 
6.5.1 Comparison of the components of the standardised matrix against widely used multi-
country health facility survey tools (SPA, SARA, EmONC assessment) and identification of gaps 
in measurement of structural and process domains 
The SPA, the SARA and the EmONC assessment tools are summarised in Table 6.1. All three tools have 
different purposes, are measured at different intervals, and have different approaches to 
measurement and sampling. 
Table 6.2 and Table 6.3 summarise the review of the interventions showing the structures and 
processes currently measured by the SPA, the SARA and the EmONC survey tools, and highlighting 




Table 6.1. Summary of three multi-country health facility assessment tools: Service Provision Assessment, Service 
Availability and Readiness Assessment and Emergency Obstetric and Newborn Care Assessment 
 Service Provision 
Assessments (SPA) 
Service Availability and 
Readiness Assessment (SARA) 
Emergency Obstetric and 
Newborn Care (EmONC) 
Assessment 
Purpose of tool For comprehensive 
monitoring of a country’s 
formal health care system; 
monitors the overall 
availability of different facility-
based health services in a 
country and their readiness to 
provide those services 
For assessing readiness of 
facilities using a standard set of 
indicators that cover all main 
health programmes. Only 
designed to assess service 
readiness (not performance or 
client perspectives) 
For monitoring and assessment 
of the availability, use and quality 
of routine and emergency 
obstetric and newborn care in 
the formal health system.  
Organisation(s) The Demographic and Health 
Survey (DHS) Program, United 
States Agency for 
International Development 
(USAID) 
World Health Organization 
(WHO), USAID 
Averting Maternal Death & 
Disability (AMDD), United 
Nations Population Fund 
(UNFPA), United Nations 
Children’s Fund (UNICEF), WHO. 
Sample Sample survey or census of 
formal sector health facilities 
designed to provide nationally 
representative results by 
facility type, managing 
authority, and geographic 
region. 
Sample survey or census of at 
least 150 public and private 
facilities  
 
Census of hospitals and census or 
sample of lower-level delivery 
sites (public and private 
facilities). Sample may be 
random, or selection may be 
restricted lower-level facilities 
that meet a specific volume of 
deliveries. 
Modules Facility inventory, exit 
interviews (antenatal care, 
family planning, sick child), 
clinical observations 
(antenatal care, family 
planning, sick child), health 
worker provider interviews 
Facility inventory, health worker 
interview  
Facility inventory, human 
resources, essential drugs, 
equipment and supplies, facility 
case summary, Emergency 
Obstetric Care (EmOC) signal 
functions, provider knowledge 
for maternal and some newborn 
care & chart reviews. 
Numerator for 
indicators 
Number of facilities ready to 
provide MNCH, family 
planning, HIV/AIDS, STIs, 
Malaria, Tuberculosis, basic 
surgery, non-communicable 
diseases services.  
Proportion of health facilities, 
number of core medical 
professionals, proportion of 
facilities offering a defined 
service and the density and 
distribution of the facilities 
Number of facilities providing 
EmOC, number of facilities 
providing each EmOC signal 
functions by level of care. 
Denominator 
for indicators* 
All formal facilities All facilities,  
per 10,000 population 
All surveyed facilities by level of 
care; availability of EmOC is 
measured per 500,000 
population or 20,000 births* 
 
Timeframe  15-18 months to complete 
fieldwork and report 
Variable, but shorter than SPA or 
EmONC 
12-18 months to complete field 
work and report 
Frequency 4-5 yearly intervals Designed to be repeated annually 4-5 yearly intervals 
*
(note discussion ongoing on whether denominator should measure births or population); expected number of births is the denominator 




Table 6.2 A summary of the Service Provision Assessment (SPA), Service Availability and Readiness 
Assessment (SARA) and Emergency Obstetric and Newborn Care (EmONC) assessment tool’s capacity 
to measure domains of service readiness for newborn interventions in the labour and delivery room 
Intervention and components of structural domain Health facility assessment tool 
 
SPA SARA EmONC 
Immediate/essential newborn care: 
Infrastructure Y Y Y 




Training Y Y Y 
Routine practice Y Y Y 
Thermal protection: 
Infrastructure Y Y Y 
Equipment & drugs    
Guidelines Y Y Y 
Training Y  
 
Routine practice Y  Y 
Immediate and exclusive breastfeeding: 
Infrastructure   
 
Equipment & drugs   Y 
Guidelines Y  Y 
Training Y Y Y 
Routine practice Y Y Y 
Resuscitation with bag and mask: 
Infrastructure Y Y Y 
Equipment & drugs Y Y Y 
Guidelines Y Y Y 
Training Y Y Y 
Routine practice Y Y Y 
PMTCT if HIV-positive mother:† 
Infrastructure  Y Y Y 
Equipment & drugs Y Y Y 
Guidelines Y Y Y 
Training Y Y Y 
Routine practice Y Y Y 
EmONC – Emergency Obstetric and Newborn Care, SPA – Service Provision Assessment, SARA – Service 
Availability and Readiness Assessment 
*Y – measured by the tool. †May only be applicable in settings with high HIV prevalence. 
141 
 
Table 6.3 A summary of the Service Provision Assessment (SPA), Service Availability and Readiness 
Assessment (SARA) and Emergency Obstetric and Newborn Care (EmONC) tool’s capacity to 
measure domains of service readiness for interventions in the newborn inpatient care unit 
Intervention and components of structural domain Health facility assessment 
tool  
SPA SARA EmONC 
Kangaroo mother care (KMC) including follow up: 
Infrastructure    
Equipment & drugs    
Guidelines   Y 
Training Y  Y 
Routine practice Y Y Y 
Alternative feeding if baby unable to breastfeed (cup feeding and nasogastric feeding): 
Infrastructure    
Equipment & drugs    
Guidelines    
Training    
Routine practice   Y 
Safe administration of oxygen (including equipment for resuscitation): 
Infrastructure Y Y Y 
Equipment & drugs   Y 
Guidelines   Y 
Training   Y 
Routine practice   Y 
Intravenous fluids and management of hypoglycaemia: 
Infrastructure   
 
Equipment & drugs   Y 







Injectable antibiotics for neonatal infection: 
Infrastructure  Y Y Y 
Equipment & drugs Y Y Y 








Infrastructure    
Equipment & drugs    
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Guidelines    
Training    
Routine practice    
Seizure management: 
Infrastructure Y Y Y 
Equipment & drugs Y Y Y 
Guidelines    
Training    
Routine practice    
Continuous positive airway pressure and assisted/mechanical ventilation: 
Infrastructure Y Y Y 
Equipment & drugs    
Guidelines    
Training    
Routine practice    
Blood transfusion for newborns: 
Infrastructure Y Y Y 
Equipment & drugs    
Guidelines    
Training    
Routine practice    
Treatment and screening for retinopathy of prematurity: 
Infrastructure    
Equipment & drugs    
Guidelines    
Training    
Routine practice    
EmONC – Emergency Obstetric and Newborn Care, SPA – Service Provision Assessment, SARA – Service 
Availability and Readiness Assessment 
*Y – measured by the tool. 
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Table 6.4 shows an example minimum drug list for inpatient care of small and sick newborns showing rationale for use in newborns and what is measured 
by the SPA, SARA and EmONC assessment tools. 
Table 6.4 Example minimum drug list for inpatient care of small and sick newborns showing rationale for use in newborns and summary of the SPA, 
SARA, EmONC tools and essential medicine list* 
Drug name SPA SARA EmONC EML Drug description/use 
Antibiotics 
Amoxicillin (oral suspension) Y Y Y Y Penicillin antibacterial for neonatal infections 
Amoxicillin (injection) 
  
Y Y Penicillin antibacterial for serious neonatal infections 
Amikacin (IV or IM) 
   
Y Aminoglycoside antibacterial; alternative treatment of ophthalmia neonatorum 
Ampicillin (IV or IM) Y Y Y Y Penicillin antibacterial for serious neonatal infections 
Ampicillin (oral) 
    
Penicillin antibacterial for neonatal infections 
Azithromycin (oral) Y Y 
 
Y Penicillin antibacterial for P-PROM (maternal use) 
Benzathine benzylpenicillin 
(benzathine penicillin G) (IM) 
Y Y 
 
Y Penicillin antibacterial for treatment of congenital syphilis 




Y Y Penicillin antibacterial for serious neonatal infections 
Cefalexin (oral suspension) 
   
Y First generation cephalosporin used in newborns for skin and soft tissue infections  
Cefotaxime (IV or IM) 
  
Y Y First generation cephalosporin with broad spectrum for treatment of serious neonatal 
infections 
Ceftriaxone (IV or IM) Y Y Y 
 
Third generation cephalosporin for neonatal infections, genital gonococcal and/or 
chlamydial infection 
Ciprofloxacin (injection) 
   
Y Second generation fluoroquinolone antibacterial sometimes used as second line 
treatment 
Ciprofloxacin (oral) Y Y 
 
Y Second generation fluoroquinolone antibacterial for treatment of bacterial diarrhoea 
Clindamycin (IV) 
  
Y Y Lincosamide antibacterial, second line treatment (e.g., streptococcal or soft tissue 
infections) 








    
Penicillin antibacterial used for neonatal skin infections 
Cotrimoxazole (oral) Y Y 
  
Combined antibiotic for prophylactic treatment of HIV 
Erythromycin (oral) Y 
 
Y Y Penicillin antibacterial for P-PROM (maternal use) 
Flucloxacillin (IV/IM) (cloxacillin) 
  
Y Y Penicillin antibacterial treatment for neonatal sepsis 
Flucloxacillin (oral) 
  
Y Y Penicillin antibacterial. Can be used in newborns as follow on from intravenous 
flucloxacillin 
Gentamicin (IM or IV) Y Y Y Y Aminoglycoside antibacterial used for treatment of neonatal sepsis 
Isoniazid (oral) Y Y 
 
Y Antituberculous antibacterial used occasionally for congenital TB 
Kanamycin 
   
Y Aminoglycoside antibacterial; alternative to gentamicin 
Metronidazole (IV) Y Y Y Y Antiprotozoal antibacterial used for neonatal meningitis and/or anaerobic bacterial 
infections 
Metronidazole (oral) Y Y 
 
Y Antiprotozoal antibacterial used for neonatal meningitis and/or anaerobic bacterial 
infections 
Procaine benzylpenicillin (IM) 
 
Y Y Y Penicillin antibacterial used for congenital syphilis 




   
Y Sedative, anticonvulsant, muscle relaxant mostly used for neonatal tetanus 
Diazepam emulsion (IV) Y Y Y Y Sedative, anticonvulsant, muscle relaxant used for neonatal tetanus 
Midazolam (oral solution) 
   
Y Sedative, anticonvulsant used for seizures 
Paraldehyde (rectal) 
    
Anticonvulsant for seizures 
Phenobarbital (IV or IM) 
 





Y First line anticonvulsant for tonic clonic and partial seizures 
Phenytoin (IV) 
  
Y Y Anticonvulsant for tonic clonic and partial seizures 
Emergency drugs: 











Y Y Y Parasympatholytic, antispasmodic used for intubation 
Calcium gluconate (injection) Y Y Y Y Used for hypercalcaemic seizures and hyperkalaemia 
Hydrocortisone (injection) Y 
 
Y Y Steroidal anti-inflammatory used for hypotension or severe broncho-pulmonary 
dysplasia 




Y Y Specific opioid antagonist for respiratory depression in newborns 
Analgesics: 
Ibuprofen (IV) 
   
Y Analgesic sometimes used in newborns for closing patent ductus arteriosus 
Morphine (IV) Y Y 
 
Y Centrally acting opioid analgesic for severe pain, sedation and intubation 
Morphine (oral) 
 
Y Y Y Used for severe pain 
Paracetamol (oral) Y Y Y Y Analgesic for minor pain 
Paracetamol (suppository) 
   
Y Analgesic for minor pain 
Paracetamol (injection) 
    
Analgesic for minor pain. Also used for newborns for closing patent ductus arteriosus. 
Corticosteroids: 
Betamethasone (IM)  Y Y Y 
 
Not used in newborns; used in mothers with threatened preterm labour <34 weeks 
gestation for fetal lung maturation 
Dexamethasone (IM) Y Y Y Y Not used in newborns; used in mothers with threatened preterm labour <34 weeks 
gestation for fetal lung maturation 
IV fluids: 
Calcium gluconate 10% Y Y 
 
Y Supplement used to treat calcium deficiency. Dependent on programme context - 
careful monitoring required 
Dextrose 10% with normal saline Y 
 
Y Y Solution used for maintenance fluid therapy 
Dextrose/glucose 5% Y Y Y Y Solution used as vehicle for administration of IV drugs 
Dextrose/glucose 10% 
 
Y Y Y Solution for treatment of hypoglycaemia and maintenance fluid therapy on first day of 
life for sick babies who cannot feed 
Potassium chloride (KCl) 7.5%, 10%, 
15% 
   
Y Solution only to be used in contexts where monitoring of potassium levels is available. 
Sodium bicarbonate 
   
Y Solution used to dissolve artesunate 
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Sodium chloride 0.9% Y Y Y Y Solution used as a vehicle for administration of IV/parenteral drugs, fluid replacement 
and flushing IV lines 
Ringer’s lactate Y Y Y Y Compound solution for severe dehydration/hypovolaemia can be added to 
dextrose/glucose for a mix 
Water for injection 
    
Sterile water for mixing drugs 
Anti-malarials: 
Artesunate (IV or IM) Y Y 
 
Y First line treatment for neonatal malaria 
Artesunate (rectal) Y Y 
 
Y Neonatal malaria treatment if IV/IM access not available 
Arthemeter (IM) 
   
Y Second line treatment for neonatal malaria 
Artemisinin-based combined 
therapy (oral) 
Y Y Y Y Second line anti-malarial treatment followed by ACT 
Antiretrovirals (may vary depending on national HIV guidelines): 
Azidothymidine/Zidovudine (AZT) 
(oral) 
Y Y Y Y Antiretroviral 
Lamivudine Y Y Y Y Antiretroviral 
Nevirapine (NVP) (oral) Y Y Y Y Antiretroviral 
Other drugs: 
Aciclovir (IV) 
   
Y Antiviral used for herpes and encephalitis 
Acyclovir 3% topical eye ointment 
   
Y Antiviral active against herpes virus used to prevent neonatal herpes keratitis in babies 
born to mother with genital herpes 





To prevent Rhesus disease (haemolytic disease of the newborn) given to mothers 
Caffeine citrate (oral) 
   
Y Preventive treatment for apnoea 
Caffeine citrate (IV) 
   
Y Oral preferred over IV 
Chlorhexidine digluconate 7.1% gel 
(delivering 4% chlorhexidine) 
Y 
 
Y Y topical treatment of omphalitis 
Domperidone 
    
Anti-reflux drug for gastro-oesophageal reflux 
Ethambutamol (oral) Y Y 
 
Y First line oral anti-tuberculous drug 
Ferrous fumarate (oral) Y 
 
Y Y Oral suspension used for preterm neonates to prevent iron deficiency 
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Folic acid Y Y Y Y Oral suspension used for folate supplementation 
Fluconazole (IV) 
   
Y Antifungal drug used in newborns over 1 week 





Y Diuretic used for chronic lung disease, oedema in advanced settings 
Furosemide (oral) Y 
 
Y Y Diuretic 
Glycerin chip 
    
Suppository used in newborns to stimulate stooling 
Hepatitis B immune globulin (HBIG) 
    
Treatment of Hepatitis B in neonates 
Human milk fortifier 
    
Fortifier adds protein, calories and micronutrients to expressed breastmilk for LBW 
babies 
Insecticide treated bed nets (in 
malaria endemic areas) 
Y Y Y 
 
For mothers’ beds in KMC ward and for discharge home 
Lidocaine solution Y Y Y Y Local anaesthetic 
Miconazole cream (or equivalent 
e.g., gentian violet) 
Y 
  
Y Topical antifungal for candida dermatitis used for nappy area 
Multivitamin 
    
Containing zinc, vitamin A etc. 
Nystatin (oral solution) Y 
 
Y Y Topical antifungal for oropharyngeal candidiasis used prophylactically with antibiotic 
treatment 
Nystatin cream 
   
Y Topical antifungal 
Omeprazole (IV) Y 
  
Y Acid blocker for gastro-oesophageal reflux 
Omeprazole (oral) Y 
  
Y Acid blocker for gastro-oesophageal reflux 
Oral rehydration solution Y Y Y Y Powder to mix with drinking water for oral rehydration; breastmilk feeding should be 
encouraged 
Oxygen supply 
   
Y Medical inhalation gas for treatment of respiratory distress 
Phosphate and calcium 
supplements 
    
Supplementation 
Potassium Chloride (1mmol/ml) 
(oral) 
   
Y Powder solution for maintenance oral potassium replacement 
Pyridoxine (oral) 
   
Y Preventive therapy for tuberculosis 
Pyrazinamide (oral) Y Y 
 




   
Y Antacid drug for gastro-oesophageal reflux 
Ranitidine (oral) 
   
Y Antacid drug for gastro-oesophageal reflux 
Rifampicin (oral) Y Y 
 
Y First line oral anti-tuberculous drug 
Sucrose 30% (oral) 
    
Non-pharmacological pain management for minor procedures (e.g., cannulation) 
Tetanus immunoglobulin (HTIG) 
(IM) 
  
Y Y Anti-tetanus immunoglobulin for treatment of neonatal tetanus 
Vitamin B6 (pyridoxine) (IV or IM) 
    
Vitamin for B6 deficiency 
Vitamin D 
    
Supplementation. 
Vitamin K1 (Phytomenadione) (IM 
or IV) 
  
Y Y Vitamin and anti-haemorrhagic for prophylactic treatment of haemorrhagic disease of 
the newborn 
Water based lubricant 
    
For inserting suppositories and/or other procedures. 
Zinc oxide cream 
    
Topical for nappy/diaper rash 
Vaccines: 
BCG vaccine Y Y Y Y Prevention of TB 
Diphtheria Y Y 
 
Y Prevention of diphtheria 
Pertussis vaccine Y Y 
 
Y Prevention of pertussis 




Y Prevention of haemophilus influenzae type B 
Hepatitis B vaccine Y Y 
 
Y Prevention of hepatitis B in countries where perinatal infection is common, as per 
vaccination schedule 
Oral poliomyelitis vaccine Y Y Y Y Prevention of poliomyelitis 
Tetanus toxoid Y Y Y Y Prevention of tetanus in wound management, prevention of maternal and neonatal 
tetanus in pregnant women 
EmONC – Emergency Obstetric and Newborn Care, SPA – Service Provision Assessment, SARA – Service Availability and Readiness Assessment, EML – Essential Medicines 
List, IM – intramuscular, IV – intravenous 
*Y – measured by the tool. 
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For ease of presentation, and to avoid repetition, we summarise the findings from the review in this 
section by structural and process domains. 
6.5.2 Gaps in structural domain 
6.5.2.1 Infrastructure 
All three tools measured elements of general health facility infrastructure, such as electricity supply, 
means of communication, referral and transport and availability of water, toilets/latrines and waste 
disposal. 
All tools measure availability of a table or surface for performing resuscitation. Some infrastructural 
requirements to support essential newborn care both in the labour and delivery room and the 
postnatal ward, such as space, privacy (screens) for mother to express breastmilk and infrastructure 
for storage of breastmilk (and whether there is consistent power supply for refrigeration) were not 
measured by any of the tools. All tools collect details on infrastructure to provide PMTCT. 
The SPA measured space for mothers to provide KMC in its facility inventory, but only the EmONC 
assessment asked about space allocation for sick newborn care or a special care unit (e.g. 
infrastructure to provide services beyond KMC, such as assisted feeding, thermal protection, fluids 
and/or oxygen support). As oxygen is a crosscutting infrastructural component needed for several 
interventions outside of newborn health, all tools measured availability of an oxygen source. However, 
none of the tools  measured the newborn-specific infrastructure that would be needed for safe oxygen 
therapy for newborns. Continuity of electricity and oxygen is especially important for facilities offering 
care for small and sick newborns who may be dependent on consistent oxygen source and/or electric 
equipment. None of the tools measured service readiness infrastructure for screening services (for 
example, developmental milestones, hearing and vision) or follow-up for high-risk infants. 
None of the tools measured advanced infrastructure for intensive care for very small and sick 
newborns, such as that required for mechanical ventilation, newborn blood and/or exchange 
transfusion, and specialist laboratory infrastructure beyond that needed for obstetric, and some 
paediatric and adult services. 
6.5.2.2 Equipment 
All tools measured provision of basic equipment for neonatal resuscitation, including smaller-sized 
face masks and resuscitation bag in the labour and delivery room. None of the tools measured 
whether resuscitation equipment was available in the room where small and sick newborns are cared 
for to ensure safety and continuity of care. 
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Simpler interventions for small newborns, such as assisted feeding (plastic feeding cups and small 
sized nasogastric tubes) were only measured by the EmONC assessment, and hats or caps (including 
small sizes) are not consistently measured among the tools. 
Phototherapy equipment needed to treat neonatal jaundice was only measured by the EmONC 
assessment (fluorescent tubes and icterometry). Lower cost phototherapy technologies, such as LED 
phototherapy devices were not included in any of the tools. 
Although the infrastructure for oxygen was measured, most likely for paediatric and adult services, 
safe delivery of oxygen to newborns requires significant additional equipment items, such as newborn 
pulse oximetry, neonatal nasal prongs, oxygen-air blenders, low-flow metres and humidifiers, which 
were not captured by the tools. 
Higher level respiratory support for newborns, such as CPAP ventilation, was not measured by any of 
the tools. Our matrix shows that for safe delivery of CPAP, beyond the drivers themselves, facilities 
would require critical emergency equipment in case of pneumothorax such as transilluminators, chest 
tubes and valves. 
Intubation equipment (e.g., laryngoscopes blades in small sizes) were measured by the EmONC 
assessment, but other critical components to support a ventilated newborn were not measured, 
including the ventilator machine. 
6.5.2.3 Drugs 
The EmONC assessment tool had the most extensive list of drugs and medicines for newborns detailing 
106 medicines and drugs for mothers and newborns, but very few of these are specified for newborns. 
There were several notable omissions of medicines for care at birth within the SPA and SARA, such as 
vitamin K (SPA only asks whether it is routinely administered). 
All three tools measured antibiotic drugs for treating small and sick newborn infections (amoxicillin 
oral and injection, ampicillin injection and gentamicin injection as a minimum). However, inventories 
did not seek to specify whether the antibiotic was available in the injectable form, with the 
appropriate concentrations and diluents (usually water for injection, sodium chloride 0.9% and 
glucose 5%), or the availability of smaller intravenous cannulas/catheters and syringe drivers. The 
tools measured standard intravenous fluid preparations, but only EmONC included glucose 10%, which 
is most frequently used for neonates. For seizure management, only the EmONC tool measured the 
first- and second-line treatments (intravenous phenobarbitone and phenytoin). 
Several drugs that might be used for advanced level care, such as procedural sedation and pain relief, 
were not currently included in any of the tools. 
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In Table 6.4 we present an example drug list for inpatient care of small and sick newborns indicating 
which drugs are measured by each tool and whether these are on the most recent WHO model 
essential medicines list(252). This includes the commodities needed for retinopathy of prematurity 
screening and treatment, such as dilating and anaesthetic eye drops, which are not currently included 
in existing tools. 
6.5.2.4 Health providers 
There were several notable gaps in measurement of specialist newborn staff. Only the EmONC tool 
measured specialist staff cadres for newborns (e.g., neonatologist) and none of the tools measured 
specialist neonatal nurses. Allied staff and support staff (e.g., social workers, speech therapist) were 
not measured. None of the tools measured ophthalmologists or related professions that are needed 
in settings where newborns may require screening and treatment for retinopathy of prematurity, or 
biomedical engineers for equipment maintenance. 
6.5.2.5 Guidelines 
The table of guidelines used for the matrix and review is shown in chapter 5 (Table 5.2). There were 
notable gaps in available guidelines for some of the more complex interventions and the specialist 
diagnostics needed for continuous positive airway pressure, blood transfusion, exchange transfusion, 
ventilation, and treatment and screening of retinopathy of prematurity. 
6.5.3 Gaps in process domain 
Measurement of regular practice or training of health staff in specific interventions was considered as 
a proxy measurement for the process domain for service readiness as it looks at what is regularly done 
to patients in the institution. 
6.5.3.1 Measurement of regular practice 
All the tools relied on direct health worker reports, the register, or chart reviews to measure whether 
select interventions were regularly provided for small and sick newborns. 
The SPA looked at whether a limited number of interventions relevant to newborns (neonatal 
resuscitation and corticosteroids for preterm labour) were ever practiced and practiced in the last 3 
months. The SPA also included a series of questions on essential care for newborns, but none on 
inpatient care for small and sick newborns, other than if KMC was practiced in the facility. 
The SARA asked whether a limited number of functions were provided in the last 12 months: 
antibiotics for preterm or prolonged premature rupture of membranes, antenatal corticosteroids, 
neonatal resuscitation, KMC, and injectable antibiotics. 
152 
 
The EmONC assessment had the most detailed list of newborn interventions (newborn resuscitation, 
antenatal corticosteroids, antibiotics for preterm premature rupture of membranes, antibiotics for 
neonatal infections, KMC, administration of oxygen and administration of IV fluids). 
The EmONC tool included specific knowledge questions on small and sick newborn care, including a 
few interventions, such as resuscitation, oxygen therapy and infections. 
Table 6.5 summarises the approaches used by each of the tools to capture regular practice and 
training. 
The synthesis of these findings to provide recommendations on improving these measurements is 
provided in the discussion section. 
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Table 6.5 The approach used by Service Provision Assessment (SPA), Service Availability and Readiness Assessment (SARA) and Emergency Obstetric and Newborn Care 
(EmONC) tools to measure regular practice and training for interventions included in the tools 
 SPA SARA EmONC 
Regular practice Training Regular practice Training Regular practice Training 
Essential newborn care 
 
 
Routinely practiced Training in last 24 months Routinely carried out Training in last 24 months Performed in last 3 
months 




 Training in last 24 months   As part of essential 
newborn care 
As part of essential 
newborn care 
Early initiation and support 
for exclusive breastfeeding 
Routinely practiced Training in last 24 months Routinely carried out Training in last 24 months As part of essential 
newborn care 
As part of essential 
newborn care 
Neonatal resuscitation with 
bag and mask 
Ever practiced, 
practiced in last 3 
months 
Training in last 24 months Practiced in last 12 
months 
Training in last 24 months Performed in last 3 
months 
Ever received training 
Prevention of mother to 
child transmission of HIV 
 
Routinely practiced Training in last 24 months Service is offered Training in last 24 months ARVs given to newborns 
in the last 3 months 
Ever received training 
Kangaroo mother care  
 
 
Ever practiced Training in last 24 months Practiced in last 12 
months 
 Performed in the last 3 
months 
Ever received training 
Assisted feeding (cup 
feeding and nasogastric 
feeding) 
    Performed in last 3 
months 
 
Safe administration of 
oxygen 
 
    Performed in last 3 
months 
 
Injectable antibiotics for 
neonatal infection 
 
 Training in last 24 months Practiced in last 12 
months 
 Performed in last 3 
months 










Our review of three health facility assessment tools identified measurement gaps for almost all 
newborn interventions, even for the more basic interventions, such as thermoregulation and feeding. 
The most significant measurement gaps are for more complex interventions, which are currently not 
captured by any of the tools in our review. We found many commonalities among these tools, but also 
highlighted important differences that show how they have evolved with important, but distinct 
purposes, and different measurement approaches (103). The size and cost of these assessments 
already limits the frequency of carrying out these surveys; adding a long list of indicators for small and 
sick newborn care would compound this challenge (253). To improve the existing tools, we found that 
a number of indicators for basic service readiness could be harmonised, and some proxy indicators of 
service readiness for more complex care could potentially be added. As with other more complex 
areas of care, monitoring all the structures and processes for small and sick newborns will likely 
require a facility-based monitoring system (254-256). 
Used in tandem with the matrix in the previous chapter (Appendix I), this work is a step towards 
developing a more general facility-based monitoring system or core module. Following validation, 
such a tool could be adapted for different settings as has been done in India (254-256). 
The following sections provide a synthesis of findings and recommendations for improving the widely 
used tools for measurement of small and sick newborn care. 
6.6.1 Harmonisation of existing health facility assessment tools 
6.6.1.1 Indicators 
The interventions that are best represented by the existing tools are those that have been promoted 
as vertical programmes, such as neonatal resuscitation (which is a core indicator for obstetric and 
newborn care assessments), essential newborn care (for all babies) and PMTCT. The measurement 
approach and indicators for many of the more basic newborn interventions would benefit from more 
standardisation between tools. As a minimum, this should include service readiness indicators for 
essential newborn care (including service readiness for drying, skin to skin contact, cord clamping and 
initiation of breastfeeding), neonatal resuscitation and KMC (253). 
All of the existing tools have some questions on KMC, but for monitoring of operational KMC (253), 
the facility inventories require adaptations to incorporate more of the items needed for KMC including 
the equipment for feeding support, antibiotics and amenities for mothers to stay in the facility (15, 
193, 257). Whilst listing the items needed for antenatal care exceeded the scope of this exercise, these 
should be considered in future tools, such as availability of antenatal corticosteroids for threatened 
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preterm labour, antibiotics for preterm rupture of membranes (per WHO guidelines) as a minimum 
(258). 
Measurement of training and skills for newborn interventions could be harmonised between tools 
such that these indicators are comparable between different surveys (see Table 6.5). 
6.6.1.2 Crosscutting service readiness needs 
Health providers, especially midwives and specialist nurses, play a critical role in neonatal care (5, 16, 
30, 208, 259). Specially trained neonatal nurses may not be available in all health facilities, but 
previous studies show it is important to monitor who, if anyone, cares for newborns in the absence of 
specialised staff (16). Recent studies in higher income settings, where neonatal nursing is a specialist 
cadre, show that reducing the nurse-to-patient ratio in neonatal units increases in-hospital mortality 
(207, 259). As a minimum, all health facility assessment survey tools could include questions on staff 
rotation policies to ensure specialist staff are not regularly being rotated to other areas of care (16), 
however this is currently only included in the EmONC tool. Other allied and supportive professionals 
may be a necessary addition to the list of staff cadres, such as biomedical engineers for maintaining 
equipment and nursing support staff. For all health facility assessment tools, the capacity and 
readiness of a facility to provide referral to facilities that can provide more complex care for small and 
sick is a critical indicator of service readiness. The difficulty and inconsistency in measurement of 
provider skills and training also illustrates the need for further research into human resource tracking, 
and work to set benchmarks for staffing ratios for neonatal care (16). 
Infection prevention and control is essential for all areas of the facility with newborns particularly 
vulnerable, and most of the newborn deaths from infections occurring in small babies. The current 
tools have several general water and sanitation indicators, which should be harmonised across tools 
to ensure that the basic soap, running water and safe and effective antiseptics are available in labour 
and delivery and neonatal care areas. A standard indicator that measures whether the newborn space 
is separate from the paediatric ward, and for whether there is a system for inborn and out born babies 
could be a potential proxy indicator for service readiness. 
6.6.2 Measuring more complex inpatient care for small and sick newborns 
Small and sick babies, especially those born preterm, are at higher risk of multiple childhood 
morbidities (including visual, hearing and neuro-developmental), with increasing gradient of adverse 
developmental outcomes by lower gestational age of survivors (44, 97). These newborns often require 
more complex interventions, such as respiratory support (oxygen, continuous positive airway 
pressure), treatment of specific complications (feeding, seizures, jaundice), and screening and follow 
up services (16). Many of these interventions carry a risk of harm when not performed with safe 
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equipment or by trained staff. This is illustrated in middle-income settings, where we have seen an 
increase in impairments in survivors of neonatal care, especially where complex care has been scaled 
up without due attention to service readiness needs (44, 97). 
The existing tools do not capture the large number of items required to deliver complex interventions 
safely, which would require a facility-based monitoring register or module that also includes process 
and outcome data (morbidity and mortality) (260). Such modules have been developed in higher- and 
middle-income settings (256, 260-262), but are not standardised routine systems. Further research 
into adaptations of existing tools is an important next step. 
Clinical care charts and protocols are essential for quality and safety of neonatal care that requires 
complex calculations of drug concentrations and specific diluents, dosages, and delivery mode for 
newborns. In addition to service readiness needs, the risks of certain interventions can be mitigated 
by ensuring clinical record keeping, which is known to be sub-standard in many settings (263). 
Standardised observation charts for monitoring of vital signs (e.g., hourly or three-hourly), fluid input 
and output, feeding method and volume, and monitoring medications and laboratory tests (e.g., 
serum bilirubin and exchange transfusion thresholds) could support facilities, alongside up to date 
standardised evidence-based guidelines, a list of which is included in the documentation section of 
the matrix (Appendix I). 
6.6.3 Implications and next steps for monitoring service readiness for inpatient care of small 
and sick newborns 
Amongst existing partners and initiatives, there is widespread recognition of the need to harmonise 
monitoring systems for maternal and newborn care. The existing EmOC signal functions do not 
represent the full set of facility-based interventions for mothers and newborns, and small and sick 
newborns are especially neglected. Given the large number of service readiness requirements for 
small and sick newborn care, a short list of signal functions for monitoring purposes is a potential 
solution. Work has been done on this previously by Gabrysch and colleagues (188) and a global survey 
led by Every Newborn partners, alongside a technical group led by AMDD and UNFPA are currently 
working on linking this to the emergency obstetric care indicators, with plans to finalise 
recommendations for newborn signal functions 2019-2021. 
Periodic evaluation, using health facility surveys, is currently necessary, but ultimately the goal should 
be to incorporate such assessments into functional and sustainable routine national systems. These 
should operate independent of donor funding and project mandates. The current health facility 
assessment tools are costly and time-consuming. Lighter assessments that can be carried out more 
frequently are also required, and need more research (264). Even in HIC, not all national facilities feed 
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information into one database for national monitoring of inpatient care of small and sick newborns. 
LMIC which have not moved to electronic information systems have an advantage in that they can 
leap-frog the situation of having fragmented and discrepant electronic data collection forms which 
differ from facility to facility or region to region. Exploration of the potential use of DHIS-2 platforms 
for facility-based monitoring of service readiness is being carried out as part of the Every Newborn 
measurement improvement roadmap (246). This work supports the growing interest in use of routine 
health management information systems to monitor aspects of service delivery in facilities (15), and 
of LMIS to track logistics and supplies. 
6.7 Conclusions 
Tracking of service readiness to provide inpatient care of small and sick newborns is needed to gain 
the required policy attention, accountability and investment that is critical to end preventable 
newborn deaths and improve child development. This is reflected in the Global Strategy for Women, 
Children and Adolescents, the WHO Quality of Care Framework, and is supported by the Every 
Newborn metrics working group. The existing health facility assessments do not generate comparable 
data and have very limited assessment of more complex care for small and sick newborns. Indicators 
in existing tools can be harmonised, but the size and cost of these assessments limits their frequency. 
Developing a core list of harmonised indicators for use in routine health information system could 
help address this gap.  Improvements in these monitoring systems are urgently needed to inform 
efforts to improve quality of care and investments in health systems scale-up, to end preventable 




Chapter 7. Categorising interventions to levels of inpatient care for 
small and sick newborns: Findings from a global survey 
7.1 Introduction 
The paper presented in this chapter entitled “Categorising interventions to levels of inpatient care for 
small and sick newborns: Findings from a global survey” addresses the fifth objective of the thesis that 
identifies potential signal functions and levels of care for small and sick newborns. The paper presents 
the results of a quantitative analysis of a survey of global practitioners on signal functions and levels 
of inpatient care for small and sick newborns. It discusses findings from the survey in the context of 
existing EmONC signal functions and levels of care. This paper was published in PloS one in July 2019 
as an open access article (18).  
See Appendix P for the published version of this article.  
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In 2017, 2.5 million newborns died, mainly from prematurity, infections, and intrapartum events. 
Preventing these deaths requires health systems to provide routine and emergency care at birth, and 
quality inpatient care for small and sick newborns. Defined levels of emergency obstetric care (EmOC) 
and standardised measurement of “signal functions” has improved tracking of maternal care in low- 
and middle-income countries (LMICs). Levels of newborn care, particularly for small and sick 
newborns, and associated signal functions are still not consistently defined or tracked.  
Between November 2016-November 2017, we conducted an online survey of professionals working 
in maternal and newborn health. We asked respondents to categorise 18 clinical care interventions 
that could act as potential signal functions for small and sick newborns to 3 levels of care they 
thought were appropriate for health systems in LMICs to provide: “routine care at birth”, “special 
care” and “intensive care”. We calculated the percentage of respondents that classified each 
intervention at each level of care and stratified responses to look at variation by respondent 
characteristics.   
Six interventions were classified to specific levels by more than 50% of respondents as “routine care 
at birth,” three interventions as “special care” and one as “intensive care”. Eight interventions were 
borderline between these care levels. Responses were more consistent for interventions with relevant 
WHO clinical care guidelines while more variation in respondents’ classification was observed in 
complex interventions that lack standards or guidelines. Respondents with experience in lower-
income settings were more likely to assign a higher level of care for more complex interventions.  
Results were consistent with known challenges of scaling up inpatient care in lower-income settings 
and underline the importance of comprehensive guidelines and standards for inpatient care. Further 
work is needed to develop a shortlist of newborn signal functions aligned with emergency obstetric 







7.3 Introduction to paper 
Each year an estimated 2.5 million newborns die in the 28 days after birth (265). The main causes of 
death are direct complications of prematurity (35%), infections (23%), and intrapartum complications 
leading to birth injury (24%) (3). Most of these deaths occur in low- and middle-income countries 
(LMICs). Many lives could be saved – and morbidity prevented – through a health systems approach 
along the continuum of care (4). Such an approach requires delivery of quality packages of care 
including routine and emergency care for mothers and newborns at birth, and inpatient care for small 
and sick newborns (4, 23).  
In addition to routine essential newborn care, many low birth weight (LBW) newborns, including both 
preterm infants, and those born small for gestational age, require additional support to feed and to 
maintain their temperature (16, 33). Preterm newborns face increased risks of respiratory problems, 
infections, and jaundice (9). Even amongst those born at full term, significant numbers of newborns 
face complications including, systemic infections, neonatal encephalopathy, severe jaundice, and 
congenital disorders, with high mortality risk in the absence of quality care (16, 21).  Many of these 
small and sick babies will require inpatient care for them to survive and minimise chances of 
developing future morbidities and/or long-term disability (27, 42, 44, 60, 97). Access to appropriate 
level and quality care remains challenging, especially for mothers and newborns experiencing 
complications, and notably in LMICs (4, 16, 266). 
Based on evidence from higher income settings, a rational approach to organising and delivering 
quality services is through an integrated network of facilities providing increasing levels of care, 
referred to as regionalisation of care (267-269). Managing mothers and newborns experiencing 
complications by more skilled staff working in specialised, better equipped facilities than in lower level 
facilities or those staffed solely by generalists allows for an efficient use of resources, and is an 
effective strategy to improve access to care for complications (266, 267, 269). Higher levels of care 
build on the capabilities of lower level(s) with the additional infrastructure, equipment, supplies and 
health providers to manage more complex levels of care (17, 267). For such an approach to work, 
synergy in institutional capabilities for mother and newborns is needed with a functional 
communication and referral system (91, 267, 270). Levels of care need to be clearly defined with 
accompanying monitoring systems to identify issues in availability, access and quality of care for 
services (15, 17, 268). Defined levels of maternal and newborn care are common in high-income 
settings (267, 268, 270-272), but there is a need for such a delineation for newborns in LMICs (16).  
In LMICs, maternal care has been categorised by United Nations (UN) agencies at two levels referred 
to as basic emergency obstetric care (BEmOC) or comprehensive emergency obstetric care (CEmOC) 
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(118). These levels of care act as a proxy measure of the availability of the human resources, 
infrastructure, equipment, and supplies needed to provide specific services. This delineation allows 
Ministries of Health and technical partners to manage and monitor emergency obstetric care services 
in LMICs through “signal functions”, a core list of life-saving services that have been used to assess the 
provision of emergency obstetric care at either a basic or comprehensive levels (118, 188, 273). 
Currently, there are seven signal functions assessed for BEmOC and two additional CEmOC signal 
functions; they mostly address the obstetric complications that lead to maternal death and disability, 
including post-partum haemorrhage, infections and hypertensive disorders (118).  
Throughout this article, we will refer to the “Emergency Obstetric Care (EmOC) signal functions” in 
recognition of the fact that these were primarily designed from an obstetric perspective and do not 
represent the full spectrum of interventions required for emergency newborn care. More recently, 
the newborn has been more intentionally included and the term Emergency Obstetric and Newborn 
Care (EmONC) has emerged, a change that has been welcomed by maternal and newborn health 
experts, policy makers and programme implementers.  We will use the term EmONC whenever we are 
referring to programmes, policies or indicators that were designed with a view to include both 
obstetric and newborn care and/or when we refer to the health facility assessments (EmONC 
assessments) that have been carried out with a view to looking at both maternal and newborn health 
services.  
For small and sick newborn care in LMICs, one newborn-specific signal function, newborn resuscitation 
with bag and mask, was added to the core list of BEmOC signal functions nearly a decade ago (118). 
However, despite the addition of a resuscitation indicator, the signal functions do not accurately 
represent the full package of interventions needed by the mother-baby dyad, most notably care for 
small and sick newborns (15, 188, 266). This gap was highlighted by Gabrysch and colleagues in 2012, 
who proposed a new set of signal functions for routine and emergency maternal and newborn care 
following a systematic review of newborn survival literature and a consultation with 39 experts (188). 
Gabrysch and colleagues proposed additional signal functions for routine and emergency care for 
mothers and newborns, however, this work has yet to lead to the formal definition and adoption of 
levels of care and accompanying newborn signal functions. Furthermore, this work did not focus 
intentionally on the levels of care needed for those babies born small and sick. 
Since 2012, there has been a significant increase in epidemiological data for newborns (21), including 
better estimates of mortality,  morbidity and outcomes beyond survival (9, 27, 274). The global Every 
Newborn Action Plan, launched in 2015, called for increased focus on the programmatic and 
monitoring needs of newborns in order to end preventable maternal, newborn death, disability and 
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stillbirth (6, 13, 15). Every Newborn highlighted the need to improve the quality care for small and sick 
newborns and develop accompanying monitoring systems (15, 21). During the past years increasingly 
efforts are being made by the global health community to tackle the specific health problems of small 
and sick newborn babies though investment in quality neonatal care. This article builds on this 
platform and the previous work to develop levels of care and associated signal functions (188) for 
small and sick newborns, in particular. The specific aim of this article is to describe the findings of an 
online global survey undertaken to categorise a list of newborn interventions, potential newborn 
signal functions, to different levels of care.   
 7.4 Methods 
7.4.1 Study design and population 
We designed an online survey to collect opinions from individuals working in maternal and newborn 
health, including clinicians with neonatal and obstetric and experience (midwives, nurses and doctors), 
researchers and programme managers or governmental officials (e.g. Ministry of Health).  Whilst LMIC 
health services for small and sick newborns was the focus, the survey was not limited to respondents 
based in LMICs.  
7.4.2 Questionnaire 
We developed an online questionnaire to collect respondent characteristics (profession, current 
country/region of practice/employment, experience (geography, length, private/public) and type of 
experience (e.g. clinician, research etc.).   
We generated a list of 18 newborn services or interventions based on WHO guidelines, previous work 
on the subject (188) and specific work carried out as part of the Every Newborn process (4, 8, 16, 29, 
189, 193), including an expert focus group at an Every Newborn workshop where participants 
discussed interventions for small and sick newborns and voted on a shortlist (246). Interventions for 
the shortlist were prioritised based on potential contributions to mortality reduction and LMIC health 
system feasibility (4, 29).  
In the questionnaire, we asked respondents to assign the 18 interventions to one of 3 levels of care 
appropriate for health systems in LMICs to provide: “routine care at birth”, “special care”, “intensive 
care” as well as a classification category for services that would not be appropriate as a signal function. 
Routine care at birth was included based on the rationale that all newborns (including those born 
small and sick) will require these interventions before they are admitted to inpatient care. To avoid 
biasing respondents, the questionnaire generated the list of interventions/services in random order 
for each respondent.  
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The levels of care were described in the questionnaire as follows:  
o Routine care at birth: This should be available at all facilities and for all babies including those 
that need inpatient care because they are small and sick newborns. 
o Special care: this service is part of inpatient care for small and sick newborns. In many settings, 
this is referred to as special care or level 2 care (268). These inpatient care signal functions are 
interventions for small and sick newborn that should be provided in addition to routine care 
at birth.   
o Intensive care: This service is part of inpatient care for very small and sick newborns. In most 
settings this will only be available at the highest level of hospital. In many settings, this level 
is referred to as neonatal intensive care (NICU), or level 3 care (268). These services are for 
very small and sick newborns in addition to all the services provided at the special care level.  
We piloted the questionnaire for face validity among a group of four experienced public health 
colleagues (not part of the study team) who pre-tested and provided feedback on the question flow 
and wording. We then refined the wording of questionnaire based on this pilot. We translated the 
final version into French and Spanish, using native speakers with clinical or programmatic experience 
in maternal and newborn health. The final version of the questionnaire is available at 
http://doi.org/10.17037/DATA.00000902. 
7.4.3 Recruitment 
The survey was accessible online for 12 months from November 2016-November 2017 in English, 
Spanish and French via the online platform Survey Monkey (www.surveymonkey.co.uk). Respondents 
could only complete the survey after giving informed consent. Respondents were given the option to 
exit the survey at any point. This study was granted ethical approval by the Research Ethics Committee 
of the London School of Hygiene &Tropical Medicine (reference number 11922). 
Given that no sampling frame for this population exists, it was not possible to achieve a probability 
sample. Therefore, we employed a multi-faceted approach to recruit participants with diverse 
experience in maternal newborn health from a variety of settings, especially LMICs. We  made the 
survey available on a wide range of professional networks, including Healthy Newborn Network  
https://www.healthynewbornnetwork.org/ and CHIFA http://www.hifa.org/forums/chifa-child-
health-and-rights to reach both professionals working in international organisations and health 
professionals working on the ground. These platforms were used with the aim of recruiting a wide 
range of both clinicians (including nurses, midwives, doctors and allied professionals) and programme 
professionals with a breadth of experience. We encouraged snowball sampling by suggesting that 
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respondents share the survey widely amongst colleagues. In addition, we promoted  the survey at 
international conferences on newborn health:  http://inkmc.net/index.php/11th-workshop-and-
congress and midwifery  https://www.internationalmidwives.org/events/triennial-congress/toronto-
2017/. 
7.4.4 Statistical analyses 
We calculated descriptive statistics for the respondents, including background characteristics and 
respondent experience. We categorised respondent experience by age group (18-34, 35-54, 55-74, 75 
years or older), experience in LMIC and/or high income countries (HICs), clinical and non-clinical 
experience, regional base (using World Bank regions 
https://datahelpdesk.worldbank.org/knowledgebase/articles/906519-world-bank-country-and-
lending-groups) and experience in the public and the private sector.  
For each signal function: 
o We calculated the percentage of respondents that classified each intervention at each 
level of care  
o We stratified responses by respondent characteristics and looked at variation for each 
signal function and respondent group using chi-squared tests to identify significant 
differences between respondent groups and selected level of care. 
7.5 Results 
7.5.1 Respondent characteristics 
A total of 372 individuals accessed the survey, of which 110 (29.6%) were excluded as they did not 
answer any questions relating to interventions and levels of care. The final sample included 262 
respondents from 61 countries and 7 regions of the world (Figure 7.1). Data summary tables are 










Respondent experience of working in maternal and newborn health ranged from 1-49 years with a 
median of 19 years. The largest percentage of respondents was based in Europe and Central Asia (31%) 
and the smallest percentage of respondents was based in the Middle East and North Africa (5%); 
thereon 14% based in North America, 11% based in Latin America & Caribbean, 8% were based in 
South Asia, and 7% East Asia & Pacific. Over half of respondents (52%) had previous experience 
working in both HICs and LMICs, 13% of respondents had experience from only a high-income country 
and 35% only LMIC experience. The majority of respondents were trained clinicians (75%). Of these 
the majority were doctors (71%) followed by nurses (25%), midwives (2%) and allied health 
professionals (2%). Almost all clinicians had experience working in the public sector; 65% with public 
sector experience only, 30% with a mix of private and public-sector experience and 6% with only 
private sector experience.   
7.5.2 Levels of care 
For the list of interventions selected as potential signal functions and the percentage of respondents 
that categorised these at each level of care see Figure 7.2.
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Figure 7.2 Bar graph showing list of interventions and percent of respondents for each level of care (n=262) 
 
PMTCT=Prevention of mother to child transmission of HIV, KMC=Kangaroo mother care, ABX=antibiotics, IV=intravenous, CPAP=Continuous positive airway pressure, ROP=retinopathy of 
prematurity*Only intervention classified by >50% of respondents as “intensive care”.
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In the following sections, we present the results by levels of care; a service was described under a 
specific level of care when it was selected at that level by >50% of respondents. This threshold was 
defined as an iterative process, based on exploration of the data.  
7.5.2.1 Routine care at birth 
Six services were selected by >50% of respondents as “routine care at birth”. Prevention of mother to 
child transmission of HIV (PMTCT) (83%), basic neonatal resuscitation (86%), thermal protection (87%), 
immediate and exclusive breastfeeding (93%), and essential newborn care (93%) were all classified by 
over 80% of respondents as routine care at birth. Prevention and treatment of hypoglycaemia was 
selected by over 60% of respondents at this level. 
Other than for prevention and treatment of hypoglycaemia, we found no significant variation by 
respondent characteristics of the six interventions that were classified as routine care at birth. 
Classification of hypoglycaemia by clinicians and non-clinicians did vary significantly: 70% of clinicians 
classified this as care at birth compared with only 44% of non-clinicians (p<0.01). Neonatal 
resuscitation, the only intervention in the list that is an existing EmOC signal function, was the option 
with the lowest number of responses identifying it as “not a potential signal function” (1%) .  
7.5.2.2 Special care 
Three services were selected by >50% of respondents as “special care”: Intravenous (IV) fluids (59%), 
injectable antibiotics (57%) and phototherapy (51%). Respondents with only experience in LMICs, 
were significantly more likely to classify IV fluids at a higher level of care compared with those with 
experience in a high-income setting (p<0.05). For injectable antibiotics, respondents based in high 
burden settings, such as South Asia, were more likely to classify this option at higher levels of care 
whereas Latin American respondents were more likely to classify it at a lower level (p<0.05). For 
phototherapy, there was some variation between non-clinician and clinician respondents. Non-
clinicians were more likely to classify phototherapy at either “special care” or “intensive care” than 
clinicians; 28% of non-clinicians categorised this as “intensive care” compared with only 12% of 
clinicians (p<0.05). A larger percentage of respondents with experience in the private sector classified 
phototherapy as “routine care at birth” (63%) than respondents with public (35%) or those with mixed 
public-private experience (27%) (p<0.05).  
7.5.2.3 Intensive care 
Mechanical ventilation was the only intervention classified by >50% of respondents as a service for 
“intensive care”. Respondents with experience in LMICs were more likely to classify mechanical 
ventilation  as “intensive care” than respondents who had not worked in LMICs (66% vs. 41% 
respectively) (p<0.05).   
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7.5.2.4 Interventions/services without clear categorisation (borderline) 
Borderline “routine care at birth”/”special care” refers to interventions not meeting the >50% threshold 
for any level of care but categorised by close to 50% of respondents as “routine care at birth” or ”special 
care”. Three interventions were classified as borderline “routine care at birth”/”special care”: safe 
oxygen therapy (46%/41%), KMC (44%/47%) and assisted feeding (41%/49%), respectively.  
For oxygen and assisted feeding, experience of working in LMICs, regional and experience working in 
the public and private sector were significantly associated with variation. Those with LMIC experience 
or from higher burden settings were more likely to classify these interventions at higher levels of care.  
For KMC, there was no significant variation between levels of care and respondent characteristics.  
Borderline “special care”/”intensive care” refers to interventions not meeting the >50% threshold for 
any level of care but categorised by close to 50% of respondents as  “special care” or “intensive care”. 
Five interventions were classified as borderline “special care”/”intensive care”: specialised follow up 
of high risk (41%/49%), continuous positive airway pressure (CPAP) (50%/34%), seizure management 
(44%/30%),blood transfusion (36%/46%) and retinopathy of prematurity (ROP) (29%/50%). 
For management of seizures, blood transfusion and CPAP, clinicians were significantly more likely to 
classify these interventions as special care while non-clinicians were more likely to classify them as 
intensive care (p<0.05).  
For blood transfusion, CPAP and screening and treatment of ROP, experience in a LMIC was 
significantly associated with variation in the selected levels of care. Those with experience in LMICs 
were significantly more likely to classify these interventions as “intensive care” and while those with 
only experience in a high-income country more likely to classify them as “special care” (p<0.05). For 
example, 71% of respondents with only HIC experience classified CPAP as “special care” compared to 
only 33% of respondents with only LMIC experience; respondents with only LMIC experience were 
significantly more likely to classify it as “intensive care” (49%) (p=<0.05). For ROP, 16% of those who 
had only worked in LMICs responded that ROP was not a signal function compared to no respondents 
with only HIC experience and 7% of respondents with experience in both LMICs and HICs (p<0.05). For 
specialised follow up of high risk, there was no significant variation in respondent characteristics 





This article presents results from a global survey of 262 respondents from 61 countries to classify 18 
newborn care interventions, into 3 levels of care. Applying the >50% threshold to 18 potential signal 
functions, 10 of these clearly aligned to specific levels of care: six for “routine care at birth”, three for 
“special care” and one for “intensive care”. The remaining eight signal functions did not meet the 
>50% threshold for a specific level of care. Previous work has encouraged the development of routine 
and emergency newborn signal functions (188), but levels of newborn care have not yet been well-
defined for LMICs, particularly for small and sick newborns. This work contributes new insights into 
levels of neonatal care in LMICs as a step towards formally defined newborn care levels that could be 
aligned with EmOC.  
7.6.1 Interpretation of categorisation of levels of inpatient care for small and sick newborns 
from global survey 
7.6.1.1. Consistency with existing guidelines 
Out of the interventions that were clearly classified as “routine care at birth” by more than 80% of 
respondents, four have existing WHO guidelines (PMTCT (83%) (275), neonatal resuscitation (86%) 
(144), immediate and exclusive breastfeeding (93%) (276), and essential newborn care (93%) (277)). 
These interventions also had little variation among respondents. For more complex interventions that 
do not have specific WHO guidelines, level of care classification was less clear and there was greater 
respondent variation. This may be related to individual respondents applying existing classification 
systems within countries where they had worked. For example, in many settings the capacity to 
provide neonatal mechanical ventilation is the defining feature of an intensive care unit (278), as it 
requires more complex health system capacity (17). The wording of the intervention as injectable 
antibiotics may have led to ambiguity with respondents by differentiating intravenous from 
intramuscular antibiotics. Some respondents may have perceived that intravenous infusions of 
antibiotics for treatment of infection may require special care capacity in contrast to intramuscular 
antibiotics that WHO recommends as feasible at low levels of the health system (57).  
7.6.1.2 Low- and middle-income experience 
Overall, experience in LMIC was most frequently associated with variation in response as was the case 
with oxygen, assisted feeding, blood transfusion, continuous positive airway pressure (CPAP) and 
screening and treatment for ROP. There was a clear pattern for respondents with experience in lower 
income settings or those based in LMIC to classify interventions more cautiously (not classifying them 
as interventions for lower levels of care). That respondents with LMIC experience were more 
comfortable assigning a higher level of care for certain interventions may reflect the respondents’ 
perceptions of feasibility of introducing or scaling up interventions such as CPAP (279-281). It may also 
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be indicative of a lack of experience delivering those interventions and/or the challenges of scaling up 
inpatient care in these settings. Experience in the private sector may have driven a more optimistic 
perception about interventions that could be provided at lower levels of care, as was the case with 
phototherapy, despite the increase in availability of low-cost phototherapy devices that can safely be 
used in LMIC (16, 68). 
7.6.1.3 Clinical experience and knowledge of interventions 
For more complex interventions, non-clinicians may not have been familiar with nomenclature or have 
had less knowledge of the clinical significance or the potential feasibility of these interventions. This 
may explain some of the variation in responses for hypoglycaemia, treatment of seizures and 
phototherapy. For example. clinicians may be more likely than non-clinicians to recognise the 
significance of seizures in the neonatal period and the frequency of intrapartum injury in LMIC 
settings. The majority of respondents were clinicians that had worked in a LMIC (197/262); very few 
non-clinicians who had worked only in HICs (2/262) responded to the survey. However, arguably 
programmatic or clinical experience in LMICs was a motivating factor to respond to the survey, which 
related directly to LMIC health programmes and was advertised through forums relevant to these 
professional groups.  
7.6.1.4 Transitional interventions 
There is marked variation health system requirements between different levels of care. For example, 
facilities may be able to provide high quality routine care at birth, but lack the infrastructure, 
equipment and human resources to provide special care. Perceptions of the potential harm that can 
be caused by certain interventions if not provided in a safe, enabling environment may have 
influenced respondents. The perception is justified by epidemiological data showing long term 
consequences of poor-quality neonatal care, a pattern that has been seen in countries where there 
has been rapid scale up without sufficient attention to safety and monitoring systems (27, 95). For 
example, countries in Asia and Latin America are seeing an epidemic of childhood blindness caused by 
unregulated use of oxygen in neonatal units, as well as poor screening and follow up services for 
survivors of neonatal care (97).  
One interpretation of the results of this survey for potential signal functions that lacked clear 
classification may be to consider them as “transitional”. This would refer to interventions or services 
that bridge the nexus between two defined levels of care. This approach allows facilities that are 
developing inpatient care capacity at either the special care or intensive care level to go through a 
transitional phase whereby interventions are added in a stepwise manner before moving up to the 
next level of care. Facilities offering newborn care would need to offer all service category 
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requirements at lower levels of the hierarchy before adding transitional interventions linked to higher 
levels (282). For example, facilities offering routine care at birth may begin a transitional phase to 
building special care capacity by adding interventions such as oxygen and assisted feeding (starting 
with cup feeding of expressed breastmilk) in addition to or as part of stabilisation and referral. The 
progressive or stepwise introduction of such interventions will also be influenced by context; hospitals 
with larger catchment areas may need to cover a wider range of services than smaller ones. To move 
to the next level, all transitional interventions would need to be available and provided to a minimum 
standard (17).  
In practice the introduction of transitional interventions would require policy and implementation 
discussions and further operational research, as settings differ widely (91). Much of the existing 
evidence and guidance on neonatal care pertains from high income countries (267, 268, 270, 272, 
282), with the majority of implementation studies from LMICs being hospital level only with few from 
a health systems perspective (283). Further research is needed to document and develop quality 
evidence from LMICs on the organisation of neonatal care.  
 
7.6.2 Next steps: Aligning levels of inpatient newborn care with routine and emergency 
obstetric care measurement 
Agreed levels of care are urgently needed for newborns, but further work is needed to align these 
with existing EmOC levels and determine an appropriate integrated and dynamic approach for 
monitoring. Figure 7.3 shows how the results of the survey could potentially align with the existing 
emergency obstetric care signal functions and levels of care. Critically, this figure places the mother 




Figure 7.3 Interventions and levels of inpatient care for small and sick newborns aligned with Emergency Obstetric Care (EmOC) signal functions and 
levels of care 
 
 
Green=existing signal function 
Grey=transitional interventions 
PMTCT=Prevention of mother to child transmission of HIV, IV=intravenous, IM=intramuscular, CPAP=continuous positive airway pressure.  
Basic emergency obstetric care 
(BEmOC)
o Administer parenteral antibiotics
o Administer uterotonic drugs (e.g. oxytocin)
o Administer parenteral anticonvulsants (e.g. 
magnesium sulphate)
o Manually remove the placenta
o Remove retained products (e.g. manual vacuum 
extraction, dilation and curettage)
o Perform assisted vaginal delivery
Routine and essential care at birth
Transitional interventions to special care
o Safe oxygen therapy
o Kangaroo mother care
o Assisted feeding
o (IM antibiotics as per WHO guideline)
Basic emergency newborn care
o Neonatal resuscitation
o PMTCT
Routine and essential newborn care




o Perform blood transfusion







Transitional interventions to intensive care
o Screening and treatment of retinopathy of 
prematurity
o CPAP
o Specialised follow up of high risk
o Seizure management
o Blood and exchange transfusion
176 
 
Interventions in green are those which are existing signal functions. Starting from the bottom of the 
figure, routine and preventive care interventions reduce the need for emergency and inpatient care 
by preventing complications and there is a strong argument for their inclusion in the list of signal 
functions. The special care level may align with existing comprehensive signal functions as these are 
interventions that are only likely to be feasible to provide at a first level referral facility or regional 
hospital that has the capacity to have a dedicated newborn inpatient care ward and staff. A higher 
level, intensive care will likely only be available at a very small number of CEmOC facilities (e.g. central 
hospitals). Intensive care would less likely to be part of the existing EmOC framework that does not 
currently cover an intensive level of care for women with severe obstetric complications. These 
findings are also consistent with previous work that promotes the inclusion of routine and preventive 
care signal functions for EmOC monitoring (188).  However, one might argue that by including 
preventive, routine care and inpatient care measures, the framework ceases to be an “emergency 
framework” and becomes a framework for interventions for intrapartum and postnatal care.  
Further discussion and consensus to formulate measurable newborn signal functions from this list of 
interventions will be needed. As currently presented, the list of interventions are potential signal 
functions not yet validated by being shown to link to improved outcomes, although each of these 
interventions does have evidence of impact (4, 16). As part of further formative research, piloting and 
testing the measurement of a selection of these interventions in existing LMIC inpatient care facilities 
would be important. Qualitative work may be needed to look at the use of a selection of signal 
functions at the country and facility level in different settings. In addition, these would need to be 
used alongside complementary indicators that could be used for newborn care that reflect access, 
utilization and quality dimensions, aligned with the WHO quality of care framework (11). The 
availability and density of facilities capable of providing both routine, emergency obstetric and small 
and sick newborn care as well as the proportion of population at a defined travel time from such 
facilities are useful health system tools for planning and monitoring the supply-side towards ensuring 
sufficient services for both maternal and newborn care. Such guidance has been lacking for small and 
sick newborn care, which faces major gaps in availability of and access to facilities. 
This work is timely, as a revision of the EmONC monitoring handbook and associated indicators is 
planned. Such a revision is intended to build on lessons learned from implementation and better 
reflect the needs of the mother-baby dyad, including routine maternal and newborn care and 







Since health system contexts in LMICs differ, we used an online approach to collect a wide range of 
opinions from different settings and professional backgrounds. However, a number of limitations of 
this approach must be noted. Firstly, our sample was not fully representative of all regions. Whilst the 
sample was geographically diverse, selection bias is a limitation and opinions of those who could not 
or did not access the survey due to limited internet connection, language or access issues is unknown. 
For example, few middle-income countries in sub-Saharan Africa were represented in the sample. The 
findings may also be biased by the larger frequency of respondents from Europe and the Americas, 
although the majority of respondents reported experience in LMIC settings even if currently based in 
higher-income settings. Secondly, survey fatigue may have occurred, although the list of interventions 
appeared in random order to avoid biasing results through respondent attrition. Survey fatigue may 
partially explain the number of individuals that accessed the survey but did not complete any 
information on newborn interventions. There may also have been a number that accessed it and 
realised they did not have the background knowledge to be able to answer the questions on the 
interventions.  Several factors may have influenced the classification of inpatient care interventions, 
including knowledge of the intervention, perception of the importance of the intervention (e.g. its 
potential impact on mortality and morbidity) and perceived feasibility. This may have resulted in a 
conflict between perceived feasibility (can do) and perceived need (should do) and respondents may 
have been strongly influenced by their own personal clinical or contextual programmatic experiences. 
Finally, for ease of interpretation, a threshold of >50% was used to classify interventions into different 
levels. This was pragmatic, but entirely arbitrary threshold and the findings would be slightly different 
if other thresholds were applied. 
This work was focused on inpatient care for small and sick newborns that occurs in the postnatal 
period. It does not discuss community interventions or interventions that benefit newborns but are 
delivered in the antenatal period. The use of antenatal corticosteroids for mothers with threatened 
preterm labour (139) and antibiotics for preterm premature rupture of membranes (P-PROM) (284) 
are two interventions for small and sick newborns that have an evidence base, but that do not 
naturally fit into the inpatient newborn care package due to the timing in the peripartum period. 
7.7 Conclusions 
This article has shown how practitioners categorised 18 newborn interventions that could act as 
potential signal functions to different levels of care, including routine care at birth and inpatient care 
for small and sick newborns. Findings were consistent with existing clinical guidelines and previous 
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work on the subject, but also provided new insights on how newborn care programmes, including 
more complex interventions for small and sick newborns, could be organised and monitored. Future 
research should focus on refining the list to a small selection of measurable signal functions and testing 
of these potential signal functions in existing inpatient care units. Further work is needed to align these 
newborn signal functions to the existing obstetric care levels to create a dynamic and integrated 
framework for maternal and newborn care. Working towards universal health coverage, future 
adaptations, including improvements to indicators of service availability, access and quality, should 




Chapter 8. Application of overall findings to measurement of service 
readiness for small and sick newborns 
The overall aim of this PhD has been to contribute a body of work that will help to guide and improve 
the measurement of service readiness for inpatient care for small and sick newborns – a package along 
the continuum of care that has been neglected to date in LMIC. Measuring service readiness, requires 
an understanding of the needs of health systems delivering inpatient care for small and sick newborns. 
For the first theme, using the lens of both health system building blocks and the Donabedian 
framework, I mapped the health system structures and identified the challenges to scaling up 
inpatient care for small and sick newborn in LMIC health systems. The second theme drew on the 
findings from the first theme to explore how measurement of service readiness for inpatient care of 
small and sick newborns can be integrated within existing metrics systems. The PhD, therefore, has 
been iterative; the first theme of this PhD serves to inform the second theme. In this discussion 
chapter, I first synthesise the findings by theme and outline the implications for measuring care of 
small and sick newborns in LMIC. Finally, I return to the quality of care framework to contextualise my 
findings within the SDG era and make recommendations for policy, programmes, and future research. 
8.1 Synthesis of overall findings by theme 
In the introduction and background, I described how the first 28 days of life, the newborn period, 
represents the time of highest risk in the human lifecycle. In 2016, an estimated 2.5 million newborns 
died, mainly of complications of prematurity (35%), infections (23%), and intrapartum complications 
leading to birth injury (24%) (2). Many newborns facing life-threatening conditions also go on to 
develop long-disabilities or poorer health outcomes. Preventing newborn mortality and morbidity 
requires a health systems approach along the continuum of care (4, 21). Health systems need to be 
able to deliver routine newborn care for all babies (cleanliness, thermal care and support for 
breastfeeding), with additional care for babies according to need (newborn resuscitation and PMTCT), 
and timely provision of quality inpatient care for babies born small and sick (23).  
The introduction and background section conclude that high quality coverage at scale of inpatient care 
for small and sick newborns could have some of the highest potential impact on newborns deaths of 
all the packages of care along the care continuum for mothers and newborns. For example, a recent 
analysis using the lives saved tool estimated that inpatient care of small and sick newborns could avert 
over half a million (580,000) newborn deaths per year by 2025, which does not include the potential 
impact on long-term well-being and disability (4). This is especially relevant to LMIC, where the burden 
of death and disability is the greatest. Despite this, the package of inpatient care for small and sick 
newborns has been poorly defined in LMIC settings compared to other packages of care along the care 
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continuum. Policy analysis has shown a lack of investment and targeted efforts for wider scale-up (25). 
There are also known deficiencies in the quality of care for small and sick newborns (16). However, 
these quality issues are difficult to address without data on the structures and processes of care that 
these vulnerable babies receive (15). Given the pivotal role of quality newborn care in affecting long 
term newborn outcomes, this PhD viewed defining the structures and health system challenges as a 
critical starting point to understanding how measurement of inpatient care can effectively be 
improved. This could help to identify service delivery gaps and support wider scale up of quality 
inpatient care for small and sick newborns.  
8.1.1. Theme A: Delivering quality inpatient care services for small and sick newborns 
Theme A has two distinct objectives (Table 1.1). Firstly, to describe the health system challenges to 
delivering quality inpatient care. Secondly, to delineate and map the structural components required 
to deliver small and sick newborn care. 
8.1.1.1 Health system challenges to scaling up inpatient care for small and sick newborns 
In chapter 4, I analysed bottleneck data collected using a structured tool to explore challenges to 
scaling up inpatient care for small and sick newborns in 12 high-burden settings challenges across the 
health system. The analysis explored and summarised quantitative and qualitative data from national 
stakeholder workshops on perceived challenges to scaling up inpatient care based on 3 tracer items 
(nasogastric feeding, IV fluids and oxygen). Looking at these elements of inpatient care through the 
lens of health system building blocks, findings showed that for these countries, inpatient care was an 
intervention package which faces major challenges. Based on the area of health system with the 
highest graded bottlenecks, stakeholders perceived health financing and the health workforce to be 
the most significant challenges (Figure 4.5). 
8.1.1.1.1 Health financing 
Data in chapter 4 showed how more than three quarters (10 out of 12) countries graded health 
financing as a major or significant bottleneck to scaling up inpatient care for small and sick newborns 
(Figure 4.5). Country stakeholder team specifically highlighted lack of earmarked funds in national 
RMNCH plans for inpatient newborn care. Thematic analysis of the qualitative data collected in these 
workshops shows links between the financing issues, bottlenecks in essential medical products and 
service delivery, with the perception that the lack of specific funds often resulted in general lack of 
infrastructure (not enough buildings or dedicated spaces for inpatient care) and poorly maintained 
supplies due to inaccurate forecasting, procurement and distribution (e.g. issues with supply chain 
management and maintenance of supplies).  
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In chapter 4, data also showed the lack of insurance policies for small and sick newborn care, often 
resulting in user-fees imposed on families of small and sick newborns (e.g. to purchase drugs and pay 
out of pocket for clinical services). Combined, the health financing bottlenecks, suggest that health 
financing barriers affected access to small and sick newborn care in two ways: precluding the 
availability of care (physical presence of well-equipped facilities) and affordability (the ability of service 
users to pay) (76). For services to have effective coverage, they need to be both ready and available 
to the users (in the case of sick newborns – their families) and for which high burden countries perceive 
this to be a major challenge. Standardised clinical and service provision guidelines, as well as 
mechanisms for tracking and accountability were missing for governments and programme planners 
to be able to identify and priority service gaps for targeting of scarce resources.  
8.1.1.1.2 Health workforce 
As shown in chapter 2 and 4, providing inpatient care for small and sick newborns requires continuous 
services, 24 hours a  day, 7 days a week, from a multidisciplinary team of trained healthcare providers 
(especially doctors and nurses) with specialised skills in caring for small and sick newborns. The 
analysis of bottleneck data showed that health workforce was graded as a significant system gap in 
providing quality inpatient care of small and sick newborns; 10 out of 12 countries identified the health 
workforce as a major or significant bottleneck to the scaling up of inpatient care. Within this 
bottleneck, the two main thematic areas that were identified by country teams, were safe-staffing 
levels (sufficient numbers of staff) and competency-based and/or specialised training with 
appropriate supervision. According to the Donabedian’s quality of care framework, discussed in the 
background and chapter 5, both structure and process are needed to improve overall outcomes. 
Sufficient numbers of staff (structure) and training and supervision (elements of process) were both 
described as bottlenecks to quality of care. For the former, the staff to patient (number of nurses to 
small and sick newborn inpatient) are not yet defined nor benchmarked to guide scale up of the 
package of care (285). The UK recommends nurse-to-patient ratios of 1:1 in neonatal intensive care, 
and between 1:2 - 1:4 in special care (204, 272, 278); ratios which are almost certainly not feasible in 
LIC settings. In existing guidelines from India, ratios vary from 1:3 -1:4, which is used as a basis for 
administrative and resource planning to improve care of small and sick newborns. However, it is 
common for reported staff ratios to be 1:20 or higher in some LMIC facilities (104) yet, there is no 
consensus nor WHO recommendation on what these ratios should be in LMIC. A number of challenges 
identified related to recruitment, retention and staff organisation often leading to low morale and 
lack of opportunities for career progression.  
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8.1.1.1.3 Community ownership and partnership 
Data from my analysis in chapter 4 also showed that community ownership and partnership presented 
significant challenges for inpatient care of small and sick newborns with 9 of 11 countries (missing 
data for one country) grading this health system building block as major or significant. A cycle of lack 
of community awareness and care seeking paired with lack of knowledge of rights to access care were 
described by stakeholders. These issues may be compounded by negative experiences in the facility 
(including lack of attention to the needs of families during the inpatient care process) and experiences 
of poor quality of care. This links to previous literature that has identified a culture of fatalism 
(assumption that all small and sick newborns will die) as a barrier to care seeking and demand for 
quality services (23, 229).  
8.1.1.2 Health system structures for delivering inpatient care for small and sick newborns 
8.1.1.2.1 The interventions 
Figure 2.1 situates inpatient care of small and sick newborns within the continuum of care for maternal 
and newborn health. In order to define structural requirements, it is necessary to define the inpatient 
care package (what interventions it entails and what it does not). This PhD drew on several processes 
to identify which interventions comprise the inpatient care package.  
For chapter 4, the analysis of bottlenecks was based on 3 tracer items: feeding support (intragastric 
feeding), intravenous fluids and safe oxygen. These tracer items were selected at the time that the 
bottleneck tool was designed (a priori to this PhD) to represent the common challenges to 
implementing the package, to stimulate and focus discussion, and to facilitate the identification of 
bottlenecks that hinder the scale up of quality inpatient care (29, 189). The tracer interventions are 
described in detail in chapter 4, Figure 4.3. The inpatient care package, however, is clearly broader 
than 3 tracer interventions. In chapter 4, the omission of phototherapy as a potential tracer was 
discussed (Figure 4.4).  
To further explore the package of inpatient care for small and sick newborns in LMIC, I conducted an 
expert focus group (described in chapter 5) to help develop a shortlist of 18 evidence-based 
interventions. This was then extended to a global survey to categorise interventions to levels of 
inpatient care for small and sick newborns, which is described in chapter 7. Apart from chapter 4, 
remaining work in this thesis was based on these newborn interventions.  
The challenge of identifying and justifying the selected interventions persisted throughout this PhD 
and involved a compromise between known, published evidence (covered in literature review in 
chapters 2 and 4 and expert discussion, including expert focus group and a global survey). From both 
the expert focus group (chapter 5) and the global survey (chapter 7), this PhD showed that consensus 
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on the interventions comprising the package is not easy to obtain. There are context specific issues 
that relate both to health system capabilities (e.g. with surfactant, CPAP or blood transfusion) and 
culture of care (e.g. KMC). With respect to health system capabilities, the global survey (chapter 7) 
showed significant variation in how respondents classified interventions between those with 
experience in LMIC and those with only HIC. This finding reflects the known challenges to delivering 
care that were identified in chapter 4. Context specific culture issues also affect the perception of 
interventions in different settings, as can be seen with KMC, which another study of health system 
challenges found to have greater challenges in Asian than African countries (29). The delivery of 
inpatient care for small and sick newborns in LMIC needs to be viewed carefully from the perspective, 
culture and health system capabilities in LMIC rather than a “drag and drop” approach from HIC. 
Defining the inpatient care package, therefore, required prioritisation of core, high impact 
interventions that could feasibly be introduced in less developed health systems (282).  
8.1.1.2.2 The structural components/health system inputs 
In chapter 5, the grey literature review resulted in a matrix of 654 structural components, to deliver 
18 interventions. Of these, 114 were medicine and drugs. As shown in chapter 6, 22 of these were not 
included in the essential medicines list. The matrix in chapter 5 provides a starting point to defining 
the structural components of inpatient care for small and sick newborns. However, it is limited by the 
18 interventions that were selected and the lack of standard guidelines available for review for more 
complex newborn interventions. 
In view of the identified health system challenges highlighted in chapter 4, the findings in chapter 5 
were intended as a practical and feasible way to provide countries with a structured checklist from 
which to start planning inpatient care services. Such a checklist can be adapted and used for multiple 
purposes, including development of inventories for health facility surveys and tools, checklists for 
management of stock, as well as development of logistics and human resource management systems. 
Items on the matrix were reviewed by multiple clinicians from LMIC, including nurses, paediatricians, 
neonatologists, and obstetricians to ensure that the suggested inputs were practical for a broad range 
of LMIC health systems. For the laboratory service readiness requirements, I was only able to delineate 
the minimal requirements of the tests that the laboratory, such as biochemistry, haematology 
(including blood bank) and microbiology should be able to perform as well as what facilities should be 
able to perform for blood grouping, screening and storage. Laboratory readiness, closely related to 
antibiotic stewardship, has an especially important role in tackling the growing public health problems 
with antimicrobial resistance e.g. to ensure cultures are available for antibiotic prescribers (53, 286). 
Testing of the tool alongside implementation research to look at specific issues related to laboratory 
readiness will be important for future research in this area. As part of laboratory readiness, 
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consideration of the health system needs for safe neonatal blood transfusion will also be needed. In 
chapter 5, I also summarised the basic structural needs for referral and transport. Given the critical 
role of referral systems (chapter 7) in supporting a regional system of care for maternal and newborn 
health, this is also an area that requires significant further research.  
8.1.1.2.3 Levels of care 
In chapter 4, I described how inpatient care has been traditional defined by 3 levels (Figure 4.1), 
broadly referred to as “routine care at birth”, “special care” and “intensive care”. According to 
stakeholders in the analysis in chapter 4, the organisation of inpatient newborn services was a major 
health system concern. There is a lack of quality evidence from LMIC on how to organise neonatal care 
and much of the existing evidence and guidance pertains from high income countries (267, 268, 270, 
272, 282).  
The argument for providing stratified levels of maternal and newborn services has a long history and 
is strongly influenced by the 1976 March of Dimes (https://www.marchofdimes.org/) report “Towards 
improving the outcome of pregnancy”(271). This report first described the concept of regionalised 
maternal-newborn care based on evidence of more favourable outcomes and cost effectiveness. Later 
on in 2004, Paul and colleagues (91) argued against regionalisation of care in LMIC, suggesting that 
such an organisation works for developed, well-funded health systems, but is less relevant for LMIC. 
A more recent systematic review published in 2011 aimed to assess whether the existing evidence 
from interventional studies provides robust evidence on the effectiveness of regionalisation for 
improving maternal and newborn outcomes. This review found limited evidence from well-designed 
studies (e.g. a lack of controlled trials or studies that applied interrupted time series analyses) and 
very little evidence from LMIC. Also, multiple confounding factors, including socioeconomic changes 
and developments in clinical medicine, are difficult to extrapolate from the observed association with 
improved outcomes in HIC. In LMIC, where equivalent progression may not have occurred, the review 
concluded that regionalisation of care as an approach is not fully supported by the current evidence 
base (270).    
One of the arguments against regionalised neonatal care is based on mortality rates. Earlier work 
(2004), argued that settings with high neonatal mortality (NMR >15 per 1000 live births) can achieve 
substantial mortality reductions by focusing on community interventions, antenatal care and essential 
newborn care (91). At the time of this publication, focus on these areas of care could achieve 
substantial mortality reductions; partly because a larger number of births occurred at home where 
babies were not resuscitated and/or parents may not have sought care for those born small and sick. 
In the SDG era, quality antenatal care remains critical for the health and growth of the baby in-utero 
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and for identifying high risk cases and maternal complications. Obstetric and routine care at birth are 
essential to reduce cases of neonatal encephalopathy and newborn infections. However, even with 
quality antenatal care and high quality obstetric and care at birth, a certain proportion of newborns 
will still require inpatient care (e.g. those born preterm or that develop infections or jaundice). As the 
place of birth has increasingly shifted from community to the hospital, inpatient care is required as 
part of the continuum of care to ensure those small and sick newborns in hospitals are able to access 
quality inpatient care should they require it. To reach the targets for the SDGs and Every Newborn 
Action Plan of ≤12 neonatal deaths per 1000 live births by 2030, inpatient care for small and sick 
newborns, is necessary to achieve the ambitious mortality reductions as part of universal healthcare 
(UHC). Subsequently, organisation of care needs to reflect this need through provision of a feasible, 
safe and affordable inpatient care package. Meanwhile, further research and robust evidence is 
needed on organisation of maternal and newborn care in LMIC.  
Implementation of inpatient care need not be at the expense of routine and essential newborn care 
at birth. Core components of this care – provision of warmth, support for breastmilk feeding and 
prevention of infection – are core to small and sick newborn care due to the enhanced vulnerability 
to hypothermia, poor growth and infections (5, 16, 282). To reflect this, I included routine newborn 
care interventions throughout the work in this thesis. Similarly, introducing “intensive care” should 
not be at the cost of “special care” services. A study in Uganda that implemented lower levels of small 
and sick newborn care through a staged approach found that without quality implementation of 
routine and special care levels, adding more specialist, high technology care may be futile (282). 
However, their study showed that focused attention on the lower levels of care had a significant 
impact on neonatal deaths (282). While this study may not be widely generalisable, this is supported 
by estimates published in 2014 that provision of quality special care for small and sick newborns could 
avert 70% of newborn deaths without provision of intensive care (4).  
An additional important finding relates to the private sector. My analysis of the global survey in 
chapter 7 found that there was significant variation between perceptions of service feasibility for 
different levels of care between those that had experience in the public and private sectors. Those 
with only experience in the private sector more likely to categorise complex interventions at lower 
levels of care. This may be explained by a level of “optimism” in the private sector due to greater 
access to resources and/or smaller caseloads. For example, findings from a study in Kenya showed 
that services in Nairobi were disproportionately distributed between public and private sector despite 
more private sector facilities offering neonatal inpatient care; four public facilities out of 33 facilities 
in total accounted for 71% of neonatal admissions (105).  Ensuring service readiness and quality of 
care within the private sector within the context of a broader health system is an important challenge 
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that has not been covered in detail in this PhD and has specific implications for measurement, tracking, 
and accountability mechanisms.  
8.1.1.2.4 Transitional interventions 
As shown in the background, chapters 4 and 7, there is marked variation in health system 
requirements between different levels of care. From findings in both chapters 5 and 7, I found that 
certain interventions represented a significant jump in health system service readiness requirements. 
Many district level facilities may be able to provide safe oxygen therapy to newborns (including 
monitoring with pulse oximetry), but not be able to provide CPAP or mechanical ventilation due to 
lack of trained staff, equipment and infrastructure.  
In chapter 7, I discussed “transitional interventions”, as a potential strategy for organising delivery of 
inpatient care across different levels. The transition refers to interventions or services that bridge the 
nexus between two defined levels of care. This approach allows facilities that are developing inpatient 
care capacity at either the special care or intensive care level to go through a transitional phase 
whereby interventions are added in a stepwise manner before moving up to the next level of care. As 
levels are defined by the services they provide, it was decided that services allocated to each category 
must represent a realistic minimum and transitional interventions represent those that can be added 
to this minimum before graduating to the next level. Thus, newborn units should meet all service 
category requirements at lower levels of the hierarchy before adding transitional interventions linked 
to higher levels (282). For example, facilities offering routine care at birth may begin a transitional 
phase to building special care capacity by starting KMC, intragastric feeding and oxygen before adding 
intravenous fluids and phototherapy treatment.  
Such systems have been developed in LMIC settings; for example, India has newborn stabilisation units 
that focus on management and stabilisation of sick newborns prior to referral to special newborn care 
unit at the sub-district and district level (256). The concept of transitional interventions, therefore, 
whilst still providing overall guidance on the capabilities and service readiness requirements for a 
special care unit and an intensive care unit should allow individual countries to develop more granular 
categories and context-specific recommendations.  
8.1.2 Theme B: How can measurement of small and sick newborn service readiness be 
integrated within existing and evolving maternal and newborn measurement systems? 
Theme A focused on the structures required and the challenges to delivering inpatient care for small 
and sick newborns within health systems. Theme B described in this section of the chapter builds on 
theme A to explore how measurement of small and sick newborn service readiness can be integrated 
into measurement systems.  
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As described in the background section, planning, resource allocation and day-to-day management 
for care of small and sick newborns requires timely information from routine health information 
systems in order to track the delivery of quality health care services and related support systems that 
include equipment, and supplies, infrastructure and human resources (100). For inpatient care, 
information is needed to help ensure commodities are available (service readiness) to enable quality 
service delivery to small and sick newborns.  
8.1.2.1 Health facility assessments 
Whilst health facility assessments are only a small part of broader routine health information, I have 
focused a significant part of the work in this PhD on health facility assessment tools. This is justified 
by the fact that service readiness information specific to small and sick newborns found in routine 
health information systems is still limited. As covered in chapters 3, 5 and 6, health facility assessment 
surveys may be one of the only sources of national level information on facility readiness to provide 
small and sick newborn care.  
In chapter 6, as one approach to measurement of small and sick newborn care within existing maternal 
and newborn measurement, I reviewed three multi-country health facility assessment tools that cover 
areas of MNH services, the SPA, the SARA and the EmONC assessment tools. The review showed that 
there are commonalities between the tools, but the histories of these tools are different, and they 
serve distinct purposes and have different approaches to measurements. Overall, my review showed 
that the existing health facility assessments do not always generate comparable data and have very 
limited assessment of more complex care for small and sick newborns. Training and skills of providers 
are especially variable (Table 6.5). Indicators in existing tools can be harmonised, but the size and cost 
of these assessments limits their frequency.  
Findings from chapter 6 are consistent with a literature review that carried out a comparative analysis 
of different tools that are currently used to assess the service delivery capability of different health 
facility assessment tools used in LMIC (103). The review found methodological inconsistencies 
between health facility assessment tools and showed that health facility assessment tools were often 
designed with an emphasis on vertical, disease oriented programmes, which limited their ability to 
capture broader health system approaches needed to provide packages of care, as is the case with 
inpatient care of small and sick newborns (16). Furthermore, existing health facility assessment tools 
tend towards assessment of care at the primary care level. This is pragmatic for capturing population 
level data without prohibitively large sample sizes to power the study.  
Revisions of the health facility assessments are generally planned on a regular basis. Findings from this 
thesis can serve to inform these revisions and ensure harmonisation with other tools, as well as 
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addition of minimal content to the health facility inventories, such that some of the needs of small 
and sick newborns are covered within the boundaries of the overall objectives of the individual tools.  
Findings from chapter 6 showed that of the all the health facility assessment tools reviewed, the 
EmONC assessment contained the most detailed content on small and sick newborns.  
8.1.2.2 EmONC signal functions and indicators 
For obstetric care, EmOC has been defined by two levels of care - “basic” and “comprehensive” - with 
associated signal functions (which are a list of core lifesaving services) and indicators that have helped 
advocate for staff and equipment, link to accountability and identify and track programmes progress. 
The levels of care and signal functions have remained static for nearly two decades except in 2009 
when one newborn care indicator/signal function was added: newborn resuscitation with bag and 
mask. As covered in the background and chapter 7, it has long been recognised that these nine signal 
functions do not reflect the full spectrum of interventions needed by the mother-baby dyad, most 
notably ongoing inpatient care for small and sick newborns. As discussed in the background and 
chapter 4, unlike obstetric care, LMIC are often introducing neonatal care units without standardised 
guidance on the structures required or levels of care (4, 16, 29, 282). 
In 2012, Gabrysch and colleagues (188) proposed a set of signal functions to expand emergency 
newborn care and add functions for routine care for mothers and babies, including general 
infrastructure. Subsequently, significant newborn content has been added to the EmONC assessment 
tool, although there are many gaps and the content has not yet been associated with agreed newborn 
signal functions (16).  In chapter 7, through a global survey, I aimed to explore which inpatient care 
interventions for newborns could be signal functions for different levels of care with in a broader 
stratified system for mothers and newborns. By integrating these interventions into existing EmOC 
measurement tools it would allow for a structured inclusion of the respective infrastructure, 
equipment and human resources to identify gaps, track progress and ensure accountability as part of 
the maternal-newborn programmes. The defined levels of care for EmOC support the system well 
beyond health facility assessment measurement; evidence suggests routine tracking can drive change 
at the implementation level and overall organisation of care (264, 287, 288). With an integrated 
maternal and newborn approach, managers at national and sub-national levels would therefore be 
able to more continuously assess the functionality of all facilities providing maternal and newborn 
care, as is done in some countries within a BEmONC and CEmONC network (264). 
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8.2. Implications of findings: Moving beyond surveys towards routine data systems for 
inpatient care of small and sick newborns 
Throughout this thesis, my findings emphasise the importance of moving beyond surveys alone 
towards sustainable routine health information system that are nationally managed and respond to 
national and locally identified programme needs. In chapter 3, I discussed the challenge of measuring 
coverage of small and sick newborn interventions through household surveys and described how 
health facility assessments can fill an important measurement gap on service readiness for facility-
based care that cannot be covered by household surveys. The health facility assessment tools explored 
in later chapters of this PhD are generic tools applied in multiple settings. As data systems transition 
from dependence on surveys towards routine information systems, the hope is that useful content 
and indicators within health facility assessment will increasingly harmonise with those in routine 
health information systems with the latter subsuming the role of the former as they develop in 
capability. 
Health data come from a variety of sources, including population-based sources, censuses, civil 
registration and vital statistics, surveys, such as health facility assessments, facility records and 
individual patient records. Figure 8.1 shows the wider health information system and where 
components of service readiness measurement may enter this system. 
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Figure 8.1 Data entering the health information system with a functional health interoperability layer 
 
Source. Adapted from Open HIE (289) by Landry (SEARO) and Thorell, L and D Jackson (UNICEF) 
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To improve measurement for small and sick newborns within the context of a wider routine health 
information system, there is a need to understand how the system is organised and how various 
components intersect with each other to influence health information system performance (290). In 
the current climate, with so many indicators and targets, data systems are expanding to capture, store, 
manage and transmit information on the heath and the activities of the health system. Service 
readiness, which does not fit into any one vertical system, but requires multiple sources of data 
collection (100). Acknowledging the wider context in which health systems operate, and the different 
people engaged in the data process, is critical to understanding mechanisms and actions which can 
improve measurement across different health sectors. There is a large body of literature on 
strengthening and improving routine health information systems, largely spurred by health system 
strengthening efforts (291-293). Frameworks, such as the Performance of Routine Information 
Systems (PRISM) framework (100, 290, 294) and the human, organization and technology-fit (HOT-fit) 
(295), have emerged to support routine health information systems to improve their overall 
performance. Improving the use of heath information is increasingly seen to be integral to scaling of 
up the delivery of quality health care systems (296). Such frameworks stress the importance of human 
and organisational factors, as well as technology, to improve overall performance and achieve the 
requisite impact on health (100, 296). 
Increasingly, literature on health information stresses the need to shift the debate away from the 
superiority of one data source over another and focus on improving and harmonising the existing 
routine data systems (100, 289, 290). An important feature of figure 8.1 is the reference to the 
interoperability layer at the centre of the figure. An interoperability layer receives information (or 
“transactions”) from a variety of systems and coordinates interactions between the different 
components of the health information system. It’s existence provides a common core functionality to 
simplify the data exchange between systems (289). i.e. its main function is to enable disparate health 
information systems to share information more easily. Interoperability layers vary greatly in 
functionality between different countries. However, for service delivery of complex packages of care, 
such as inpatient care of small and sick newborns, such interoperability will be critical for effective 
measurement and subsequent performance of health information systems.  
In figure 8.1 the blue circles highlight health management information systems and logistics 
management systems – these are still underdeveloped in many settings and reviewing the available 
data on small and sick newborns available in different LMIC settings exceeded the scope of this PhD. 
However, as these systems develop, this thesis has contributed concrete recommendations to help 
harmonise and standardise the priority content for small and sick newborn care with the intent that 
this be included as part of the overall RMNCH package of care. DHIS-2 is an open source, web-based 
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HMIS platform (187) that is now used at national scale by 46 LMIC as the national HMIS, often 
replacing paper-based systems or aggregating and reporting from paper-based systems (297). Web-
based systems, such as DHIS-2 have facilitated the ability to collect more accurate and efficient data 
capture needed to inform planning and decision-making and availability of routine data for decision 
making (298). Such systems can also facilitate incorporation of the private sector into the national 
information system (297), which is critical for monitoring of the overall health system. Exploration of 
the feasibility of DHIS-2 platforms for facility-based monitoring of newborn care as part of the EN-
BIRTH study within the ENAP metrics project is being carried out alongside this work (299).  
Some countries are also developing the capacity of their human resource information systems. In DRC, 
the ministry of health put in place an electronic human resource information system (HRIS) for use at 
multiple levels of the system (300). The system facilitates health workforce tracking, management, 
deployment and health worker mapping and has aided the ministry of health to understand and use 
data to reallocate health workers and limited financial resources to where they are most needed. It 
has also helped to reduce paperwork at the facility level and to reduce the problem of ghost workers 
(individuals who are listed on payroll, but do not show up for work). While the system needs to 
improve its interoperability to further reduce transactions, the creation of a human resource 
information system has allowed the ministry of health to manage a workforce more effectively (300). 
Such examples show how technology can be used to reduce complexity of procedures at the facility 
level and reduce reliance on external and periodic monitoring systems for service readiness, such as 
health facility assessment surveys (296).  
Even in HIC, it is rare for all inpatient care facilities to feed information into one database and it is 
acknowledged that there is still limited capacity to share standardised data across neonatal care 
facilities (301). Databases and networks, such as the Vermont Oxford Network 
(https://public.vtoxford.org/) have been developed and widely used to monitor the delivery of 
neonatal intensive and special care services in higher-income settings.  The Vermont Oxford Network 
is voluntary quality and safety collaborative (with paid membership) that maintains a database 
including information about the care and outcomes of infants treated at member institutions. For 
example, in the US, the Vermont Oxford Network contains 578 hospitals representing approximately 
65% of all neonatal intensive care units (302).  Such a network has reporting forms and manuals on 
service characteristics that could potentially be adapted and simplified to work for wider reporting in 
LMIC to work in tandem with existing routine information system. Some LMICs are also reporting in 
the Vermont Oxford Network, largely for research purpose. However, the manuals and forms are not 
open source nor available free of charge. Therefore, it may not be a feasible option beyond special 
studies or donor-driven research programmes. Furthermore, voluntary and paid membership to the 
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data network raises questions over the representative nature of the data for the functionality of a 
national system.  
The concept of a national network or module for monitoring small and sick newborn care has the 
potential to be developed specifically for LMIC, as has been done in India, where UNICEF has 
developed a real time online data monitoring system for newborn special care units (Figure 4.7). The 
system records vital information on service delivery, as well as data on antenatal, labour room, 
inpatient care and post discharge follow up. It provides data on both service readiness, treatment and 
outcomes for newborn inpatients and has helped health workers, as well as policy makers and 
programme managers to target resources and initiate HR related actions. It is supported by a national 
cell that builds capacity in data management, monitoring and interpretation of data for policy and 
programmatic use. In addition, India has well established guidelines and toolkits for standardised 
infrastructure, human resources and services at different levels of care (16, 254-256). Currently scaled-
up in 28 out of 29 states, covering 84% of the SNCUs (661 out of 792 SNCUs) and with 2.7 million 
newborns enrolled (303). The system model has been adapted and will be adapted for other settings 
e.g. Malawi. It is important, however, that as these systems are shared and developed for other 
settings that they are designed to link with other routine information systems. LMICs which have not 
moved to electronic information systems may have an advantage in that they can leap-frog the 
situation of having fragmented and discrepant electronic data collection forms which differ from 
facility to facility or region to region.  To move beyond health facility assessment surveys as the main 
source of information on small and sick newborn care towards routine data systems it is important 
not to focus on individual systems, but broader overall interoperability.  
8.3 Limitations 
Specific limitations to each of the objectives have been noted in the relevant chapters. The main 
overall limitation of this PhD is the reliance on background information (literature review) and 
professional opinion (expert focus group and a global survey) to define the interventions that comprise 
the package of inpatient care for small and sick newborns. Information from expert and stakeholder 
opinion is usually ranked lowest on the evidence pyramid (with experimental design and meta-analysis 
at the top) (304). The evidence used for this PhD, therefore, is likely to have been influenced by beliefs 
and opinions, as well as context-specific politics and cultural issues. This is discussed in more detail in 
the relevant chapters. I acknowledge that had different interventions been selected, some of the 
findings of this PhD may have been different. Exploration of other interventions for small and sick 
newborns (which extends beyond the 18 interventions included) could be both valuable and 
important for future scale up efforts and measurement.  
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Another limitation of this PhD was the focus on the organisational and technical aspects of 
measurement (the tools and the health systems) without full exploration of the critical human and 
behavioural factors (100, 295). The collection and use of much of service readiness data is the 
responsibility of health workers who often have a priority, primarily, to deliver clinical care. 
Measurement of care for small and sick newborns, therefore, requires an understanding of the 
behaviour of health workers responsible for data collection and use (305). Originally, as an additional 
objective of this PhD, I had planned to collect qualitative data in Malawi as a case study for 
measurement of care of small and sick newborns. The work aimed to use qualitative methods to 
identify barriers and enablers to recording and use of service readiness data for care of small and sick 
newborns in Malawi. The objective was ultimately not feasible in the timeline for this PhD (the full 
research protocol is available in appendix L), but it is important to acknowledge the added value that 
a greater understanding of the many challenges faced by those recording and using data at different 
levels of the health system. 
Finally, service readiness itself is a limited measure of quality of care. The Donabedian model of 
structure-process-outcome allows for measurement of quality by assuming a linear relationship 
between these three domains. However, there is a difficulty in establishing the exact relationship 
between these domains and how they interact. Structural inputs are viewed as the necessary 
foundations for quality of care but are insufficient to describe the content of care delivery or its effects 
(76). Strictly delineating structures and processes and which of these processes pertain to service 
readiness was a challenge and could arguably include process measures to a larger or lesser extent.  
The next and final section on recommendations for policy, programmes and future research also 
consider how service readiness will continue to evolve in changing shape of quality of care 
measurement.  
8.4 Recommendations for policy, programmes, and future research 
Service readiness refers to the capacity of a health system to deliver the services offered (101). Given 
the critical role of the quality of newborn care in impacting long term outcomes, this PhD has framed 
service readiness measurement as a starting point to identify service delivery gaps and support scale 
up of quality care for small and sick newborns. For this final section, I return to the WHO quality of 
care framework and situate findings from this PHD within this broader SDG era vision to provide 
recommendations for policy, programme and future research.  
8.4.1 The WHO quality of care framework 
In the background section I framed service readiness as a prerequisite for quality of care. Mirroring 
the conceptual frameworks applied for this PhD, the WHO framework for quality of care for maternal 
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and newborn health care, builds on both the Donabedian model and the six WHO health system 
building blocks (leadership and governance, financing, essential medicines, information systems, 
workforce, service delivery) (11). The WHO framework outlines both dimensions of “experience of 
care” and “provision of care” which can be targeted to assess, improve, and monitor care within the 
context of a health system.  
Achieving UHC, including quality essential service coverage and financial protection for all, is target 
3.8 of the SDGs. According to WHO, UHC means that all people can obtain the health services they 
need without suffering financial hardship (22, 306). National governments and policy makers need to 
develop a shared vision in tandem with stakeholders and specify the standard provision and 
experience of care that people can expect for health services to provide (297). Therefore, 
incorporating the tenets of the WHO quality framework into country-led initiatives also serves to 
support attainment of wider goals of universal health coverage and the SDGs.  
In Figure 8.2, I show the areas of the WHO framework that are explored within this PhD. These are 
mainly centred around the provision of care dimension of the framework starting with the health 
system building blocks as a foundation. Measurement of service readiness is therefore viewed as a 
mechanism for identifying areas of health system weakness in provision of inpatient care that can be 
targeted to improve of quality of care. On the other side of the WHO framework, the experience of 
care incorporates dignity and respect, effective communication, and emotional support. Providing 
these components of quality care for small and sick newborns in practice requires providing care that 
is family-centred care (11, 307, 308). Both dimensions of the framework are underpinned by 





Figure 8.2 WHO framework for the quality of maternal and newborn health care  
highlighting focus areas of this PhD  
 
 
8.4.2 Is service readiness measurement sufficient?  
Empirical data increasingly shows health system input measures to be weakly related to the quality of 
care received and poorly correlated with patient outcomes (76, 102, 297). Pragmatically, however, 
health systems cannot deliver quality of care without the structural inputs in place. For example, an 
inpatient care unit cannot treat respiratory distress in small and sick newborns, nor prevent disability 
associated with unregulated oxygen use, without safe, oxygen systems (including pulse oximetry). 
Measuring the essential physical resources (service readiness inputs), therefore, is a critical starting 
point for quality of care measurement. The presence of the physical resources (structures) needs to 
be accompanied by application of evidence-based practices by a competent health providers 
(processes). Thus, aspects of process are also included in this PhD, including discussion of staff 
competency, evidence-based guidelines and standards of care, and organisation of care. 
In a rapidly evolving measurement field, nuanced measures of quality of care are also needed for 
developing health systems to capture the broad dimensions of health and well-being laid out in the 
SDG era. As shown in figure 8.2, the experience of care, including effective communication, respect 
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and preservation of dignity and emotional support are increasingly viewed as playing a critical role in 
influencing and affecting individual and facility level outcomes, as per the WHO framework. For this 
reason, future policy and research for improving measurement for small and sick newborns needs to 
focus not only on the service provision inputs and processes, but the experience of care to ensure that 
the quality services are delivered. Service readiness as a measurement construct, therefore, may also 
need to adapt and evolve. This evolution will require dynamic metrics that build on the foundations 
of health system readiness and capture domains such as experience of care, as well as other health 
system processes, such as safety, organisation of care, coordination and integration with other areas 
of the continuum of care (297, 309).  
According to the global health commission on high quality health systems in the SDG era, future 
measurement of quality of care needs to be focused on two critical areas: accountability and action 
(102, 297). For accountability, measurement needs to show progress against benchmarks and for 
actions and provide answers to the specific questions about the functionality of the health system. 
Service readiness measures are critical to identify areas of health system weakness for targeting 
inputs, but do not necessarily promote full accountability for high quality health systems. To capture 
more nuanced constructs, measures need to shift towards assessing the performance of the system 
and ensure that this incorporates aspects of integration, safety, and experience of care (including trust 
and confidence in the health system). More recently, this has been referred to in the literature as 
system competence (297). Building on service readiness and developing these measures towards 
dimensions of system competence, therefore, may be the logical progression for improving service 
readiness measurement, incorporating broader concepts of the fabric of the health system overall.  
Table 8.1 summarises the recommendations for policy, programmes and future research.  In this table, 
I have showed how the different recommendations laid out in this section link to specific findings 
within the thematic areas of this PhD. For theme A, delivery of quality inpatient care services, I have 
focused on the priority health system bottlenecks identified in chapter 4 as sub-themes to highlight 
the priority areas of the health system that require targeting. For theme B, measurement of service 
readiness, I have prioritised two sub-themes – health facility assessments and routine data systems, 
which have been the main measurement focus of this PhD. Overall, the hope is for a shift whereby 
routine information systems take over the service readiness inputs, and health facility assessment 
tools are used to capture and measure more complex measures of process that may be less feasible 




Table 8.1 Improving measurement of service readiness; summary of recommendations for policy, programmes and future implementa tion research  
















Develop norms and standards for programme planning and benchmarking   
 
• Evaluate benchmarks of facility and 
workforce capabilities and numbers (e.g. 
by cot numbers and staff-patient ratios) 
• Evaluate integration, organisation and 
levels of care, referral systems 
• Evaluate cost of care 
 
Test and evaluate minimum service 
standards (including safety) for: 
• Medicines and equipment 
• Infection control 
• Laboratory  





• set minimum numbers of inpatient care facilities (including cot numbers) by national 
























Enable country-led routine data systems   
 
• Test/validate signal functions in 
operational neonatal units 
• Test/validate population denominators 
for estimating and tracking service need 
(effective coverage of services) 
• Evaluate service readiness data quality, 
including interoperability of 
measurement systems  
• Explore determinants of measurement 
recording and use   
• Explore approaches to better measure 




• Harmonise newborn service readiness content in existing health facility assessment tools  
• Integrate newborn signal functions for future maternal-newborn health facility 
assessment tools and incorporate service readiness measures in routine systems 
• Develop health facility assessment tools and surveys to incorporate measures of system 
competence and process measures that cannot be captured easily in routine systems e.g. 





• Strengthen and invest in logistics management systems and add small and sick newborn 
service readiness equipment and medicine items  
• Strengthen and invest in health worker registries, linking to pay role 




8.4.3 Develop norms and standards for programme planning and benchmarking 
Working towards UHC, national governments and policy makers need to develop a shared vision in 
tandem with stakeholders of the care that people can expect for health services to provide. With the 
forthcoming WHO guidelines and standards for inpatient care of small and sick newborns planned for 
release in 2020-2021, there is a critical window of opportunity to spur national governments and 
policy makers to formulate corresponding national recommendations on standards for programmes 
implementing small and sick newborn care. These are dependent on numerous factors, including 
budget, demographic factors and health system structure (297), as well as linked to national and global 
standards for routine and emergency maternity and paediatric care.  
As a minimum, these norms, and standards for care of small and sick newborns would include: 
• the recommended minimum numbers of inpatient care facilities (specified by numbers of 
neonatal cots/bed spaces) by national population or birth rates, including minimum service 
standards for medicines and equipment, infection control and laboratory stratified by defined 
levels of care 
• the recommended safe staffing numbers, including nurse (and/or midwifery) and physician 
ratios to small and sick inpatients, stratified by defined levels of care and accompanying 
capabilities/competencies. Where possible, accompanying allied health worker ratios can also 
be included  
• Minimum standards for family centred care, stratified by defined levels of care. 
8.4.3.1 Facility and workforce capabilities and numbers 
For national planning for UHC, standard minimum safe staff-patient ratios are needed for small and 
sick newborn care to ensure that sufficient health workers, especially skilled midwives and nurses, are 
available to provide the hands-on care needed at the facility level. Every level of neonatal care should 
delineate the expected level of care with the accompanying standards and guidelines (282). 
Geographical availability of facilities alone may overstate health system performance (297), therefore, 
it is not just numbers of health facilities and health workers that are critical but defining actual 
capabilities (102). Work in this PhD has begun to delineate and describe the different levels of care 
and structural inputs and how they align with an existing maternal health EmOC framework. However, 
the attainment of high quality inpatient care for small and sick newborns will depend not only the 
availability of adequate numbers of health workers, but on their distribution, quality and performance 
(266, 306). In tandem with functional information systems on service readiness, such 
recommendations will provide an urgently needed mechanism for national and local benchmarking 
and accountability purposes (102, 297).  
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Greater numbers of health workers caring for small and sick newborns only becomes a stronger health 
workforce when there is sufficient and targeted funding to secure the correct investment in 
competencies and skills’ development over the longer term (310). Competency-based training 
programmes have been shown to improve knowledge and skills of health providers, but ongoing 
mentorship is also needed (211, 212, 283, 311). A clear definition of the package of inpatient care 
would allow for specific interventions to be prioritised in training and ongoing skills-based training to 
maintain and supervise the development of specialist nurses. e.g. competency to provide NG feeding, 
IV fluids and oxygen as well as for other interventions (e.g. jaundice). There is a strong case for nurses 
with specialist skills in neonatal care, working towards a global cadre of neonatal nurses (Figure 4.6) 
(30). Pre-service training needs to be a central focus, and dimensions of respectful care, 
communication and ethics specific to care of newborns, as well as clinical and technical skills, included 
as part of health worker training specific to care for small and sick newborns (297).  
Health financing and workforce issues are not entirely separate and investing in the health workforce, 
particularly in Africa and Asia, has potential for maximising the investment returns through improving 
the quality of care for small and sick newborns with resultant gains in human capital (306). Investment 
in the health workforce can also create demand and generate funding for needed jobs through 
enabling macroeconomic frameworks that create additional fiscal space (189, 312).  
8.4.3.2 Organisation and levels of inpatient care for small and sick newborns 
Historically, research and policy efforts have been more targeted towards vertical programme efforts 
for small and sick newborns focused on individual conditions such as prematurity, neonatal infections, 
or specific interventions, such as KMC. For more competent health systems that can care for small and 
sick newborns, a shift is needed to include the small and sick newborn package as part of broader 
health system strengthening systems for RMNCH.  Overall, quality related implementation research 
remains overwhelmingly from HIC (297) and there remains a dearth of quality implementation 
research on small and sick newborns in LMIC (270). Future implementation research in LMIC is needed 
to understand what works for health systems delivering inpatient care and at what cost.  
An important research question is to explore the minimum package of inpatient care required to 
achieve optimal newborn outcomes. Addressing such a question would require significant resources 
and complex evaluation design, such interrupted time series analyses, given that randomisation is 
unlikely to be feasible or ethical (313). Separating the effects of different interventions within the 
inpatient care package is methodologically challenging, especially as many of the small and sick 
newborns requiring inpatient care, by nature, have multiple co-morbidities (314). Lack of existing 
routine data on hospital capabilities will further complicate such studies, as has been found in studies 
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from high income settings, which has limited the ability of researchers to relate study findings to other 
systems and/or translate it into practical recommendations (315). Where randomised controlled trials 
and interrupted time series analyses are not affordable or feasible in all settings for evaluating 
effective organisation and delivery of care, documenting the process of implementation can provide 
valuable lessons. Much of the existing evidence is provided from single centres or initiatives (micro-
level) rather than multi-centre or district level to demonstrate meso or macro level coordination of 
care (283, 297). The absence of information on the potential cost implications of newer interventions 
and of approaches to organising and delivering inpatient care for small and sick newborns in LMIC to 
allow for more pragmatic and informed decision making in countries (297).  
Referral and transport systems are often a missing link in the organisation of a national system for 
maternal and newborn health and is critical for a competent system. Whilst referral for obstetric 
complications is challenging, transport and referral of small and sick newborns is even more inherently 
risky and complex (266). Small and sick newborns can die in minutes without the correct stabilisation 
and cannot be transferred and referred in the same manner as larger children or adult patients. As 
countries invest in referral systems to achieve UHC, it is critical to document the process and provide 
successful models of referral systems for newborns as examples to settings struggling with referral 
challenges.  
As innovative and novel devices become available for inpatient care for small and sick newborns 
(including point of care diagnostics and devices for respiratory support, phototherapy), research into 
quality and safety is needed. Other important areas for implementation research highlighted through 
this PhD are laboratory readiness for inpatient care of small and sick newborns linked to infection 
control and antibiotic stewardship.  
8.4.3.3 Family-centred care 
Families are critically concerned with the health of their newborns, for whom negative outcomes may 
have devastating social, emotional and financial consequences. Meanwhile newborns are dependent 
on their families (especially their mothers) as a source of nutrition, warmth and immune factors, as 
well as emotional nurturing (5, 16, 26). Family-centred care approaches not only have benefits for 
newborns (such as breastfeeding, growth and development), but can positively influence parents’ 
mental health, as well as confidence and trust in the health system caring for their newborn (26, 276, 
308, 316). The needs of families as part of inpatient care for small and sick newborns are often 
neglected in programmes. Families often suffer from a lack of very basic items, such as food and 
facilities to wash baby clothes. They also lack emotional support for dealing with caring for a small and 
sick newborn, as well as their own physical and mental health and support for their families caring for 
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other children at home whilst their newborns are inpatients (16, 317). Negative experiences of care 
can influence confidence in the health system and are a known deterrent to uptake of services (318), 
including attendance at follow up appointments (297). For competent health systems that families 
will trust, national governments need to define what standards of family-centred care they are able 
provide, engage families in this process and ensure that the health system values, culture and 
leadership are supportive of family-centred care.  Further research to understand the role and 
experience of mothers (and indeed the wider family) in delivering quality inpatient care unit is needed, 
especially for LMIC.  
8.4.4 Enable country-led routine data systems  
One of the overall aims of the SDG era is for all countries to own their data systems and to define their 
data needs. For accountability and action for care of small and sick newborns, measurement for 
specific countries will need to show results against benchmarks and be possible to disaggregate for 
sub-populations and levels of care. Health facility assessments and surveys needs to move away from 
measures that can otherwise be collected by real-time routine information systems and instead focus 
on measures of tenets of quality that may be more difficult to capture through routine systems, such 
as experience of care. In order to weave improvements in measurement of into the fabric of the health 
systems, more attention is needed to the performance of the routine information systems.  
8.4.4.1 Explore determinants of measurement and use and evaluate service readiness data quality, 
including interoperability of measurement systems 
Content of surveys and indicator definitions are just the tip of iceberg and it is the complex system of 
national data collection that makes the content and indicators meaningful and useful (305). More 
work is needed to explore the quality of routine data on newborns and the behavioural factors that 
are integral to the overall performance of the health information system for measuring care of small 
and sick newborns. Do the routine data collection system provide the data that health workers caring 
for small and sick newborns want and need? If indicators are irrelevant, data collection forms are 
complex, and computer software is not user-friendly, it will affect the confidence level of those 
collecting and using the data and data will not be used effectively for action (100, 298). Health 
information systems (whether paper or electronic) are of little use without the capacity of workers to 
collect them. For competent health systems, it is critical for there to be a net gain to the individual 
worker from actioning the data (305). Better understanding of the feedback loops and where the data 
gaps exist from the perspective of those organising, delivering and receiving care is needed. Caution 
is needed in embracing untested electronic and web-based technologies, such as DHIS-2, without 
evidence of its functionality and feasibility in practice (305). Application of tools, such as the PRISM 
tool (100), which have been validated and tested in multiple LMIC settings are available for this 
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purpose and can be applied as part of wider health system strengthening efforts to understand the 
performance of health information systems (290). Whilst this recommendation is applicable to all 
areas of the RMNCH continuum of care and health system strengthening efforts, care of small and sick 
newborns is especially relevant given its current measurement gap, potential impact and the 
potentially large number of structural items that need to be measured to ensure readiness, safety and 
coordination of care. Service readiness information is only useful to health systems when used in 
tandem with information on effective coverage, quality processes and overall health outcomes and 
therefore needs to be looked at in tandem with HMIS, CRVS and audit systems (Figure 8.1) to ensure 
that health systems are fully accountable to the users and that data can be used for action (106, 172).   
8.4.4.2 Test/validate signal functions in operational neonatal unit and explore population 
denominators for estimating and tracking service need 
A revision of the EmONC measurement implementation manual and associated signal functions and 
indicators is set for 2020-2022 (118). This is an important opportunity to align the measurement needs 
of mothers and newborns. Work within this PhD has the potential to contribute to this revision process 
and proposes a potential list of newborn interventions that could act as signal functions allocated to 
different levels of care, aligned with the EmOC signal functions (see Figure 7.3). Before such measures 
are incorporated in routine systems, further work is needed to refine this list to measurable signal 
functions and to test feasibility of measurement of these signal functions in existing inpatient care 
units. A critical step is operationalising these signal functions against feasible and measurable 
population denominators to capture effective coverage of services. EmONC assessments, to calculate 
service need, have mostly used numbers of facilities with a certain level of readiness for a population 
of 500,000, set against a benchmark of five facilities (118). Research has shown that tracking the 
numbers of basic and comprehensive facilities per 20,000 births (rather than population size) is 
consistent across settings with different fertility rates and is a better predictor of mortality (188, 319). 
Exploring different denominator options is needed to measure effective coverage of services for small 
and sick newborns.  
8.4.4.4 Explore approaches to measure experience of inpatient care of small and sick newborns  
The provision of respectful, dignified care is included as an equal tenet of quality in the WHO quality 
of care framework, paralleling the provision of more traditional health service inputs (318). Respectful 
maternity care is an area with a growing body of research and related policy. Increased awareness of 
the problem of disrespect and abuse has highlighted the need for valid measures to document and 
quantify the issue. However, even with more clear definitions of disrespect and abuse (320) and the 
emergence of tools to measure the experience of respectful care (321), the prevalence and frequency 
of such experiences is poorly known for mothers, even less is known for newborns, especially when 
204 
 
small and sick. To explore approaches to measure the experience of care for small and sick newborns 
and their families, lessons will need to be shared from paediatric and disability disciplines, as well as 
the respectful maternal care agenda. Documenting and studying how communication, ethics and 
respectful care can be incorporated into pre- and in-service training for health workers is needed. 
Tools to measure the experience of care (e.g. through combinations of exit interviews with families, 
bedside pain assessments, and observation of care) require testing in different contexts. Positive user 
experience is a critical marker of health system trust (297) and in the case of small and sick newborns, 
we are reliant on communication with the families of these vulnerable patients to build confidence in 
the health system.  
8.4 Conclusions 
Inpatient care for small and sick newborns is a complex intervention package with multiple health 
system challenges that need to be addressed to reduce the estimated 2.5 million newborn deaths that 
occur each year. High quality inpatient care is critical to both prevent deaths and minimise disability 
in vulnerable small and sick survivors. The package of care for small and sick newborns lacks standards 
and benchmarks for countries to track against, which are foundational to ensure safety and target 
actions to improve the quality of care at different health system levels. Competency and capacity of 
sufficient numbers of specially trained health workers is fundamental to ensure that service readiness 
inputs are delivered at high quality. This PhD has contributed to knowledge on how to improve 
measurement of service readiness for small and sick newborns in view of evolving measurement 
systems and transitions in data sources and technology. Investment in improving routine 
measurement systems and their interoperability as part of health system strengthening is required to 
track service readiness. Future work needs to develop understanding of families’ experiences of 
inpatient care to ensure trust and subsequently to improve the availability, demand and use of high-
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y of data 
grading
IMPACT Maternal Mortality Ratio some 
countries 
depending 
COIA and CD A 1
IMPACT Neonatal Mortality Rate
Yes
COIA tracks % 
of U5MR that 
is NMR. 
A 1
IMPACT Low birth weight rate
no






Skilled attendant at birth




Yes Yes A 1
COVERAGE 
OUTCOMES
Early initiation of breast 
feeding
Yes Yes A 1
IMPACT Stillbirth Rate Countries 
with VR
 CD A 2














No No A 2
COVERAGE 
OUTCOMES
Early postnatal care for babies
Yes Yes A 2
COVERAGE 
OUTCOMES
Early postnatal care for 
mothers
Yes Yes A 2
QUALITY 
OUTCOMES 
Birth companion of choice 
and skilled attendant at birth
No Not yet A 2
QUALITY 
OUTCOMES
"MotherBaby" high quality 
care package at birth No Not yet A 2
IMPACT Neonatal morbidities eg PSBI, no A 3
IMPACT Long term disability after 






No No A 3
COVERAGE 
OUTCOMES
Use of chlorhexidine cord 
cleansing 
No No A 3
ACCOUNTABILITY REPORTING GRADING








Treatment of neonatal sepsis









   
COVERAGE 
OUTCOMES
Exclusive breastfeeding <6 
months
Yes Yes B 1
QUALITY 
OUTCOMES 
Proportion of women and 
newborns who stay in facility  
at least 6 hours after giving 
birth






















































NEXT PRIOIRTY MEASUREMENT GAPS ACCORDING 
TO RANKING
Proportion of health facilities 
that without no stock outs of 
essential life savings 
medicines
No No B 2
CD B 2
Proportion of health facilities 
with safe uninterrupted 
oxygen supply in the 
childbirth, neonatal and 
No No B 2
Women's group participation
No No B 2
Health facilities offering 
maternity services that have 
BFHI certification and 
recertification not older than 
two years 
No Not yet B 2
Health facilities where 
Kangaroo Mother Care 
services are operational No
Do they have an RMNCH 
costed plan
CD (and will 




Care seeking for newborn 
danger signs No No B 2
No B 2
Health facilities offering 
comprehensive obstetric 
emergency care No
ODA mentioning newborn CD and now 
added to CD 
profiles and 
will be tracked 
annually
B 1
All countries have adopted 
legislation in order to 
implement the International 
B 1
All countries have adopted 
legislation on maternity 
B 1
Birth weight recorded 
Yes No B 1
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with maternity services that 
have functional bag & masks 
(2 neonatal mask sizes) in the 
delivery areas 
No No B 1
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with availability of soap, 
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based rub in labour and 
childbirth, neonatal and 
No No B 1
Density of doctors
No Yes B 1
Density of midwives




































Proportion of countries that 
have assessed their health 
workforce and developed 
human resource development 
and retention plans to 
increase access to quality 
maternal and newborn care at 
community, primary and 
referral health care levels
B 2
Proportion of countries that 
have updated national policies 
and guidelines for the 
continuum of care of 
reproductive,  maternal, 
newborn and child health in 
line with most recent 
evidence-based guidelines
B 2
Proportion of countries that 
have adopted standards of 
quality of maternal and 
newborn care in their national 
strategies and action plans for 
RMNCH
B 2
Proportion of countries that 
have included the 13 life-
saving commodities prioritized 
by the Commission on Life-
saving Commodities for 
Women’s and Children’s 
Health in their essential 
medicine and commodities list 
 CD  (just 




Proportion of countries  with 
the highest burden of 
newborn mortality that have 
sharpened their national 
strategies and action plans for 
B 2
Is the core set of indicators for 
assessing maternal and 
newborn health incorporated 
into the health information 
systems
B 2
Maternal, stillbirth and 
neonatal death reviews (audit)
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Facility neonatal mortality rate 
disaggregated by birth weight: 
>4000 g, 2500-3999 g, 2000-
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National BCC strategy that 
included key newborn care 
messages eg recognition of 
danger signs, bfing, warmth, 
cleanliness
B 3
Density of community health 
workers for newborn care No No B 3
Country commitments to 





Proportion of countries with 
information on national and 
donor expenditures for 
reproductive, maternal, 
newborn and child health, 
disaggregated by sources
2 B 2
Proportion of countries with a 
high burden of neonatal 
deaths have conducted a 
health facility service 
availability and readiness 
assessment to assess 
indicators of quality of 
maternal and newborn care   
B 2
Proportion of countries with a 
high burden of neonatal 
deaths have conducted a 
population-based survey to 
assess progress in coverage of 
essential interventions for 
maternal and newborn health  
B 2
Proportion of acute 
humanitarian emergency 
responses including newborn 
kits in their service delivery
B 2
Proportion of countries that 
have taken significant steps 
 to establish a system for birth 
and death registration 
including neonatal causes of 
death
B 2
Proportion of countries that 
have taken steps to harness 
community participation and 
supported local champions 
and existing community 
structures to take action for 
maternal and newborn health 
B 2
Proportion of countries that 
have authorized health 
workers at appropriate levels 















IMPACT Total Fertility Rate Yes  CD C 1
INPUTS
Legislative
All countries have adopted 
legislation on maternal death 




Yes CD C 1
COVERAGE 
OUTCOMES
Prevention of mother-to-child 




treatment for malaria in 
pregnancy
Yes CD C 1
COVERAGE 
OUTCOMES
Antenatal Care Coverage (four 
or more visits)
Yes COIA and CD C 1
COVERAGE 
OUTCOMES
Antenatal Care Coverage (one 
or more visits) Yes CD C 1
COVERAGE 
OUTCOMES
Demand for family planning 
satisfied
Yes COIA and CD C 1
Proportion of countries that 
have developed and are 
implementing national e-
health strategies including 
specifics on how this benefits 
maternal and newborn health
B 3
Proportion of countries where 
local health providers and 
private sector actors have 
been incentivized to increase 
production, distribution and 
appropriate promotion of life-
saving commodities for 





Appendix C: Bottleneck tool questionnaire for inpatient care of small and sick 
newborns 
TOOL TO SUPPORT COUNTRIES TO IDENTIFY  
BOTTLENECKS AND SOLUTIONS TO SCALE-UP NEWBORN CARE 
 
Intervention 9: INPATIENT SUPPORTIVE CARE FOR SICK AND SMALL NEWBORNS 
 
Focus on IV fluids, feeding support and safe oxygen 
 
Severely sick newborns with severe infections or who are too small to maintain their body temperature, to breath 
or to feed actively need full supportive in-patient care. This includes a number of interventions, including regular 
monitoring and assessments by health workers. As tracers for full supportive care, however, the following 
interventions have been identified: provision of IV fluids, intragastric tube feeding (IGTF), and safe oxygen 
administration. 
 
1. Leadership and governance  
1.1 Explain if full supportive in-patient care for severely sick newborns been identified as a priority 
intervention to avert preventable newborn deaths in the national RMNCH plan/strategy (specify the 
name of the documents).  
 
If so, does the plan/strategy include specific actions for in-patient supportive care for severely sick 




1.2 Explain if there are national standard treatment guidelines or clinical protocols covering full 
supportive care for severely sick and small newborns after delivery. (Specify name of the 
guidelines/clinical protocol document and year of publication). 
- Describe whether they address the most common potentially lethal conditions requiring in-
patient care, i.e. severe infections (e.g. sepsis/meningitis) and complications of prematurity.  
- Describe whether they address the need for feeding support for severely sick newborns, 
including intragastric tube feeding? Do they promote family –centered care? 
- Explain whether all recommendations are regularly updated and in line with current best 




1.3   At what level of care is inpatient care for sick and small/LBW babies recommended?  
- First referral level (e.g. district hospital)? 
- Second referral level (e.g. with specialized care available)? 




1.4 Describe whether all relevant policies or regulations are aligned with the recommendations for 
inpatient care for sick and small/LBW babies. For example:  
- Explain how/whether health facilities are organized and equipped for appropriate inpatient care 
and monitoring for sick and small/LBW babies in line with national guidelines. 
- Explain how health facilities maintain hygiene standards to ensure quality care for sick and 
small/LBW newborns. 
- Describe whether there is a cadre of health personnel authorized and trained to perform extra 
care for sick and small/LBW newborns. Explain whether health workers who assess and 
manage these newborns provide adequate extra support for feeding (including exclusive 









After responding to the questions above, please make an overall assessment of whether leadership 
and governance mechanisms in place for inpatient care for sick and small/LBW newborns are: 
 Good (not a bottleneck to scale up) 
 Need some improvements (minor bottleneck to scale up) 
 Need major improvements (significant bottleneck to scale up) 
 Inadequate (very major bottleneck to scale up) 
2. Health financing 
2.1 Describe any specific financing  issues related to the implementation of inpatient care services for 
sick and small/LBW newborns at all recommended level of care. For example: 
• At the national level: 
o Explain whether there are sufficient funds in centralized procurement and distribution systems 
to procure and distribute necessary equipment (IV fluids and safe oxygen) at all recommended 
levels of care to continuously provide inpatient care to sick and small/LBW babies at all health 




• At the district or facility level: 
o Explain whether there are sufficient funds in decentralized procurement and distribution 
systems, to procure and distribute necessary equipment (IV fluids and safe oxygen) at all 
recommended levels of care to continuously provide inpatient care to sick and small/LBW 





2.2 Describe any financial barriers that prevent sick and small/LBW newborns from receiving 
appropriate care at the health facility. For example: 
- Describe barriers to care-seeking for all sick and small/LBW newborns as a result of out-of-
pocket payments. .  
-  Explain whether user fees represent a barrier to admission of sick newborns and if the costs 
related to extra care for small/LBW babies are an issue for the clients who need it (e.g. fees for 
a neonatologist). 




2.3 Describe other financial barriers to the expansion of newborn health services for inpatient care of 










After responding to the questions above, please make an overall assessment of whether health 
financing for inpatient care for sick and small/LBW newborns is: 
 Good (not a bottleneck to scale up) 
 Needs some improvements (minor bottleneck to scale up) 
 Needs major improvements (significant bottleneck to scale up) 
 Inadequate (very major bottleneck to scale up) 
3. Health workforce 
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3.1 Explain whether there are sufficient numbers of competent health care workers who can provide 
inpatient care for sick and small/LBW babies, at each level of care, where this intervention should be 
implemented. Issues may include: 
- There are insufficient health workers to provide full supportive newborn care in the health 
facilities.  
- There might be sufficient numbers of trained health care workers, but they do not have the 
necessary competencies to provide full supportive care. 
- How is the distribution of skilled personnel trained to provide extra care for sick and small 
newborns between rural and urban populations? Is there an HR strategy to expand BNC to all 
newborns living in remote areas through community health workers? 
- Are there policies in place to insure monitoring and handling of sick/small babies by competent 
staff around the clock? 
 
3.2 What cadre of health care workers are authorized and skilled to provide extra newborn care to sick 
and small/LBW babies with: (please, check for each of these intervention)    




• Auxiliary midwives   
• Physicians/Clinicians 
• Other cadre (please specify all): ……….    
 
3.3 What cadre of health care workers are authorized to prescribe and/or administer IV fluids to sick and 
small newborns? 
• Midwives                                                ☐Administer only ☐Prescribe and administer ☐ Prescribe 
only 
• Auxiliary midwives:                             ☐Administer only ☐Prescribe and administer ☐ Prescribe 
only 
• Nurses:                                          ☐Administer only ☐Prescribe and administer ☐ Prescribe 
only 
• Physicians/clinicians                  ☐Administer only ☐Prescribe and administer ☐ Prescribe 
only 




What cadre of health care workers are authorized to prescribe and/or administer oxygen to sick and small 
newborns? 
• Midwives                                                ☐Administer only ☐Prescribe and administer ☐ Prescribe 
only 
• Auxiliary midwives:                             ☐Administer only ☐Prescribe and administer ☐ Prescribe 
only 
• Nurses:                                          ☐Administer only ☐Prescribe and administer ☐ Prescribe 
only 
• Physicians/clinicians                  ☐Administer only ☐Prescribe and administer ☐ Prescribe 
only 




What cadre of health care workers are authorized to prescribe and/or administer IGT feeding to sick and 
small newborns? 
• Midwives                                                ☐Administer only ☐Prescribe and administer ☐ Prescribe 
only 




• Nurses:                                          ☐Administer only ☐Prescribe and administer ☐ Prescribe 
only 
• Physicians/clinicians                  ☐Administer only ☐Prescribe and administer ☐ Prescribe 
only 
• Other cadre (please specify all): ……… ☐Administer only ☐Prescribe and administer ☐ Prescribe 
only 
 
3. 4 Explain whether there are job descriptions and job aids for health workers at all levels of care, which 




3.5 Are there competency-based training programmes through which the respective cadre of health care 
workers acquire the necessary knowledge and skills to provide IV fluids? 
• Nurses                                     ☐Pre-service training ☐ In-service training 
• Midwives                                                 ☐Pre-service training ☐ In-service training 
• Auxiliary midwives                              ☐Pre-service training ☐ In-service training 
• Auxiliary nurses                              ☐Pre-service training ☐ In-service training 
• Clinical officers                                       ☐Pre-service training ☐ In-service training 
• Physicians/clinicians                  ☐Pre-service training ☐ In-service training  
• Other cadre: ………….  ☐Pre-service training ☐ In-service training 
 
Are there competency-based training programmes through which the respective cadre of health care 
workers acquire the necessary knowledge and skills to provide oxygen? 
• Nurses                                     ☐Pre-service training ☐ In-service training 
• Midwives                                                 ☐Pre-service training ☐ In-service training 
• Auxiliary midwives                              ☐Pre-service training ☐ In-service training 
• Auxiliary nurses                              ☐Pre-service training ☐ In-service training 
• Clinical officers                                       ☐Pre-service training ☐ In-service training 
• Physicians/clinicians                  ☐Pre-service training ☐ In-service training  
• Other cadre: ………….  ☐Pre-service training ☐ In-service training 
 
 
Are there competency-based training programmes through which the respective cadre of health care 
workers acquire the necessary knowledge and skills to provide IGT feeding? 
• Nurses                                     ☐Pre-service training ☐ In-service training 
• Midwives                                                 ☐Pre-service training ☐ In-service training 
• Auxiliary midwives                              ☐Pre-service training ☐ In-service training 
• Auxiliary nurses                              ☐Pre-service training ☐ In-service training 
• Clinical officers                                       ☐Pre-service training ☐ In-service training 
• Physicians/clinicians                  ☐Pre-service training ☐ In-service training  
• Other cadre: ………….  ☐Pre-service training ☐ In-service training 
 





After responding to the questions above, please make an overall assessment of whether health 
workforce mechanisms in place for inpatient care for sick and small/LBW newborns are: 
 Good (not a bottleneck to scale up) 
 Need some improvements (minor bottleneck to scale up) 
 Need major improvements (significant bottleneck to scale up) 
 Inadequate (very major bottleneck to scale up)Good 
 
4. Essential medical products and technologies 
237 
 
4.1 Are the following appropriate IV fluids included in the National Essential Medicines List (NEML) 
for the indication of management of sick and small newborns?  
☐ 10% Glucose 
☐  0.45 NaCl/5% glucose 
☐ 0.18% NaCl/4% glucose 
 
 
4.2 Explain if oxygen is included in the National Essential Medicines List (NEML) for the indication of 
the management of sick and small newborns and if all necessary equipment for safe oxygen therapy is 





4.3 Explain whether sufficient medical products (branded or generic), that can be used for treatment of 
sick and small/LBW newborns, are licensed. 
 
 
4.4 Explain if there are functional national or local systems in place to accurate forecasting and 
distribution of IV fluids and oxygen for the management of sick and small/LBW newborns in 
health facilities. 
 
4.5 Describe and explain the reasons for stock-outs of IV fluids and oxygen at national and sub-national 
levels in the last twelve months, if any. 
 






After responding to the questions above, please make an overall assessment of whether 
procurement and management systems in place for inpatient care for sick and small/LBW 
newborns are: 
 Good (not a bottleneck to scale up) 
 Need some improvements (minor bottleneck to scale up) 
 Need major improvements (significant bottleneck to scale up) 
 Inadequate (very major bottleneck to scale up) 
5. Health service delivery 
5.1 Explain whether the organization of newborn care services within health facilities allows for full 
supportive care of sick and small/LBW newborns. 
- Are there a limited number of health facilities that provide extra care for sick and small/LBW 
babies? What is the balance between urban and rural/remote areas? 
- Is the service available on a daily basis? 
- Is there a clearly defined supportive environment in place for extra support for feeding 
methods, extra support for warmth to sick and small/LBW babies? 
- Is there a public-private partnership that enhances delivery of newborn health care services? 
 
5.2 Describe the systems in place to promote the adherence to national standard and clinical protocols on 
inpatient/extra care for sick and small/newborns (see section 1.2 on leadership and governance for 
relevant guidelines). For example: 
- Describe quality improvement mechanisms in place with standardized tools such as check lists 
for quality of inpatient care for sick and small/LBW babies. 
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- Explain specific efforts made by public and private (for-profit) health care facilities to promote 
and ensure quality basic newborn care. 
- Explain whether districts or health facilities conduct periodic reviews to ensure the provision of 
quality inpatient care for sick and small newborns. 
- Describe guidelines available and used by staff to improve the quality of inpatient care services 
for newborns. 
 
5.3 Describe other barriers to the delivery of basic newborn health care services that need to be 
addressed. For example:  
- Lack of information on clients’ needs for improved performance  
- Health care workers’ attitudes 








After responding to the questions above, please make an overall assessment of whether health 
service delivery in place for full supportive care for sick and small/LBW newborns is: 
 Good (not a bottleneck to scale up) 
 Needs some improvements (minor bottleneck to scale up) 
 Needs major improvements (significant bottleneck to scale up) 
 Inadequate (very major bottleneck to scale up) 
6. Health information systems 
6.1 Explain whether there is information available on extra newborn care coverage for sick and small 
newborns. For example:  
- What are the indicators used to track the sick or small/LBW newborns that received extra care 
(number of newborns hospitalized?) or to record the weight of small/LBW babies assessed? 
Please specify the reference document for the indicators used, including publication dates and 
the page. 
 
6.2 Explain whether the findings observed during inpatient care for sick and small/LBW newborns are 
included in standard clinical records or checklists. 
 
6.3 Explain whether the critical review of appropriate inpatient care for sick and small/LBW babies is 
included in protocols for clinical audits and perinatal death reviews. 
 
 





After responding to the questions above, please make an overall assessment of whether health 
information systems in place to assess and monitor full supportive care for sick and small/LBW 
newborns are: 
 Good (not a bottleneck to scale up) 
 Need some improvements (minor bottleneck to scale up) 
 Need major improvements (significant bottleneck to scale up) 
 Inadequate (very major bottleneck to scale up) 
7. Community ownership and participation 
7.1 Explain whether sick and small/LBW babies in need of extra neonatal care can use the services at all 
levels of care. For example:  
- Explain whether care seeking is limited by socio-cultural barriers (misconceptions, beliefs, 
seclusion of newborns, etc.), lack of male involvement or long distance to health facilities. 
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- Describe strategies in place to facilitate the use of inpatient neonatal care services by sick and 
small/LBW newborns living in rural and remote areas. 
- Describe the referral mechanisms in place between the community and health facilities 
organized to facilitate timely referral and access to care for all newborns. 
 
 
7.2 Describe specific efforts to increase the awareness of the general public, adolescent girls, pregnant 
women and young couples of the benefits of (1) timely recognition of a newborn with LBW or with 
signs of illness and (2) timely care seeking to a health facility.  For example: 
- Is information on the benefits of timely recognition of signs of illness and referral to an 
appropriate provider available in the appropriate local language? 
- Do women and the general public know about that information?  
- Are there IEC materials available in the appropriate local language? 








Please provide a summary of key bottlenecks. 
 
 
After responding to the questions above, please make an overall assessment of whether community 
ownership and participation to increase full supportive care for sick and small/LBW newborns is: 
 Good (not a bottleneck to scale up) 
 Needs some improvements (minor bottleneck to scale up) 
 Needs major improvements (significant bottleneck to scale up) 






IDENTIFICATION OF SOLUTIONS TO ADDRESS THE CHALLENGES 
Please add sheets as appropriate 
 
 
Intervention 9: INPATIENT SUPPORTIVE CARE FOR SICK AND SMALL NEWBORNS  - Focus on 
IV fluids, feeding support, and safe oxygen 
 




Strategies and solutions to address identified 
challenges and bottlenecks 























































































































































Governance Poor governance leading to 
increasing the cost of care 
 
✓             
Policy/strategy No state level uniform policy for 
relevant supportive policies, like 
discharge policy (medical colleges 
vs District level & peripheral 
SNCUs) 
 
        A    
Strategy is available but not 
prioritized 
 
         ✓    
No standard plan/policy for care 
of sick babies  
 
          A,G  
Only physicians authorized for 
prescribing the drugs. ANMs 
skilled to provide only oxygen 
but not to prescribe 
 
        
 
O,A 
✓  A  
Management of sick newborns is 
not part of BPHS/EPHS package 
so service delivery does not 
exists  
✓       ✓       
Guidelines / standards No guidelines or 
recommendations 
 



































































































There is a WHO Guideline on 
inpatient care but not well 
circulated  
 
    ✓         
Feeding is not emphasized in the 
standard treatment guidelines at 
district level 
 
   ✓          
Guidelines do not promote 
family-centered care 
 
  ✓          ✓  
Dissemination of guidelines is 
limited to senior officials, 
especially in tertiary care 
hospitals and does not reach the 
service providers at lower levels 
 
        
 
A 
   
Guidelines in place but not in 
practice (e.g. do not stay for 48 
hours). Following the guidelines 
varies from institution to 
institution due to technical 
limitations 
 
        
 
O 
  ✓  
Protocol Non-adherence to and lack of 
standard, clinical protocols for 
treatment of sick newborns and 
lack of adherence putting further 






















































































Lack of clear public-private 
partnership 
 
✓         
 
O 
   
Awareness Lack of awareness 
 




















Funding Competing needs for available 
funds 
 
  ✓           
Insufficient / lack of funds for 
distribution of necessary 
equipment and services (e.g. for 
lab support and blood 
components) 
 







Availability of funds - not 
allocated for inpatient care for 
sick and small newborns at all 
recommended levels of care 
 
      ✓  ✓    K  
Problems in funds disbursement 
at district / lower level and fund 
flow from national and state 
level 
 
        
 
O, A 
   
Low state subsidy 
 












































































Insurance Almost no insurance companies 
and lack of coverage of certain 
medicines for treatment of 
preterm newborns at certain 
levels 
 
 ✓           ✓  
Financial barriers to 
care  
Government cannot promote 
adequate medicine due to 
financial barriers 
 
          A, P  
LBW babies need treatment, but 
financial problems are barriers to 
treat them 
 
          B  
Hospital acquired infection 
requires costly antibiotics  
 
          A  
Out-of-pocket expenses 
/ user fees 
No grants to families to pay for 
care 
 
✓             
User fees - patient having to 
purchase drugs and out of pocket 
payment 
 
  ✓   ✓     
 
A 
✓  K ✓  
Awareness Clients and service providers not 
aware of free entitlements and 
available funds 
 
        
 
O 


















































































and role of health 
workers 
Lack of trained personnel in 
neonatal care in quantity and 
quality (knowledge, training and 
skills), particularly at lower levels 
 







Disparity in the distribution of 
personnel (urban vs. rural) 
 
✓  ✓    ✓     
 
O 
 P  
Selection and posting of trainees 
(inappropriate selections and 
post-training deployment) 
 
        
 
O 
   
No integrated care for sick 
newborns by community workers 
 
 ✓            
Supervision  Lack of supportive supervision 
 
✓  ✓    ✓    ✓  
 
O 
   
Accountability No accountability  
 
          G  
Incentives and 
motivation 
No providers’ incentive scheme 
(e.g. lack of encouragement for 
task-shifting) leading to lack of 
motivation  
 
 ✓    ✓      ✓    
Training No/inadequate competency-
based training/CME in care of 
small and sick babies (particularly 
at lower levels) including pre-and 
in-service and refresher training 
 ✓    ✓   ✓   
 
O, A 










































































Job descriptions available but not 
known/clear to all 
  
✓         
 
O 
   
No job chart available on the 
specific mentioned areas  
 
        
 
A 





















Lack of supplies and 
equipment 
General stock-outs / lack of 
supplies and equipment / 
inadequate supply 
 







Electronic weighing machine not 
available in all units 
 
        
 
O 
   
0.45 NaCl/5% glucose not 
available 
 
        
 
A 
   
Shortfall in supply of oxygen due 
to demand and supply gap and 
non-availability 
 
        
 
A 
 A, G  
NICU in tertiary care and 
teaching hospitals in capital city 
has only ventilator support with 
oxygen 
 
          A  
Essential Medical List 
(EML) 
No oxygen in the list of essential 
features 
 



















































































All equipment required for 
oxygen are not included in the 
LNME (other than those included 
in the kit but not for continuity 
and many children) 
 
 ✓            
Fluids not on list 
 
 
          P  
Policy The essential medicine list policy 
is available but not fully 
implemented 
 
    ✓     
 
A 
   
No national policy of supplies 
 
          G  
Procurement and 
supply management 
Poor and inaccurate forecasting, 
procurement, distribution and 
supply management (e.g. not 
available at all levels, no system 
in place to forecast demand for 
oxygen and IV fluids, issues with 
supply chain management and 
maintenance of supplies) 
 
  ✓   ✓    ✓  
 
O, A 





Service availability / 
capacity of services 
Some facilities have limited 
availability of services (e.g. 
services for caring for low birth 
weight / small babies) 
 
✓  ✓       ✓  
 
A 
































































































Side labs with special newborn 
care units not functioning 
optimally 
 
  ✓           
Limited number of facilities 
providing inpatient care for 
severely sick and small newborns 
(particularly at lower levels) 
 
 
  ✓         K, P  
Skewed distribution of Health 
facilities between rural and 
urban  
 
    ✓         
No professional postnatal care 
system 
 
           ✓  
Many available building plans are 
outdated for recommended 
inpatient care of sick and small 
baby 
 
  ✓           
National scale-up of inpatient 
care for supportive care for sick 
and small/LBW yet to be done 
beyond selected hospitals 
supported by projects 
 

































































































No nursery and proper 
management of LBW babies 
 
          B  
Referrals Referrals are not as per the 
guidelines 
 
        
 
O 
   
Space Limited space  
 
   ✓      
 
O 
 A ✓  
No space for mothers of 
inpatient newborns to stay when 
their babies are admitted to 
facilities 
 
         ✓    
Quality improvement Poor adherence to existing 
guidelines/ recommendations/ 
protocols and no strategies in 
place for improvement 
 
✓     ✓      ✓    
Lack of guidelines to improve the 
quality of services 
 
✓             
No standardized quality tools and 
consequent performance reviews 
 
   ✓          
Quality of care at facilities is a 
major issue / inadequate 
 
       ✓  
 
O 
   
Inadequate monitoring, quality 
assurance, maintenance and 




























































































Lack of mechanism to ensure the 
guideline are properly applied 
and adhered to 
 
           ✓  
Mentoring / supervision 
guidelines not in place 
 
        
 
A 
   
Service quality is different 
between levels of care 
 
           ✓  
Health worker attitudes  Poor health worker attitudes 
toward care of newborns 
 
  ✓       
 
A, O 
   
Communication Ineffective communication (with 
clients and between community 
and facility) 
 
        
 
A 
   
Supportive 
environment 
No family-centred, supportive 
care for the mother and newborn 
 
 ✓           ✓  
Facilities lack supportive 
environment (e.g. for feeding) 
 
  ✓       
 
O 







































































Non-compliance with hygiene 
standards in the majority of 
structures 
 






















Tools for information 
system  
Neonatal registers not developed 
 
  ✓           
Records not being maintained 
uniformly at both higher and 
lower level facilities 
 
        
 
A 
   
Indicators No harmonization of information 
on outcomes of hospital care in 
the registers 
 
✓             
HMIS for inpatient supportive 
care for sick and small newborn 
is not yet functioning in all 
facilities or captures relevant 
information 
 
       ✓    G ✓  
Few indicators on newborns / no 
definition of indicators on sick 
newborns, only deaths 
 
 ✓           ✓  
Lack of tracking of referrals and 
treatment 
 
        
 
O 































































































Lack of information on 
management system for sick 
newborns or LBW management 
 
         ✓  B, K  
Use and dissemination 
of information 
Poor dissemination and 
utilization of health information 
materials 
 
    ✓         
SNCU software in place but not 
analysed regularly 
 
        
 
O 
   
Quality improvement 
tools 






 ✓            
Standardized tools such as check 
lists for quality of inpatient care 
needs review to ensure optimal 
inpatient newborn care and 
proper dissemination 
 
    ✓         
Quality improvement 
assessment system  
Absence/poor coverage of 
clinical audits and perinatal 
deaths listed 
 
















































































No regular reviews on mortality 
and performance at hospital level 
and at district level 
 
        
 
A 
 A ✓  
Technical information needed for 
treatment is not properly filled 
out 
 
           ✓  
Data not disaggregated into 
specific neonatal causes 
 



















Communication materials only in 
French  
 
 ✓            
No communication strategy in 
place 
 
         ✓    
Lack of information on newborn 
care 
 
           ✓  
Awareness Lack of community awareness 
(e.g. of treatment process, care-
seeking, available care and 
rights) 
 
✓  ✓      ✓  ✓  
 
O 
 K, G  
No specific efforts to increase the 
awareness of the general public, 
adolescent girls, pregnant 
women and young couples of the 






























































































benefits of timely recognition of 





Females have limited mobility 
(and say in decision-making) and 
males may not be available all 
the time that care should be 
sought 
 
      ✓   
 
A 
   
Poor health seeking behaviour in 
community 
 
        
 
A 
   
Poor referral system and linkages 
between facility and community 
 
        
 
A 
 B  
Barriers / challenges 
faced by mothers 
Socio-cultural barriers 
 ✓   ✓       
 
A 
   
Delay in recognition of danger 
signs and prompt referral         
 
A 
   
Transport available but not 
utilized 
 
        
 
O 
   
Illiteracy  
 
 ✓            
Loss of wages 
         
 
O 
   








































































Communities suffer due to 
increasing costs of IV funds, 
antibiotics and other cost 
incurred 
 
          G  
Lack of social security system for 
poor 
 
          G  
Access Inability to / limited access to 
services at all levels 
 




Poor involvement of men 
 
✓  ✓  ✓   ✓     ✓    ✓  
Poor engagement of community 





mobilization models not available 
/ limited community mobilization 
        
✓  
O 




Appendix E: Solutions for inpatient care for small and sick newborns 




Cameroon DRC Kenya Malawi Nigeria Uganda 
Leadership and 
Governance 
• Revise the IMCI 
module will take 
better account of 
the newborn 




hospital care for 
small children / 




• Capacity building of 
staff in extra care 
to sick newborns 
and small / low 
birth weight 
 
• Extension of 
hygiene standards 
to the level of 
structures 




• Review the 
guideline/strategie
s and include 
medical social 
guidelines 
• No solutions 
proposed 
• Create enabling 
environment with 
targeted advocacy  
 
• Promote effective 
Coordination at all 
levels of care  
 
• Making guidelines 





• Strengthening the 
quality assurance 
teams to monitor 
and supervise  
 
• Full dissemination 
of all relevant 
guidelines 
 
• PAN / NISONM to 
support the 
process 
















• Advocacy for the 
mobilization of 
funds for the care 
of the newborn 





• Creation and 
expansion of 
mutual health 




• Alternative funding 
mechanism 
• No solutions 
proposed 
• Health insurance 












based on periodic 
needs assessment) 
 




• Initial and 
continuing training 
of health 
personnel in the 
care of the 
newborn 
• Integration of 
competency-based 
training at the 
initial training 
 
• Policy affection 
balanced staff 
• Recruitment and 
redistribution 
 
• Scale up the in-
service training and 
update pre-service 
training 
• No solutions 
proposed 
• Mapping of health 
worker 
 












Cameroon DRC Kenya Malawi Nigeria Uganda 
 
• Capacity building of 
staff 
 
• Extension of the 
FBR 
 • Fast track the 
implementation of 
task shifting policy 
 












• Plea to include 
oxygen on the 
essential drug list 
 




• Improve inventory 
management 
• Update the LNME 
 








• No solutions 
proposed 
• Implementation of 
essential medicine 






















Cameroon DRC Kenya Malawi Nigeria Uganda 
• Ensure Abuja 



















• Increase the 
number of health 
facilities 
• No solutions 
proposed 
• Decentralization of 
in- patient 
neonatal care:  Sick 
but Not critically ill 
newborns can be 
managed at 





• Mother friendly 















• Develop neonatal 
registers 
 
• Ensure data is 
disaggregated 




utilization of health 
information 
materials 








Cameroon DRC Kenya Malawi Nigeria Uganda 
integration in the 
NHIS 
 












• No solutions 
proposed 
• Translation of 
MNCH 
communication 











• Implementation of 
OAC for women's 
literacy 




• No solutions 
proposed 





• Increase the public 
enlightenment on 
sick newborn signs 
and importance of 
early health 
seeking for the sick 
newborn 











Appendix G: Literature search strategy for bottlenecks paper on inpatient care of 
small and sick newborns 
 
For the background section, we used the following search terms in Pub Med. Limits were applied 




(neonat* OR newborn* OR new-born* OR infant, newborn/ OR infant, low birth weight/ OR infant, 
small for gestational age/ OR infant, very low birth weight/ OR infant, extremely low birth weight/ 
OR infant, premature/ OR infant, extremely premature/) 
AND 
Oxygen 
(Oxygen therapy OR o2 therapy OR continuous positive airway pressure OR CPAP or nasal prong or 
nasal cannula* OR head box or (oxygen or o2)) 
AND 
Enteral/intragastric feeding 
(Nasogastric feed* OR orogastric feed* OR oro-gastric feed* OR naso-gastric feed* OR enteral feed* 
OR enteral nutrition OR gavage feed*) 
AND 
IV fluids 
(Maintenance fluid* OR IV fluid* OR intravenous fluid* OR supplemental fluid* OR infusion*) 
For the discussion section we searched the following terms in pub med and google. Only relevant 
articles were retrieved. 
Health Financing  
(Health) AND (financial access OR financial barrier OR out-of-pocket payment OR user fees OR 
conditional cash transfers OR cash benefits OR performance based incentives OR voucher OR 
reimbursement of transport costs) 
Budget allocation 
Innovative funding 
Social health insurance 
Universal health insurance 
Community based insurance 




(Heath worker OR staff) AND (pre-service training OR in-service training OR recruitment OR 
recognition of midwifery staff OR task-shifting OR training OR performance incentive OR retention 
OR contracting out OR increase in availability OR skill mix OR remuneration OR salaries) 
Community health workers 
Task shifting  
Skills based training 
Neonatal nursing 
Competency based training 
Community: 
(Health) AND (information education communication OR community mobilization OR utilization OR 
sensitization OR male involvement) 






Behavior change communication (BCC) 





Appendix H: Summary of notes from expert focus group on levels of inpatient care for 
small and sick newborns 
 
Intervention Comments/discussion 
Thermal care Almost universal consensus that thermal care should be available and emphasised 
at all levels. For inpatient care combination of warmed cots, KMC, incubator will 
need to be considered.  
PPROM All agreed that this is important to emphasise as a maternal intervention, but was 
not focus of discussion due to the timing of the intervention (before birth).  
Antenatal corticosteroids All agreed that this is important to emphasise as a maternal intervention, but was 
not focus of discussion due to the timing of the care (before birth).  
Alternative feeding if 
baby unable to 
breastfeed (cup feeding 
and nasogastric tube 
feeding) 
The original signal function only included cup feeding, but the group agreed that 
nasogastric feeding should be included as part of the signal function. 
Safe oxygen therapy Long discussion on safe oxygen and the need for the signal function to outline 
pulse oximetry, blenders and humidifiers and consistent O2 supply. Point made 
that need to stress importance of safe administration, just because a facility have 
O2 does not mean the facility is safe and ready to provide oxygen for newborns. 
Management of 
hypoglycaemia 
Particularly focused on glucose measurement etc.  
Intravenous fluids Safety and laboratory support.  
Effective phototherapy Management of bilirubin levels.  
Intravenous antibiotics 
for the treatment of 
newborn infections 
Sepsis management with infection treatment (IV) – challenges exist for IV 
antibiotics for week long courses/ two weeks and will need to be able to finish the 
course.  
Kangaroo mother care, 
including follow up 
Important that the signal function captures the facility readiness to provide follow 
up structures as well as the inpatient components of KMC 
Management of seizures Eg. phenobarbitone and associated care 
Total parenteral nutrition 
(TPN) 
General agreement that this should not be a signal function but formed important 
part of the discussion.  
Continuous positive 
airway pressure (CPAP) 
Many felt that although CPAP is becoming increasingly available, there was still a 
need for caution on scaling up without due attention to safety.  
Mechanical ventilation Require significant associated support and potential for long term damage means 
safety is critical.  




Few settings able to do this, but would be important for higher level facilities to 
build into their care of preterm given the importance of ROP as a cause of 
preventable blindness.  
Bronchopulmonary 
dysplasia screening 
This was mentioned but most felt not feasible or realistic as a signal function. 
Head ultrasound Mentioned but not discussed in detail.  
Exchange transfusion  Many noted that CEmOC facilities can do blood transfusion but this should not be 
automatically assumed that these same facilities can carry out transfusions for 
newborns.  
Haemodialysis This was mentioned but most felt not feasible or realistic as a signal function.  
Cooling Group participants felt evidence for this strong, but still a relatively new 
intervention in higher income settings.  
Mechanical ventilation Many felt very few facilities will be able to do this in many low income settings 
Specialised follow up of 
the small and sick 
newborn 
The group emphasised the importance of this component of offering inpatient 
care and that services need to think about how to build this into their facility 





Final list of interventions for inaptient care of small and sick newborns showing number of votes by level 
of care 
 




Appendix I: Matrix of structural components for inpatient care of small and sick newborns 
 





Access to drinking water (for staff and patients) Back up generator 25-50 KVA capacity (may be shared with other units) See specific drugs list   
Access to first stage labour room and postnatal room Blood pressure apparatus (sphygmomanometer) 
Area for newborn resucitation Blood pressure accessories including neonatal sized blood pressure cuff (sizes 1-5)
Clean storage space for supplies (linen and general equipment) Blood sugar glucose dipsticks
Communication infrastructure (telephone, internet or radio access (may be shared with other units)) Bowls (preferably polypropylene)
Consistent, uninterrupted 24 hour stabilised power supply Computer (may be shared with other units)
Dedicated space for labour and delivery only Cot/bassinet/bayonets on castors
Fan or air conditioning Delivery beds (for mothers)
Health management information system (shared with other units) Delivery packs
Heating arrangements Doppler
Lighting to ensure good illumination day and night Dressing trolley (or equivalent)
Consistent oxygen source/supply Dressing trays/procedure trays (or equivalent) (sterile and non-sterile)
Midwives station/charting or staff work area Emergency trolley (or equivalent)
Sufficient infrastructure for privacy for mothers, including curtains Endotracheal tubes
Toilet or latrine for patients and visitors Episiotomy scissors
Toilet or latrine for staff Fetal stethoscope
Water supply (uninterrupted) (for hand washing, cleaning etc.) Flashlight/torch with spare batteries
Waiting area for visitors/family Forceps (large and medium)
24 hour service availability Gauze
Gauze bandages




IV cannula 22G, 24G, (25G, 28G rarely used)
Kidney bowls (polypropylene, stainless steel) 825ml
Magills forceps
Manual vacuum extractor
Measuring tape (preferably vinyl coated)
Mucus extractor 
Nasogastric feeding tubes 3.5-10 with caps
Oxygen tubing
Paediatric infusion set (60 drops per ml burette)
Partograph
Recharger for batteries




Sterile needles (19-26 gauge) or butterfly set (23-25 gauge)
Sterile syringes (small sizes 0.5, 1ml, 2ml, 5ml, 10ml, 20ml) 
Sterile tissue forceps 
Sterile drapes 
Stethoscope (neonatal)
Suction pump (portable, electrical with accessories)
Suction pump (manual, non-electric power dependent)
Suture set (needle and materials)
Swabs and/or cotton wool balls
Vital sign monitors (NIBP, HR, SpO2, ECG,, RR, Temp) with accessories
Wall clock/timer with second hand
Weighing scales for newborns (preferably with 5-10g increments)
Labour and Delivery Room




Access to laundry facilities Alcohol-based hand rub
Areas for hand washing Antiseptics (e.g. chlorhexidine 7%, ethanol, povidone-iodine, chlorhexidine gluconate 4% gel, aqueous chlorhexidine 0.05% and 0.2%). 
Area for cleaning and disinfecting supplies and equipment Autoclave  (or equivalent sterilisation equipment can be shared with other units)
Autoclave room or sterilization space (can be shared with other units) Contaminated waste bin (leak proof)
Hand washing stations/sinks Decontamination container
Incinerator (eg. burn in incinerator, off-site incineration can be shared with other units) Disinfectant solutions (e.g. chlorine bleach)
Sterilisation space (eg.space for dry heat, steam, electric boiler or steamer or non-electrics with cover for 
boiling and steaming & drum and stand) (can be shared with other units)
Eye shields
Storage space for soiled utility Gloves (disposable)
Ventilation Gloves (sterile)
Gloves (elbow length heavy duty)
Gloves (heavy duty rubber or latex utility gloves)
Hand drying options (paper towels or appropriate hand dryers)
Iodine
Instrument sterilizer
Mayo stand (or equivalent) on castors
Nail brushes or sticks
Non-sterile protective clothing (e.g. plastic aprons)
Pictorial hand washing instructions
Regular trash/waste bin
Receptacle for soiled linen
Sharps containers (puncture proof)
Sluice
Soap for handwashing
Surgical masks, drapes and cap and boots for procedures
Umbilical vein catheters sizes 3.5 and 5 (where expertise available)
As per general and infection control infrastructure for labour and delivery room As per general equipment and infection control items for labour and delivery room See specific drugs list for eye ointment and Vitamin K
Clean blankets, towels and linen (for drying baby)
Disposable diapers/nappies
Newborn hats/caps (including preterm sizes)
Newborn mittens, socks
Sterile scissors and/or sterile blade to cut cord
Umbilical cord clamp (sterile ligatures or clamp of Barr) or cord ties/sterile thread
As per general and infection control infrastructure for labour and delivery room As per general equipment and infection control items for labour and delivery room
Expression space/expressing room and storage for expressed breastmilk (see also sick newborn space) Educational information on breastfeeding for mothers (e.g. written and pictoral information, support classes or groups, posters)
Space/allowance for patient privacy for mothers
As per general and infection control infrastructure for labour and delivery room and essential newborn care As per general equipment and infection control items for labour and delivery room and essential newborn care
Newborn emergency space for resuscitaire/newborn resuscitation Airway suction apparatus (suction bulb manual, mechanical or electrical)
Bag self inflating (neonatal size, ideally with filter)
Neonatal sized face masks (size 0-1)
Nasal prongs 1mm and 2mm (if nasal prongs not available use nasal catheter (8-F and 6-F sizes)
Neonatal sized pulse oximetry probes/sensors for oxygen saturations
Mucus extractor 
Oxygen humidifiers
Oxygen low flow device
Oxygen flow splitter for newborn
Oxygen tubing
Resuscitation mannequin (for practice)
Resuscitaire (with heat source)
Suction catheters size 5, 8, 10, 12 & 14 (sterile disposable)
Pulse oximeter
T-piece resuscitator (only where expertise available)
Wall charts/action sequences for neonatal resuscitation (e.g. HBB flowchart)
Infection Prevention and Control 
Essential Newborn Care 








As per general and infection control infrastructure for labour and delivery room As per general equipment and infection control items for labour and delivery room and essential newborn care See specific essential drugs table, protocols may vary between settings
See laboratory section - access to infrastructure for HIV testing equipment and screening for congenital TB
Documentation for newborn unit
GUIDELINES AND/OR PROTOCOLS for the following:
CEmOC and BEmOC guidelines 
Classification of breathing difficulty and SpO2 thresholds
Cleaning of instruments and equipment
Essential newborn care guidelines 
Infection prevention and control guidelines for the labour and delivery unit and standard precautions
Management of pregnancy and childbirth (Integrated management of pregnancy and Childbirth - IMPAC)
Management of pregnancy and newborn complications
Newborn resuscitation guidelines
National immunisation schedule
PMTCT guidelines, including vaccination schedule
Referral and transfer to neonatal unit
Standards on immediate and exclusive breastfeeding
Use of radiant warmers
CHECKLISTS 





Newborn screen filter cards (per national protocol)
General birth records/notes (ongoing  medical care)




Referral forms (if needed)
GENERAL REGISTERS/LOG BOOKS
Birth registration (or access to)
Cause of death certificates
Death/mortuary register
General register for labour and delivery ward 
Newborn death stillbirth audit
Referral register
Postpartum ward register
PMTCT labour and delivery register







24 service availability Adhesive strapping for peripheral lines (or IV film dressing) See drugs list
Access to drinking water (for staff and patients) Baby nappies/diapers napkins
Area for preparing IV drugs and fluids Back up generator 25-50 KVA capacity
Clean storage space for supplies (linen, diapers, clinical supplies and general equipment) Blood collection tubes (appropriate small size) e.g. vacuum tubes serum and EDTA 3ml and 6ml       
Communication infrastructure (telephone, internet or radio access (may be shared with other units)) Blood collection tube holders
Consistent, uninterrupted 24 hour stabilised power supply Blood collection vacuum tube needles 22G
Dedicated space/room or building (only for small and sick newborns) Blood pressure apparatus (sphygmomanometer) 
Dedicated workspace for doctor on duty Blood pressure accessories including neonatal sized blood pressure cuff (sizes 1-5)
Examination space or area for treatment/stabilisation (allowing for good lighting, warm, with facilities for 
resuscitaiton and patient privacy)
Blood pressure transducer (for central arterial lines)
Fan or air conditioning with air filters (to prevent risk of airborne infection) Bowls (polypropylene)
Food provision for mothers that are rooming-in/providing KMC (access to) IV cannula 22G, 24G, 25G 28G
Health management information system Capillary sample tubes (glass collection tubes)
Heating arrangements Comfortable chairs for mothers
Lighting to ensure good illumination day and night Comfortable chairs for staff
Nurses station/charting or staff work area Communication equipment (e.g. radio, telephone)
Rooming in facility with chairs and beds for mothers (see kangaroo mother care) Computer (for electronic records or data system may be shared with other unit)
Toilet or latrine for staff Clean blankets, towels and linen including survival blankets 
Toilet or latrine for patients and visitors Cots/bayonets for newborns
Water supply (uninterrupted) (for hand washing, cleaning etc.) Cot and incubator mattresses
Waiting area for visitors/family with educational materials/parent information Dressing trolley (or equivalent)
Dressing trays/procedure trays
Emergency trolley (or equivalent)
Examination lights mobile - 220-12V
Flashlight/torch with spare batteries
Gauze, swabs, cotton wool
Gauze bandages




Intra-osseous needle (or 22G needles)
Kidney bowls (polypropylene, stainless steel) 825ml
Long line packs (for percutaneously inserted central lines)
Lumbar puncture needles (or 23G needles)
Measuring tape (preferably vinyl coated)
Mucus extractor 
Newborn hats/caps (including preterm sizes)
Newborn mittens, socks
Padded boards and/or splints for neonates and preterm
Room thermometer
Radiant warmer, fixed height, with trolley, drawers and O2 bottles
Recharger for batteries
Refridgerator (for drugs etc.)
Sample collection tubes (pus, cerebrospinal fluid)
General for neonatal unit (service availability 24/7)





Soft gauze torniquet (or rubber band for scalp vein)
Spacer 
Spatula
Sterile equipment stand/dressing tray
Sterile gauze
Sterile tissue forceps 
Sterile (low flow) lancet for heel pricks
Sterile blades/scissors 
Stethoscope (neonatal)
Suction catheters size 5, 8, 10, 12 & 14 (sterile disposable)
Suction pump (portable, electrical with accessories)
Suction pump (manual, non-electric power dependent)
Suture set
Thermometers (preferable digital for newborns that measure 32°C-43°C - must measure below 35.5°C degrees)
Umbilical vein catheters sizes 3.5 and 5 (where expertise available)
Urinary catheter sizes 5-8
Urine bags (paediatric)
Urine dipsticks (Multistix) 
Vital sign monitors (NIBP, HR, SpO2, ECG, RR, Temp) with accessories
Wall clock/timer with second hand
Weighing scales for newborns (preferably with 5-10g increments)
X-ray system (preferably mobile for chest x-ray e.g. for pnuemothorax) (may be shared with other units)
X-ray viewer (negatoscope) (may be shared with other units)
CT scanner (may be shared with other units)
Echocardiography
Electrocardiagram (ECG) recorder, portable, with accessories (may be shared with other units)
MRI (unlikely to be available in most settings. If available, may be shared with other units)
Ultrasound scanner (portable) with appropriate probes (e.g. for cranial ultrasound) (not available in all settings and 
may be shared with other units)
Access to laundry facilities Alcohol-based hand rub
Areas for hand washing Antiseptics (e.g. chlorhexidine 7%, ethanol, povidone-iodine, chlorhexidine gluconate 4% gel, aqueous chlorhexidine 0.05% and 0.2%). 
Area for cleaning and disinfecting supplies and equipment Autoclave (or equivalent sterilisation equipment) (may be shared with other units)
Autoclave room or sterilization space (may be shared with other units) Contaminated waste bin (leak proof)
Hand washing stations/sinks Decontamination container
Hand drying towels (single use) Disinfectant solutions (e.g. chlorine bleach)
Incinerator (e.g. burn in incinerator, off-site incineration) (may be shared with other units) Gloves (sterile)
Sterilisation space (e.g. space for dry heat, steam, electric boiler or steamer or non-electrics with cover for 
boiling and steaming & drum and stand) (can be shared with other units)
Gloves (regular/disposable)
Storage space for soiled utility Gloves (heavy duty rubber or latex utility)
Ventilation Instrument sterilizer
Mayo stand (or equivalent) on casters
Nail brushes or sticks
Non-sterile protective clothing (e.g. plastic aprons)
Pictorial hand washing instructions
Regular trash/waste bin
Receptacle for soiled linen and diapers
Sharps containers (puncture proof)
Sluice (may be shared with other units)
Soap for handwashing
Surgical masks, drapes, gowns and cap for procedures




As per general and infection control infrastructure for small and sick newborn space As per general and infection control equipment for small and sick newborn space 
See oxygen adminstration for other items Bag and mask self inflating (neonatal size, ideally with filter)
Oropharyngeal airway/guedel airway
Neonatal sized face masks (size 0-1)
See oxygen adminstration for other items
As per general and infection control infrastructure for small and sick newborn space As per general and infection control equipment for small and sick newborn space See drugs list for supplements, vitamins etc. 
Dedicated, separate room or space for mothers to room in (KMC room/ward) Beds for mothers (lateral position) with curtains for privacy
Private washing areas and toilet for mothers Cabinets for mothers
Food provision for mothers/area for preparation of food Caps/hats for small babies
Sufficient space for mothers to store personal items, comfortable chairs and privacy Comfortable chairs for mothers
Insecticide treated bednets for KMC mothers (in malaria endemic areas)
As per general and infection control infrastructure for small and sick newborn space As per general and infection control equipment for small and sick newborn space See drugs list for supplements, vitamins etc. 
Area or room for breastmilk expression Adhesive tape/strapping for NG tubes
Milk room/area for preparing milk feeds and storage of expressed breastmilk Bottles, teats, dummies (as appropriate for feeding guidelines)
Breast pumps (battery powered)
Breastmilk subsitute (only for babies with mothers unable to express mik)
Collection containers (for expressed breastmilk)
Feeding cups and spoons/paladai/feeding syringes
Lithmus paper/testing strips (or equivalent)
Nasogastric feeding tubes 3.5-10 with caps
Educational information on breastfeeding for mothers (e.g. written and pictoral information, posters)
Refrigerator and freezer (for milk storage only)
Sterile feeding syringes (2.5ml, 5ml, 10ml)
Stethoscope
Utensils and containers for preparing milk feeds especially graduated measuring jug/cup
As per general and infection control infrastructure for small and sick newborn space As per general and infection control equipment for small and sick newborn space See drugs list
Consistent oxygen source/supply (e.g. oxygen concentrators) Apnoea monitor 
Bag and mask self inflating (neonatal size, ideally with filter)
Head box (optional)
Mucus extractor 
Nasal prongs 1mm and 2mm (if nasal prongs not available use nasal catheter (8-F and 6-F sizes)
Neonatal sized face masks (size 0-1)
Neonatal sized pulse oximetry probes/sensors
Oxygen blenders
Oxygen humidifiers
Oxygen low flow device
Oxygen flow splitter for newborn
Oxygen tubing
Pulse oximeters (bedside)
Resuscitation mannequin (for training and practice)
Suction bulbs
Suction catheters size 5, 8, 10, 12 & 14ch
Suction pump (portable, electrical with accessories)
Suction pump (manual, non-electric power dependent)
Neonatal Resuscitation on neonatal unit 
Safe administration of oxygen (including equipment for resuscitation) 
Alternative feeding if baby unable to breastfeeding (cup & nasogastric feeding)




As per general and infection control infrastructure for small and sick newborn space As per general and infection control equipment for small and sick newborn space See drugs section for specific IV fluid preparation
See laboratory section Butterfly sets (22-25 gauge)
Separate area/clean space for preparing IV fluids (can be the same area as for preparation of IV drugs) Glucometer 
IV tubing/infusion set (neonatal giving set) with burette 100-150ml, sterile, single use
IV infusion stands on castors
Sterile needes (19-26 gauge) or butterfly set (23-25 gauge)
Sterile syringes (small sizes 0.5, 1ml, 2ml, 5ml, 10ml, 20ml) 
Stopcocks 2 or 3 way
Syringe driver/syringe pumps 10, 20, 50ml (single phase)
Rapid blood sugar testing strips/paper reagent strips or equivalent
As per general and infection control infrastructure for small and sick newborn space As per general and infection control infrastructure for small and sick newborn space See drugs section for specific antibiotics, including gentamicin, ampicillin and fluids for dilution
Lab infrastructure for septic screening (blood culture, Full blood count, C-Reative Protein) (see lab) See general equipment and specific equipment for IV fluids
Separate area/clean space for preparing IV drugs (can be the same as area for IV fluids)
As per general and infection control infrastructure for small and sick newborn space As per general and infection control equipment for small and sick newborn space 




Phototherapy lamps/units with fluorsecent tubes (high intensity)  or LED phototherapy
Spare fluorescent tubes
Trancutaneous bilirubinometer
White linen for babies on phototherapy for cot and to cover unit
As per general and infection control infrastructure for small and sick newborn space As per general and infection control equipment for small and sick newborn space See drugs section for emergency drugs including phenobarbital
See laboratory section 
As per general and infection control infrastructure for small and sick newborn space As per general and infection control equipment and safe oxygen therapy equipment for small and sick newborn space See drugs section
See laboratory section CO2 detector
Chest drain set
CPAP driver system (standard or bubble CPAP) with accessories (may vary dependent on CPAP system used)
Distilled water
Drainage tubing and under water seal drainage bottle plus accessories
Endotracheal tubes (disposable cuffed or uncuffed), sizes 2.0, 2.5, 3.0 and 3.5
Endotracheal tube introducers 
Infant laryngoscope set with spare bulb and batteries
Infant laryngoscope (0,1 blades) 
Large forceps (e.g spencer wells)
Laryngoscope light bulb (spare)
Oxygen air blenders
Pump suction, portable, bottle with accessories




Intravenous fluids and management of hypoglycaemia 
Injectable antibiotics for neonatal infection
Effective Phototherapy
Seizure Management 





Blood bank (see lab and blood bank for specifics) Neonatal blood transfusion set See essential drugs list
4-way stopcock for umbilical venous line
Exchange transfusion sets
Portable monitors
As per general and infection control infrastructure for small and sick newborn space As per general and infection control equipment and safe oxygen therapy equipment for small and sick newborn space Dilating eye drops (tropicamide 0.5% + phenylepherine 2.5%)
Opthalmology service (does not need to be 24 hour) Indirect opthalmoscope (with small pupil adjustments) x1 per neonatal unit Local aneasthetic eye drops (proparacaine 0.5%)
Condensing lenses 20D and 28D for indirect opthalmoscope Artifical tear drops - for lubrication during procedure
Neonatal lid speculums (Alfonso) Antibiotic drops (moxifloxacin/betadine) - at end of procedure
Scleral depressors (Schoket/wire vectis) 
Solution for corneal wetting (e.g. Ringer's lactate)
Newborn pulse oximter
Laser (can be shared between more than one facility/service)
Portable diode/green laser with indirect delivery system (can be shared between more than one facility)
Laser goggles
Blood Transfusion for Newborns 





GUIDELINES AND/OR PROTOCOLS for the following:
Admission guidelines
Blood transfusion and exchange transfusion procedural guidelines
Classification of breathing difficulty and SpO2 thresholds and protocols for oxygen therapy and monitoring
Cleaning of instruments and equipment
Discharge and follow up
Disease specific treatment guidelines (e.g. malaria, tetanus, hepatitis, Zika)
Drug doses, dilutions and preparations for the neonatal unit
Gestational age assessment
IMNCI
Inborn and outborn infants
Infant feeding for the neonatal unit, including enteral feeding volumes by weight and age, IV fluid volumes
Infection prevention and control for the neonatal unit
Kangaroo mother care 
Management of gastric residuals
Management of newborn convulsions and spasms
Medication formulary (with neonatal doses) or prescribing guideline
Neonatal practical procedure guideline or advanced neonatal guidelines
National immunisation schedule
Parental/family visitation and access
Referral
Thermal protection, including bathing
Treatment of HIV on the neonatal unit and vaccination schedule for HIV exposed infants
Treatment thresholds for phototherapy and exchange transfusion
Use of incubators and radiant warmers
Visitation
Use of phototherapy units (eg. positioning of phototherapy lamps, baby etc.)
CHECKLISTS and JOB AIDS




Fluid volumes and medications
Follow up 
Prescription charts
DOCUMENTATION FOR EACH INPATIENT
Discharge forms
Fluid balance and feeding chart (fluid input and output)
General clinical records/notes (ongoing medical care)
Growth chart (weight, length, head circumference) (premature and infant charts)
Health insurance form (if relevant)
ID labels for inpatients
Lab request forms
Observations charts for recording of vital signs
Prescription chart
Referral forms (if needed)
Tetanus observation charts
Transfusion surveillance/vital signs document (for blood transfusions)
GENERAL REGISTERS/LOG BOOKS
Birth registration
Cause of death certificates
Civil Vital registration system
Death/mortuary register
Discharge register
Kangaroo mother care register
Newborn care unit register
Newborn death stillbirth audit
Referral register






Vehicle maintainance infrastructure (or access to) Adhesive tape IV fluids
Communication for transport vehicle (e.g. radio ) Antiseptic solution Drugs/medicine (any medicine newborn is taking if receiving a dose during trip)
Fuel source/system Blankets/linens Expressed breastmilk (if baby is able to feed or, preferably, mother with newborn)
Butterfly set or cannula
Cotton wool balls and /or guaze
Diapers/napkins
Fuel for transport vehicle
Gastric tubes (size 5, 6, 7, 8)
Gloves
Hats, socks, mittens (for baby)
IV infusion set
Resuscitation bag and mask
Portable suction apparatus
Pulse oximetry
Oxygen cylinder with flow metre
Oxygen cylinder (portable)
Nasal prongs/and or nasal catheter
Source of warmth
Stethoscope
Sterile needes (19-26 gauge) or butterfly set (23-25 gauge)
Sterile syringes (small sizes 0.5, 1ml, 2ml, 5ml, 10ml, 20ml) 
Torch with extra batteries and bulb
Thermometer
Transport incubator(s)
Transport vehicle (type may vary by context)




Distance to nearest intensive care and special care unit and contact number of centre with advanced care
DOCUMENTATION









Administration staff Lactation counsellor/infant feeding coordinator Pediatrician
Anesthetist Midwifery professional (eg enrolled midwife, degree, diploma) Pharmacist
Biomedical engineer Nursing professsional Pharmacy technicians/assistants
Cleaners Neonatal nurse (or nursing/midwifery professionals with specialist training in sick newborn care) Porters
Community health worker (or equivalent) Neonatalogist Psychologist 
Driver (transport vehicle) Nutritionist Physiotherapist
General medical doctor Obs/gyne doctor Radiographer
Health officer/Clinical officer (may be context specific) Other nursing professionals (e.g. enrolled nurse), nursing assistants or auxillaries Security staff
Health information technologist/data manager Other anesthetics staff (e.g. nurse anasthetist, diploma etc.) Social worker
Lab scientist Opthalmologist Speech therapist (or equivalent)
Lab technician Pathologist Surgeon
Provider







Pharmacy service availability 24/7
Supply management system
Refridgeration for vaccination
Refridgeration for other drugs/medicines
Safe drug storage conditions (protection from moisture, heat, infestation)
Drug inventory (also in health information section)
Antiretrovirals (may vary depending on national HIV guidelines) Anticonvulsants Emergency Drugs
Azidothymidine/Zidovudine (AZT) (oral) Diazepam (oral/NG) Adrenaline/epinephrine (IV)
Lamivudine Diazepam emulsion (IV) Aminophylline
Nevirapine (NVP) (oral) Midazolam (oral solution) Atropine (injection)
Paraldehyde (rectal) Calcium gluconate 10% (injection)
Phenobarbital (IV or IM) Hydrocortisone (injection)
Phenobarbital (oral) Magnesium sulphate (IV)
Phenytoin (IV) Naloxone (IV)
Analgesics Corticosteroids IV Fluids
Ibuprofen (IV) Betamethasone (IM)
* Calcium gluconate 10%
Morphine (IV) Dexamethasone (IM)
 * Dextrose 10% with normal saline
Morphine (oral) Dextrose/glucose 5%
Paracetamol (oral) Dextrose/glucose 10%
Paracetamol (suppository) Potassium chloride (KCL) 7.5%, 10%, 15%





Artesunate (IV or IM) BCG vaccine
Artesunate (rectal) Diptheria
Arthemeter (IM) Pertussis vaccine









Amoxicillin (oral suspension) Aciclovir (IV) Phosphate and calcium supplements
Amoxicillin (injection) Acyclovir 3% topical eye ointment Potassium chloride (1mmol/ml) (oral)
Amikacin Anti-Rho (D) immune globulin (injection) Pyridoxine (oral)
Ampicillin (IV or IM) Caffeine citrate (oral) Ranitidine (IV)
Ampicillin (oral) Caffeine citrate (IV) Ranitidine (oral)
Azithromycin (oral) Chlorhexidine digluconate 7.1% gel (delivering 4% chlorhexidine) Rifampicin
Benzathine benzylpenicillin (IM) Domperidone Pyrazinamide
Benzylpenicillin (Penicillin G) (IV or IM) Ethambutol Sucrose 30% (oral)
Cefalexin (oral suspension) Ferrous fumerate (oral syrup) Surfactant (not likely to be available in many settings due to cost)
Cefotaxime (IV or IM) Folic acid Tetanus immunoglobulin (HTIG) (IM)
Ceftriaxone (IV or IM) Fluconazole (IV) Vitamin B6 (pyridoxine) (IV or IM)
Ciprofloxacin (injection) Fluconazole (oral) Vitamin D 
Ciprofloxacin (oral) Furosemide (IV) Vitamin K1 (Phytomenadione) (IM or IV)
Clindamycin (IV) Furosemide (oral) Water based lubricant
Co-amoxiclav (oral suspension) Glycerin chip Zinc oxide cream
Co-amoxiclav (injection) Hepatitis B immune globulin (HBIG)
Cotrimoxazole (oral) Human milk fortifier
Erythromycin (oral) Insecticide treated bed nets (in malaria endemic areas)
Flucloxacillin (IV/IM) (cloxacillin) Lidocaine solution
Flucloxacillin (oral) Miconazole cream (or equivalent e.g. gentian violet)
Gentamicin (IM or IV) Multivitamin
Isoniazid (oral) Nystatin (oral solution)
Kanamycin Nystatin cream 
Metronidazole (IV) Omeprazole (IV)
Metronidazole (oral) Omeprazole (oral)
Penicillin G Procaine (IM only) Oral rehydration solution
Procaine benzylpenicillin (IM) Oxygen supply





Biochemistry should be able to perform: Haemotology should be able to perform: Microbiology should be able to perform: 
Blood glucose (e.g. glucometer and test strips) Blood typing and cross matching Culture and sensitivity on samples of blood, pus, cerebrospinal fluid and urine
C-reactive protein (CRP) Coagulation profile Cerebrospinal cell count
Electrolytes (urea, sodium, potassium, calcium, magnesium and creatinine) Coombs test Gram staining
Serum bilirubin (or transcutaneous bilirubinometers as cheaper alternative) Full blood count (FBC)/Full blood examination (FBE) Stool analysis
Cerebrospinal fluid analysis (glucose and protein) Haemaglobin (e.g. haemacue, haemoglobin colour scale refill kit/starter kit) and or haematocrit testing 
(erythrocyte volume fraction)Liver function testing
Blood gas analysis
Urine dipstick for urinalysis that measure: pH, proteins, glucose, ketones, blood nitrates, leucocytes
Glucose 6-phosphate deyrogenase (G6PD) screening
STI Testing including Other important tests: 
Chlamydia testing TB testing (tuberculin skin testing, access to Ziehl-Neilsen staining and ideally GeneXpert)
Enzyme immuno assay (EIA), gonnorhea Ag, kit Malaria testing (preferabily blood film microscopy as more reliable option than rapid diagnostic tests for neonatal 
malaria)Hepatitis B surface antigen (HbsAg) Glucose 6-phosphate deyrogenase (G6PD) screening
HIV testing kit Thyroid function tests
Syphilis testing
Blood bank should have facilities to perform: 
Blood typing and cross matching
Coombs test
Storage of fresh whole blood, including type 0, Rh-negative blood, packed cells and fresh frozen plasma
Blood screening for HIV, Hep B, Hep C, Syphilis and malaria
Blood transfusion guidelines for neonates
Laboratories and Blood Bank 
 
 
Appendix J: Ethics approval for global survey on levels of inpatient care for small and 
sick newborns 
   
 
 
   
 
 


































































   
 
 
Appendix L: Research protocol for Malawi mixed methods approach to assessing 
measurement of care for small and sick newborns in Malawi 
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I - ABSTRACT 
 
Of the 2.6 million newborns deaths globally each year, an estimated 18,000 of these deaths occur in 
Malawi. The main causes are prematurity complications, intrapartum hypoxia and neonatal infections. 
Preventing these deaths requires quality neonatal inpatient care for babies that are born small and 
sick. In Malawi, there is limited availability of neonatal inpatient care facilities and facility-based care 
for small and sick newborns is not consistently measured and tracked. The aim of this research is to 
assess approaches to measurement of care for small and sick newborns, using quantitative and 
qualitative methods. 
 
We will use data from a register review from maternity hospitals collected in 2014 as part of a national 
Emergency Obstetric and Newborn Care (EmONC) assessment and compare this with HMIS (DHIS-2) 
data from 28 facilities from the same period. We will look at data agreement for select maternal and 
newborn indicators between the EmONC assessment and DHIS-2 data. Through the quantitative 
analysis, we will use Bland Altman approach to plot the difference of paired variables versus their 
average to look at data agreement between the two sources. Where there are significant differences, 
we will use linear regression to identify potential factors associated with these discrepancies. 
We will then use qualitative approaches, including data flow assessment combined with in-depth 
interviews with data handlers in 8-10 randomly selected  hospitals. Through the data flow assessment 
and in-depth interviews, we will map the data journey from the neonatal care unit to the ministry of 
health, and gain understanding of the perceptions regarding this data recording and data use process. 
We will then hold a national level workshop with data stakeholders to explore potential strategies to 
improve data recording and use. We will use a prefigured thematic analysis (applying an established 
framework) to analyse the combined data. We will identify organisation, technical and environmental 
barriers and facilitators, and potential strategies to improve data collection and use.  
The learning and implications from this work will inform the refinement of existing measurement 
tools in Malawi, and contribute to the wider global learning and development of new approaches to 




II - BACKGROUND  
The first 28 days of life - the newborn period - is the riskiest time in the human lifecycle. In 2016, an 
estimated 2.6 million babies died during the first month of life globally (1). The main causes of death 
are direct complications of prematurity (35%), intrapartum events (previously called birth asphyxia) 
(24%), and infections (23%) (1). Direct complications of preterm birth are now the leading cause of 
child death worldwide. Many lives could be saved, and morbidity prevented, through a combined 
health systems approach along the continuum of care, with timely provision of quality inpatient care 
for small and sick newborns (2). Core components of this care include the provision of warmth, feeding 
support, safe oxygen therapy and effective phototherapy, including kangaroo mother care as a 
cornerstone of care for preterm and low birth weight newborns (3, 4). Such care needs to be delivered 
by health workers with specialist training and skills in a facility with a dedicated ward space equipped 
to prevent and treat infections. Globally, many newborns do not have access to such care if they were 
to require it (see Figure 1) (3).   
 
Figure 1. Estimated coverage of neonatal care by region of the world and level of care (from Moxon et al, 2015 Inpatient 
care of small and sick newborns BMC Pregnancy & Childbirth) 
Malawi and the Every Newborn Action Plan 
Malawi is a low-income country that faces numerous health system challenges, including unevenly 
distributed and poorly resourced health facilities, a lack of trained health workers and a high birth 
rate. The neonatal mortality rate is 22 per 1000 live births (5). In addition to this, Malawi has the 
highest preterm birth rate in the world, estimated at 18% of live births (6). Each year an estimated 
18,000 of the 2.6 million global newborn deaths occur in Malawi, a significant number of the total 
global burden.  
 
The Malawi Newborn Action Plan (7) was developed in response to the global Every Newborn Action 
Plan (8, 9), a multi-partner initiative launched in 2014 with the overall goal of ending preventable 
newborn deaths and stillbirths by 2030. Every Newborn has a specific stream of work on improving 
measurement, which is co-chaired by LSHTM and the World Health Organisation (Every Newborn 
metrics). Strengthening of existing facility-based systems for the care of vulnerable newborns is the 
most effective approach for saving newborn lives and is central to achieving Every Newborn goals (10). 
One of the five global Every Newborn strategic objectives – to count every newborn (and birth) – 
underlines the need for improved data and accountability (9, 11). The global Every Newborn 
milestones, linked to a World Health Assembly resolution, have a particular focus on inputs required 





The Malawi Every Newborn plan focuses on identifying what actions are necessary for newborns to 
realise their right to survival and well-being and harmonise actions for newborns with other country 
plans, such as the Safe Motherhood Initiative and Integrated Maternal and Newborn Health plan. 
Despite numerous challenges, Malawi has made significant efforts to implement initiatives in response 
to the problems of both maternal and newborn morbidity and mortality. This includes exemplary 
efforts to institutionalise high impact interventions for small and sick newborns, most notably, their 
focus on facility based kangaroo mother care (KMC) (12), resuscitation training for health workers 
though the Helping Babies Breathe (HBB) initiative (13) and development of newborn care protocols. 
Through implementation of the Malawi Every Newborn Action Plan, the intention is to support and 
track progress to reach national and global targets, including the Family Planning 2020 Initiative and 
the Global Sustainable Development goals for 2030.  
As Malawi began to develop their monitoring strategy for their national newborn plan, increasing 
attention has been paid to facility level data and data on small and sick newborns.  In 2013, the Central 
Monitoring and Evaluation Division (CMED) of the MOH rolled out the District Health Information 
System 2 (DHIS2) platform nationally.  By 2014 all districts were reporting data for the main HMIS 
monthly reports, including data on maternity, delivery and newborn care (kangaroo mother care, 
helping babies breathe, etc).  While reporting rates are generally high (>90%) for the standard forms 
supported by CMED, there are notable gaps in reporting, particularly among the high volume central 
hospitals, which often do not report.  However, as of 2015, CMED and partners have been working to 
address these reporting gaps and reporting rates by central hospitals are improving.   
For countries that are fast developing their newborn health programmes, such as Malawi, Every 
Newborn recognises a unique opportunity to learn from their experience.  One approach to learn from 
Malawi is to consider the existing data system and use both quantitative and qualitative methods to 
explore data quality and identify data barriers and enablers within the system for improving the data 
on care for small and sick newborns. Through this process, Every Newborn aims to provide learning 
for newborn health data and programmes globally.   
III - JUSTIFICATION 
The aims of this project are closely aligned to support Malawi to achieve the goals of their national 
newborn action plan, especially focused on service delivery and health information systems for small 
and sick newborns. The learning from this work will inform the refinement of existing measurement 
tools, and contribute to wider global learning for Every Newborn and development of tools and 
approaches to measure care for small and sick newborns. 
The Malawi newborn plan identified specific challenges within the national health information 
systems, such as ineffective data use, and limited newborn indicators in the routine health 
management information system. The plan also identified a lack of accountability systems in maternity 
facilities and limited availability of quality newborn care services, especially for small and sick newborn 
care.  
IV - LITERATURE REVIEW 
Existing tools to measure service readiness for inpatient care of small and sick newborns 
Delivery of interventions to small and sick newborns requires facilities that are prepared, which is 
termed as “service readiness”. Service readiness refers to the structures (the necessary 
infrastructure, equipment, drugs and guidelines); and processes (services performed by health 
professionals with requisite training and skills) that are needed to provide a package of care (14, 15). 
This requires strong health systems with the capacity to monitor and track service readiness and 




In most low and many middle-income countries (LMIC), there are still very little routine data 
available on care for sick newborns, especially on service readiness, and the structures that support 
the care that small and sick newborns receive (11). The data are particularly lacking in settings where 
access to neonatal special or intensive care is the lowest and where facilities are most in need of 
targeted efforts to strengthen services and improve the quality of care. 
Information on care for small and sick newborns may be collected through multiple systems within a 
wider health information system (see Figure 2).  Notes on clinical care are often found in the hospital 
admission or care records, but these data are not reported in national health information systems. 
Human resource databases, financing and logistics managements systems are operational to a 
different extent in many settings. Most low and middle-income settings still rely on national surveys 
to supplement information on service readiness and coverage of interventions and on the processes 
and content of facility-based care. Surveys, notably health facility assessments, are frequently used 
to capture information on service readiness, and are best suited to measure the number of facilities 
that are prepared to provide components of the service such as sufficient number of trained staff, 
equipment availability, spatial organisation and service delivery information.  
 
Figure 2. Figure showing a comprehensive routine health information system and the interaction of different components of the  
system 
A number of standardised health facility assessment tools exist to measure service readiness, the 
most commonly employed being the World Health Organisation Service Availability and Readiness 
Assessments (SARA)(16), the DHS programme Service Provision Assessments (SPA) (17) and the 
Averting Maternal Death and Disability (AMDD) Emergency Obstetric and Newborn Care (EmONC) 
assessments (18). These allow health systems to report on a sample of facilities that provide a 
certain service or have health workers trained in specific skills, but are not routine reporting 
mechanisms. A recent review of the health facility assessment tools, identified EmONC as having the 
most comprehensive content on newborn care (19).  
  





















Emergency obstetric and newborn care surveys 
The Emergency Obstetric and Newborn care (EmONC) needs assessments surveys are detailed 
assessments of service readiness for women and newborns at and around the time of birth. They are 
based on a core list of life-saving services, or ‘signal functions’, that define a health facility’s capacity 
to treat obstetric emergencies at either a basic or a comprehensive level known as basic emergency 
obstetric care (BEmOC) and comprehensive emergency obstetric care (CEmOC). More recently, 
additional newborn content has been added to the surveys, which have been piloted in Malawi 
(2015) and Ethiopia (2016) (19). There are 10 modules in the EmONC assessment. Module 4 of the 
EmONC assessment contains a register review and facility case summary, which reviews service 
statistics on deliveries, interventions and outcomes.  
It is often argued that surveys, such as health facility assessments, yield better quality information 
than routine information systems and generate more objective data with less bias (20). However, 
there are still relatively few countries where regular EmONC assessments have been carried out. 
EmONC, and other health facility assessment surveys, are run by external agencies and therefore are 
resource intensive and costly. Access to the data that is generated can be complex and time 
consuming. As more content is added to these surveys, the cost of carrying out the surveys 
increases.  
Health management information systems 
Health management information systems (HMIS) are a more sustainable form of health information 
and are relatively inexpensive compared with health facility assessments. Further, they are largely 
driven by national decision makers meaning there is real potential to streamline and improve the 
existing data and its quality. HMIS provide routine information for health managers to monitor and 
track progress of key health indicators. Such systems have the potential to also link to the 
management information for other associated support services (Figure 2).  However, in low and 
middle-income countries, HMIS systems are often struggling to balance national data demands with 
their limited resources. Other systems, such as logistics management, human resource databases 
are also functional to different extents and their interoperability is often limited.  
In Malawi, there is a functional LMIS and human resource database (IHRIS) alongside the HMIS, but 
it is not always possible for these systems to communicate between each other due to different 
management structures.  
Improving routine measurement of service readiness for inpatient care of small and sick newborns  
There is a large body of literature on strengthening and improving routine health information 
systems, largely spurred by health system strengthening efforts(21-23). Good quality health 
information supports health systems to improve accountability, and ensure evidence based decision 
making at local, district and national levels (11, 20, 24, 25). A number of authors have indicated a 
need to shift the debate away from the superiority of one data source over another and focus on 
improving the existing routine data systems and their interoperability (20, 24). As a result, tools and 
frameworks have emerged to support health systems, rather than specific disease programmes, to 
strengthen country capacity for health information production and use, such as the Health Metrics 
Network Framework (26) and later the Roadmap for Health Measurement and Accountability (27). 
Work identified by the Every Newborn metrics group also identified a wide-spread need to 
strengthen HMIS in low income settings, especially to build national capacity for the use of HMIS 
data for improving programme performance, and to improve the quality of the data (11, 28).  
 
 
The challenges that are faced by routine information system management, such as country led DHIS-
2, is partly related to the number of different people engaged from the point of data recording down 
to handling and data use.  Highly complex data collection forms can then result in inaccurate transfer 
of data from patient records and high data errors (20). And the complexity of the systems – often 
which do not communicate or speak the same language in order for interoperability between 
different systems. Measurement challenges are also created by different tools, data collection 
mechanisms, indicators that are difficult to measure or lack of the indicators needed at the point of 
planning and level of health system.  There are also issues with who collects the data and the 
frequency of data collection. Such complex challenges have been well articulated by the 
Performance of Routine Information System Management (PRISM) framework that separates these 
into technical factors (e.g. complexity of forms), organization factors (e.g. training and supervision) 
and behavioural factors (e.g. level of knowledge and/or confidence of data handlers) (Figure 3).  
 
Figure 3. Applying the PRISM (Performance of routine information system management) framework to identify barriers and enable rs to data 
collection and use for service readiness data for small and sick newborns adapted from: 
https://www.measureevaluation.org/resources/publications/ja-09-99  
Acknowledging the wider context in which health systems operate, and the different people 
engaged in the data process, is critical to understanding mechanisms and actions which can improve 
the recording and use of the data (29).  
V – OBJECTIVES 
Our overall aim is to evaluate and improve approaches for routine measurement of service 
readiness for inpatient care of small and sick newborns in Malawi to inform global Every Newborn 
metrics and use in other countries.  
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Malawi uses District Health Information System 2 (DHIS 2) as their HMIS platform (30) and a national 
EmONC assessment was completed in Malawi in 2015.  
Objective 1: To analyse selected maternal and newborn indicators comparing Malawi district health 
information system (HMIS) data with a national health facility assessment for EmONC (2013-2014)  
• Compare the different estimates of select maternal and newborn indicators from District 
Health Information System – 2 (DHIS-2) and the EmONC health facility assessment register 
review from the same time period (2013-2014) 
• Identify missing data, under or over reporting, bias and variation for selected maternal and 
newborn indicators between the two data platforms  
• Explore quantitative factors associated with discrepancies using linear regression.  
Objective 2: To identify barriers and enablers to recording and use of service readiness data for care 
of small and sick newborns in Malawi  
• Randomly select 2-4 hospitals from each of the 3 regions in Malawi 
• Carry out a data flow assessment to explore the data processes for service readiness data for 
care of small and sick newborns 
• Using in-depth interviews with data handlers, explore the perceived barriers and facilitators 
to data recording and use for monitoring service readiness for small and sick newborns 
• Through consensus building workshop 
o explore data that could potentially be added or removed from existing tools based on 
perceived relevance, completeness, timeliness, and accuracy  
o explore other potential sources of data and indicators needed to measure service 
readiness (infrastructure, equipment, drugs, providers) for inpatient care of small and 
sick newborns 
VI – METHODOLOGY  
Type of study 
This is a mixed methods observational study involving secondary quantitative analysis of existing data 
sources (objective 1), data flow assessment, in-depth interviews with data handlers and a consensus 
building workshop with national stakeholders (objective 2).  
Place of study 
Place of study for objective 1: The secondary data analysis will compare the different estimates of 
select maternal and newborn indicators from DHIS-2 and the EmONC health facility assessment 
register review from the same time period (2013-2014). As part of an EmONC health facility 
assessment, a register review was carried out for events between September 2013 and August 2014. 
Support for the data collection came from UNFPA, in-country experts and Averting Maternal Death 
and Disability (AMDD).  The sample included a census of all maternity hospitals in Malawi (hospitals 
that did not offer maternal and newborn health services were not included). DHIS-2 data for the 
same time period was collated and reported by local data clerks and programme focal points at the 
facility and district level. In 2013-2014 28 facilities in Malawi were reporting maternal and newborn 
health indicators into the DHIS-2 system. This gives us 28 facilities with data that can be compared 
between the DHIS-2 and the EmONC assessment.  
All quantitative data is anonymised and was collected in Malawi through the Ministry of Health.  
Place of study for objective 2:  
In order to select the hospitals, we created a sampling frame of all of the hospitals with DHIS-2 data 
from the relevant time period and then generated a random number list for North, Central and 
 
 
Southern regions of Malawi. We then selected the lowest numbers from each region, including one 
central hospital.  
For each selected hospital, we have sought permission from the respective District Health Officer. The 
list of selected hospitals and subsequent permissions is as follows: 
Region Hospital Permission from DHO 
Northern region Chitipa District Hospital   
Karonga Distrcit Hospital   
Rumphi District Hospital  
Central region Kamuzu Central Hospital  
Mchinji District Hospital  
Ntchtisi District Hospital  
Salima District Hospital  
Southern region Chiradzulu District Hospital  
Machinga District Hospital  
Nsanje District Hospital  
 
Data flow assessments will be carried out at the hospital site using a structured tool. In-depth 
interviews with health facility staff will also be carried out at the health facility (to minimise disruption 
to clinical staff).  
Study period 
The secondary analysis for objective 1 will be conductedMarch-May 2018. For objective 2, the data 
flow assessment, in-depth interviews and national workshop will be carried out in May-June 2018. 
We will conduct the analysis of the qualitative data June-September 2018 (See section VII for Gantt 
chart). 
Sample size 
For objective 1, the data analysis involves a secondary analysis of data from 28  maternity hospitals 
that were reporting DHIS-2 data between September 2013-August 2014.  
For objective 2,a random sample of 6-8  hospitals has been selected for data flow assessment and in-
depth interviews with data staff  During the data flow assessment, we will purposively select 2-4 data 
handlers (such as clinicians, nurses and data clerks) in each facility who document, record, or use 
hospital level information on services for small and sick newborns. This type of sampling is consistently 
used in qualitative research to identify informants and interviewees with specific expertise or 
experiences (23). The number of in-depth interviews is chosen based on previous similar studies of 
this type  (31, 32) and per recommendations from Green and Thorogood (33). Should this number be 
deemed insufficient to meet the study objectives, additional interviews may be arranged. We will also 
use snowball sampling to identify further individuals at the hospital level, if needed.  
Data Collection 
Objective 1 is a secondary analysis, there will not be any new data collection for this objective.  
For objective 2, we will begin qualitative data collection in May 2018 starting with observation of the 
data flow process followed by in-depth interviews using semi-structured interview guides (see 
example data flow assessment and in-depth interview guide in tools).  The two senior researchers, IN 
and SM, will carry out the data flow assessments and in-depth interviews with support from an 
experienced research assistant from REACH Trust.  
 
 
The REACH Trust team has wide experience collecting qualitative data in Malawi and is familiar with 
the Malawi health system. 
Before data collection, a two-day training workshop will be conducted for the study team to familiarise 
well with the study tools and on ethical issues around the study.  
Informed written consent will be sought from hospital managers before observing data flow and then 
individual informed consent will be obtained from each participant before any in-depth interviews. 
Study participants will be informed that participation in the study is voluntary and that they are free 
to withdraw at any point during the interviews. All data will be collected in English. 
A national level workshop with policy makers and key staff from the ministry of health or programme 
management level that use or require data for planning purposes will be held following initial analyses 
from the secondary data analysis, the data flow assessment and the in-depth interviews to consolidate 
information and probe any further themes for discussion (See Figure 4). Per diems, refreshments and 
transport will be provided for the workshop participants. Participants in the workshop will include 
representatives from the Reproductive Health Department, CMED, Planning department, and 
implementing partners.  
Data analysis  
For objective 1, the quantitative analysis will be carried out by the principle investigator at LSHTM in 
collaboration with the advisory group (including AMDD, Saving Newborn Lives, Malawi, REACH Trust) 
following appropriate ethical approval.  
Data from the EmONC health facility assessment was double entered into CSPro 5.0 by the data 
collection teams. The cleaned data files will be exported to STATA for analysis by the principle 
investigator. Data from September 2013-2014 will be extracted from the DHIS-2 system and exported 
to STATA for analysis. The relevant reports from DHIS-2 data sources are: a) the maternity monthly 
report; b) the monthly HMIS form.  
 
The quantitative data sources will be analysed for data completeness and range. Since the data are 
based on the same original source, the two samples are not independent, and appropriate statistical 
methods considering the paired nature of the data are necessary for this analysis. For each indicator 
value the ratio and difference between EmONC health facility assessment rates and DHIS-2 will 
calculated by facility, district and national. Paired t-tests will be used to examine differences between 
the aggregate rates obtained with both data sources to calculate a p-value. Bland Altman plots will be 
used to examine agreement between the data collection platforms. This is achieved by plotting the 
differences (or ratios) between the two platforms against their average.  
Where discrepancies are found, further analysis will be undertaken to explore potential facility level 
variables that explain the discrepancy (For example: rural/urban, facility level and type, health sector, 
staffing and caseload) using linear regression.   
The following comparable data points have been identified from the EmONC health facility assessment 
and the DHIS-2: 
 
Maternal 
Spontaneous vertex deliveries 
Breech deliveries 
Deliveries with vacuum extraction 
C-section deliveries 










Referrals out of the facility due to obstetric indications 
Referrals out of the facility due to newborn 
complications 
Kangaroo mother care 
LBW babies initiated on facility based KMC 
LBW babies on KMC discharged alive 
LBW babies on KMC who died before discharge 
 
For objective 2, in-depth interviews will be recorded. Following completion of data collection, we will 
transcribe data. All names of those participating in the qualitative analysis will be removed from the 
scripts and replaced with pseudonyms. We will then carry out prefigured thematic analysis applying 
the PRISM framework (Figure 3) (20, 24), to identify the organisational, technical and behavioural 
barriers and enablers to data recording and use for small and sick newborns in Malawi. Qualitative 
data analysis will be conducted using Nvivo software.  
 
The prefigured thematic analysis of the qualitative data will follow the five steps proposed by Green 
and Thorogood applying the PRISM framework (Figure 3) (33): 
• Familiarisation – listing important ideas and recurrent themes by listening to the tapes and 
reviewing the transcripts. 
• Pre-figured thematic analysis – identifying the principal and relevant themes by which data 
can be examined within the PRISM framework. This will help to develop a coding scheme. New sub-
themes will emerge from the focus groups and combined with themes identified from the quantitative 
analysis. 
• Indexing – the transcripts will be annotated applying the thematic framework to all of the data 
using numerical codes.  
• Charting – create summaries distilling the sub-themes within the framework 
• Mapping and interpretation – using the charts to find links between the themes with the 
purpose of providing explanation for the findings.  
Two team members will carry out coding and analysis to ensure rigour and consistency.  
VII – DISSEMINATION OF RESULTS 
Initial findings from both objectives will be shared with policy makers and key staff from the ministry 
of health or programme management level at the national workshop to ensure national engagement 
in the data analysis process.  
Results from objectives 1 and 2 will be written up in report format with detailed context specific 
recommendations to develop and improve measurement on service readiness for care of small and 
sick newborns and recommendations for the Malawi DHIS-2 and future EmONC surveys and/or other 
health facility assessments including: 
 
 
• Summary of results from both analyses 
• Recommendations on indicators that can be added and removed from existing data modules 
in both the DHIS-2 and emergency obstetric and newborn care (EmOC) surveys in Malawi 
• Recommendations on other potential sources of data (including at the facility level), tools, 
and indicators needed to measure service readiness (infrastructure, equipment, drugs, providers) for 
care of small and sick newborns. 
These consolidated findings will then be shared again with Ministry of Health and other key 
stakeholders and partners following completion and write-up of results. The potential for extending 
the DHIS-2 and health facility comparative analysis to other country settings will also be explored. 
The combined findings of objective 1 and 2 may also be written up as a publication. 
VIII – ETHICAL CONSIDERATIONS 
Data collection for both quantitative data sources to be used in objective 1 was overseen by the 
Malawian National Ministry of Health. The Ministry of Health in Malawi uses DHIS-2 as their health 
management information system and regular quality check are built into the system. The Malawi 
EmONC Health Facility Assessment was carried out by the Malawi Ministry of Health and Malawi 
government with technical support from various development partners, notably Averting Maternal 
Death and Disability (AMDD), Saving Newborn Lives - Save the Children, United Nations Family 
Planning Association (UNFPA), United Nations Children’s Emergency Fund (UNICEF) and United 
States Agency for International Development (USAID).  The Ministry of Health and the Government 
of Malawi, as the overseers of the assessment, assured that the data collection process followed 
ethical principles. The data collectors were trained on the principles of confidentiality. No person’s 
name was recorded on any of the modules except that of the data collector. Permission was 
requested from in-charge of facilities to visit the facility and interview members of staff. Team 
leaders carried with them letters of introduction from the Ministry of Health. The facility in-charges’ 
responses and those of members of staff were always respected. Providers who were interviewed 
for module 7 provided oral consent. 
 
For objective 2, The qualitative research approach will take into account the local context, power 
relationships between different participants and the position of the researchers, as well as local 
cultural and professional norms, in the data collection phase and in interpretation of results (33). 
Informed written consent will be sought from hospital managers (see example letter to hospital 
managers, and informed consent for hospital managers) before observing data flow and then 
individual informed consent (see informed consent forms) will be obtained from each participant 
before any in-depth interviews. 
All names of those participating in the qualitative analysis will be removed from the scripts and 
replaced with pseudonyms. In cases where participant’s do not want the name of another person 
disclosed, the name will be replaced with a pseudonym and/or tag that typifies that person’s role 
(e.g. data technician). In cases where participant’s do not want the name of a facility or a geographic 
location disclosed, the facility name will be replaced with a meaningful descriptive term that typifies 
the facility type or location (eg. private maternity hospital).  
 
The Principle Investigator will be responsible for the data and only members of the research 
technical team will have access to the data. Data collection and data analysis processes will follow 
LSHTM Guidelines on Good Research Practice. Data will be stored in a password encrypted file on a 
backed-up server, in compliance with the LSHTM Information Security Policy. Local copies will be 
stored securely on an encrypted drive held in a locked drawer. Data will be retained following 
 
 
LSHTM records retention and disposal schedule.: 
http://intra.lshtm.ac.uk/infoman/records/retention.html 
This study has been presented to the national Safe Motherhood Committee who support the study, 
and a copy of the protocol shared with the Committee prior to submission the National Health 
Sciences Research Committee (NHSRC). Ethical approval for this study has already been obtained 
from the London School of Hygiene and Tropical medicine (approval letter included as part of this 
proposal: LSHTM ethics ref: 10668). The research will not commence in Malawi until ethics approval 





IX – PERSONNEL AND INSTITUTIONS 
Principle Investigator 
Sarah Moxon is a Research Fellow and PhD Candidate within the Maternal, Adolescent, Reproductive 
and Child Health (MARCH) Centre at the London School of Hygiene and Tropical Medicine (LSHTM). 
Sarah’s work is focused on improving the quality of care for small and sick newborns, strengthening 
health systems and developing the associated metrics for monitoring maternal and newborns health 
programmes. Sarah has a background in neonatal nursing and has a Masters in Public Health. She 
has worked in research, monitoring and evaluation of health systems in low and middle-income 
settings since 2008.  
Co-Investigators 
Ireen Namakhoma is a senior social scientist focusing on the development of practical 
recommendations to promote equity in access to health care for the poor. Her primary interest is in 
the implementation of qualitative and quantitative research activities to promote equitable access 
to health services in Malawi. 
Hastings Banda is a Senior Clinical Researcher and the Acting Executive Director with REACH Trust. 
He has a Masters in Community Health from Liverpool School of Tropical Medicine and has attended 
courses in epidemiology, statistics and research methodologies. Hastings leads REACH Trust’s Clinical 
Research Team, developing the clinical research portfolio for the Trust as well as managing relevant 
research projects and all clinical staff.  
Advisory group for research 
Dyson Likomwa (USAID Malawi) 
Tanya Guenther (Saving Newborn Lives, DC)  
Kondwani Chavula (Saving Newborn Lives, Malawi) 
Tanya Marchant (LSHTM) 
Patricia Bailey (Averting Maternal Death and Disability) 
Loveday Penn-Kekana (LSHTM) 
John Bradley (LSHTM) 
Joy Lawn (LSHTM co-chair for Every Newborn metrics and Principle Investigator for CIFF grant) 
 
Tanya Guenther works as an Advisor, Monitoring and Evaluation and HMIS for Save the Children, 
with a focus on newborn and child health.  She will provide technical support for the study design, 
implementation and data analysis, working closely with counterparts in SC Malawi.   
Lara Vaz is the Senior Advisor, Monitoring and Evaluation for Saving Newborn Lives, Save the 
Children with expertise in qualitative research.   She will provide technical oversight for the study 
implementation, analysis and dissemination. 
Dyson Likomwa is a monitoring and evaluation technical officer for USAID in Malawi.  He will provide 
technical inputs into the study design and support analysis and reporting. 
Patricia Bailey, is a Senior Scientist at FHI 360 and a Senior Technical Advisor to the Averting 
Maternal Death & Disability (AMDD) program at Columbia University’s Mailman School of Public 
Health. She will provide technical guidance on the Emergency Obstetric and Newborn Care 
assessment.  
John Bradley is a lecturer in statistics at the LSHTM and will provide guidance on statistical analysis.  
Loveday Penn-Kekana is a medical anthropologist and lecturer at LSHTM and has extensive 
experience using a range of methods such as participant observation, in-depth interviews, reflective 
 
 
diaries and focus groups, and expertise working in mixed method research projects on maternal 
health and health systems. 
Dr Tanya Marchant, a Senior Lecturer in epidemiology at LSHTM, will provide guidance on research 
design and analysis.  
Professor Joy Lawn is a global expert in perinatal epidemiology, the Director of the Maternal, 
Adolescent, Reproductive and Child Health Centre (MARCH) at the LSHTM, and co-chairs the global 
Every Newborn Action Plan metrics group.   
Curriculum Vitae of all the members of the technical team are included in annex B. 
London School of Hygiene and Tropical Medicine 
The London School of Hygiene &Tropical Medicine is the co-chair of the ENAP metrics working group 
alongside the WHO. LSHTM a world-leading centre for research and postgraduate education in 
public and global health. The LSHTM mission is to improve health and health equity in the UK and 
worldwide; working in partnership to achieve excellence in public and global health research, 
education, and translation of knowledge into policy and practice. http://www.lshtm.ac.uk   
REACH Trust  
The Reach Trust is a centre of excellence for multidisciplinary health research that generates 
evidence; advocates for the development of inclusive health policies; and practices in promoting 
equity in access to health care, mostly for the vulnerable, poor and marginalized populations in 
Malawi.    
Saving Newborn Lives, Save the Children 
Save the Children’s Saving Newborn Lives program is funded by the Bill and Melinda Gates 
Foundation and seeks to reduce global neonatal mortality by working in partnership with countries 
to develop packages of effective, evidence-based newborn care interventions and to implement 
these innovations at scale. http://www.savethechildren.org/site/c.8rKLIXMGIpI4E/b.6234299/ 
Saving Newborn Lives has supported the Reproductive Health Department and Central Monitoring 
and Evaluation Division in Malawi for a number of years helping to integrate newborn indicators and 




X – WORKPLAN 
Study Gantt chart 
 
Malawi in-country ethics approval (NHSRC 
expedited)
Data analysis plan
Quantitative data analysis for Malawi
Options 1, 2 and 3 
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Design of qualitative tools  (complete) Field based work
Finalisation of qualitative tools Desk-based work
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In-depth interviews
National workshop 1 2 3
Transcription
Analysis of qualitative data
Combine findings from objectives 
Write up of results into country specific report 












   
 
 
Figure 4. Flow diagram for qualitative data collection (objective 2) including data flow assessments, in-depth interviews and consensus building workshop 
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The time for Sarah Moxon is funded by a grant from Children’s Investment Fund Foundation (CIFF) to 
LSHTM for Every Newborn metrics research. Sarah’s time until October 2017 is also co funded by 
Save the Children’s Saving Newborn Lives project.  The qualitative work described in this proposal 
will be funded by the CIFF grant at LSHTM. Other partners such as USAID, AMDD and LSHTM 
academics are part of the work but funded through other means. All costs for data collection will be 
covered by Children’s Investment Fund Foundation (CIFF) and are already included in grant for Every 
Newborn Action Plan metrics to the London School of Hygiene and Tropical Medicine.  
Personnel (technical team) 
Time for the REACH Trust team will be covered by the CIFF grant at LSHTM through an existing 
agreement. Other partners such as USAID, AMDD and LSHTM academics are part of the work but 
funded through other means.  
Unit Cost Totals
Data collection 
Vehicle hire 18 60000 1,080,000          
Fuels costs 672.05 825 554,441             
Per diems and accommodation (3 people for 18 
days 54 25000 1,350,000          
Airtime and internet 18 2000 36,000               
Lunch/Snack for interviewees 30 2000 60,000               
SUBTOTAL 3,080,441         
National Focus Group
(Venue- REACH/MOH MNH Conference) 20 78200 1,564,000          
Transport refund for national focus group 5 5000 25,000               
Accomodation for national focus group 5 25000 125,000             
Tea and lunch for national focus group 20 8000 160,000             
SUBTOTAL 1,874,000         
General items
Printing and stationery 1 200000 200,000             
Recorders?? 2 100000 200,000             
400,000             
NHSRC fees 1 110000 110,000             
NHSRC 10% of the budget 1 500000 500,000             
610,000             
SUBTOTAL 2,020,000         
SUBTOTAL 6,974,441         




Travel and accommodation 
Travel and accommodation for Sarah Moxon is covered by the CIFF grant at LSHTM.  
Logistics 
All equipment for the analysis and data collection will be provided by the London School of Hygiene 
and Tropical Medicine. The Principle Investigator will use her own computer (lap top) for data analysis.  
Other materials and cost 
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Abstract
Background: The Every Newborn Action Plan (ENAP), launched in 2014, aims to end preventable newborn deaths
and stillbirths, with national targets of ≤12 neonatal deaths per 1000 live births and ≤12 stillbirths per 1000 total
births by 2030. This requires ambitious improvement of the data on care at birth and of small and sick newborns,
particularly to track coverage, quality and equity.
Methods: In a multistage process, a matrix of 70 indicators were assessed by the Every Newborn steering group.
Indicators were graded based on their availability and importance to ENAP, resulting in 10 core and 10 additional
indicators. A consultation process was undertaken to assess the status of each ENAP core indicator definition, data
availability and measurement feasibility. Coverage indicators for the specific ENAP treatment interventions were
assigned task teams and given priority as they were identified as requiring the most technical work. Consultations
were held throughout.
Results: ENAP published 10 core indicators plus 10 additional indicators. Three core impact indicators (neonatal
mortality rate, maternal mortality ratio, stillbirth rate) are well defined, with future efforts needed to focus on
improving data quantity and quality. Three core indicators on coverage of care for all mothers and newborns
(intrapartum/skilled birth attendance, early postnatal care, essential newborn care) have defined contact points, but
gaps exist in measuring content and quality of the interventions. Four core (antenatal corticosteroids, neonatal
resuscitation, treatment of serious neonatal infections, kangaroo mother care) and one additional coverage
indicator for newborns at risk or with complications (chlorhexidine cord cleansing) lack indicator definitions or data,
especially for denominators (population in need). To address these gaps, feasible coverage indicator definitions are
presented for validity testing. Measurable process indicators to help monitor health service readiness are also
presented. A major measurement gap exists to monitor care of small and sick babies, yet signal functions could be
tracked similarly to emergency obstetric care.
Conclusions: The ENAP Measurement Improvement Roadmap (2015-2020) outlines tools to be developed (e.g.,
improved birth and death registration, audit, and minimum perinatal dataset) and actions to test, validate and
institutionalise proposed coverage indicators. The roadmap presents a unique opportunity to strengthen routine
health information systems, crosslinking these data with civil registration and vital statistics and population-based
surveys. Real measurement change requires intentional transfer of leadership to countries with the greatest disease
burden and will be achieved by working with centres of excellence and existing networks.
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Background
The close of the Millennium Development Goals
(MDGs), with a halving of maternal mortality and under
five child deaths, demonstrates that global targets are
linked to national and global accountability and can drive
change. Under-five deaths due to HIV/AIDS, malaria and
measles (among others), have seen the greatest propor-
tional declines [1]. Where indicators for high impact, evi-
dence-based interventions are carefully tracked, previous
analysis has demonstrated that coverage tends to
improve, largely due to focused policy attention, invest-
ment and informed planning, leading to better popula-
tion health outcomes [2]. Interventions for child health
and causes of child death have had more programmatic
data (coverage and process), collected more frequently, at
a more granular level (e.g. district level, by various equity
analyses groups), than for newborn health, where the
data is of poorer quantity and quality, and has been col-
lected with less frequency [3].
As the MDGs transition to the Sustainable Development
Goals (SDGs), there remains an unfinished agenda for 2.7
million neonatal deaths, for whom progress has been
much slower than progress towards reducing the overall
under 5 mortality rate. An estimated 2.6 million stillbirths
were not counted at all in the MDGs[4]. Well-functioning
civil registration and vital statistics (CRVS) systems gener-
ate policy, ensure access to services and are associated
with better health outcomes worldwide [5]; counting
births and deaths, especially the deaths around the time of
birth, lies at the heart of post-2015 health monitoring,
accountability and action [3]. Tracking vital events and
measuring coverage is also central to developing national
health management information systems (HMIS), such as
in the Measurement and Accountability for Results in
Health (MA4Health) Roadmap [6], which aims to increase
investment in national data systems and data use.
The Every Newborn Action Plan (ENAP) [7] is a global
multi-partner movement to end preventable maternal
and newborn deaths and stillbirths. Through a series of
consultations, multiple stakeholders (governments, Uni-
ted Nations (UN) agencies, donors, business commu-
nities, professional associations, academic and research
institutions, global initiatives and civil society members)
developed an impact framework and an action and mea-
surement agenda for integration within national newborn
health plans [3,8].
To reach 2030 national targets for neonatal mortality
and stillbirth rates of ≤12 per 1000 births, high and equi-
table coverage of the evidence-based interventions identi-
fied by ENAP is needed [9]. ENAP prioritises achieving
universal coverage of these interventions particularly dur-
ing childbirth and the first week of life. Yet many of these
interventions are not systematically measured. One of the
five ENAP strategic objectives - to count every newborn
(and birth) - underlines the need for improved data and
accountability. The ENAP milestones, linked to a World
Health Assembly resolution [7], have a particular focus
on inputs required prior to 2020 and more than half refer
to improving metrics for targeting and driving change
(Figure 1). One such milestone is to develop a monitor-
ing framework building on the Commission on Informa-
tion and Accountability (COIA) for Women’s and
Children’s Health [10] to track global progress post 2015
and align with country priorities and objectives.
The principal focus of this paper is based on the ENAP
milestone to define and improve priority coverage indica-
tors, as this was where the largest measurement gaps
were identified. Many newborn care interventions lack
standard indicator definitions and are not routinely mon-
itored at national or global level, especially in low and
middle-income countries (LMIC). We define a coverage
indicator as a population-level metric that measures the
number of individuals that receive an intervention or ser-
vice (numerator) out of a total population that should
receive the intervention or service (the denominator). For
the numerator, indicators rely on clear technical defini-
tions of the service or intervention. Where there is diffi-
culty capturing the population in need (the denominator)
particularly for specific treatment interventions, some
indicators (such as the caesarean-section rate) use total
live births as the denominator to give a proxy. In such
cases, where the aim is not for 100% coverage, the rate is
then benchmarked against a target threshold.
The coverage indicators prioritised by the Commission
for Information and Accountability (COIA) mainly reflect
contact points along the continuum of care, notably
antenatal care, skilled birth attendance and postnatal
care. Such coverage indicators capture contact with the
health system or delivery of a specific intervention, but
not always detailed, accurate information on the content
or quality of the care delivered [11], although antenatal
care now has a detailed content module within the
Demographic and Health Survey (DHS) [12]. In high-
burden countries the main current data source is through
household surveys. The most commonly employed
household surveys are the United States Agency for
International Development (USAID)-supported DHS [13]
and the United Nations International Children’s Fund
(UNICEF)-supported Multiple Indicator Cluster Survey
(MICS) [14]. However, coverage of many maternal and
newborn interventions cannot feasibly and/or accurately
be collected through household surveys.
For health information collected through household
surveys, the data quality usually depends on the validity
of the mother’s report, often up to two to five years after
the intervention occurred. There is evidence suggesting
that maternal recall of events that occurred during labour
is poor [12], especially if there were complications. In
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addition, how the question is asked can affect the accu-
racy of the response. For surveys, large sample sizes are
needed to generate sufficient statistical power to assess
social and demographic factors. Bryce et al: [15]
described some of the limitations of household surveys
for measuring coverage of interventions, including the
time, cost and limited validity (sensitivity and specificity)
of many of the indicators.
Health facility assessments (HFAs) are frequently used to
complement HMIS, facility-based logistics and service
delivery information systems. These provide information
on staffing, equipment availability, spatial organisation,
data collection capacity, and service readiness. A number
of standardised HFA tools exist, the most commonly
employed being the Service Availability and Readiness
Assessment (SARA) [16], Service Provision Assessments
(SPA) [17] and the Emergency Obstetric Care (EmOC)
needs assessments [18]. These allow health systems to
report on a sample of facilities that provide a certain ser-
vice or have health workers trained in specific skills, but
are not routine reporting mechanisms. In addition, the
WHO Health Access/Action International database has
data on medication availability. Service availability and
quality indicators provide complementary metrics to popu-
lation coverage which can be used to ensure that services
achieve adequate coverage and give due attention to the
availability of care, and the readiness of facilities to deliver
the safe and quality care that is fundamental to the Every
Newborn movement.
Since coverage of evidence-based care for mothers and
newborns is often unknown, or data may be old or not
locally available, this is a major “bottleneck”, impeding
scale up of high-impact, evidence-based interventions for
newborns. Such data have been critical in accelerating pro-
gress in the implementation and scale-up of immunisation
and HIV programmes through increased policy attention,
focused investment of resources and better accountability
structures [15]. Such data are critical for informed plan-
ning, driving programme improvement and targeting
underserved populations to reduce inequities.
Figure 1 Every Newborn Action Plan (ENAP) Measurement Improvement Roadmap: the arc of change. In support of Health Measurement
and Accountability post-2015: A Common Roadmap WHO (2015) [6]. ENAP: Every Newborn Action Plan; WHO: World Health Organization.
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The objectives of this paper are to:
1. Describe the systematic process used to select
ENAP indicators and present the core and additional
indicators.
2. Assess the status (technical definitions and data
availability) of the ENAP coverage indicators and
identify actions needed to improve these for mea-
surement at scale, particularly for coverage of the
treatment interventions.
3. Identify priorities for testing validity and feasibil-
ity, in order to institutionalise these metrics within
large scale data collection platforms and outline a
five-year measurement improvement roadmap.
Methods
Objective 1: systematically grade to select the ENAP core
and additional indicators
A multi-stage process was carried out to identify a list of
potential indicators and then prioritise a short list. This
process involved a working group appointed by the ENAP
management team who compiled a comprehensive list of
indicators, drawing on existing databases such as COIA
[10], UNICEF’s State of the World’s Children (SoWC)
[19], Countdown to 2015 [20] and other World Health
Organization (WHO) statistics and reports. Standardised,
nationally representative survey tools currently in use
(MICS, DHS, SPA, SARA and EmOC surveys) were con-
sidered as sources of data. In addition, possible indicators
relating to common causes of neonatal death were
included. This resulted in a matrix of over 70 relevant
indicators measuring impact (mortality and morbidity),
outcome (coverage of care for all babies and coverage of
treatment interventions), outputs (service quality, availabil-
ity, demand, and the enabling environment) and inputs
(human resources, essential medicines and supplies) (see
Additional file 1). The current status of definitions, mea-
surability and data availability were reviewed for each of
the proposed indicators.
A systematic scoring process was applied to prioritise
core indicators that could track the main focus of the
action plan, particularly on quality of care at birth and
the five strategic objectives. Each indicator was graded by
its importance to the ENAP focus (A to C) and by cur-
rent data availability (1 to 3). A grade of A was given to
indicators of highest relevance and match to the ENAP
focus and a score of 1 was given to indicators with a
common and consistent definition already measured in
existing data sources. Scoring was completed by an
expert working group and decided via group consensus
with priority given to indicators in terms of their rele-
vance to the ENAP focus, rather than data availability.
Given the principle of accelerating impact, a decision
was taken to focus on a shorter list of important indicators
and ensure those would be made measureable, rather than
to just select those that were already measureable. Hence,
indicators were prioritised first based on their importance
to the ENAP focus (category A) and then on data availabil-
ity. Indicators in Category A ranged from those with defi-
nitions and existing data (availability 1) to those without
standard definitions and existing data (availability 2 or 3).
The latter were identified as having priority measurement
gaps that needed to be addressed with a specific program
of work.
Objective 2: assess status of ENAP coverage indicators
and identify priorities to improve measurement at scale
For each of five high impact interventions identified with
the greatest measurement gap (red box in Figure 2), a
Task Team was established. These included antenatal
corticosteroids (ACS), newborn resuscitation, Kangaroo
Mother Care (KMC), case management of serious neona-
tal infection and chlorhexidine cord cleansing. The Task
Teams sought to represent both the maternal and new-
born health communities and reflect multiple stake-
holders, e.g. non-governmental organisations, UN
organisations, professional associations, and research
institutions; ensuring representation from LMIC. With
the support of the ENAP metrics coordination group,
Task Teams carried out a consultation process to define
indicators based on a technical definition, suggest feasible
indicators that can be measured now through existing
data collection platforms, and outline research priorities
to test validity and feasibility for these coverage metrics
for each area, including data collection tools.
WHO hosted a consultation at a meeting in Geneva,
December 2014 to review the work of the Task Teams,
and also gain inputs on the other core indicators. This
meeting developed a draft plan to deliver on the ENAP
metrics milestones, including discussion on the specific
actions needed to improve coverage indicators. Plans for
improving measurement tools and tracking systems
were also discussed; for example, perinatal audit tools,
neonatal care registers and Civil Registration and Vital
Statistic (CRVS) improvements. The draft plan was then
advanced by those at the meeting and through wider
consultation.
The priorities for testing validity and feasibility to
institutionalise these metrics within large scale data col-
lection platforms and the measurement improvement
roadmap (Objective 3) are discussed in detail in the dis-
cussion section of this paper.
Results
Objective 1: systematically grade to select the ENAP core
and additional indicators
Following the process described above, ENAP listed 10
core indicators (Figure 2). For the three impact
Moxon et al. BMC Pregnancy and Childbirth 2015, 15(Suppl 2):S8
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indicators that already have agreed definitions (Figure 3),
the priority is for improved quality and quantity of data.
There is increasing consensus on the need to invest in
CRVS and linked facility-based tracking to improve relia-
bility of impact indicators [3,4,21].
The principal focus of this paper is on the coverage
indicators, where the largest metrics gaps were identified.
The coverage indicators fall into two groups: key contact
points for care for all mothers and newborns (Figure 4),
and specific treatment interventions (mainly for care for
newborns at risk or with complications) (Figure 5 and 6).
For essential newborn care, early initiation of breastfeed-
ing was identified as a tracer indicator, with exclusive
breastfeeding up to 6 months as an additional indicator.
Chlorhexidine cord cleansing was also added to the
improvement agenda, given the gaps in coverage data.
Objective 2: assess status of ENAP coverage indicators,
and identify priorities to improve measurement at scale
For each coverage indicator, we describe technical defi-
nitions, current data availability, improvements needed
and steps to be taken.
Coverage: care of all mothers and newborns
(contact points)
Intrapartum care
Technical definition of package
A package of support and healthcare around the time of
birth integral to maintaining perinatal and maternal
safety along the continuum of care [9,22]. Skilled birth
attendance is used as the contact point indicator to
monitor coverage of this care.
Indicator to track contact point
A skilled birth attendant (SBA) is described by the WHO
as an accredited health professional (such as a midwife,
doctor or nurse) educated and trained to proficiency in
the skills needed to manage normal (uncomplicated)
pregnancies, childbirth and the immediate postnatal per-
iod and in the identification, management and referral of
complications in women and newborns [23].
Current data availability
SBA data are available mostly from DHS, MICS, and are
reported in many UN documents and by the Countdown
to 2015 report series, which charts country progress
towards meeting MDG goals and targets. However, no
robust time series has been published for all countries for
the MDG era to date, although SBA was the main indica-
tor under MDG5 for maternal health. Of 75 countries
participating in Countdown, all but 15 provide equity
analysis in relation to the coverage of SBA [20] (countries
who do not report equity compared with SBA coverage
are: Angola, Botswana, Brazil, China, Djibouti, Equatorial
Guinea, Eritrea, Korea, Mexico, Myanmar, Papua New
Guinea, Solomon Islands, South Sudan, Sudan and Turk-
menistan). These suggest SBA coverage has the widest
equity gap for any contact point along the COIA conti-
nuum of care indicators [20]. SPA also has a new
optional observational module for labour and delivery
care that has been applied in Kenya, Malawi and Bangla-
desh developed by the Maternal and Child Health
Figure 2 Every Newborn Action Plan (ENAP) core and additional indicators. Shaded= Not currently routinely tracked at global level. Bold
red= Indicator requiring additional testing to inform consistent measurement. Indicators to be disaggregated by equity such as urban/rural,
income and education. Adapted from WHO and UNICEF, Every Newborn Action Plan. WHO, 2014. http://www.everynewborn.org/ and Mason
et al: Lancet 2014.
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Integrated Program (MCHIP) that provides supplemen-
tary data for assessment of quality of care.
What can we do to improve the data?
While WHO’s definition of a SBA has a defined list of
core midwifery skills [18], measurement of SBA is chal-
lenged by the variety of cadres included in the definition
and the lack of consistency in training, skills and core
functions across countries [24]. Besides doctors, nurses
and midwifes, there are several other country specific
cadres of auxiliary midwifes, medical assistants and
other health professionals that are included in the SBA
category in many countries; these may also be subject to
Figure 3 Every Newborn Action Plan (ENAP) core indicators regarding impact, with definitions and data sources. Shaded= Not currently
routinely tracked at global level. Bold= indicator requiring additional evaluation for consistent measurement. *The time period will normally be
calculated per year. **ICD assumes weight and gestational age are equivalent, which they are not (see Stillbirth series Lawn et al: 2011). ICD:
International Classification of Disease; UNFPA: United Nations Population Fund; UNICEF: United Nations International Children’s Emergency Fund;
WHO: World Health Organization.
Figure 4 Every Newborn Action Plan (ENAP) core indicators regarding coverage of care for all mothers and newborns, with definitions
and data sources. DHS: Demographic and Health Survey; MICS: Multiple Indicator Cluster Survey.
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change over time, or across survey programmes. Current
work towards standardising the professional remit of
SBAs and foster more universal accountability mechan-
isms are being carried out by WHO, UNICEF and
UNFPA. Expert consultations will be held in late 2015
to discuss operational definitions and develop measure-
ment guidance for survey programmes.
In addition, SBA is an indicator of contact with the
health system and does not provide information on the
content or quality of care making it an incomplete and
misleading proxy for quality of care at birth [12]; addi-
tional information about equipment, provider skills,
referral availability, content of care and other measures
of quality are also required. Process indicators on facility
readiness are collected by SPA, SARA and EmOC needs
assessments (Figure 4) though the range of data col-
lected varies between surveys and there is limited focus
on newborn care. Current DHS and MICS survey tools
do not collect extensive data on the content of care at
time of birth [12]; therefore, increasing the capacity and
availability of routine facility level data is a priority for
improvement.
Early postnatal care
Technical definition of package
A package of healthcare provided to women and their
newborn either at the facility or during consultation at
home. For women who deliver at a health facility, WHO
recommendations support inpatient care for at least 24
hours, and/or provision of care as early as possible and
Figure 5 Every Newborn Action Plan (ENAP) core indicators regarding coverage of care for newborns at risk or with complications,
with definitions and data sources. Blue coloured cells= not currently tracked and collated by United Nations. Bold italics= indicator needing
further work to ensure availability of consistent data in routine information systems. All coverage indicators to be tracked in such a way that
they can be broken down to assess equity- e.g. urban or rural, regional, wealth quintile. ACS: antenatal corticosteroids; GA: gestational age; HMIS:
Health Management Information System; KMC: kangaroo mother care; QoC: quality of care; SARA: Service Availability and Readiness Assessments;
SPA: Service Provision Assessments; WHO: World Health Organization.
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at least within 24 hours for women and newborns who
are born at home [25].
Indicator to track contact point
Early postnatal care is defined as a contact provided to a
woman and her newborn during the 2 days (48 hours)
following birth (whether in a facility or at home) (see
Figure 4) and excludes immediate postpartum care [13].
Current data availability
The early postnatal care contact point is measured in
household surveys as two separate indicators (a postna-
tal health check for the newborn and a postnatal health
check for the mother) tracking coverage of a first post-
natal contact within 2 days of delivery. The questions
used to derive this indicator have changed significantly
over time and have been different between the DHS and
MICS [14], however Phase 7 of DHS [13] now includes
questions allowing computation of a comparable postna-
tal care indicator.
What can we do to improve the data?
Postnatal care is a package of services for women and
babies, therefore, data on content and quality are
required in addition to tracking the contact point. One
critical question is to ensure the data can distinguish
between intrapartum and postnatal care [26]. In both
DHS and MICS, this is being attempted through the use
of question prompts to better describe the content of
the postnatal check and recent revision of the DHS core
questionnaire includes a question on the content of
PNC checks. Supplementary data pertaining to the con-
tent of care, provider skill and other quality control
measures is urgently required; a move away from inter-
mittent survey based data collection towards sustainable
HMIS is essential in ensuring that effective management
mechanisms can be facilitated and support routine qual-
ity of care tracking.
Essential newborn care
Technical definition of package
Preventive and supportive care required for all newborns
including: warmth, cleanliness, breastfeeding, cord and
eye-care, Vitamin K and immunisations [27-29].
Indicator to track care
Due to the strong evidence of a reduction in newborn
mortality and morbidity with early initiation of breastfeed-
ing, especially through decreased rates of infection [30-32],
early initiation of breastfeeding was prioritised as a tracer
indicator for essential newborn care, with exclusive breast-
feeding at 6 months as a further marker (Figure 4). Indica-
tors of other components such as skin-to-skin care, may
also be possible, and are recalled accurately by mothers
Figure 6 Every Newborn Action Plan (ENAP) core indicators regarding coverage of complications and extra care (specific treatment
indicators), with definitions and data sources. Blue coloured cells= not currently tracked and collated by United Nations. Bold italics=
indicator needing further work to ensure availability of consistent data in routine information systems. Red= service delivery package for which
norms and standards will be defined and tracked. All coverage indicators to be tracked in such a way that they can be broken down to assess
equity- e.g. urban or rural, regional, wealth quintile. CHX: chlorhexidine; DHS: Demographic and Health survey; EmOC: emergency Obstetric Care;
HMIS: Health Management Information System; MICS: Multiple Indicator Cluster Survey; UN: United Nations.
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[12]. However, these data are not currently widely avail-
able, and further testing is required to ensure that routine
skin-to-skin can be accurately distinguished from KMC by
survey respondents.
The WHO recommends the early initiation of breast-
feeding within one hour of birth [33] and then exclusive
breastfeeding for the first 6 months of life [34]. To sup-
port this, babies should be placed skin to skin with their
mothers immediately following birth and offered help to
breastfeed when needed [35].
Current data availability
MICS, DHS and other national household surveys col-
lect data measuring coverage of the early initiation of
breastfeeding [1,36] and it is reported in Countdown
and SoWC [20]. Both MICS and DHS contain measure-
ment questions focusing on feeding behaviours within
the last 24 hours from the time of survey. This approach
allows for more accurate recall of the behaviour, how-
ever, does not capture breastfeeding practises across the
infant time period and, therefore, the results may not
reflect breastfeeding practises over time.
What can we do to improve the data?
A recent validation study reported that the early initia-
tion of breastfeeding indicator had high sensitivity (0.82)
but poor specificity (0.25), using a household survey
instrument [12]. Although the instrument used in the
study posed a slightly different question than what is in
DHS, this suggests a need for further testing and valida-
tion. Additional research to determine the impact of
other essential newborn care practices would enable
more informed and targeted behaviour change and asso-
ciated measurement approaches.
Coverage: care for newborns at risk or with
complications (specific treatment interventions)
Antenatal corticosteroids
Technical definition of intervention
Currently, antenatal corticosteroid therapy (ACS) (24 mg
of intramuscular dexamethasone or betamethasone in
divided doses over 24 hours) is recommended by WHO
for all mothers at risk of imminent preterm birth (delivery
before 34 completed weeks of gestation) when the mother
is in a facility where accurate gestational age can be
obtained, where there is no clinical evidence of maternal
infection, and there are adequate levels of maternity care
and special newborn care available [37] (WHO guidelines
are currently being revised). These guidelines reflect
changes after the Antenatal Corticosteroids Trial (ACT)
which evaluated prescription of ACS at lower levels of the
health system, with approximately half of births occurring
at home, and found a risk of adverse outcomes especially
amongst births after 34 completed weeks of gestation [38].
This trial underlines the importance of measuring gesta-
tional age, and better tracking of coverage and outcomes.
Current coverage data availability
Coverage data on provision of ACS for neonatal admis-
sions are routinely collected within most high income
countries (HIC), but are not consistently part of HMIS
or standardised facility surveys. Since the intervention is
used in health facilities [38], improved facility level data
are a priority for capturing ACS coverage. Household
surveys are unlikely to be a useful source for this infor-
mation, as mothers may not accurately report ACS
(with difficulties to differentiate between ACS and other
drugs given at the time of labour). In addition, data may
have low statistical power given the relatively small
numbers in the population who receive ACS for fetal
lung maturation [12].
Process indicator to track now
In many LMICs, where HMIS does not capture ACS cov-
erage, a commodities-based process indicator can be mea-
sured for tracking in the short term; SARA and SPA
includes the availability of dexamethasone within their
facility checklist. WHO Health Access/Action Interna-
tional database also collect data on availability of dexa-
methasone and betamethasone in their existing pharmacy
and facility audits [39]. However, a denominator of all
health facilities may not be fully accurate as not all facil-
ities would meet WHO criteria for safe provision of ACS
(see definition above), including provision of appropriate
maternal and newborn care [1,40]. Countdown reports the
number of countries whose national policy recommends
antenatal corticosteroids for preterm labour [1]. While this
indicator is distal to coverage, it is available and helpful in
tracking changes in policy context (Figure 5).
What can we do to improve the data?
It is challenging to define a precise indicator that can
capture both eligible women who should receive ACS
and measure ACS provision. Recent evidence suggests
use of ACS may be associated with a risk of adverse out-
comes for babies whose gestational age is ≥34 completed
weeks [38]. A major challenge is defining the denomina-
tor of eligible mothers presenting in labour <34 weeks. In
LMICs, the recall of last menstrual period (LMP) is often
poor or inaccurate in settings with low rates of literacy
and antenatal care. Access to ultrasonography is low and
mothers frequently present for ANC late in pregnancy,
when ultrasound dating is inaccurate. Thus improved
assessment of gestational age before and/or after birth,
and documentation of gestational age in medical records,
is an urgent priority in all settings irrespective of resource
availability, along with improved tracking of safety and
non-fatal outcomes. Studies are needed to validate differ-
ent and feasible methods of ascertaining gestational age
compared to accurate gestational age dating (early ultra-
sonography) in LMIC. Furthermore, methods require
validation in different regions and in settings with high
rates of fetal growth restriction.
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Thus, present capacity within most LMICs may only
extend to crude coverage of ACS (e.g. all mothers who
received 1 dose) and will not differentiate between those
who received ACS before (true positives), or after (false
positives) 34 weeks completed gestation. To capture such
information, existing datasets from high or middle income
countries may be analysed to facilitate the development
and testing of a more refined indicator. Improved gesta-
tional age assessment and documentation is needed in all
settings irrespective of resource availability, along with
improved tracking of safety and non-fatal outcomes.
Observation of facility births in a number of countries
would allow for testing and validation of a number of
options for the denominator (Figure 5). The measure-
ment improvement roadmap aims to assess whether
using these denominators is feasible in routine HMIS,
and the extent to which proposed options for testing
yield useful programmatic tracking information.
As with many of the treatment intervention coverage
indicators, the option of using all live births as a denomi-
nator will not give accurate population-representative
treatment coverage in settings where reporting in HMIS
is poor, such as settings with low facility births or a large
private sector. In such contexts it may be worth consider-
ing estimated births within a facility catchment area as
denominator, which is more challenging where popula-
tions are not well defined or birth cohorts are uncertain.
A denominator that is not restricted to the population in
need, will require definition of target coverage levels. For
ACS this target benchmark could potentially be defined
by the recent estimates of national preterm birth rate
(<34 weeks), which was shown to vary from around 4%
to 18% globally [41].
Neonatal resuscitation
Technical definition of intervention
Basic neonatal resuscitation describes assessment and
actions for every newborn at the time of birth, to assist
in establishing breathing and circulation [42]; it should
be practised on all non-macerated newborns not breath-
ing spontaneously following immediate drying in accor-
dance with current WHO guidelines [43]. Effective and
safe resuscitation of these babies is highly time-sensitive
and should be initiated within the first minute after
birth. The actions include additional stimulation and
positive pressure ventilation with bag and mask if clini-
cally indicated following stimulation [44]. The interven-
tion definition does not include advanced resuscitation
measures such as intubation and/or medications.
Current coverage data availability
National coverage data are not currently available on
neonatal resuscitation and the intervention lacks a stan-
dard measurable indicator. As with ACS, there are several
known and suspected limitations of using household
surveys to measure neonatal resuscitation coverage,
including the likely inability of mothers to report accu-
rately as they may not understand or know if their new-
born was resuscitated at birth, and small numbers
resulting in low statistical power [12,45].
Process indicator to measure now
Data on the availability of a functional newborn size bag
and mask in the delivery area of a health facility offering
maternity services may be utilised as a service readiness
indicator for neonatal resuscitation, as these data are
easy to document and already available now for many
countries (see Figure 5) [16-18]. SPA and SARA capture
the availability of at least one neonatal size bag and
mask in the labour and delivery ward (SARA captures
two sizes of masks) and neonatal resuscitation was
added to the UN EmOC signal functions in 2009 with
data collected as part of standard EmOC needs assess-
ments supported by UNICEF. Since a neonatal-size bag
and mask is on the UN essential commodities list, this
equipment is also increasingly tracked in logistics man-
agement information systems (LMIS). This indicator has
strong negative predictive value (a labour ward with no
bag and mask cannot ensure adequate resuscitation
when needed) and was recommended by the WHO con-
sultation on quality of care [46]. However, the presence
of resuscitation equipment does not equate to appropri-
ate and timely use of the neonatal bag and mask, and
not all newborns who do not breathe at birth require
positive pressure ventilation. Many newborns may
respond to stimulation alone, and there is evidence
demonstrating that the provision of resuscitation train-
ing is associated with a reduction in bag and mask use
[47]. Supplementary information regarding the presence
of staff who have received newborn resuscitation train-
ing in the last two years is collected as part of the
SARA and SPA surveys; however, these data may be dif-
ficult to compare depending on question framing
[16,17].
What can we do to improve the data?
One of the major challenges in capturing precise neona-
tal resuscitation coverage is the identification and accu-
rate measurement of a denominator that reliably
captures babies requiring resuscitation to establish
breathing after birth. As with other treatment indicators,
accurate identification of the target population depends
on correct diagnosis and classification of the individuals
in need by health care providers. Accurate classification
of babies needing resuscitation is challenging in all set-
tings due to variable diagnostic skills and experience of
individual providers [45,48]. Independent of provider
competence, this would likely be difficult data to collect
in routine systems; we can speculate that it is unlikely
that any healthcare worker would record a case where a
baby required resuscitation but did not receive it. As
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with ACS, the measurement improvement roadmap out-
lines the priority denominators for testing and the vali-
dation of observed compared with reported resuscitation
practises. Appearance, Pulse, Grimace, Activity, Respira-
tion (APGAR) scores were intended to assess the condi-
tion of the newborn after birth, but are not useful for
measuring of resuscitation for monitoring purposes as
they are not reported until 1 minute of life, after the
time within which resuscitation should be initiated. In
addition, APGAR scores may not be predictive of out-
come unless the score is very low at 5 minutes, and in
busy labour wards the scores are often recorded after
the event, if at all.
There are further challenges associated with defining a
numerator to accurately and feasibly track neonatal
resuscitation coverage. An important principle in effec-
tive and safe neonatal resuscitation is careful assessment
and stimulation of the newborn who does not start
breathing spontaneously after routine drying, and only
using bag and mask if needed in order to reduce inap-
propriate use of positive pressure ventilation [44,49,50].
However, bag and mask use may be easier to recall and
validate than distinguishing stimulation actions, such as
back rubbing, from routine drying and wrapping. A study
in Sweden found that neonatal resuscitation documenta-
tion was inadequate for reliable evaluation [51]; docu-
mentation of resuscitation is unlikely to be more
adequate in LMICs. Several countries such as Bangla-
desh, Nepal and Tanzania, propose testing collection of
routine information on newborn resuscitation by action
step. Further analysis of such efforts is likely to be useful.
Proposed testing includes comparison of health
worker documentation of newborn resuscitation actions
in facility records with observed or video recorded
resuscitation care; some of this may be possible using
existing videos from Nepal or birth records from Ban-
gladesh. New work to observe births in health facilities
across a number of countries would allow testing of the
resuscitation denominator options (Figure 5) in line
with the other treatment indicators, including various
case definitions of babies who do not breathe at birth,
or do not breathe after stimulation. A simpler denomi-
nator for resuscitation based on live births would
require defined target levels. According to estimates
(based on limited observational data) approximately 6-
10% of newborns may require some assistance to begin
breathing at birth [48,52].
Kangaroo mother care
Technical definition of intervention
A method of caring for low birthweight newborns
(mostly preterm) in direct and continuous skin-to-skin
contact, in the kangaroo position, with their mother (or
guardian), with support for early and exclusive
breastmilk feeding. The current evidence to achieve
mortality reductions supports KMC for clinically-stable
newborns, weighing less than 2000 g, initiated in a facil-
ity [53]. WHO guidelines support that the infant is
cared for in the kangaroo position for the equivalent
number weeks it would have taken for the infant to
reach full term (or as long as the baby will tolerate the
position) accompanied with appropriate follow up after
discharge [54].
Current coverage data availability
Limited data on KMC are available from facility-based sur-
veys and HMIS for several countries, including Malawi,
Dominican Republic, and El Salvador. Some middle-
income countries, especially in Latin America, have
detailed program data on KMC received, but there is no
existing standardised coverage indicator definition. There
may be differences between the level of facility in which
KMC can be safely provided or initiated and the eligibility
criteria for KMC, which creates difficulties in comparing
data between settings. Measurement of KMC is not cur-
rently carried out by routine household survey platforms.
Process indicator to measure now
Given the immediate challenges for capturing coverage,
a service-readiness indicator is proposed: the number of
facilities in which a space is identified for KMC and
where at least one staff member has received KMC
training (SPA measures within the last 2 years) (see Fig-
ure 5). This measure is similar to that defined in a
recent consultation by WHO on improving measure-
ment on the quality of maternal, newborn and child
health care in facilities [46] and is consistent with cur-
rent SARA and SPA facility assessment tools [16,17].
What can we do to improve the data?
It is possible to measure the number of newborns initiated
on facility based KMC in a number of settings through
HMIS or hospital admission records (e.g. El Salvador,
Dominican Republic, Malawi, Tanzania). However, mea-
suring a denominator of <2000 g is challenging given that
nearly half of all newborns globally are not weighed at
birth. Where birthweight is recorded, there is a known
tendency for digit preference and heaping, especially at
2500 g and 2000 g [55]. The denominator could be mea-
sured as a rate per 100 or per 1000 live births, avoiding
the difficulties of including weight in the numerator and
identifying babies in need for the denominator. However,
this doesn’t measure whether babies were truly eligible or
benefitted from KMC. Since KMC is an intervention that
benefits predominantly preterm infants, the proportion of
live births that could benefit from KMC will vary between
settings (4 to 18%); identical rates may correspond to a dif-
ferent unmet need for KMC [41].
Efforts to improve birthweight recording and gesta-
tional age assessment are integral to the scale-up and
measurement of more precise indicators for KMC.
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Existing datasets from countries with established KMC
programmes and accurate assessment of gestational age
and birthweight should be used for testing the denomi-
nators and proposed numerators (Figure 5). Linked to
the measurement improvement roadmap, developing
and validating questions for household surveys is also
important if the practice is widespread enough to ensure
a sufficient sample size. Recent work in Colombia has
shown that women can accurately and reliably recall
KMC, even decades later [56].
To develop the service readiness indicator, both the
WHO quality of care report and the KMC Acceleration
Group propose a measure of “operational” KMC [46],
although this would need further work to identify and test
its specific components. The operational indicator could
be based on available “tracers"; for example, SPA currently
collects data on allocated KMC space, infant weighing
scales, thermometer, and whether staff has received train-
ing. Other items (feeding cups, NG tubes, job aids) or
improvements to the questions on training and space
could be added where more detailed assessments are
being carried out. In Colombia, a manual of minimum,
desirable and optimal standards for KMC has been devel-
oped [57], which could be adapted for different settings.
Treatment of neonatal infection
Technical definition of intervention
The provision of antibiotics to newborns admitted for
inpatient care with possible serious bacterial infection
(pSBI), in accordance with current WHO treatment
guidelines [58,59] and diagnostic algorithms [60]. Case
management can also be considered by levels of care:
administration of oral antibiotics only, injectable antibio-
tics only, or full case management of neonatal infection
(potentially second line antibiotic therapy, IV fluids, oxy-
gen therapy, other supportive measures) [61]. Recent
trials of Simplified Antibiotic Therapy show that, where
referral is not possible, treatment with the simpler
regimes by lower level workers is feasible [62].
Current coverage data availability
Most LMICs do not collect or aggregate the number of
newborns treated for pSBI in HMIS. Household surveys,
including DHS and MICS, do not collect data on new-
borns treated for pSBI because these would likely be
unreliable (given recall issues measuring incidence of
pneumonia in children under five years) [63]. This con-
trasts with HIC settings where HMIS data is routinely
maintained with additional data points specific to moni-
toring antibiotic resistance.
Process indicator to measure now
Given challenges in measuring coverage of treatment of
serious neonatal infection, a process indicator is proposed:
the proportion of facilities in which gentamicin is available
(at a suitable peripheral level) for treatment of serious
neonatal infection [46]. This is collected by both the SPA,
SARA facility assessment tools [16,17] and the WHO
health action/access international database [39]. However,
as with resuscitation, the presence of the antibiotic in the
facility does not directly measure correct use of antibiotics
to treat newborns for pSBI or guarantee that the antibiotic
is available in paediatric doses [64].
What can we do to improve the data?
The number of newborns treated with at least one dose of
injectable antibiotic at a facility is proposed for validation
and feasibility testing against a number of denominator
options, including total live births, the number of new-
borns presenting with illness, or the number of newborns
diagnosed with pSBI (Figure 5). As treatment regimens
may vary between settings, the measurement improvement
roadmap aims to assess multiple options for a numerator
and explore the validity, feasibility and utility of using
HMIS to collect this data. For measurement of the dose of
any antibiotic, more details would be required at program
and/or facility level (rather than from the coverage indica-
tor); notably, which antibiotic(s) were used and whether
the course was completed. It will be necessary to deter-
mine appropriate use of antibiotics, as over treatment may
increase anti-microbial drug resistance. Routine, national
systems are required to track all injectable antibiotic doses
given, and those not given, with associated clinical out-
comes. A recent review found that within facility based
audits, the availability of data on neonatal specific formula-
tions (lower concentration gentamicin, procaine benzylpe-
nicillin) was scarce [64] and therefore, more data is
needed regarding the availability of neonatal formulations
and specific requirements for administration to newborns.
At first level facilities, testing of the new WHO module on
“where referral is not possible” with new simplified anti-
biotic regimens [65] will be possible in five countries
(Democratic Republic of Congo, Bangladesh, Pakistan,
Ethiopia and Nigeria). Process and quality indicators
should also be improved at the facility level, for example,
gentamicin has a narrow therapeutic index and is asso-
ciated with toxicity risks [58]; therefore, monitoring its
safe administration at program or facility level is an impor-
tant marker of quality care. Specific data on neonatal
administration of medicines (formulations, concentrations)
could also help monitor safety and quality of care in facil-
ities. In addition, where direct patient observations are car-
ried out (as with SPA for the treatment of suspected
pneumonia), this could be extended to the treatment of
serious neonatal infection in facilities to ensure health
worker compliance with IMCI guidelines [59].
Chlorhexidine cord cleansing
Technical definition of intervention
Chlorhexidine (CHX) cord cleansing is the routine
application of topical chlorhexidine digluconate 7.1%
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(solution or gel, delivering 4%) to the cord stump within
the first 24 hours of life. The WHO currently recom-
mends this intervention in settings with an NMR
>30:1000 or for homebirths [66,67].
Current coverage data availability
The recommended routine administration of chlorhexi-
dine cord cleansing is a recent policy development [25].
Data are not collected by most HMIS or as part of stan-
dardised household survey tools. Both SPA and SARA
track the availability of chlorhexidine used for general
disinfection in their commodity checklists [16,17]. Moni-
toring use of 7.1% chlorhexidine for cord cleansing
requires documentation of the presence of the specific
concentration of chlorhexidine (7.1% formulation rather
than any type of chlorhexidine product). Because of
country-specific variations in policy for routine cord
cleansing, documenting availability of 7.1% chlorhexidine
in a health facility will only be of use in settings where
programs that use chlorhexidine for umbilical cord
cleansing exist.
Process indicator to measure now
Given the current challenges in measuring coverage, the
inclusion of chlorhexidine 7.1% (solution or gel) within
national essential drug lists for the purpose of cord
cleansing has been identified as an interim process indi-
cator (Figure 6). These data are collected by the RMNCH
Trust (formerly UN Commodities Commission) and are
reported by Countdown [20]. As with ACS, this indicator
is distal and is not a measure of coverage; however, it is
an important enabling condition, data are currently avail-
able, and it would facilitate tracking of policy changes in
the coming years.
What can we do to improve the data?
Household surveys can be used to measure chlorhexidine
coverage, as carried out in Nepal [68], The number of
newborns who had chlorhexidine applied to the cord
stump within the first day of birth can be evaluated
against a denominator of live births in the survey popula-
tion. DHS has incorporated an optional five question
chlorhexidine module for countries with a national chlor-
hexidine for umbilical cord cleansing programme as part
of its newborn module. In countries where chlorhexidine
has been introduced at scale (e.g. Nepal, Bangladesh and
Nigeria), the chlorhexidine technical working group is
recommending adding a follow-up probe question speci-
fically asking about chlorhexidine use.
Refinement of both the numerator and denominator
with rigorous assessment of sensitivity and validity will
be beneficial. Showing the respondent a picture of the
locally marketed chlorhexidine during a household
interview might assist with recall, improve validity and
will be tested as part of the measurement improvement
roadmap. Due to variations in national policy on use of
chlorhexidine within facilities, further testing is required
to assess the sensitivity and specificity of household sur-
vey questions on chlorhexidine cord cleansing following
birth within a facility, where cord cleansing may have
occurred away from the mother, or performed in her
absence. Further validation will be undertaken to com-
pare observed chlorhexidine use with reported practice.
Depending on findings, longer-term efforts towards
institutionalising chlorhexidine coverage questions
within routine household survey platforms would be
essential to achieve consistent coverage data.
Discussion
The Every Newborn movement is committed to support-
ing countries to reach a target of ≤12 neonatal deaths
and stillbirths per 1000 births by 2030, also closely
linked to ending preventable maternal deaths [7]. The
ENAP metrics process has highlighted major gaps and
lack of tracking for newborn interventions at all levels
of the health management information system. To date,
insufficient technical work and investment has been
dedicated to strengthening national data systems and to
rigorous testing of coverage data. Both validation and
feasibility testing using standard research protocols for
rigorous testing are needed. The multistage ENAP
metrics process identified 10 core indicators and a set of
10 additional indicators (Figure 2). Of the core ENAP
indicators, five newborn-specific interventions are high
impact and central to ENAP, yet coverage information
is not collected through existing measurement platforms
with comparable data. Our findings highlight the prior-
ity actions required to improve ENAP indicators, espe-
cially coverage, and detail the technical and research
priorities that will enable countries to collect and use
the data in health sector review processes (Figure 1);
these findings are informing a roadmap to address mea-
surement deficits by 2020.
Measurement improvement roadmap
The ENAP measurement improvement roadmap aims to
build on existing national and global metrics work, par-
ticularly linking to maternal health metrics, whilst iden-
tifying and addressing key measurement gaps for the
focus around care at birth and care of small and sick
newborns (Figure 7). Through this process the measure-
ment improvement roadmap aims to intentionally trans-
fer data collection, management and analysis skills at a
country level (Figure 8).
Impact indicators
Impact indicators are fundamental to tracking progress
for Every Newborn. Without impact data we cannot accu-
rately measure progress towards goals to end preventable
maternal and newborn deaths and stillbirths. Child mor-
tality data have seen the most significant improvement
progress over the last decade [69]. For example, the UN
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Inter-agency Group for Child Mortality Estimation report
more than tripling input data, mostly through surveys.
ENAP milestones by 2020 include a number of tools to
link facility-based minimum perinatal datasets with CRVS
to increase birth/death registration [70] and birthweight
capture, and in settings with a high proportion of home
births, links to intermittent surveys or population surveil-
lance may also be possible (Figure 1). Some countries are
now implementing maternal death surveillance and
response [71] and have begun to count maternal deaths in
real time. A few countries are also incorporating perinatal
death audits, which represents a key opportunity to
expand use and quality of perinatal audit data [72]. A
major focus is needed for inclusion of stillbirth rates in
reporting and accountability mechanisms, and especially
increasing data on intrapartum stillbirths. Further oppor-
tunities have been identified in increasing the coverage
and quality of CRVS and verbal autopsy to improve cause
of death estimates for maternal, neonatal and stillbirths
[73,74]. Substantial work is required on the additional
indicators measuring newborn morbidity, disability and
child development, which are critical to validate and insti-
tutionalise particularly as countries scale up neonatal
intensive care services (Figure 7).
Improving measurement of gestational age is essential
given that prematurity is the leading cause of newborn
deaths and deaths in children under five [75]. Preterm
birth is also a major risk factor for deaths from infections
and other morbidities [76]. Gestational age is an essential
part of clinical targeting of interventions to reduce morbid-
ity and mortality and can be measured both during preg-
nancy (using methods ranging from the dating of LMP to
using more resource intensive ultrasound scans) to clinical
assessments of the newborn. The skill sets needed for the
measurement approaches that are currently available are
different. Estimating gestational age using first trimester
ultrasound and the date of last menstrual period is stan-
dard in most HIC, but these methods are not available for
most women in LMIC. LMP recall is often poor or inaccu-
rate in settings with low literacy. Universal access to ultra-
sonography is unlikely to be available to large numbers of
women in LMIC in the shorter term, and/or mothers who
present late in pregnancy, when ultrasound dating is inac-
curate (+/- 3 weeks). Current work is looking at the poten-
tial for simplified tools for more accurate assessment of
gestational age [77], including simplified clinical tools, and
surrogate anthropometric measures that could be used by
community health workers [78-80]. Validation of new
methods in cohorts with early accurate ultrasonography
dating is a critical need. Feasible and innovative approaches
need to be validated in different regions, populations and
settings, across which their performance may vary.
Figure 7 Measurement improvement roadmap for coverage indicators (including care of small and sick newborns). DHS: Demographic
and Health Survey, HFA: Health Facility Assessment, HMIS: Health Management Information System, MICS: Multiple Indicator Cluster Survey, PPV:
positive predictive value, WHO: World Health Organization.
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Coverage indicators
The next five years demands an ambitious and systematic
process for data improvement (through effective partner-
ship) to address the gaps in newborn coverage indicators.
Shared goals across the MNH community will facilitate
metrics testing and help institutionalise capacity for sys-
tems to collect and use these data (Figure 1). In the short
term, desk-based testing and validation of indicator
Figure 8 Every Newborn Action Plan (ENAP) Measurement Improvement Roadmap. ENAP: Every Newborn Action Plan; HMIS: Health
Management Information System; WHO: World Health Organization.
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definitions using existing datasets (from LMIC) is
required. Additionally, these indicators need to be field-
tested in a range of settings. The research process for
validation of indicators involves collecting empirical data
through direct observations of care in a facility and
directly comparing this data with both health worker
reports and maternal recall of events. Relatively large
numbers of direct observations may be needed to ensure
sufficient sample power for estimating sensitivity and
specificity of the indicators using appropriate statistical
tests. Initial testing sites have been identified as part of
the measurement improvement roadmap (Figure 8).
Once finalised, testing protocols will be made available to
facilitate wide-scale testing across many different settings
to yield comparable results. Where indicator definitions
already exist and are being collected at scale, there is
potential to increase the quantity, quality and frequency
of the data (Figure 4). Crosscutting work on increasing
the availability, quality, and accuracy of birth weight and
gestational age assessment (both in pregnancy and the
neonatal period) is needed and will support the develop-
ment of more precise indicators. It is anticipated that
findings from these studies will inform refinements to
the proposed indicators before institutionalisation into
existing systems (Figure 7).
Household surveys for tracking coverage
Household surveys remain the primary data collection
method to estimate coverage of contacts with the health
system. The Population Council is carrying out ongoing
work to assess the validity of current indicators measur-
ing skilled attendance at birth [81]. Such work provides
invaluable evidence on the validity of maternal recall of
interventions at the time of birth, with MICS using two
year recall and DHS now using the last birth within two
years for some maternal and newborn indicators
(although collects data for a five year retrospective per-
iod). Even where recall achieves higher specificity (such
as location of birth or Caesarean-section), their infre-
quent cycles (currently averaging 5 years) and high cost
[82]) make population level surveys less sensitive for
annual programme planning and timely decision-making
[83]. Previous efforts to improve measurement of many
interventions have focused predominantly on household
surveys [12,26,84], including recent validation studies
from the Improving Coverage Measurement Group.
Many of the challenges of measuring the treatment of
pneumonia in children through household surveys, espe-
cially in identifying the true population of children with
pneumonia for the denominator [58], are also applicable
to measuring coverage of treatment of neonatal infec-
tions and other specific treatment interventions.
The sample size required to generate point estimates
of coverage of newborn interventions with sufficient
precision through household surveys is often too high;
even more so when attempting to consider equity, and
analyse by socioeconomic and demographic factors. For
chlorhexidine cord cleansing in settings where policy is
provision for all live births [25], data collection through
a household survey such as DHS could be feasible.
Other treatment indicators address subsets of newborns,
and therefore, sample sizes and recall issues may make
household surveys very challenging for coverage mea-
surement. For measurement of treatment indicators, the
results of the ENAP metrics process suggest a shift away
from household surveys towards a focus on facility
based data collection tools where these interventions
can be more feasibly and accurately measured, and a
range of denominators tested for use (Figure 9).
Facility data for tracking coverage
For most of the treatment interventions, KMC, ACS, and
currently most neonatal resuscitation and serious neona-
tal infection case management, policy recommendations
are focused largely on facility-based initiation or adminis-
tration. This has meant that preliminary task team work
has focused predominately on facility platforms (with the
exception of Chlorhexidine). Combined testing in a num-
ber of facilities of the range of treatment interventions
would enable more efficient testing of a range of numera-
tors and denominators for each intervention using the
same datasets, and help to harmonise and align indicators
with national and facility-level needs.
Where there is no denominator
Task teams found denominators the most technically
challenging issue for measurement of intervention indi-
cators and have identified a list of denominator options
for testing wherever possible. Where detailed datasets
are available with complete and accurate birthweight
and gestational age data (for example in higher or mid-
dle income settings), these will be analysed to test and
compare the simplified per 100 or per 1000 live births
denominator to a more precise indicator option to
ascertain correlation between risk and the more precise
indicator, and sensitivity to change over time.
In view of contextual variation, such as varying pre-
term birth rates, or pSBI in different countries, there
may be a need to define thresholds or upper and lower
limits for indicator values. The proportion of C-section
deliveries, for example, has been roughly benchmarked
against a threshold of 5-15% in order to highlight where
there is an unmet need (less than 5%) or to identify an
excess number of C-sections (more than 15%) within a
population [85-87]; this threshold is not without contro-
versy. Learning from such processes is important to set
realistic, useful ranges for countries to monitor whether
interventions are reaching a sufficient number of new-
borns within safe limits.
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Health management information systems
Work towards sustainable, real-time, locally owned and
used systems underlines the need for strengthening
national HMIS [83]. HMIS refers to health information
collected and routinely reported from health facilities
and districts (often from government or public sector
facilities only) and are an ideal platform to influence as
they are present in most settings, relatively inexpensive
(compared with large scale representative household
surveys) and largely driven by national decision makers.
Electronic platforms are evolving to support data collec-
tion, management, analysis and report generation, link-
ing to other systems including logistics management
(rather than external agencies). The emphasis for
strengthening HMIS needs to fall on improving the
validity of HMIS indicators and increasing the use of
this data for improving programme performance at the
ground level. Many settings are now using District
Health Information Systems 2 (DHIS 2)[88]. DHIS 2
software has a field-tested flexible data model with data
entry forms for indicators and the ability to support
data collection, management and analysis, including
generating reports to monitor indicator trends over time
and produce maps to visualise subnational variations for
identification of inequities. There is potential for new-
born treatment indicators (particularly KMC, ACS) to
be included in HMIS/ LMIS, SPAs and other facility
audits along with the supplies and equipment for ACS,
neonatal resuscitation and pSBI treatment in settings
where they do not already exist.
Before recommending inclusion of indicators into any
national data collection system, indicators will need test-
ing for validity and then for feasibility and usefulness, as
per the steps of the measurement improvement plan
(see Figure 1 and 7). Given the ongoing tension between
demand for more information for decision making, ver-
sus the need to be parsimonious with the number of
indicators to avoid overburdening frontline workers and
information systems, prioritisation of the ENAP treat-
ment indicators for inclusion in these systems should be
country specific and consider relevance to national pol-
icy and health system needs. Overloading an HMIS sys-
tem with data can limit its usefulness and negatively
affect data quality. In addition to validity testing, consid-
eration of national data needs, existing levels of facility,
infrastructure, resources and technical capacity is essen-
tial before introducing new indicators into a national
HMIS. Furthermore, data from HMIS may be more lim-
ited in settings where a large proportion of births take
place in the community (e.g. Ethiopia), or where there is
a large private sector (e.g. India).
Input and process data for tracking content and quality
of care
Given the challenges in measuring coverage for several of
the treatment interventions, appropriate process indica-
tors were identified that can be measured immediately.
For the purpose of this discussion, “process” data refers
to any measurement of the presence of specific elements
needed to deliver an intervention, such as supportive pol-
icy, trained staff, commodities, documentation or infra-
structure. Process data are not a replacement for
coverage data, but ensure a standardised proxy can be
used immediately. These data can be measured through a
variety of platforms, including HMIS, routine audits and/
or facility based supervision checklists. Additionally, peri-
odic or intermittent health facility assessments, such as
SPA [17] and service readiness assessments, such as
SARA [16] and EmOC needs assessments [15] monitor
process indicators. As many of the indicators (impact and
Figure 9 Large scale data collection platforms for coverage and process indicators. ✓ Already collected. * Feasible to collect. X=Not likely
to be feasible to collect (due to recall of numerator, denominator identification challenges, sample size issues). DHS: Demographic and Health
Surveys, MICS: Multiple Indicator Cluster Surveys, HMIS: health management information systems, SPA: Service performance assessments, SARA:
Service Availability and Readiness Assessments, EmOC: Emergency Obstetric Care.
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coverage) measured through household surveys require
relatively long periods of time to see significant change fol-
lowing policy adjustments, facility level programmatic data
is essential for measurement of more proximate factors in
the facility that are more amenable to change in the
shorter term. Furthermore, facility surveys can provide
external validation for self-reported data, such as those
emerging from HMIS. Harmonisation of core modules for
HFAs should include the priority ENAP process indicators
to maximise their use and allow for comparison between
surveys (Figure 9). However, the use of periodic health
facility assessments is expensive and does not replace rou-
tine supervision or programme monitoring.
Some task teams proposed indicators regarding exis-
tence of supporting policy at national level as a key mea-
sure of process. For example, the task teams for both
ACS and CHX proposed a measure of the number of
countries with ACS or CHX respectively on the essential
drug list since their addition is recent (2013) [37]; data
are collected in the RMNCH Trust data system and
reported in Countdown (Figures 5 and 6). Given that
these interventions are at an earlier point in policy to
programme change, these may be useful trackers for now
but as programme implementation accelerates, the pro-
cess indicator should be shifted to more proximal readi-
ness indicators and coverage.
The ENAP measurement improvement roadmap, in
partnership with other tracking data harmonisation
efforts, aims to test both simple and composite readiness
indicators for newborn interventions, considering the
presence of essential commodities, trained staff, and
space.
Care of small and sick babies
There is a major gap in the definition of standards for the
care of small and sick newborns; the provision of quality
inpatient care for small and sick babies could have a signif-
icant impact on neonatal deaths [9]. The UN EmOC indi-
cators are based on process indicators referred to as
“signal functions” for basic and comprehensive emergency
obstetric care [18]; currently only one signal function spe-
cifically relates to newborn care, but does not fully repre-
sent all interventions needed for emergency newborn care.
New research supports the addition of signal functions
specific to newborn care and strongly recommends that
these indicators should be updated [89]. Specific chal-
lenges and details on the levels of care are explained in
greater detail elsewhere in the series [90] and ENAP
recommends an ongoing process with the UN to define
indicators for newborn care intervention packages by
levels of care.
As a milestone from ENAP linked to EPMM, addres-
sing quality of care at birth is critical; the Every Mother,
Every Newborn (EMEN) Initiative is part of this process
as discussed in paper 1 of this supplement [91].
Challenges and opportunities going forward
Integrating maternal health and broader roadmaps for
improving metrics
It is essential to unite maternal and neonatal health
communities towards a common metrics agenda with a
convergence of global efforts to end preventable mortal-
ity and coordinated support to countries to assess pro-
gress meeting targets set within the SDGs, ENAP and
the ending preventable maternal mortality movement
(EPMM). These functions are the remit of the WHO,
other UN agencies and academic partners, and can be
aligned through the creation of an over-arching MNH
reference group. This remit will also aim to link existing
work and relevant convening groups, including those
working on wider metrics systems change.
Intentional development of leadership to assess, improve
and use data
In order to institutionalise the proposed metrics, there is
a need to build leadership skills to assess and use data in
high burden settings (Figure 8). These include INDEPTH
Network’s Maternal and Newborn Working Group,
which aims to improve population-based metrics, espe-
cially pregnancy tracking, mortality, cause of death and
social autopsy, birthweight and gestational age.
INDEPTH is a network of currently 52 health and demo-
graphic surveillance sites (HDSS) in twenty countries
where a total population of 3.8 million people are tracked
each year. The Maternal and Newborn Working Group
is building the capacity of member sites to use standar-
dised tools and to make data regularly available to the
public. The All India Institute of Medical Sciences/WHO
Collaborating Centre for Newborn Care is well placed to
develop a simplified database for follow up of at risk neo-
nates, track and minimise disability outcomes and maxi-
mise child development, especially preterm, for example
preventing blindness from retinopathy of prematurity
[92,93]. ENAP is identifying provisional country hubs for
testing of proposed indicator numerators and denomina-
tors initially linked to focus countries for EMEN.
Conclusions
Major gaps have been identified in the measurement of
core ENAP indicators to track the progress towards tar-
gets to end preventable deaths for women, stillbirths,
newborns and children; key messages and action points
are summarised in Figure 10. The quality and quantity of
impact data must be improved, but coverage indicators
need the most urgent work. Content and quality of care
is the current priority for the three contact point indica-
tors. For the treatment indicators, preliminary work to
identify measurable denominators is required in prepara-
tion for the quality improvement agenda. The findings of
this work underline the need for increasing prioritisation
for strengthening and improving routine facility based
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data, CRVS and national HMIS. This paper has laid out a
systematic, yet ambitious testing agenda - the ENAP
Measurement Improvement Roadmap - to move towards
use of these indicators at scale, which must be combined
with an intentional transfer of technical leadership, espe-
cially to countries with the greatest disease burden. The
strengthening of institutional capability to collect, analyse
and convert data into action is essential. By 2020, the aim
is to institutionalise the proposed metrics at scale across
all countries. A roadmap that focuses on counting births,
deaths and improves tracking of coverage and equity is
central to support countries to build a strong national
Figure 10 Key messages and action points. ENAP: Every Newborn Action Plan; HMIS: health management information systems.
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data system that can be used to inform policy and focus
investment and resources towards quality service delivery
for every newborn to have the chance of a healthy start
in life [6].
Additional material
Additional file 1: Listing of relevant indicators according to level of the
impact framework (from impact down to inputs).
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Abstract
Background: Preterm birth is the leading cause of child death worldwide. Small and sick newborns require timely,
high-quality inpatient care to survive. This includes provision of warmth, feeding support, safe oxygen therapy and
effective phototherapy with prevention and treatment of infections. Inpatient care for newborns requires dedicated
ward space, staffed by health workers with specialist training and skills. Many of the estimated 2.8 million
newborns that die every year do not have access to such specialised care.
Methods: The bottleneck analysis tool was applied in 12 countries in Africa and Asia as part of the Every Newborn
Action Plan process. Country workshops involved technical experts to complete the survey tool, which is designed
to synthesise and grade health system “bottlenecks” (or factors that hinder the scale up) of maternal-newborn
intervention packages. For this paper, we used quantitative and qualitative methods to analyse the bottleneck data,
and combined these with literature review, to present priority bottlenecks and actions relevant to different health
system building blocks for inpatient care of small and sick newborns.
Results: Inpatient care of small and sick newborns is an intervention package highlighted by all country workshop
participants as having critical health system challenges. Health system building blocks with the highest graded
(significant or major) bottlenecks were health workforce (10 out of 12 countries) and health financing (10 out of 12
countries), followed by community ownership and partnership (9 out of 12 countries). Priority actions based on
solution themes for these bottlenecks are discussed.
Conclusions: Whilst major bottlenecks to the scale-up of quality inpatient newborn care are present, effective
solutions exist. For all countries included, there is a critical need for a neonatal nursing cadre. Small and sick
newborns require increased, sustained funding with specific insurance schemes to cover inpatient care and avoid
catastrophic out-of-pocket payments. Core competencies, by level of care, should be defined for monitoring of
newborn inpatient care, as with emergency obstetric care. Rather than fatalism that small and sick newborns will
die, community interventions need to create demand for accessible, high-quality, family-centred inpatient care,
including kangaroo mother care, so that every newborn can survive and thrive.
Background
Severely sick newborns, including those with infections,
severe intrapartum insults, severe jaundice or those who
are too small to maintain their body temperature or to
breathe or to feed actively, will require inpatient care to
survive. This paper forms part of a series on high quality
maternal and newborn care and examines bottlenecks
and solutions specific to the provision of newborn inpa-
tient care for small and sick babies.
The first 28 days of life is a vulnerable time for new-
borns, with an estimated 2.8 million babies dying during
the first month of life worldwide in 2013 [1]. The main
causes of death include direct complications of prema-
turity (36%), intrapartum events (previously called birth
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asphyxia) (23%), and infections (23%) [2,3]. Nearly three-
quarters of all neonatal deaths occur in the first week of
life [3]. The highest risk of death or serious morbidity
occurs among the 10 million born at term with low
birth weight (<2500 g) [4] and the 15 million born pre-
term (before 37 completed weeks of gestation) each year
[5]. Many lives could be saved, and morbidity prevented,
through a combined health systems approach [6] along
the continuum of care, with identification of those at
high risk and timely provision of quality inpatient and
supportive care [7]. Strengthening of existing facility-
based systems for the care of vulnerable newborns is the
most effective approach for saving newborn lives [8] and
is central to achieving the goals of the Every Newborn
Action Plan (ENAP) [9].
Inpatient care is usually delivered across three levels
(Figure 1) and refers to the facility-based care of new-
borns focused on both treatment and prevention of
infection and further complications. Prevention includes
protection from hypothermia (ensuring warmth) and
hospital acquired infection, as well as the provision of
adequate nutrition (often with nasogastric or cup feed-
ing), with the overall goal of establishing exclusive
breastfeeding where possible. Treatment, where avail-
able, centres on the management of common neonatal
conditions including respiratory distress syndrome
(RDS), neonatal infections, hyperbilirubinaemia, feeding
difficulties [7] and the prevention and treatment of reti-
nopathy of prematurity (ROP) [10]. Advanced treatment
for other important conditions, such as necrotising enter-
ocololitis (NEC), patent ductus arteriosis (PDA), correct-
able congenital anomalies and broncho-pulmonary
dysplasia (BPD) may also be undertaken. Basic newborn
care (providing cleanliness, warmth and support for
breastfeeding) is essential for all babies, including timely
resuscitation for up to 10% of babies that may require
resuscitation at birth [11] and is covered elsewhere in
this series [12]. Inpatient care for small or sick babies
includes two cornerstone components: Kangaroo Mother
Care (KMC) and sepsis case management, which are also
considered elsewhere in this series [13,14]. While in a
well-functioning health system all three levels of care will
be available (Figure 1), many small babies can be mana-
ged without provision of any higher level neonatal inten-
sive care and can be looked after in special care units [7].
Currently, however, over three quarters of babies born in
Sub-Saharan Africa and Southern Asia cannot access
special care if they were to require it (Figure 2).
High quality inpatient care for sick neonates includes
careful monitoring by trained health professionals with a
sound understanding of the physiological and psychoso-
cial needs of the small or sick newborn baby and their
families. A recent DELPHI exercise estimated that opti-
mal supportive care in a hospital Special Care Baby Unit
(SCBU) could avert 70% of neonatal deaths due to pre-
term birth complications, and that 90% could be averted
with availability of hospital Neonatal Intensive Care
Units (NICUs) [6]. Whilst coverage of these inpatient
care packages are near universal in high-income settings,
both the coverage and the quality of care available in
middle-and low-income settings are highly variable [15].
The provision of high quality nursing and inpatient
medical care of small and sick newborns not only saves
lives, but could also help to facilitate more rapid dis-
charges from health facilities, leading to better short and
long-term morbidity outcomes for these babies, includ-
ing reduction of BPD and ROP. This need is reflected
by the current burden of long term disability in survi-
vors following preterm birth being greatest in middle
income countries, particularly where coverage of inpati-
ent neonatal care has expanded without due attention to
the quality of care provided [10].
Inadequate care in facilities can be caused by a num-
ber of constraints usually related to health worker
shortages and poorly equipped facilities, compounded by
a lack of specific knowledge and competencies in deal-
ing with small and sick newborns amongst existing clini-
cians and nursing staff [9,16]. Facility-based neonatal
care frequently remains under-prioritised and under-
funded in many parts of the world, particularly in low
and middle income countries (LMIC). Few standardised
indicators exist to measure quality of newborn care in
facilities and challenges remain to improve the metrics
and core competencies [17]. Inadequacies in supplies
and safe use of medicines and equipment (including
effective phototherapy and case management for sick
neonates) are common problems despite the fact that
evidence-based interventions exist that can be delivered
in resource-constrained environments [18].
The vision of providing quality care to sick newborns is
part of a wider global movement - the United Nations
(UN) Secretary General Global Strategy in 2010 [19]
called for innovative approaches to provide quality care
for mothers and newborns, using coordinated research
and the formulation of accountability mechanisms
through the Commission on Information and Account-
ability for Women’s and Children’s Health (COIA). Pub-
lished in 2014, The Lancet Every Newborn Series (http://
www.thelancet.com/series/everynewborn) demonstrated
the progress that has been made, even in challenged set-
tings, and outlined the urgent steps still needed to
improve newborn survival. The Lancet papers proposed a
package of integrated quality interventions [16,20] - the
Every Mother, Every Newborn (EMEN) initiative - that
have been outlined in the Every Newborn Action Plan
(ENAP) alongside specific actions and ambitious targets
for newborn survival [9]. This paper aims to interrogate
country-level data on “bottlenecks” to quality care and to
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draw out innovative solutions, in order to aid the formu-
lation of country led health plans and strengthen the
capacity of health systems to respond to the needs of
small and sick newborns.
Objectives of this paper are to:
1. Use a 12-country analysis to explore health system
bottlenecks affecting the scale up of inpatient sup-
portive care for small and sick newborns
2. Present the solutions to overcome the most signif-
icant bottlenecks including learning from the
12-country analyses, literature review and pro-
gramme experience
3. To discuss policy and programmatic implications
and propose priority actions for programme scale
up.
Methods
This study used quantitative and qualitative research
methods to collect information, assess health system
bottlenecks and identify solutions to scale up of mater-
nal and newborn care interventions in 12 countries:
Figure 1 Inpatient care of small and sick babies, showing health system requirements by level of care. Red text signifies tracer indicator
for bottleneck tool analysis. *See Vesel et al (2015) Kangaroo mother care, Enweronu-Laryea et al (2015) Basic newborn care and resuscitation,
and Simen-Kapeu et al (2015) neonatal sepsis. Neonatal intensive care image source: Getty images/Save the Children. Special care for small and
sick newborns image source: Ian Hurley/Save the Children. Basic care for all newborns image source: Jonathan Hyams/Save the Children.
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Afghanistan, Cameroon, Democratic Republic of Congo
(DRC), Kenya, Malawi, Nigeria, Uganda, Bangladesh,
India, Nepal, Pakistan and Vietnam.
Data collection
The maternal-newborn bottleneck analysis tool (addi-
tional file 1) was developed to assist countries in the
identification of bottlenecks to the scale up and provi-
sion of nine maternal and newborn health interventions
across the seven health system building blocks as
described previously [16,20]. The tool was utilised dur-
ing a series of national consultations supported by the
global Every Newborn Steering Group between July 1st
and December 31st, 2013. The workshops for each coun-
try included participants from national ministries of
health, UN agencies, the private sector, non-governmen-
tal organisations (NGOs), professional bodies, academia,
bilateral agencies and other stakeholders. For each
workshop, a facilitator oriented on the tool coordinated
the process and guided groups to reach consensus on
the specific bottlenecks for each health system building
block. This paper, seventh in the series, focuses on the
provision of inpatient care of small and sick newborns.
Tracer interventions were defined for each package to
focus the workshop discussion. For the purpose of this
bottleneck analysis, three interventions required for the
treatment of common neonatal conditions were
included as tracer items for the package of inpatient
care: safe oxygen administration, intragastric tube feed-
ing (IGTF) and the provision of intravenous (IV) fluids
(Figure 3). Oxygen therapy is a mainstay treatment for
small and sick babies, with respiratory compromise
commonly seen in RDS (following preterm birth, neona-
tal pneumonia and neonatal sepsis) and respiratory
failure being an important mechanism in most neonatal
deaths [3]. Developmental immaturity of the preterm
newborn (especially those born before 34 weeks gesta-
tion), or severe illness in a more mature neonate, may
limit their ability to coordinate sucking and swallowing
required for successful exclusive breastfeeding. In these
instances, intragastric feeding is a commonly used low-
tech intervention to deliver nutrition, using expressed
breast milk where possible. In addition, many of the
most small and sick newborns will require administra-
tion of IV fluids to prevent dehydration as a result of
insensible water loss, and to manage the delicate fluid,
electrolyte and glucose balance, especially in the first
days after birth [21,22].
Safe implementation and monitoring of these inter-
ventions can be challenging, especially in low-resource
settings. The list of tracers is not exhaustive and other
important interventions, notably, effective phototherapy
for the treatment of hyperbilirubinaemia (Figure S2,
additional file 2), basic newborn care and resuscitation
[12], KMC [13] and management of neonatal sepsis [14]
are covered by other sections of the bottleneck analysis
tool.
Data analysis methods
Data received from each country were analysed and the
graded health system building blocks were converted
into heat maps (Figures 4 and 5). Bottlenecks for each
health system building block were graded using one of
the following options: not a bottleneck (=1), minor bot-
tleneck (=2), significant bottleneck (=3), or very major
bottleneck (=4) (Figure 5). We first present the number
of countries from which workshops participants cate-
gorised health system bottlenecks as significant or very
Figure 2 Estimated coverage of neonatal care by region of the world and level of care. *By Special Care Baby Unit, this is the highest
level of care available (i.e. no Neonatal Intensive Care). Data source: Adapted from Beyond Newborn Survival: The Global Burden of Disease due
to Neonatal Morbidity. Estimates of neonatal morbidities and disabilities at regional and global levels for 2010: introduction, methods overview,
and relevant findings from the Global Burden of Disease study. Pediatric Research; December 2013, Volume 74, (Supplement 1).
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major, by mortality contexts (Neonatal Mortality Rate
(NMR) <30 deaths per 1000 live births and NMR ≥30
deaths per 1000 live births) and region (countries in
Africa and countries in Asia) (Figure 4). We then devel-
oped a second heat map showing the specific grading of
health system bottlenecks for each country (Figure 5).
Context specific solutions to overcome challenges to
scaling up inpatient care identified in all countries were
categorised into thematic areas and then linked to the
specific bottlenecks in the results section (Table 1/
Table S1, additional file 2). We undertook a literature
review to identify further case studies and evidence-
based solutions for each defined thematic area (Addi-
tional file 2). For more detailed analysis of the steps
taken to analyse the intervention specific bottlenecks,
please refer to the overview paper [20].
Results
Our analysis identified bottlenecks across seven health
system building blocks relating to the inpatient suppor-
tive care of small and sick newborns. Twelve countries
submitted their responses to the inpatient care of small
and sick newborns bottleneck tool. Afghanistan, Camer-
oon, Democratic Republic of Congo (DRC), Kenya,
Malawi, Nigeria, Uganda, Bangladesh, Nepal and
Vietnam returned national level responses. Pakistan pro-
vided subnational data from all provinces, Gilgit-Baltisan,
Azad Jammu and Kashmir, excluding two tribal terri-
tories. India returned subnational data from three states:
Andhra Pradesh, Odisha and Rajasthan.
DRC did not provide a grade for health service deliv-
ery and community ownership and partnership; and
Malawi did not provide a grade for health information
systems. In these cases the country was removed from
the sample for the quantitative grading of that building
block, but included for all other building blocks; their
examples of described bottlenecks were still included in
the analysis and presented in the results. Afghanistan
listed their bottlenecks and completed rating for all
building blocks, but did not propose any solutions.
The solution themes are summarised by health system
building block in Table 1 (with more details in additional
file 2). Care of small and sick newborns is a newborn
intervention area highlighted by all country workshop
Figure 3 Definitions of tracer indicators for inpatient care of small and sick newborn bottleneck analysis tool. For more details see the
complete bottleneck analysis in the additional file 2.
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participants as a major challenge to health systems, espe-
cially when considered in comparison with other inter-
vention areas studied in the workshop. Grading
according to the number of countries that reported very
major or significant health system bottlenecks for inpati-
ent supportive care for small and sick newborns is shown
in Figure 4. Overall, the health systems building blocks
with the most frequently reported very major or signifi-
cant bottlenecks were health financing (10 out of 12
countries), health workforce (10 out of 12 countries), fol-
lowed by community participation (9 out of 11 coun-
tries), suggesting these may be priority areas within
which to tackle barriers to the scale up of inpatient care
for small and sick newborns. As expected, building blocks
were rated more poorly in countries with higher NMR.
African countries reported a higher number of major and
significant bottlenecks, but Afghanistan had the highest
level of very major bottlenecks and Malawi had the low-
est graded bottlenecks, as shown in Figure 5.
Leadership and governance bottlenecks and
solutions
The first building block, leadership and governance, was
considered to have very major or significant bottlenecks
across 5 of the African countries, and 3 of the Asian
countries (Figure 4). Countries in both regions com-
monly identified a lack of national level advocates
(including policy makers, key individuals within profes-
sional bodies, academics and national institutions) for
advancement of quality care for newborns. At the
governance level, country workshop participants high-
lighted lack of supportive policies for care of small and
sick babies. Specifically, workshop participants noted
that their existing policies were not inclusive of the key
supportive and organisational policies for newborn care,
such as well-defined, rational referral systems, discharge
criteria and standardised levels of care at the district
and peripheral level. Policy documents in circulation
amongst senior officials were not always disseminated to
the managers at lower levels of the health service and
did not always incorporate guidelines with important
components of special care for newborns, such as sup-
portive policies, guidelines for breastfeeding and family
centred care (Table 1/ Table S1, additional file 2).
Solutions proposed by country teams centred on the
need for targeted advocacy and political will. They
focused on improving the organisational and supportive
structures for sick newborns at the policy and governance
level and building local champions. Country workshop
teams proposed reviewing the existing organisational
policies and guidelines at a central level and ensuring
these were disseminated to all levels of the health system
(Table 1/ Table S2, additional file 2).
Health financing bottlenecks and solutions
Health Financing bottlenecks were frequently graded as
needing significant work for inpatient care of newborns -
10 out of all 12 country teams (Figure 4) graded it as very
major or significant, with only Malawi and India perceiv-
ing there to be only minor bottlenecks (Figure 5).
Figure 4 Very major or significant health system bottlenecks for inpatient care of small and sick newborns. NMR: Neonatal Mortality
Rate. *Cameroon, Kenya, Malawi, Uganda, Bangladesh, Nepal, Vietnam. **Democratic Republic of Congo, Nigeria, Afghanistan, India, Pakistan. See
additional file 2 for more details.
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Revenue collection for newborn health, and competing
calls for financing of other areas of healthcare, was clearly
viewed as a barrier, and insufficient earmarked funds at
the facility was impeding their ability to provide quality
care to sick newborns. Participants specifically described
a lack of designated funding for laboratory support and
to purchase supplies such as blood components, antibio-
tics and other equipment for newborns, such as oxygen
cylinders. The most frequently described health financing
challenges pertain to prohibitive user-fees and insurance
policies that do not cover inpatient care of newborns
showing that families are frequently put at risk of severe
financial hardship in the event of a baby being born small
or sick (Table 1/ Table S1, additional file 2).
Country workshop participants proposed solutions
including the need to increase amount of earmarked
funding available for sick newborns and the need to
mobilise and advocate for increased funding at the
health system level. Participants also proposed more
innovative funding mechanisms in order to remove the
prohibitive user fees placed on care of sick newborns,
either through more comprehensive health insurance,
community-based finance or mutual health schemes
(Table 1/ Table S2, additional file 2).
Health workforce bottlenecks and solutions
Almost all countries identified the lack of trained person-
nel in neonatal care in quantity and quality (knowledge,
training, skills) and 10 out of 12 graded these bottlenecks
as significant (Figure 4), with Afghanistan grading their
bottlenecks as very major (Figure 5). Poor supervision
and the need for specialist and refresher training in
Figure 5 Individual country grading of health system bottlenecks for inpatient care of small and sick newborns. Part A: Heat map
showing individual country grading of health system bottlenecks for inpatient care of small and sick newborns. Part B: Table showing total
number of countries grading significant or major for calculating priority building blocks. DRC: Democratic Republic of the Congo.
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neonatal skills were overarching challenges. Countries
described difficulties recruiting specialist staff to work in
remote areas and staffing disparities between urban and
rural areas; 8 countries specified that problems in the
health workforce stemmed from the lack of competency-
based training and refresher training for the health work-
force managing small babies, especially at the lower levels
of the health system. Regarding task shifting, some coun-
tries noted that often only physicians are authorised to
carry out tasks that could be performed by lower level
health workers, such as prescribing oxygen or antibiotics.
Other countries indicated that job descriptions were not
clear in roles and responsibilities for those providing care
to sick newborns, which is particularly relevant for neo-
natal nurses. Country workshop participants underlined
that the motivation for neonatal nurses and other
professionals to provide high quality care to sick babies
was low (Table 1/ Table S1, additional file 2) and that
incentives and remuneration were insufficient, leading to
poor health worker attitudes, ineffective communication
and poor compliance with infection control procedures.
Participants recognised that to remove health work-
force bottlenecks, detailed health worker mapping of
those caring for sick newborns was needed to identify
the resources available and where tasks could be rapidly
shifted to make more rational use of the existing work-
force. Workshop participants also proposed improving
working conditions, motivation and skills through more
structured pre-service and in-service training and more
appropriate remuneration for neonatal skills, including
rewarding those prepared to work in rural areas
(Table 1/ Table S2, additional file 2).
Table 1. Summary of solution themes and proposed actions for inpatient care for small and sick newborns
Health system building
blocks
Solution Themes Proposed actions
Leadership and
Governance
Advocacy and political will
Improve organisation structures
Review and disseminate guidelines
• Active involvement of national advocates (professional bodies, academic, policy
makers) for care of sick newborns
• Increase number of special care units and spaces in facilities for newborns
• Develop national policies and guidelines for referral systems, organisational
standards for sick newborn care
Health Financing Budget allocation
Innovative funding and removal of
user fees
• Increase and sustain funding for sick newborns, earmark funds within facilities
caring for newborns
• Expand existing maternal health schemes (end-user incentives, insurance
schemes, voucher schemes) to cover inpatient care of newborns
• Long term vision and health systems approach towards universal coverage for
healthcare
Health Workforce Recruitment and Retention
Competency based training
Task shifting
• Develop neonatal nursing cadre with agreed standards and benchmarks
• Strategies to incentivise neonatal health workers
• Develop job descriptions, appropriate remuneration and career development
pathways for health workers caring for newborns
• Scale up of simplified, skilled based training programmes on infection
prevention, feeding, provision of warmth and family centred care for newborns





Logistic system strengthening and
forecasting
• Update and implement the essential medical list to include oxygen
• Inclusion of neonatal equipment and drugs in logistics systems
• Strengthen oxygen systems at national and local level
Health Service Delivery Increase service delivery and
rationalise service distribution
Quality improvement and assurance
Improve working conditions
• Special care baby units (or dedicated area) in every district hospital
• Decentralisation of inpatient neonatal care, stable babies cared for in KMC units
• Develop and harmonise quality assurance tools and carry out quality assessment
of neonatal units
• Provide supportive supervision and mentoring
• Improve remuneration and incentives (see also, health workforce), working
hours, food provision and facilities to stay
Health Information
System
Strengthening and integration of
HMIS
Development of indicator definitions,
reporting systems, tools and
Scale up audits and registers
• Integrate newborn indicators into national health information systems
• Define and harmonise newborn indicators, especially care of sick newborns
• Regular mortality audits in all special care and neonatal intensive care units.
Community Ownership
and Participation
Accessibility of information and
community awareness
Improve care seeking and linkages
Male involvement
• Sensitisation on importance of newborn inpatient care and entitlements to care
• Use of community volunteers, local champions and leaders
• Develop local transportation solutions for families, improve patient experience in
facilities and develop family-centred guidelines
• Male role models in the community, inclusive policies and frameworks in
facilities
• Education on maternal and newborn health targeted at men
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Essential medical products and technologies
bottlenecks and solutions
The provision of essential medical projects and technol-
ogies was graded as having very major bottlenecks by a
third of all country workshop participants (Figure 4).
The Essential Medicine List (EML) was a commonly
described bottleneck; participants noted that the EML
lacked the commodities required for special care of
newborns, such as oxygen and IV fluids and was not
implemented at the national level. Many participants
described general stock-outs of neonatal equipment,
especially cannulas and drugs (specifically antibiotics)
and lack of availability of specialist equipment, such as
continuous positive airway pressure (CPAP) and porta-
ble radiographs. Participants reported that weak and
inaccurate information systems underpinned this pro-
blem, limiting the ability of facilities to forecast the
demand for oxygen, fluids and the maintenance supplies
needed for provision of quality inpatient supportive care
(Table 1/ Table S1, additional file 2).
Solutions to the essential medical products and tech-
nology bottlenecks started with a need to update the
EML to reflect the essential commodities needed for
sick newborns (oxygen, antibiotic and IV fluids).
Following this, workshop participants recognised a
need for improving and building logistics management
capacity to support the health system to manage
inventories and prevent stock-outs (Table 1/ Table S2,
additional file 2).
Health service delivery bottlenecks and solutions
Service delivery was described as a challenge in all the
countries with higher mortality contexts (Figure 4).
Workshop participants described the limited number of
facilities available to provide any type of services or
inpatient care for sick or low birth weight babies, parti-
cularly at lower levels of the system. Poor enabling
environments, undersized and outdated buildings, and
lack of resource capacity for both delivery of care and
provision of family-centred supportive care for babies in
the public sector were commonly described. Five coun-
tries highlighted the limited space in health facilities for
the special care of sick newborns. This included poten-
tial space for mothers to stay with their baby or lack of
nurseries or side rooms for sick babies. Other country
workshop teams described quality improvement as a
major challenge due to inadequate monitoring or lack of
quality improvement tools, poor mentoring and supervi-
sion, and poor implementation of clinical guidance and
cot-side care plans for all staff caring for newborns
(Table 1/ Table S1, additional file 2).
Country workshop participants recognised that the
number of facilities or, at least, dedicated spaces for sick
newborns needed to be increased and that service
delivery needed to be rationalised. In alignment with the
health workforce bottlenecks, teams suggested that qual-
ity assurance tools, quality improvement strategies
(including care protocols), and improved mentorship
and supervision for those delivering care to newborns
could help to improve service delivery (Table 1/ Table S2,
additional file 2).
Health information system bottlenecks and
solutions
The lack of health information and standardised, well-
defined indicators to measure interventions for sick
newborns is a central issue being tackled within the
ENAP [9]. Most participants from higher mortality con-
texts graded it as a significant or very major bottleneck
to the provision of quality care in facilities (Figure 5).
Specific barriers to quality improvement in facilities
included the absence of effective mortality audits in
facilities, lack of both coverage and process indicators
and registers on sick newborns with the existing data
were not well managed. In other settings, participants
recognised the need for strengthening and integration of
newborn facility-based care indicators into their national
HMIS (Table 1/ Table S1, additional file 2).
Country workshop participants stated a need for clear
definitions for indicators and harmonising these indica-
tors such that national Health Management Information
Systems (HMIS) can be strengthened and include select
indicators for sick newborns. This would require
improved measurement tools, reporting systems and use
of appropriate software. Participants highlighted a need
for capacity building within health information to sup-
port the appropriate disaggregation, dissemination and
reporting of sick newborn data. Teams also suggested
scaling up regular mortality audits for neonatal units
(Table 1/ Table S2 and S3, additional file 2).
Community ownership and partnership
bottlenecks and solutions
The community ownership and partnership building
block was graded as having significant or very major
bottlenecks in three-quarters of countries (Figure 4).
Malawi was the only country for which workshop parti-
cipants graded this building block as having no bottle-
necks (Figure 5). Workshop participants specified a wide
ranges of issues largely related to a lack of general infor-
mation and awareness in communities about sick babies.
Limited knowledge of the treatment processes and the
severity of newborn illness, including poor awareness of
the civil rights of babies born sick or low birth weight
to access care, were highlighted. There were a number
of access related problems reported, including poor
referral and transport systems and inability to access
facilities either due to cost or availability. For mothers
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in the community, participants described the lack of
female decision-making power, loss of wages due to car-
ing for a sick newborn and lack of privacy in facilities
(Table 1). Lack of involvement of men was mentioned
by six countries partially related to poor awareness and
engagement of the wider community on issues related
to sick newborns (Table 1/ Table S3, additional file 2).
Solutions for community ownership were wide-ran-
ging, but were themed around improving the accessibil-
ity of information for carers and the services for small
and sick newborns. Participants suggested a need for
greater community awareness of the needs for sick and
small newborns in order to improve demand, compli-
ance and patient experience; specifically, encouraging
male involvement and increased participation of the
community in processes to improve family centred care
in facilities (through development of materials, tapping
into community groups and developing mutual health
type schemes) (Table 1/ Table S2, additional file 2).
Discussion
This paper has presented an analysis and synthesis of
bottlenecks and solutions for one of six key intervention
packages to reduce neonatal mortality worldwide
reviewed in this series of papers; inpatient care for small
and sick newborns. Previous analysis of the bottleneck
data showed that amongst all intervention packages
explored, inpatient care has some of the highest graded
bottlenecks hindering scale-up [16], with very major or
significant bottlenecks being reported across all health
systems building blocks. Whilst inpatient care for the
small and sick newborn forms part of the overall care
along the continuum from pre-pregnancy to childhood,
these findings are timely and this issue is new on the
global agenda. Complications from preterm birth are
now the leading cause of death in children under five
[1]. Previous experience from high income settings has
shown that initial provision of low-tech supportive inpa-
tient care and case management, followed by full high-
tech neonatal intensive care, has played an important
role in reducing overall neonatal mortality [23]; there-
fore, in order to further reduce the burden of death due
to prematurity, strategies to provide comprehensive,
high quality inpatient care for small and sick newborns
must be developed.
The methodology used in the bottleneck analyses
employed a unique consultative and participatory
approach to bring together a wide range of partners and
players in newborn health. Rather than the top down
approach employed by many research initiatives, this
data collection and analysis methodology focused on eli-
citing information from ground-level field implementa-
tion, as perceived by stakeholders and experts in 12
countries with the highest burden of neonatal mortality.
This has helped the data to capture context specific
challenges and has enabled participants to share their
experiences and work together to identify innovative
solutions. The grading process encouraged the work-
shop participants to reach consensus on the perceived
challenges and generate a quantitative measure of the
perceived bottlenecks to delivering care to this vulner-
able sub-population. Rather than reporting on systema-
tic reviews or results from randomised trials, this paper
aims to facilitate programmatic learning through the
South-to-South exchange. This paper has brought
together a wide range of programmatic experience and
technical expertise in neonatal care from across the
globe to inform programme managers and policy
makers in multiple settings facing a range of health sys-
tem challenges in delivering high quality, facility-based
care to small and sick newborns.
Health systems seek to ensure that individuals in need
of care receive high quality health services without the
risk of financial catastrophe. This analysis identified
three priority health systems building blocks with sub-
stantial barriers to implementation of facility-based care
for small and sick newborns: health workforce and
health financing followed by community ownership and
partnership. Solution themes, including examples from
literature review and programme learning, are discussed
in detail below.
Health workforce priority actions
A worldwide nursing shortage exists in both high and
low resource settings [24,25]. For small and sick new-
borns this is not simply a shortage of qualified indivi-
duals; there is a critical human resource gap for a
neonatal nursing cadre, with almost no neonatal nursing
training programmes outside of high income countries
(Figure 6). Neonatal nurses are the backbone of new-
born inpatient care, as both providers of frontline care
to the newborns and their families, but also through
extended roles such as the advanced neonatal nurse
practitioners (ANNPs) [26,27]. To improve neonatal
outcomes, particularly in those countries which account
for the highest newborn death and morbidity rates,
nurses need to be recruited and offered specialised
training in how to care for small and sick newborns,
and be provided with ongoing resources to enable them
to give consistent high quality care. There are other fac-
tors at institutional and country level including inade-
quate allocation of resources for a health workforce,
inadequate workforce planning, poor retention strate-
gies, ineffective use of existing nursing staff, and poor
working conditions [16,28].
Skills-based/competency based training
Almost all countries in the workshop highlighted the
lack of skills-based training programmes for health
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workers caring for small and sick babies. Qualitative
work on the barriers to nurse education for those caring
for sick newborns has found that educational pro-
grammes focusing on neonatal skills are often inconsis-
tent, poorly structured, or may require long, off-site
training courses making them inaccessible for large
numbers of lower level hospitals or SCBUs [29]. Survive
and Thrive is a private and public partnership with the
American Academy of Pediatrics and has developed
educational programmes focused on newborns. Essential
Care of the Small Baby (ECSB) [30] is to be released in
early 2015 and addresses skills such as nasogastric feed-
ing and prevention of infection and skin-to-skin care
through a cooperative learning approach. Learning
Figure 6 Neonatal nursing as part of national human resource planning. ANNP: Advanced Neonatal Nurse Practitioner.
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techniques used by ECSB are skills-based and focused
on small group work, using simulation methodology and
role-play to practice technical and communication skills.
Knowledge is tested through multiple-choice questions
and Observed Structured Clinical Evaluations (OSCEs).
Such pre-service and in-service training programmes are
available and could be scaled-up within health worker
training, even in lower resourced settings, as they do
not rely on electricity supplies (being flip-chart based)
and make use of low-cost simulation models. Well-
designed programmes focused on neonatal clinical skills
have been shown to be effective and improve health
provider knowledge and practice [31], but will require
supervision systems and regular refresher training to
sustain and update skills [32].
Task shifting
The World Health Organization (WHO)’s recommenda-
tions on optimising the roles of health workers aim to
address critical health workforce shortages that slow
progress towards the health-related Millennium Devel-
opment Goals [33]. A more rational distribution of tasks
and responsibilities among cadres of health workers can
significantly improve both access and cost-effectiveness
- for example, by training and enabling ‘mid-level’ and
‘lay’ health workers to perform specific interventions
otherwise provided only by cadres with longer (and
sometimes more specialised) training. These recommen-
dations are intended for health policy-makers, managers
and other stakeholders at a regional, national and inter-
national level. WHO hopes that countries will adapt and
implement them to meet local needs. The recommenda-
tions were developed through a formal, structured pro-
cess including a thorough review of available evidence.
Specific examples that have been taken up include nur-
sing auxiliaries or health care assistants supporting and
maintaining KMC [33]. In Malawi, ward attendants have
been involved in supporting KMC [34] and health sur-
veillance assistants have been trained to promote facil-
ity-based care for sick newborns [35]. ECSB training
incorporates task shifting to mothers, when appropriate,
for basic skills such as nasogastric feeding and providing
basic care to a small baby looked after in a facility [30].
Recruitment and retention
Once health workers have the skills needed to care for
small and sick babies, recruitment and retention strategies
are needed to supervise and motivate, which is especially
important for rural and hard to reach postings. Innovative
recruitment and retention strategies have been implemen-
ted with success in some settings. Thailand has historically
used a bonding system to improve recruitment of health
workers for rural areas. Newly qualified health profes-
sionals, including doctors and cadres of nurses are
required to spend a mandatory time period in rural post-
ings. On completion, professional qualifications can be
upgraded. Evidence suggests this has led to a substantial
increase in the numbers of trained professionals in rural
areas and is partially responsible for the impressive health
gains in Thailand in the last 25 years [36,37].
In addition to task shifting there are other immediate,
interim strategies that can be put in place. These could
include improving conditions for the workforce through
incentives [38] (financial, educational or other), relieving
staff of other duties, improving daily working conditions
(break areas, food vouchers, accommodation on-site or
nearby) [39] and improving job satisfaction through
structured supervision and mentoring efforts [32]. Non-
rotation of staff out of neonatal care is an important
strategy to prevent neonatal staff being shifted annually
within the hospital from department to department or
into other specialties (Figure 6).
Health financing priority actions
Budget allocation
Whilst the health financing issues faced by many low-
income countries are due to the lack of financial
resources for health and development overall, and are
not unique to the newborn [40], those newborns requir-
ing inpatient care are at greater risk due to their need for
specialised facility-based care. Newborns are relatively
neglected in official development assistance [41] and spe-
cialised, intensive care is often perceived as prohibitively
expensive. A strong economic case, including the relative
burden of newborn mortality globally, and the argument
for prevention of long-term morbidities, is required to
advocate for the earmarking of funds specifically for
developing and sustaining high quality inpatient newborn
care. The issue of health financing is explored in greater
detail in paper 1 of this series [20].
Innovative funding and removal of user fees
The birth of a small or a sick baby can be financially
catastrophic for families. Shifting from a reliance on
out-of-pocket payment to prepayment and risk pooling
is a critical part of the health financing transition that
most countries go through as they get richer [42]. Lim-
ited risk pooling means that insurance and depth of cov-
erage is a common problem for families. Removal of
user fees in the public sector is a first step, but has asso-
ciated risks and challenges and must be replaced by
alternative health financing mechanisms that could
include: social health insurance, community based
health insurance and government supply side financing
[43]. The success of these schemes is dependent on the
context within the countries where they are implemen-
ted. Rwanda’s community financing scheme is backed by
compulsory government payments into the scheme and
stringent pooling of donor funds [44]. Provision of cov-
erage for inpatient newborn care within insurance
schemes or voucher and incentive systems is a neglected
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area, with often only delivery and basic newborn care
being covered. Attention to successful schemes that
already exist in countries could partially ameliorate the
risk of financing catastrophe for families when a baby is
born small or sick, rather than introducing new schemes
for sick newborns that may further fragment health
financing systems. Sick newborn care is frequently not
covered by maternity packages or maternal health finan-
cing schemes (e.g. Nepal vouchers scheme), yet has
potentially large expenses associated with it. Schemes
using prospective case-based systems for inpatient care -
as in Kyrgyzstan [36] could be adapted to give higher
priority to newborn inpatient and special care. Further
implementation research is needed for innovative fund-
ing mechanisms to identify factors that may facilitate
their success and provide recommendations for their
implementation in different settings.
Community ownership and partnership priority actions
Whilst reported bottlenecks to high quality inpatient
newborn care are similar across regions, individual com-
munities differ in their geographical and socio-cultural
structures and available resources. Enabling maximum
effect through tailor-made solutions for a given commu-
nity will require empowering solutions from a grassroots
level.
Community awareness
Lack of demand for quality newborn inpatient care may
reflect the fatalistic assumption that all small and sick
babies will die [27]. Across settings, country teams high-
lighted the lack of awareness in communities about sick
newborns, the treatment processes and their civil rights
to access health services. Most country teams reported a
lack of awareness of the severity of newborn illness and
knowledge that timely, high quality care can save new-
born lives. In some contexts, such as India, there are spe-
cific care-seeking barriers for newborn girls. The
workshops participants’ perceptions strongly suggest
there is a lack of strategic, targeted health education on
newborn health across settings and that sensitisation and
local community education efforts are needed to reduce
fatalism and increase care-seeking and demand. Mobili-
sation of communities using women’s community groups
has been shown to have a positive effect on a range of
maternal and newborn health outcomes, including the
potential to reduce neonatal mortality in a number of set-
tings [45-47]. There is a clear role for community volun-
teers, local role models and community leaders to raise
awareness on issues surrounding newborn health and the
care of sick newborns.
Improve care seeking and transport linkages
Qualitative study of the local barriers and solutions for
care-seeking in child health in Kenya, Nigeria and Niger
highlighted important factors on perceived awareness
and the subsequent demand for care [48]. Lack of trust
in health services, perceptions that treatment is ineffec-
tive and experience of poor quality of care were per-
ceived as important in reducing demand for care.
Health services that are out-of-stock, negative experi-
ences with health workers, or poor communication
between staff and families, especially mothers, may be
detrimental to the care of the newborn. Facilities may
need to focus on community strategies to improve the
patient experience in facilities, especially for mothers. It
is critical for the mother to spend time with the sick
newborn wherever possible, therefore, local hospital pol-
icy guidelines that encourage family-centred care and
take into account the local and cultural family structure
are vital for mothers to be able to participate in the care
of their newborns. Local transport systems are needed
to facilitate access between the community and facility,
especially when newborns are in the facility for long
periods of time. Within the facility, task shifting to
mothers, in addition to the necessary support for breast-
feeding and expressing milk, can play an important part
in empowering mothers and securing the linkages
between the family and inpatient care [49,50].
Male involvement
Half of the countries in the workshop specifically
reported that there was a lack of male involvement in
the care of sick newborns. Individual, family, commu-
nity, societal and policy factors are previously identified
barriers to male involvement during pregnancy and
birth [51]. Qualitative research suggests men often
lament their lack of involvement or understanding of
maternal and newborn health issues [48] - an area that
is often seen as dominated exclusively by females.
Empirical research confirms that for pregnancies that
are wanted and where men are more educated, men are
more likely to be involved in maternity related care [52].
The care of sick newborns is no different and tackling
barriers to male involvement is an issue that spans the
care continuum from family planning to the care of a
sick newborn in a facility. Men often control family
finances or have a stronger influence on decision-mak-
ing. Women may be removed from their usual schedules
when their newborn is sick, leading to potential for
neglecting other commitments (whether work or house-
hold related) and, therefore, may need additional sup-
port. Use of male role models in the community may
help to facilitate this transition away from maternal and
newborn health being viewed as an exclusively female
domain. Using lessons learned from Prevention of
Mother To Child Transmission (PMTCT) research [53],
interventions to increase male involvement in newborn
care include addressing hospital policies and staff atti-
tudes in facilities to allow for culturally sensitive, inclu-
sive policies for men and families, such as special
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visiting hours and supporting fathers to participate in
KMC [13].
Other priority actions
As highlighted in the analysis, very major or significant
bottlenecks were reported across all building blocks.
Solution themes for three of these building blocks have
been discussed in detail above and more details on the
country-specific bottlenecks for each health system
building block are available in the additional file 2. A
few other bottlenecks described were especially relevant
to inpatient care. For example, India and Pakistan
stressed the shortfall in supply of oxygen due to demand
and supply gaps. Improving oxygen systems within
health facilities is key to enable widespread availability
when required. Oxygen cylinders are still commonly
used in many facilities in low and middle-income set-
tings, however they are expensive, require filling up reg-
ularly and are difficult to transport. Where power
supplies are reliable, oxygen concentrators can provide a
consistent and inexpensive source of oxygen. In view of
the emerging epidemic of ROP [10], the use of oxygen
in any setting should be carefully monitored using pulse
oximetry and safe delivery mechanisms to ensure opti-
mum and safe saturation levels [54,55], as described in
Figure 3. The safe and systematic use of oxygen, as with
all drugs, needs to involve training and supervision of
nurses, doctors, technicians and administrators [56] and
appropriate documentation is needed. Commonly pre-
scribed antibiotics for small and sick newborns, such as
gentamicin, which has potentially adverse effects related
to dosage and interval [57] need particular attention to
safety, especially where therapeutic drug monitoring is
not possible [58]. A number of country teams high-
lighted newborn inpatient care health information bot-
tlenecks. A recent assessment of facility-based neonatal
care in Kenya highlighted how poor data were poten-
tially undermining the quality of practice [59], especially
affecting the assessment of gestational age and symp-
toms of severe illness. At a national level, efforts are
needed to strengthen the HMIS and to develop basic
indicator definitions for monitoring inpatient care with
core competencies and standards for small and sick
newborns by levels of care [17]. At the facility level,
there is a clear need for improved documentation, regis-
tration and incorporating the use of regular mortality
audits [60].
Limitations
The data generated from the workshop came from the
subjective and consensus views of participating national
stakeholders, including government representatives and
experts. The quality and amount of information extracted
from these workshops varied depending on the level of
knowledge of participants about health system issues and
facilitation. In addition, bottlenecks were reported as per-
ceived bottlenecks relative to the other health system
building blocks under exploration. There may be
instances where known health system challenges or defi-
cits based on robust quantitative data may be in conflict
with the perceived bottleneck grading. This may be due
to the method of grading relative to other health system
building blocks, or that participants place higher subjec-
tive value on other areas of their health system. An addi-
tional explanation is that groups’ may view certain
building block areas as easier challenges to overcome
based on their knowledge of their setting and expertise in
the specific newborn intervention being discussed. The
tool is comprehensive and detailed, which is one of its
strengths. However, it also may have caused some
workshop fatigue, particularly towards the end of the
workshop where teams discussed and recorded solutions.
For example, for the inpatient care questionnaires,
Afghanistan completed the bottleneck portion of the
questionnaires, but did not submit any solutions. The
analysis focused only on three tracer items: safe oxygen,
IGTF and the provision of IV fluids. Other specific com-
ponents of inpatient neonatal care may have different
bottlenecks and solutions, for example, identification of
and effective phototherapy for neonatal hyperbilirubinae-
mia [61] (Figure S2, additional file 2).
Future agenda
Improving inpatient newborn care will require a health
systems approach and some countries are recognising
this need. For example, the securing of political, profes-
sional and financial commitment in India has led to
substantial increases in provision of quality inpatient
newborn care (Figure 7). Previously, particularly in low-
income settings, much investment has occurred in deli-
vering public health and community-based interventions
to improve newborn outcomes. This has led to impor-
tant gains in outcomes, especially in settings with the
highest neonatal mortality rates. However, as seen his-
torically in high income countries, to reduce neonatal
mortality further, attention is first required on improved
supportive case management (which for the smallest
and sickest newborns will require inpatient care) and
then should be followed by the introduction and scale-
up of neonatal intensive care [62].
Specific areas for action have been highlighted above,
with many of these bottlenecks being critical to address
to enable provision of quality inpatient newborn care
(Figure 8). Interdisciplinary linkages and a focus on bet-
ter quality data will help identify areas for improvement
so that teams delivering care to small and sick newborns
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Figure 7 India’s health systems approach to improving inpatient care for small and sick newborns. *Janani Suraksha Yojna (JSY): a
conditional cash transfer to promote institutional delivery); **Janani Shishu Suraksha Karyakram (JSSK): reducing out of pocket expenses by
making free health care an entitlement; ***Rashtriya Bal Suraksha Karyakram (RBSK): looks at developmental delays and disabilities, birth defects
and deficiencies, covering age group of 0-18 years of age. Other abbreviations: AIIMS: All India Institute of Medical Science; ASHA: Accredited
Social Health Activist; CPAP: Continuous Positive Airway Pressure; India Newborn Action Plan (INAP); NMR: Neonatal Mortality Rate; NBSU:
Newborn Stabilisation Units; ROP: Retinopathy of Prematurity; SNCU: Special Newborn Care Unit; UNICEF: United Nations International Children’s
Emergency Fund; WHO: World Health Organization.
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can plan and implement changes. Ongoing data moni-
toring helps the team recognise their improvement and
identify specific areas to focus on in the future, so that
the exercise is an ongoing cycle. The EMEN package
[16] will be crucial to this process.
Conclusions
Whilst major bottlenecks to the scale-up of quality inpa-
tient newborn care are present, in many cases, effective
solutions exist. Currently, there is a large grass roots
commitment to improving care around the time of birth
to end preventable maternal and newborn deaths and
stillbirths, and to improve healthy outcomes as part of
the ENAP [9]. Improving availability and quality of inpa-
tient newborn care has been identified as an important
area to achieve the aims of this plan, providing potential
for political, professional and financial support to
develop and scale-up solutions to these bottlenecks. We
must build on this momentum, using knowledge of
what works to ensure action, so that every small and
sick newborn baby has access to timely, high quality and
family-centred inpatient care as required to survive and
thrive.
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Service readiness for inpatient care of 
small and sick newborns: what do we 
need and what can we measure now?
Background Each year an estimated 2.6 million newborns die, 
mainly from complications of prematurity, neonatal infections, and 
intrapartum events. Reducing these deaths requires high coverage 
of good quality care at birth, and inpatient care for small and sick 
newborns. In low- and middle-income countries, standardised 
measurement of the readiness of facilities to provide emergency ob-
stetric care has improved tracking of readiness to provide care at 
birth in recent years. However, the focus has been mainly on ob-
stetric care; service readiness for providing inpatient care of small 
and sick newborns is still not consistently measured or tracked.
Methods We reviewed existing international guidelines and re-
sources to create a matrix of the structural characteristics (infra-
structure, equipment, drugs, providers and guidelines) for service 
readiness to deliver a package of inpatient care interventions for 
small and sick newborns. To identify gaps in existing measurement 
systems, we reviewed three multi-country health facility survey 
tools (the Service Availability and Readiness Assessment, the Ser-
vice Provision Assessment and the Emergency Obstetric and New-
born Care Assessment) against our service readiness matrix.
Findings For service readiness to provide inpatient care for small 
and sick newborns, our matrix detailed over 600 structural char-
acteristics. Our review of the SPA, the SARA and the EmONC as-
sessment tools identified several measurement omissions to capture 
information on key intervention areas, such as thermoregulation, 
feeding and respiratory support, treatment of specific complications 
(seizures, jaundice), and screening and follow up services, as well 
as specialised staff and service infrastructure.
Conclusions Our review delineates the required inputs to ensure 
readiness to provide inpatient care for small and sick newborns. 
Based on these findings, we detail where questions need to be add-
ed to existing tools and describe how measurement systems can be 
adapted to reflect small and sick newborns interventions. Such 
work can inform investments in health systems to end preventable 
newborn death and disability as part of the Every Newborn Action 
Plan.
Electronic supplementary material: 
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The first 28 days of life, the newborn period, represents the time of highest risk in the human lifecycle. 
In 2016, an estimated 2.6 million newborns died [1], mainly of complications of prematurity (35%), in-
fections (23%), and intrapartum complications leading to birth injury (24%) [1,2]. Preventing deaths 
from these causes requires a combined health systems approach [3] along the continuum of care. This 
approach should deliver routine newborn care for all babies (cleanliness, thermal care and support for 
breastfeeding), newborn resuscitation and prevention of mother to child transmission of HIV (PMTCT) 
for all babies who need it [4,5]; and timely provision of quality inpatient care for babies born small and 
sick [6,7].
Many low birth weight newborns, especially preterm infants, and those born small for gestational age, 
require support to feed and maintain their temperature. In addition, preterm newborns face increased 
risks of respiratory problems, infections and jaundice [8]. Even amongst those born at full term, signifi-
cant numbers of newborns suffer from systemic infections, neonatal encephalopathy, pathological jaun-
dice and congenital abnormalities, with high mortality risk in the absence of care [8]. “Small and sick 
newborns”, therefore, includes all those babies who require inpatient (facility-based) care to survive. The 
care that small and sick newborns require is not an individual intervention, but a package made up of 
multiple interventions. Previous work has discussed the specific evidence-based interventions that com-
prise this package of care [3,8,9], which are displayed in Figure 1.
Figure 1. Evidence-based newborn care interventions from basic to complex care. There are additional evi-
dence-based interventions for newborns that should be included in the antenatal period – antenatal corticosteroids 
and antibiotics for preterm premature rupture of membranes – and follow-up processes that would fall outside of 
the newborn period and be linked to paediatric services. Figure adapted from [8]. Photo credit (from top to 
bottom) Ayesha Vellani/Save the Children, ©EFCNI, JHPIEGO.
Delivery of interventions to small and sick newborns requires health facilities that are prepared, which is 
termed as “service readiness”. The underpinning principle to service readiness is based on traditional 
quality of care frameworks, such as that conceived by Donabedian (Figure 2). The framework refers to 
the structures (the necessary infrastructure, equipment, drugs, health providers and guidelines); and pro-
cesses (actions performed by health professionals with requisite training and skills) that are needed to 
provide a package of care [8]. When all of the components of the structural domain are in place, it allows 
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To achieve service readiness, the structures not only need to be present, but maintained, re-stocked 
and updated (eg, equipment requires maintenance, supplies require re-stocking, guidelines require 
updating) and staff continually trained and supervised. To deliver a quality package of care, there-
fore, requires strong health systems with the capacity to monitor and track service readiness and re-
act appropriately to service needs.
Evidence from The Lancet Every Newborn Series [13] informed the design of the Every Newborn Ac-
tion Plan, a multi-partner initiative launched in 2014, backed by a World Health Assembly Resolu-
tion. Every Newborn aims to end preventable newborn deaths and stillbirths, with national targets of 
≤12 neonatal deaths per 1000 live births and ≤12 stillbirths per 1000 total births by 2030 [7]. To 
achieve these targets, Every Newborn partners acknowledge a need to improve the measurement of 
care at birth, and to better track coverage, quality, and equity of care for small and sick newborns 
around the time of birth [14]. A dedicated sub-group – Every Newborn metrics - focuses on improv-
ing the measurement of interventions [14], and has a work stream focused on service readiness for 
inpatient care of small and sick newborns [9].
Currently, national and facility-based health information systems in low- and middle-income coun-
tries collect few data on service readiness for small and sick newborns [13-15], in contrast with child 
health programmes, notably immunisation, HIV and malaria [16]. Data are sparse in sub-Saharan 
Africa and parts of Asia where access to care for small and sick newborns is the lowest, and where 
many facilities need targeted efforts to strengthen services [8,14].
Data from functional routine national health management information systems (HMIS) and logistics 
management systems (LMIS) are able, in principle, to capture service readiness in a sustainable way, 
but the content and quality of data in national HMIS are variable in practice. This means many low- 
and middle-income countries depend on periodic evaluations, such as nationally representative fa-
cility surveys or censuses, as a key source of health information to monitor the readiness of the health 
system to provide facility-based care [14,17,18]. These surveys or censuses are referred to as health 
facility assessments.
The most common health facility assessment tools are the Demographic and Health Survey Pro-
gramme’s Service Provision Assessment (SPA), the WHO Service Availability and Readiness Assess-
ment (SARA) [19,20], and the EmONC assessments, currently managed by Averting Maternal Death 
and Disability (AMDD) [21] in collaboration with UNFPA [22]. The content of these tools with re-
gards to service readiness specifically for inpatient care of small and sick newborns has not previous-
ly been systematically evaluated.
Our overall aim was to review the current health facility assessment tools’ ability to capture service 
readiness for inpatient care of small and sick newborns.
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The specific objectives of this article are to:
1.  Create a standardised matrix of the structural components (infrastructure, equipment, 
drugs, providers and guidelines) required to deliver inpatient care for small and sick new-
borns.
2.  Compare the components of this standardised matrix against what is currently measured 
by widely used multi-country health facility survey tools (SPA, SARA, EmONC assess-
ment) and identify gaps in measurement of the structural and process domains.
3.  Synthesise these findings to provide recommendations on how to improve measurement 
of service readiness for inpatient care of small and sick newborns.
METHODS
Conceptual framework for service readiness
We applied the Donabedian framework [10,11] as a construct to map service readiness for small and sick 
newborns (Figure 2).
For the first objective, we mapped the structural domain of the framework and identified the infrastruc-
ture, equipment, drugs, health providers and guidelines required to deliver inpatient care for small and 
sick newborns. The second domain in the framework (process) links structures and outcomes, and is 
dealt with in objective 2.
Objective 1: Create a standardised matrix of structural components 
Development of matrix of service readiness requirements for inpatient care of small and sick 
newborns
We listed a total of 17 newborn interventions based on work done previously as part of the Every New-
born metrics process [5,8,23] (Figure 1). All newborn interventions were included for this exercise, in-
cluding essential newborn care, based on the rationale that small and sick newborns will require these 
basic interventions in addition to inpatient care [8,9].
We organised the matrix by six areas: 1) labour and delivery room 2) place of care for small and sick new-
borns 3) pharmacy/medicines, 4) human resources/providers, 5) laboratory & blood bank and 6) referral 
service. We organised interventions by whether they occur in the labour and delivery room or the neo-
natal unit (or both). Human resources and pharmacy were allocated as a separate area given that provid-
ers and drugs will be needed in multiple places of care. Given that most of the guidelines reviewed in-
cluded information or guidance on referral systems and the associated structural components, we 
included referral system as a separate “area”. Finally, given the wide variation in laboratory systems, we 
separated the laboratory and blood bank by capacity to perform certain tests and actions, rather than an 
itemised list of components or equipment.
We searched for existing published guidelines for all the newborn interventions, including relevant new-
born and paediatric guidelines available on the WHO website. Where no WHO guideline existed, we 
consulted relevant resources developed by UNICEF and other partners, including resources from inter-
national professional associations, such as the American Academy of Paediatrics and Royal College of 
Paediatrics and Child Health. To ensure consistency with other areas of care, we also reviewed the inter-
agency list of medical devices for essential interventions for reproductive, maternal, newborn, and child 
health [24], a master list created for newborn health in humanitarian settings by the Inter-Agency Work-
ing Group on Reproductive Health in Crises (IWAG), UNICEF and Save the Children [25] and the latest 
version of the WHO model essential drugs list [26]. See Table 1 for a list of the guidelines and resources 
used for this review.
Within each area of the matrix, where equipment items recurred (eg, components required for more than 
one intervention such as linen, gauze, swabs, weighing scale) we included these under general items for 
either the labour and delivery room or place of care for small and sick newborns. We were then able to 
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Objective 2: Compare the components of this standardised matrix against 
widely used multi-country health facility survey tools (SPA, SARA, EmONC 
assessment) and identify gaps in measurement of structural and process 
domains
We obtained the latest versions of the SARA (version 2.2, revision July 2015) [20] and the SPA (revised 
2012) [27] from their websites. The EmONC assessment tool was being revised at the time of the study 
and we obtained the version undergoing field-testing from AMDD in July 2016.
We reviewed the SARA core questionnaire tool, the SPA health facility inventory and health worker in-
terview, and the latest versions of the relevant modules from the EmONC assessment, (Module 1: Iden-
tification of facility and infrastructure; Module 2: Human Resources; Module 3: Essential drugs, equip-
ment and supplies; Module 5: EmONC interventions; and Module 7: Provider knowledge and 
competency for maternal & newborn care).
We compared the content of each of the tools to the structural components in our matrix. To identify 
gaps in structural components we checked:
•  Does the tool measure the infrastructure, equipment, drugs, health providers and/or 
guidelines needed to provide the interventions?
Many of the tools are designed to also measure aspects of the process domain in the service readiness 
framework (Figure 2). Therefore, measurement of regular practice or training was considered as a proxy 
measurement of the process domain for service readiness (as it looks at what is regularly done to patients 
Table 1. Resource materials and guidelines reviewed for newborn interventions
InterventIon resource materIal or guIdelIne Year publIshed
Essential newborn care, 
thermal protection, early 
initiation and support for 
exclusive breastfeeding
WHO essential newborn care course 2010
WHO early essential newborn care: Clinical practice pocket guide 2014
Essential care for every baby 2015
WHO Integrated management of pregnancy and childbirth: Pregnancy, Childbirth, Postpartum and 
Newborn Care: A guide for essential practice
2015
UNICEF: Baby Friendly Hospital Initiative (BFHI) 2012
WHO Interagency list of priority medical devices for essential interventions for reproductive, maternal, 
newborn and child health
2015
Neonatal resuscitation
WHO guidelines on basic newborn resuscitation 2012
Helping Babies Breathe Resources 2017
WHO guidelines on managing complications in pregnancy and childbirth 2007
WHO guidelines on managing newborn problems: a guide for doctors, nurses and midwives 2003
Prevention of mother to child 
transmission of HIV
WHO guideline update on HIV and infant feeding 2016
WHO guidelines on antiretroviral drugs for treating pregnant women and preventing HIV infection 
in infants
2010
Médecins sans Frontières: Neonatal Care Guidelines 2016
Kangaroo mother care for 
premature babies, including 
follow up, alternative feeding 
(cup feeding and nasogastric 
feeding)
Essential care for small babies 2015
WHO kangaroo mother care: A practical guide 2003
WHO guidelines on optimal feeding of low birth-weight infants in low- and middle-income countries 2011
UNHCR operational guidelines on improving newborn health in refugee operations 2014
UNICEF toolkit for setting up special care newborn units, stabilisation units and newborn care corners 2015
WHO recommendations on interventions to improve preterm birth outcomes
Injectable antibiotics for 
neonatal infections, hypogly-




WHO pocket book of hospital care for children 2013
Save the Children, UNICEF: Newborn care charts 2009
Treatment and screening for 
retinopathy of prematurity*
Guidelines on screening and treatment for retinopathy of prematurity (UK and India) 2008
Blood transfusion, Mechanical 
ventilation and continuous 
positive airway pressure 
(CPAP)
WHO pocket book of hospital care for children 2013
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in the institution). For each of the 17 interventions included in the package of care (Figure 1), we also 
checked:
• Does the tool measure whether staff are given any training to provide the intervention?
• Does the tool measure if the intervention is regularly performed?
The first author (SM), conceptualised the matrix and completed the review of each tool. The matrix was 
then verified for completeness by practicing neonatologists and nurses with experience in neonatal care 
in Ghana, Nigeria and co-author practicing neonatal clinicians with experience in India, Malawi, Ugan-
da, United Kingdom and United States.
The review of the health facility assessment tools was verified by a representative of the lead agency for 
the EmONC assessment and the SPA to ensure the findings were consistent with the most recent versions 
of the tool.
RESULTS
Objective 1: Create a standardised matrix of structural components 
We mapped a total of 654 service readiness items for inpatient care of small and sick newborns to pro-
vide 17 interventions. This included a total 167 structural items in the labour and delivery room and 266 
in the place for small and sick newborn care (or neonatal unit). We listed a total of 33 different potential 
providers, 114 essential newborn drugs and medicines. A summary list of the international resource ma-
terials and guidelines available for care of small and sick newborns used for this objective is included in 
Table 1. The essential drug list is shown in Table 2. The complete matrix is available in the supplemen-
tary material (Table S1 in Online Supplementary Document).
Table 2. Example minimum drug list for inpatient care of small and sick newborns showing rationale for use in newborns and 
summary of the Service Provision Assessment (SPA), Service Availability and Readiness Assessment (SARA) and Emergency Obstetric 
and Newborn Care (EmONC) Assessment tools and Essential Medicines list*
drug name spa sara emonc eml drug descrIptIon/use
Antibiotics:
Amoxicillin (oral suspension) Y Y Y Y Penicillin antibacterial for neonatal infections
Amoxicillin (injection) Y Y Penicillin antibacterial for serious neonatal infections
Amikacin (IV or IM) Y
Aminoglycoside antibacterial; alternative treatment of opthalmia 
neonatorum
Ampicillin (IV or IM) Y Y Y Y Penicillin antibacterial for serious neonatal infections
Ampicillin (oral) Penicillin antibacterial for neonatal infections
Azithromycin (oral) Y Y Y Macrolide antibacterial for P-PROM (maternal use)
Benzathine benzylpenicillin (benzathine 
penicillin G) (IM)
Y Y Y Penicillin antibacterial for treatment of congenital syphilis
Benzylpenicillin (Penicillin G) (IV or IM) Y Y Y Penicillin antibacterial for serious neonatal infections
Cefalexin (oral suspension) Y
First generation cephalosporin used in newborns for skin and soft tissue 
infections
Cefotaxime (IV or IM) Y Y
First generation cephalosporin with broad spectrum for treatment of 
serious neonatal infections
Ceftriaxone (IV or IM) Y Y Y
Third generation cephalosporin for neonatal infections, genital gonococcal 
and/or chlamydial infection
Ciprofloxacin (injection) Y
Second generation fluoroquinolone antibacterial sometimes used as 
second line treatment
Ciprofloxacin (oral) Y Y Y
Second generation fluoroquinolone antibacterial for treatment of bacterial 
diarrhoea
Clindamycin (IV) Y Y
Lincosamide antibacterial, second line treatment (eg, streptococcal or soft 
tissue infections)
Co-amoxiclav (oral suspension) Y Penicillin antibacterial, can be used where no IV access
Co-amoxiclav (injection) Penicillin antibacterial used for neonatal skin infections
Cotrimoxazole (oral) Y Y Combined antibacterial for prophylactic treatment of HIV
Erythromycin (oral) Y Y Y Macrolide antibacterial for P-PROM (maternal use)
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drug name spa sara emonc eml drug descrIptIon/use
Flucloxacillin (oral) Y Y
Penicillin antibacterial. Can be used in newborns as follow on from 
intravenous flucloxacillin
Gentamicin (IM or IV) Y Y Y Y Aminoglycoside antibacterial used for treatment of neonatal sepsis
Isoniazid (oral) Y Y Y Antituberculous antibacterial used occasionally for congenital TB
Kanamycin Y Aminoglycoside antibacterial; alternative to gentamicin
Metronidazole (IV) Y Y Y Y
Antiprotozoal antibacterial used for neonatal meningitis and/or anaerobic 
bacterial infections
Metronidazole (oral) Y Y Y
Antiprotozoal antibacterial used for neonatal meningitis and/or anaerobic 
bacterial infections
Procaine benzylpenicillin (IM) Y Y Y Penicillin antibacterial used for congenital syphilis
Tetracycline 1% eye ointment Y Y Y Y
Prophylactic topical antibiotic used to prevent bacterial (eg, chlamydial, 
gonococcal) neonatal conjunctivitis
Anticonvulsants:
Diazepam (oral/NG) Y Sedative, anticonvulsant, muscle relaxant mostly used for neonatal tetanus
Diazepam emulsion (IV) Y Y Y Y Sedative, anticonvulsant, muscle relaxant, used for neonatal tetanus
Midazolam (oral solution) Y Sedative, anticonvulsant used for seizures
Paraldehyde (rectal) Anticonvulsant for seizures
Phenobarbital (IV or IM) Y Y Y First line anticonvulsant for tonic clonic and partial seizures
Phenobarbital (oral) Y Y First line anticonvulsant for tonic clonic and partial seizures
Phenytoin (IV) Y Y Anticonvulsant for tonic clonic and partial seizures
Emergency drugs:
Adrenaline/epinephrine (IV) Y Y Y Y
Sympathomimetic for cardiopulmonary arrest used for advanced neonatal 
resuscitation
Aminophylline Y Methylzanthine used to prevent apnoeic attacks in premature newborns
Atropine (injection) Y Y Y Parasympatholytic, antispasmodic used for intubation
Calcium gluconate (injection) Y Y Y Y Used for hypocalcaemic seizures and hyperkalaemia
Hydrocortisone (injection) Y Y Y
Steroidal anti-inflammatory used for hypotension or severe broncho-
pulmonary dysplasia
Magnesium sulphate (IV) Y Y Y Y
Inorganic salt compound, maternal use in preterm labour, protective 
against cerebral palsy
Naloxone (IV) Y Y Specific opioid antagonist for respiratory depression in newborns
Analgesics:
Ibuprofen (IV) Y
Analgesic sometimes used in newborns for closing patent ductus 
arteriosus
Morphine (IV) Y Y Y Centrally acting opioid analgesic for severe pain, sedation and intubation
Morphine (oral) Y Y Y Used for severe pain
Paracetamol (oral) Y Y Y Y Analgesic for minor pain
Paracetamol (suppository) Y Analgesic for minor pain
Paracetamol (injection)
Analgesic for minor pain. Also used for newborns for closing patent 
ductus arteriosus.
Corticosteroids:
Betamethasone (IM) Y Y Y
Not used in newborns; used in mothers with threatened preterm labour 
<34 weeks gestation for fetal lung maturation
Dexamethasone (IM) Y Y Y Y
Not used in newborns; used in mothers with threatened preterm labour 
<34 weeks gestation for fetal lung maturation
IV fluids:
Calcium gluconate 10% Y Y Y
Supplement used to treat calcium deficiency. Dependent on programme 
context – careful monitoring required
Dextrose 10% with normal saline Y Y Y Solution used for maintainance fluid therapy
Dextrose/glucose 5% Y Y Y Y Solution used as vehicle for administration of IV drugs
Dextrose/glucose 10% Y Y Y
Solution for treatment of hypoglycaemia and maintenance fluid therapy 
on first day of life for sick babies who cannot feed
Potassium chloride (KCl) 7.5%, 10%, 
15%
Y
Solution only to be used in contexts where monitoring of potassium levels 
is available.
Sodium bicarbonate Y Solution used to dissolve artesunate
Sodium chloride 0.9% Y Y Y Y
Solution used as a vehicle for administration of IV/parenteral drugs, fluid 
replacement and flushing IV lines
Ringer’s lactate Y Y Y Y
Compound solution for severe dehydration/hypovolaemia can be added to 
dextrose/glucose for a mix
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drug name spa sara emonc eml drug descrIptIon/use
Anti-malarials:
Artesunate (IV or IM) Y Y Y First line treatment for neonatal malaria
Artesunate (rectal) Y Y Y Neonatal malaria treatment if IV/IM access not available
Arthemeter (IM) Y Second line treatment for neonatal malaria
Artemisinin-based combined therapy 
(oral)
Y Y Y Y Second line anti-malarial treatment followed by ACT
Antiretrovirals (may vary depending on national HIV guidelines):
Azidothymidine/Zidovudine (AZT) (oral) Y Y Y Y Antiretroviral
Lamivudine Y Y Y Y Antiretroviral
Nevirapine (NVP) (oral) Y Y Y Y Antiretroviral
Other drugs:
Aciclovir (IV) Y Antiviral used for herpes
Acyclovir 3% topical eye ointment Y
Antiviral active against herpes virus used to prevent neonatal herpes 
keratitis in babies born to mother with genital herpes
Anti-Rho (D) immune globulin 
(injection) *
Y
To prevent Rhesus disease (haemolytic disease of the newborn), given to 
mothers
Caffeine citrate (oral) Y Preventive treatment for apnoea
Caffeine citrate (IV) Y Preventive treatment for apnoea, oral preferred over IV
Chlorhexidine digluconate 7.1% gel 
(delivering 4% chlorhexidine)
Y Y Y Topical treatment of omphalitis
Domperidone Anti-reflux drug for gastro-oesophageal reflux
Ethambutamol (oral) Y Y Y First line oral anti-tuberculolous drug
Ferrous fumerate (oral) Y Y Y Oral suspension used for preterm neonates to prevent iron deficiency
Folic acid Y Y Y Y Oral suspension used for folate supplementation
Fluconazole (IV) Y Antifungal drug used in newborns over 1 week
Fluconazole (oral) Y Y Y Y Antifungal drug
Furosemide (IV) Y Y Diuretic used for chronic lung disease, oedema in advanced settings
Furosemide (oral) Y Y Y Diuretic
Glycerin chip Suppository used in newborns to stimulate stooling
Hepatitis B immune globulin (HBIG) Treatment of Hepatitis B in neonates
Human milk fortifier
Fortifier, adds protein, calories and micronutrients to expressed breastmilk 
for LBW babies
Insecticxide treated bed nets (in malaria 
endemic areas)
Y Y Y For mother’s beds in KMC ward and for discharge home
Lidocaine solution Y Y Y Y Local anaesthetic
Miconazole cream (or equivalent eg, 
gentian violet)
Y Y Topical antifungal for candida dermatitis used for nappy area
Multivitamin Containing zinc, vitamin A etc.
Nystatin (oral solution) Y Y Y
Topical antifungal for oropharyngeal candidiasis used prophylactically 
with antibiotic treatment
Nystatin cream Y Topical antifungal
Omeprazole (IV) Y Y Acid blocker for gastro-oesophageal reflux
Omeprazole (oral) Y Y Acid blocker for gastro-oesophageal reflux
Oral rehydration solution Y Y Y Y
Powder to mix with drinking water for oral rehydration; breastmilk 
feeding should be encouraged
Oxygen supply Y Medical inhalation gas for treatment of respiratory distress
Phosphate and calcium supplements Supplementation
Potassium Chloride (1mmol/ml) (oral) Y Powder solution for maintainance oral potassium replacement
Pyridoxine (oral) Y Preventive therapy for tuberculosis
Pyrazinamide (oral) Y Y Y First line oral anti-tuberculolous drug
Ranitidine (IV) Y Antacid drug for gastro-oesophageal reflux
Ranitidine (oral) Y Antacid drug for gastro-oesophageal reflux
Rifampicin (oral) Y Y Y First line oral anti-tuberculolous drug
Sucrose 30% (oral)
Non-pharmacological pain management for minor procedures (eg, 
cannulation)
Tetanus immunoglobulin (HTIG) (IM) Y Y Anti-tetanus immunoglobulin for treatment of neonatal tetanus
Vitamin B6 (pyridoxine) (IV or IM) Vitamin for B6 deficiency
Vitamin D Supplementation.
Vitamin K1 (Phytomenadione) (IM or IV) Y Y
Vitamin and anti-haemorrhagic for prophylactic treatment of 
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Objective 2: Compare the components of this standardised matrix against widely 
used multi-country health facility survey tools (SPA, SARA, EmONC assessment) 
and identify gaps in measurement of structural and process domains
The SPA, the SARA and the EmONC assessment tools are summarised in Table 3. All three tools have 
different purposes, are measured at different intervals, and have different approaches to measurement and 
sampling.
drug name spa sara emonc eml drug descrIptIon/use
Water based lubricant For inserting suppositories and/or other procedures.
Zinc oxide cream Topical for nappy/diaper rash
Vaccines:
BCG vaccine Y Y Y Y Prevention of TB
Diptheria Y Y Y Prevention of diptheria
Pertussis vaccine Y Y Y Prevention of pertussis
Haemophilus influenzae type b (Hib) 
vaccine
Y Y Y Prevention of haemophilis influenzae type B
Hepatitis B vaccine Y Y Y
Prevention of hepatitis B in countries where perinatal infection is 
common, as per vaccination schedule
Oral poliomyelitis vaccine Y Y Y Y Prevention of poliomyelitis
Tetanus toxoid Y Y Y Y
Prevention of tetanus in wound management, prevention of maternal and 
neonatal tetanus in pregnant women
EmONC – Emergency Obstetric and Newborn Care, SPA – Service Provision Assessment, SARA – Service Availability and Readiness Assessment, EML 
– Essential Medicines List, IM – intramuscular, IV – intravenous, NG – nasogastric
*Y – measured by the tool.
Table 2. Continued
Table 3. Summary of three multi-country health facility assessment tools: Service Provision Assessment (SPA), Service Availability 
and Readiness Assessment and Emergency Obstetric and Newborn Care (EmONC) Assessment
servIce provIsIon assessments (spa) servIce avaIlabIlItY and readIness assessment (sara)
emergencY obstetrIc and newborn care (emonc) 
assessment
Purpose of tool
For comprehensive monitoring of a 
country’s formal health care system; 
monitors the overall availability of dif-
ferent facility-based health services in a 
country and their readiness to provide 
those services
For assessing readiness of facilities using a 
standard set of indicators that cover all 
main health programmes. Only designed to 
assess service readiness (not performance 
or client perspectives)
For monitoring and assessment of the avail-
ability, use and quality of routine and emergen-
cy obstetric and newborn care in the formal 
health system.
Organisation(s)
The Demographic and Health Survey 
(DHS) Program, United States Agency 
for International Development (USAID)
World Health Organization (WHO), US-
AID
Averting Maternal Death & Disability (AMDD), 
United Nations Population Fund (UNFPA), 
United Nations Children’s Fund (UNICEF), 
WHO.
Sample
Sample survey or census of formal sec-
tor health facilities designed to provide 
nationally representative results by fa-
cility type, managing authority, and 
geographic region.
Sample survey or census of at least 150 
public and private facilities
Census of hospitals and census or sample of 
lower-level delivery sites (public and private 
facilities). Sample may be random or selection 
may be restricted to lower-level facilities that 
meet a specific volume of deliveries.
Modules
Facility inventory, exit interviews (ante-
natal care, family planning, sick child), 
clinical observations (antenatal care, 
family planning, sick child), health 
worker provider interviews
Facility inventory, health worker interview Facility inventory, human resources, essential 
drugs, equipment and supplies, facility case 
summary, Emergency Obstetric Care (EmOC) 
signal functions, provider knowledge for mater-
nal and some newborn care & chart reviews.
Numerator for 
indicator
Number of facilities ready to provide 
MNCH, family planning, HIV/AIDS, 
STIs, Malaria, Tuberculosis, basic sur-
gery, non-communicable diseases ser-
vices.
Proportion of health facilities, number of 
core medical professionals, proportion of 
facilities offering a defined service and the 
density and distribution of the facilities
Number of facilities providing EmOC, number 
of facilities providing each EmOC signal func-
tions by level of care.
Denominator 
for indicator*
All formal facilities All facilities, per 10 000 population All surveyed facilities by level of care; availabil-
ity of EmOC is measured per 500 000 popula-
tion or 20 000 births*
Timeframe
15-18 months to complete fieldwork 
and report
Variable, but shorter than SPA or EmONC 12-18 months to complete field work and re-
port
Frequency 4-5 yearly intervals Designed to be repeated annually 4-5 yearly intervals
*Discussion is ongoing on whether denominator should measure births or population); expected number of births is the denominator for several oth-
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Table 4 and Table 5 summarise the mapping of the 
interventions showing the structures and processes 
currently measured by the SPA, the SARA and the 
EmONC survey tools, and highlighting gaps in mea-
surement of structural and process domains.
For ease of presentation, and to avoid repetition, we 
summarise the findings from the review in this sec-
tion by structural and process domains.
Comparison of the matrix against 
health facility assessment tools and 
identification of gaps in measurement 
of the structural domain
Infrastructure
All three tools measured elements of general health 
facility infrastructure, such as electricity supply, 
means of communication, referral and transport 
and availability of water, toilets/latrines and waste 
disposal.
All tools measure availability of a table or surface for 
performing resuscitation. However, infrastructural 
requirements to support essential newborn care both 
in the labour and delivery room and the postnatal 
ward, such as space, privacy (screens) for mother to 
express breastmilk and infrastructure for storage of 
breastmilk (and whether there is consistent power 
supply for refrigeration) were not measured by any 
of the tools. All tools collect details on infrastructure 
to provide PMTCT.
The SPA measured space for mothers to provide kan-
garoo mother care (KMC) in its facility inventory, but 
only the EmONC assessment asked about space al-
location for sick newborn care or a special care unit 
(eg, infrastructure to provide services beyond KMC, 
such as assisted feeding, thermal protection, fluids 
and/or oxygen support). As oxygen is a crosscutting 
infrastructural component needed for several inter-
ventions outside of newborn health, all tools measured availability of an oxygen source. However, none 
of the tools measured the newborn-specific infrastructure that would be needed for safe oxygen therapy. 
Continuity of electricity and oxygen is especially important for facilities offering care for small and sick 
newborns who may be dependent on consistent oxygen source and/or electric equipment. None of the 
tools measured service readiness infrastructure for screening services (for example, developmental mile-
stones, hearing and vision) or follow-up for high-risk infants.
Table 4. A summary of the Service Provision Assessment (SPA), Service 
Availability and Readiness Assessment (SARA) and Emergency 
Obstetric and Newborn Care (EmONC) assessment tools’ capacity to 
measure structural and process domains of service readiness for 
newborn interventions in the labour and delivery room
InterventIon and components of structural domaIn health facIlItY assessment tool
SPA SARA EmONC
Immediate/essential newborn care:
Infrastructure Y Y Y
Equipment & drugs Y Y Y
Guidelines Y Y
Training Y Y Y
Routine practice Y Y Y
Thermal protection:
Infrastructure Y Y Y
Equipment & drugs
Guidelines Y Y Y
Training Y
Routine practice Y Y
Immediate and exclusive breastfeeding:
Infrastructure
Equipment & drugs Y
Guidelines Y Y
Training Y Y Y
Routine practice Y Y Y
Resuscitation with bag and mask:
Infrastructure Y Y Y
Equipment & drugs Y Y Y
Guidelines Y Y Y
Training Y Y Y
Routine practice Y Y Y
PMTCT if HIV-positive mother:†
Infrastructure Y Y Y
Equipment & drugs Y Y Y
Guidelines Y Y Y
Training Y Y Y
Routine practice Y Y Y
EmONC – Emergency Obstetric and Newborn Care, SPA – Service Provision As-
sessment, SARA – Service Availability and Readiness Assessment
*Y – measured by the tool.
†May only be applicable in settings with high HIV prevalence.
Table 5. A summary of the Service Provision Assessment (SPA), Service Availability and Readiness Assessment 
(SARA) and Emergency Obstetric and Newborn Care (EmONC) tools’ capacity to measure structural and process 
domain of service readiness for interventions in the newborn inpatient care unit
InterventIon and components of structural domaIn health facIlItY assessment tool
SPA SARA EmONC
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InterventIon and components of structural domaIn health facIlItY assessment tool
SPA SARA EmONC
Training Y Y
Routine practice Y Y Y






Safe administration of oxygen (including equipment for resuscitation):
Infrastructure Y Y Y




Intravenous fluids and management of hypoglycaemia:
Infrastructure
Equipment & drugs Y
Guidelines Y
Training Y Y
Routine practice Y Y
Injectable antibiotics for neonatal infection:
Infrastructure Y Y Y
Equipment & drugs Y Y Y
Guidelines Y Y Y
Training Y Y








Infrastructure Y Y Y




Continuous positive airway pressure and assisted/mechanical ventilation:





Blood transfusion for newborns:











EmONC – Emergency Obstetric and Newborn Care, SPA – Service Provision Assessment, SARA – Service Availability and Readi-
ness Assessment
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None of the tools measured advanced infrastructure for intensive care for very small and sick newborns, 
such as that required for mechanical ventilation, newborn blood and/or exchange transfusion, and spe-
cialist laboratory infrastructure beyond that needed for obstetric, and some paediatric and adult services.
Equipment
All tools measured provision of basic equipment for neonatal resuscitation, including smaller-sized face 
masks and resuscitation bag in the labour and delivery room. None of the tools measured whether resus-
citation equipment was available in the room where small and sick newborns are cared for to ensure safe-
ty and continuity of care.
Simpler interventions for small newborns, such as assisted feeding (plastic feeding cups and small sized 
nasogastric tubes) were only measured by the EmONC assessment, and hats or caps (including small siz-
es) are not consistently measured among the tools.
Phototherapy equipment needed to treat neonatal jaundice was only measured by the EmONC assess-
ment (fluorescent tubes and icterometry). Lower cost phototherapy technologies, such as LED photother-
apy devices were not included in any of the tools.
Although the infrastructure for oxygen was measured, most likely for paediatric and adult services, safe 
delivery of oxygen to newborns requires significant additional equipment items, such as newborn pulse 
oximetry, neonatal nasal prongs, oxygen-air blenders, low-flow metres and humidifiers, which were not 
captured by the tools.
Higher level respiratory support for newborns, such as Continuous Positive Airway Pressure (CPAP) ven-
tilation, was not measured by any of the tools. Our matrix shows that for safe delivery of CPAP, beyond 
the drivers themselves, facilities would require critical emergency equipment in case of pneumothorax 
such as transilluminators, chest tubes and valves.
Intubation equipment (eg, laryngoscopes blades in small sizes) were measured by the EmONC assess-
ment, but other critical components to support a ventilated newborn were not measured, including the 
ventilator machine.
Drugs
The EmONC assessment tool had the most extensive list of drugs and medicines for newborns detailing 
106 medicines and drugs for mothers and newborns, but very few of these are specified for newborns. 
There were several notable omissions of medicines for care at birth within the SPA and SARA, such as vi-
tamin K (SPA only asks whether it is routinely administered).
All three tools measured antibiotic drugs for treating small and sick newborn infections (amoxicillin oral 
and injection, ampicillin injection and gentamicin injection as a minimum). However, inventories did not 
specify whether the antibiotic was available in the injectable form, with the appropriate concentrations 
and diluents (usually water for injection, sodium chloride 0.9% and glucose 5%), or the availability of 
smaller intravenous cannulas/catheters and syringe drivers. The tools measured standard intravenous flu-
id preparations, but only EmONC included glucose 10%, which is most frequently used for neonates. 
For seizure management, only the EmONC tool measured the first and second line treatments (intrave-
nous phenobarbitone and phenytoin).
Several drugs that might be used for advanced level care, such as procedural sedation and pain relief, were 
not currently included in any of the tools.
In Table 2 we present an example drug list for inpatient care of small and sick newborns indicating which 
drugs are measured by each tool and whether these are on the most recent WHO model essential medi-
cines list [26]. This includes the commodities needed for retinopathy of prematurity screening and treat-
ment, such as dilating and anaesthetic eye drops, which are not currently included in existing tools.
Health providers
There were several notable gaps in measurement of specialist newborn staff. Only the EmONC tool mea-
sured specialist staff cadres for newborns (eg, neonatologist) and none of the tools measured specialist 
neonatal nurses. Allied staff and support staff (eg, social workers, speech therapist) were not measured. 
None of the tools measured ophthalmologists or related professions that are needed in settings where 
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Guidelines
Table 1 shows all the guidelines and educational resources used for this review. Some resources cover a 
number of different interventions. However, there were notable gaps in available guidelines for more com-
plex interventions, such as continuous positive airway pressure, blood transfusion, exchange transfusion, 
ventilation, and treatment and screening of retinopathy of prematurity.
Identification of gaps in measurement of the process domain to capture 
service readiness to care for small and sick newborns for each intervention
Measurement of regular practice or training of health staff in specific interventions was considered as a 
proxy measurement for the process domain for service readiness as it looks at what is regularly done to 
patients in the institution.
Regular practice
All the tools relied on direct health worker reports, the register, or chart reviews to measure whether se-
lect interventions were regularly provided for small and sick newborns.
The SPA looked at whether a limited number of interventions relevant to newborns (neonatal resuscita-
tion and corticosteroids for preterm labour) were ever practiced and practiced in the last 3 months. The 
SPA also included a series of questions on essential care for newborns, but none on inpatient care for small 
and sick newborns, other than if KMC was practiced in the facility.
The SARA asked whether a limited number of functions were provided in the last 12 months: antibiotics 
for preterm or prolonged premature rupture of membranes, antenatal corticosteroids, neonatal resuscita-
tion, KMC, and injectable antibiotics.
The EmONC assessment had the most detailed list of newborn interventions for which questions on reg-
ular or recent practice were asked (newborn resuscitation, antenatal corticosteroids, antibiotics for preterm 
premature rupture of membranes, antibiotics for neonatal infections, KMC, administration of oxygen and 
administration of IV fluids).
The EmONC tool included specific knowledge questions on small and sick newborn care, including a 
few interventions, such as resuscitation, oxygen therapy and infections.
Table 6 summarises the approaches used by each of the tools to capture regular practice and training.
Table 6. The approach used by Service Provision Assessment (SPA), Service Availability and Readiness Assessment (SARA) and 
Emergency Obstetric and Newborn Care (EmONC) assessment to measure regular practice and training
spa sara emonc








Training in last 
24 months





Training in last 
24 months
As part of essential 
newborn care
As part of essential 
newborn care








Training in last 
24 months
As part of essential 
newborn care
As part of essential 
newborn care









Training in last 
24 months












Training in last 
24 months
ARVs given to newborns 
in the last 3 months
Ever received 
training
Kangaroo mother care Ever practiced








Assisted feeding (cup feeding 
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The synthesis of these findings to provide recommendations on improving these measurements is pro-
vided in the Discussion section.
DISCUSSION
We have mapped the service readiness requirements for inpatient newborn care, detailing a total of 654 
structural components to deliver 17 newborn interventions. Our review of three health facility assessment 
tools identified measurement gaps for almost all newborn interventions, even for the more basic inter-
ventions, such as thermoregulation and feeding. The most significant measurement gaps are for more 
complex interventions, which are currently not captured by any of the tools in our review. We found many 
commonalities among these tools, but also highlighted important differences that show how they have 
evolved with important, but distinct purposes, and different measurement approaches [9]. The size and 
cost of these assessments already limits the frequency of carrying out these surveys; adding a long list of 
indicators for small and sick newborn care would compound this challenge [28]. To improve the existing 
tools, we found that a number of indicators for basic service readiness could be harmonised, and some 
proxy indicators of service readiness for more complex care could potentially be added. As with other 
more complex areas of care, monitoring all the structures and processes for small and sick newborns will 
likely require a facility-based monitoring system [29-31].
The existing, up-to-date care guidelines for inpatient care for small and sick newborns are mainly split 
between obstetric care and paediatric care (Table 2) [32-35]. To the best of our knowledge, this is the 
first time that service readiness for small and sick newborn care has been delineated and mapped by struc-
tural component. The resulting matrix can be used by implementers for programme planning, depending 
on the needs of their health system and the interventions or packages of care they intend to provide at 
their service (Table S1 in Online Supplementary Document). It is a step towards developing a more 
general facility based monitoring system or core module. Following validation, such a tool could be adapt-
ed for different settings as has been done in India [29].
The following sections provide a synthesis of findings and recommendations for improving the widely 
used tools for measurement of small and sick newborn care.
Harmonisation of existing health facility assessment tools
Indicators
The interventions that are best represented by the existing tools are those that have been promoted as 
vertical programmes, such as neonatal resuscitation (which is a core indicator for obstetric and newborn 
care assessments), essential newborn care (for all babies) and PMTCT. The measurement approach and 
indicators for many of the more basic newborn interventions would benefit from more standardisation 
between tools. As a minimum, this should include service readiness indicators for essential newborn care 
(including service readiness for drying, skin-to-skin contact, cord clamping, vitamin K and initiation of 
breastfeeding), neonatal resuscitation and kangaroo mother care [28].
All of the existing tools have some questions on KMC, but for monitoring of operational KMC [28], the 
facility inventories require adaptations to incorporate more of the items needed for KMC [23] including 
the equipment for feeding support, antibiotics and amenities for mothers to stay in the facility [14]. Whilst 
listing the items needed for antenatal care exceeded the scope of this exercise, these should be considered 
in future tools, such as availability of antenatal corticosteroids for threatened preterm labour and antibi-
otics for preterm rupture of membranes (per WHO guidelines) as a minimum.
Measurement of training and skills for newborn interventions could be harmonised between tools such 
that these indicators are comparable between different surveys (see Table 4).
Crosscutting service readiness needs
Health providers, especially midwives and specialist nurses, play a critical role in neonatal care [6,8,36-
38]. Specially trained neonatal nurses may not be available in all health facilities, but previous studies show 
it is important to monitor who, if anyone, cares for newborns in the absence of specialised staff [8]. Recent 
studies in higher income settings, where neonatal nursing is a specialist cadre, show that reducing the 
nurse-to-patient ratio in neonatal units increases in-hospital mortality [39,40]. As a minimum, all health 
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are not regularly being rotated to other areas of care [8], such a question is currently only included in the 
EmONC tool. Other allied and supportive professionals may be a necessary addition to the list of staff cad-
res, such as biomedical engineers for maintaining equipment and nursing support staff. For all health fa-
cility assessment tools, the capacity and readiness of a facility to provide referral to facilities that can pro-
vide more complex care for small and sick is a critical indicator of service readiness. The difficulty and 
inconsistency in measurement of provider skills and training also illustrates the need for further research 
into human resource tracking, and work to set benchmarks for staffing ratios for neonatal care [8].
Infection prevention and control is essential for all areas of the facility, with newborns particularly vul-
nerable, and most of the newborn deaths from infections occurring in small babies. The current tools 
have several general water and sanitation indicators, which should be harmonised across tools to ensure 
that the basic soap, running water and safe and effective antiseptics are available in labour and delivery 
and neonatal care areas. A standard indicator that measures whether the newborn space is separate from 
the paediatric ward, and for whether there is a system for inborn and out born babies could be a poten-
tial proxy indicator for service readiness.
Measuring more complex inpatient care for small and sick newborns
Small and sick babies, especially those born preterm, are at higher risk of multiple childhood morbidities 
(including visual, hearing and neuro-developmental), with increasing gradient of adverse developmental 
outcomes by lower gestational age of survivors [41,42]. These newborns often require more complex in-
terventions, such as respiratory support (oxygen, continuous positive airway pressure), treatment of spe-
cific complications (feeding, seizures, jaundice), and screening and follow up services (Figure 1) [8,43-
47]. Many of these interventions carry a risk of harm when not performed with safe equipment or by 
trained staff. This is illustrated in middle-income settings, where we have seen an increase in impairments 
among survivors of neonatal care, especially where complex care has been scaled up without due atten-
tion to service readiness and quality of care [41,42,48].
The existing tools do not capture the large number of items required to deliver complex interventions 
safely, which would require a facility based monitoring register that also includes process and outcome 
data (morbidity and mortality) [49]. Such registers have been developed in higher- and middle-income 
settings [29,49], but are not standardised routine systems. Further research into adaptations of existing 
tools is an important next step.
Clinical care charts and protocols are essential for quality and safety of neonatal care that requires com-
plex calculations of drug concentrations and specific diluents, dosages, and delivery modes for newborns. 
In addition to service readiness, the risks of certain interventions can be mitigated by ensuring clinical 
record keeping, which is known to be sub-standard in many settings [50]. Standardised observation charts 
for monitoring of vital signs (eg, hourly or three-hourly), fluid input and output, feeding method and 
volume, and monitoring medications and laboratory tests (eg, serum bilirubin and exchange transfusion 
thresholds) could support facilities, alongside up-to-date standardised evidence-based guidelines, a list 
of which is included in the documentation section of our matrix.
Implications and next steps for monitoring service readiness for inpatient 
care of small and sick newborns
Amongst existing partners and initiatives, there is widespread recognition of the need to harmonise mon-
itoring systems for perinatal care. The existing EmOC signal functions do not represent the full set of fa-
cility-based interventions for mothers and newborns, and small and sick newborns are especially neglect-
ed. Given the large number of service readiness requirements for small and sick newborn care, a short 
list of signal functions for monitoring purposes is a potential solution. Previous work by Gabrysch and 
colleagues has recommended improvements to these tools [51]. Currently, a global survey led by Every 
Newborn partners, alongside a technical group led by AMDD and UNFPA are working on linking this to 
the emergency obstetric care indicators, with plans to finalise recommendations for newborn signal func-
tions in 2018-2019 [9].
Periodic evaluation, using health facility surveys, is currently necessary, but ultimately the goal should be 
to incorporate such assessments into functional and sustainable routine national systems. These should 
operate independent of donor funding and project mandates. The current health facility assessment tools 
are costly and time-consuming. Lighter assessments that can be carried out more frequently are also re-
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mation into one database for national monitoring of inpatient care of small and sick newborns. Low- and 
middle-income countries that have not moved to electronic information systems have an advantage in 
that they can leap-frog the situation of having fragmented and discrepant electronic data collection forms 
which differ from facility to facility or region to region. Exploration of the potential use of DHIS-2 plat-
forms for facility-based monitoring is being carried out as part of the Every Newborn metrics work on 
small and sick newborns [9]. This work supports the growing interest in use of routine health manage-
ment information systems to monitor aspects of service delivery in facilities [14], and of logistic manage-
ment information systems (LMIS) to track logistics and supplies.
CONCLUSIONS
Tracking of service readiness to provide inpatient care of small and sick newborns is needed to gain the 
required policy attention, accountability and investment that is critical to end preventable newborn deaths, 
and improve child development. This is reflected in the Global Strategy for Women, Children and Ado-
lescents, the WHO Quality of Care Framework, and is supported by the Every Newborn metrics working 
group. The existing health facility assessments do not generate comparable data, and have very limited 
assessment of more complex care for small and sick newborns. Indicators in existing tools can be har-
monised, but the size and cost of these assessments limits their frequency. Developing a core list of har-
monised indicators for use in routine health information systems could help address this gap. Improve-
ments in these monitoring systems are urgently needed to inform efforts to improve quality of care and 
investments in health systems scale-up, to end preventable newborn death and disability, alongside work 
to end preventable maternal deaths and stillbirths.
Acknowledgements: We would like to acknowledge the following clinicians for their careful review of the matrix 
(Table S1 in Online Supplementary Document): Dr Olukemi Oluwatoyin, Consultant Paediatrician, University 
College, Ibadan, Nigeria; Dr Ezeanosike Obumneme, Consultant Neonatologist, Federal Teaching Hospital, Abaka-
liki, Nigeria, Dr Nana Okai Brako, Paediatrician, Greater Accra Regional Hospital, Accra, Ghana and Dr Kojo 
Ahor-Essel, Paediatrician, Maud Essabah Fandoh, Nurse, Neonatal Intensive Care and Afua Antiwiwaa Ofori, 
Nurse, Neonatal Intensive Care, Korle Bu Teaching Hospital, Accra, Ghana. Thank you also to the Every Newborn 
metrics team for support in the organisation of this work. We would like to acknowledge the important contribu-
tion of the participants at the April 2016 Every Newborn metrics workshop in the session on inpatient care for 
small and sick newborns: Lara Vaz, Juan Dewez, Ehsan Rahman, Queen Dube, Nalini Singhal, Anne-Marie Bergh, 
Michel Brun, Mary Azayo, Steve Wall, Rubayet Sayet, Indira Narayanan, Al Ayede and Goldy Mazia; and Georgia 
Gore-Langton for her detailed notes. Thank you to Matthews Mathai and Ashok Deorari who could not attend 
the session, but provided comments on the process. Thank you to Claire Gilbert for her assistance with retinop-
athy of prematurity guidelines and the laboratory team at University College Hospital, London. Thanks to Sarin-
di Aryasinghe and Victoria Ponce-Hardy at LSHTM for their assistance with formatting figures and tables. Finally, 
thank you to Bina Valsangkar and the Save the Children’s Saving Newborn Lives programme for their overall co-
ordination of this supplement.
Funding: Publication costs for this supplement and some of the time for SM were funded by Save the Children’s 
Saving Newborn Lives programme. The Every Newborn measurement improvement work coordinated by the Lon-
don School of Hygiene & Tropical Medicine (LSHTM) is funded by the Children’s Investment Fund Foundation 
(CIFF).
Authorship declaration: SGM, TG and JL were responsible for the conceptualisation of the paper. SGM was re-
sponsible for carrying out the review of the tools, the conceptualisation and collation of the matrix, the writing 
process, coordination of paper drafts and design of the figures and tables. TG reviewed early drafts of the manu-
script. A representative of the lead agency for each of the tools then verified the review of the tools. OC and JL 
provided oversight of the final drafts of the paper. All named authors reviewed drafts of the paper and approved 
the final manuscript.
Competing interests: The authors have completed the Unified Competing Interest form at www.icmje.org/coi_



































www.jogh.org •  doi: 10.7189/jogh.08.010702 17 June  2018  •  Vol. 8 No. 1 •  010702
 1  UN-IGME. Levels and trends in child mortality: Report 2017. UNICEF; WHO; World Bank Group; United Nations, 2017.
 2  World Health Organization. MCEE-WHO methods and data sources for child causes of death 2000-2015. Geneva, Swit-
zerland: Department of Evidence Geneva); 2016.
 3  Bhutta ZA, Das JK, Bahl R, Lawn JE, Salam RA, Paul VK, et al. Can available interventions end preventable deaths in 
mothers, newborn babies, and stillbirths, and at what cost? Lancet. 2014;384:347-70. Medline:24853604 doi:10.1016/
S0140-6736(14)60792-3
 4  Wall SN, Lee AC, Niermeyer S, English M, Keenan WJ, Carlo W, et al. Neonatal resuscitation in low-resource settings: 
what, who, and how to overcome challenges to scale up? Int J Gynaecol Obstet. 2009;107 Suppl 1:S47-62. Med-
line:19815203 doi:10.1016/j.ijgo.2009.07.013
 5  Enweronu-Laryea C, Dickson KE, Moxon SG, Simen-Kapeu A, Nyange C, Niermeyer S, et al. Basic newborn care and 
neonatal resuscitation: a multi-country analysis of health system bottlenecks and potential solutions. BMC Pregnancy 
Childbirth. 2015;15 Suppl 2:S4. Medline:26391000 doi:10.1186/1471-2393-15-S2-S4
 6  Lawn JE, Davidge R, Paul VK, von Xylander S, de Graft Johnson J, Costello A, et al. Born too soon: care for the preterm 
baby. Reprod Health. 2013;10 Suppl 1:S5. Medline:24625233 doi:10.1186/1742-4755-10-S1-S5
 7  World Health HO. UNICEF. Every Newborn: An action plan to end preventable newborn deaths Geneva: World Health 
Organisation2014. Available: http://www.everynewborn.org/every-newborn-action-plan/. Accessed: 1 September 2014.
 8  Moxon SG, Lawn JE, Dickson KE, Simen-Kapeu A, Gupta G, Deorari A, et al. Inpatient care of small and sick newborns: 
a multi-country analysis of health system bottlenecks and potential solutions. BMC Pregnancy Childbirth. 2015;15 Sup-
pl 2:S7. Medline:26391335 doi:10.1186/1471-2393-15-S2-S7
 9  World Health Organization, London School of Hygiene and Tropical Medicine. Every Newborn Action Plan Metrics: 
Design workshop for facility based testing of coverage metrics. 2016. Available: http://www.healthynewbornnetwork.
org/hnn-content/uploads/ENAP-Metrics-Facility-based-Workshop-Report_April-2016_FINAL.pdf. Accessed: 1 Septem-
ber 2017.
10  Donabedian A. The quality of care. How can it be assessed? JAMA. 1988;260:1743-8. Medline:3045356 doi:10.1001/
jama.1988.03410120089033
11  Donabedian A. Some basic issues in evaluating the quality of health care. ANA Publ. 1976;(G-124):3-28. Medline:826182
12  Donabedian A. Evaluating the quality of medical care. Milbank Mem Fund Q. 1966;44 Suppl:166-206. Medline:5338568 
doi:10.2307/3348969
13  Lawn JE, Blencowe H, Oza S, You D, Lee AC, Waiswa P, et al. Every Newborn: progress, priorities, and potential beyond 
survival. Lancet. 2014;384:189-205. Medline:24853593 doi:10.1016/S0140-6736(14)60496-7
14  Moxon SG, Ruysen H, Kerber KJ, Amouzou A, Fournier S, Grove J, et al. Count every newborn; a measurement im-
provement roadmap for coverage data. BMC Pregnancy Childbirth. 2015;15 Suppl 2:S8. Medline:26391444 
doi:10.1186/1471-2393-15-S2-S8
15  Kerber KJ, Mathai M, Lewis G, Flenady V, Erwich JJ, Segun T, et al. Counting every stillbirth and neonatal death through 
mortality audit to improve quality of care for every pregnant woman and her baby. BMC Pregnancy Childbirth. 2015;15 
Suppl 2:S9. Medline:26391558 doi:10.1186/1471-2393-15-S2-S9
16  Requejo J, Victora C, Bryce J. A Decade of Tracking Progress for Maternal, Newborn and Child Survival: The 2015 Re-
port. 2015. Available: http://www.countdown2015mnch.org/documents/2015Report/Countdown_to_2015-A_Decade_
of_Tracking_Progress_for_Maternal_Newborn_and_Child_Survival-The2015Report-Conference_Draft.pdf. Accessed: 
1 September 2017.
17  Bryce J, Arnold F, Blanc A, Hancioglu A, Newby H, Requejo J, et al. Measuring coverage in MNCH: new findings, new 
strategies, and recommendations for action. PLoS Med. 2013;10:e1001423. Medline:23667340 doi:10.1371/journal.
pmed.1001423
18  Stanton CK, Rawlins B, Drake M, Dos Anjos M, Cantor D, Chongo L, et al. Measuring coverage in MNCH: testing the 
validity of women’s self-report of key maternal and newborn health interventions during the peripartum period in Mo-
zambique. PLoS One. 2013;8:e60694. Medline:23667427 doi:10.1371/journal.pone.0060694
19  O’Neill K, Takane M, Sheffel A, Abou-Zahr C, Boerma T. Monitoring service delivery for universal health coverage: the 
Service Availability and Readiness Assessment. Bull World Health Organ. 2013;91:923-31. Medline:24347731 
doi:10.2471/BLT.12.116798
20  World Health Organization. Service Availability and Readiness Assessment (SARA): an annual monitoring system for 
service delivery: Reference Manual. 2015. Available: http://www.who.int/healthinfo/systems/sara_reference_manual/en/. 
Accessed: 1 September 2017.
21  AMDD. Averting Maternal Death and Disability (AMDD) 2017. Available: https://www.mailman.columbia.edu/research/
averting-maternal-death-and-disability-amdd. Accessed: 9 April 2018.
22  United Nations Population Fund. https://www.unfpa.org/. Accessed: 9 April 2018.
23  Vesel L, Bergh AM, Kerber KJ, Valsangkar B, Mazia G, Moxon SG, et al. Kangaroo mother care: a multi-country analysis 
of health system bottlenecks and potential solutions. BMC Pregnancy Childbirth. 2015;15 Suppl 2:S5. Medline:26391115 
doi:10.1186/1471-2393-15-S2-S5
24  World Health Organization. Interagency list of medical devices for reproductive, maternal, newobrn and child health. 
Geneva; World Health Organization: 2015.
25 UNICEF. Children St. Newborn Health in Humanitarian Settings: A Field Guide (Interim Version). United Nations2016.
26  World Health Organization. WHO Model List of Essential Medicines (20th list); amended August 2017. Available: http://
www.who.int/medicines/publications/essentialmedicines/20th_EML2017_FINAL_amendedAug2017.pdf?ua=1. Ac-






















































27  Program DHS. Service Provision Assessments Calverton, MD, USA: ICF Macro; 2014. Available: http://www.measured-
hs.com/What-We-Do/Survey-Types/SPA.cfm. Accessed: 1 November 2011.
28  Madaj B, Smith H, Mathai M, Roos N, van den Broek N. Developing global indicators for quality of maternal and new-
born care: a feasibility assessment. Bull World Health Organ. 2017;95:445-52I. Medline:28603311 doi:10.2471/
BLT.16.179531
29  Neogi SB, Khanna R, Chauhan M, Sharma J, Gupta G, Srivastava R, et al. Inpatient care of small and sick newborns in 
healthcare facilities. J Perinatol. 2016;36 s3:S18-23. Medline:27924106 doi:10.1038/jp.2016.186
30  Neogi SB, Malhotra S, Zodpey S, Mohan P. Challenges in scaling up of special care newborn units–lessons from India. 
Indian Pediatr. 2011;48:931-5. Medline:22253148 doi:10.1007/s13312-011-0149-z
31  Neogi SB, Malhotra S, Zodpey S, Mohan P. Assessment of special care newborn units in India. J Health Popul Nutr. 
2011;29:500-9. Medline:22106756 doi:10.3329/jhpn.v29i5.8904
32  World Health Organization. Managing complications in pregnancy and childbirth: a guide for midwives and doctors. 
Geneva: World Health Organization; 2000.
33  World Health Organization. Pregnancy, Childbirth, Postpartum and Newborn Care: A guide for essential practice. Ge-
neva: World Health Organization; 2006.
34  World Health Organization. Management of newborn problems: a guide for doctors, nurses and midwives. Geneva: 
World Health Organization; 2003.
35  World Health Organization. Pocket book of hospital care for children: Guidelines of the management of common child-
hood illnesses. Geneva: World Health Organization; 2013.
36  Premji SS, Spence K, Kenner C. Call for neonatal nursing specialization in developing countries. MCN Am J Matern 
Child Nurs. 2013;38:336-42. Medline:23792874 doi:10.1097/NMC.0b013e31829f2c94
37  Kalyan G, Moxon S. The role of neonatal nurses in the prevention of retinopathy of prematurity. Indian Pediatr. 2016;53 
Suppl 2:S143-50. Medline:27915323
38  Kalyan G, Vatsa M. Neonatal nursing: An unmet challenge in India. Indian J Pediatr. 2014;81:1205-11. Medline:25278279 
doi:10.1007/s12098-014-1567-4
39  Watson SI, Arulampalam W, Petrou S, Marlow N, Morgan AS, Draper ES, et al. The effects of a one-to-one nurse-to-pa-
tient ratio on the mortality rate in neonatal intensive care: a retrospective, longitudinal, population-based study. Arch 
Dis Child Fetal Neonatal Ed. 2016;101:F195-200. Medline:26860480 doi:10.1136/archdischild-2015-309435
40  Hamilton KE, Redshaw ME, Tarnow-Mordi W. Nurse staffing in relation to risk-adjusted mortality in neonatal care. Arch 
Dis Child Fetal Neonatal Ed. 2007;92:F99-103. Medline:17088341 doi:10.1136/adc.2006.102988
41  Blencowe H, Lawn JE, Vazquez T, Fielder A, Gilbert C. Preterm-associated visual impairment and estimates of retinop-
athy of prematurity at regional and global levels for 2010. Pediatr Res. 2013;74 Suppl 1:35-49. Medline:24366462 
doi:10.1038/pr.2013.205
42  Blencowe H, Lee AC, Cousens S, Bahalim A, Narwal R, Zhong N, et al. Preterm birth-associated neurodevelopmental 
impairment estimates at regional and global levels for 2010. Pediatr Res. 2013;74 Suppl 1:17-34. Medline:24366461 
doi:10.1038/pr.2013.204
43  Bhutani VK, Cline BK, Donaldson KM, Vreman HJ. The need to implement effective phototherapy in resource-con-
strained settings. Semin Perinatol. 2011;35:192-7. Medline:21641494 doi:10.1053/j.semperi.2011.02.015
44  Bhutani VK, Maisels MJ, Stark AR, Buonocore G. Management of jaundice and prevention of severe neonatal hyperbil-
irubinemia in infants >or=35 weeks gestation. Neonatology. 2008;94:63-7. Medline:18204221 doi:10.1159/000113463
45  Slusher TM, Zipursky A, Bhutani VK. A global need for affordable neonatal jaundice technologies. Semin Perinatol. 
2011;35:185-91. Medline:21641493 doi:10.1053/j.semperi.2011.02.014
46  Luu MN, Le LT, Tran BH, Duong TK, Nguyen HT, Le VT, et al. Home-use icterometry in neonatal hyperbilirubinaemia: 
Cluster-randomised controlled trial in Vietnam. J Paediatr Child Health. 2014;50:674-9. Medline:24888540 doi:10.1111/
jpc.12611
47  Kumar P, Chawla D, Deorari A. Light-emitting diode phototherapy for unconjugated hyperbilirubinaemia in neonates. 
Cochrane Database Syst Rev. 2011;12:CD007969. Medline:22161417
48  Blencowe H, Vos T, Lee AC, Philips R, Lozano R, Alvarado MR, et al. Estimates of neonatal morbidities and disabilities 
at regional and global levels for 2010: introduction, methods overview, and relevant findings from the Global Burden 
of Disease study. Pediatr Res. 2013;74 Suppl 1:4-16. Medline:24366460 doi:10.1038/pr.2013.203
49  Horbar JD, Soll RF, Edwards WH. The Vermont Oxford Network: a community of practice. Clin Perinatol. 2010;37:29-
47. Medline:20363446 doi:10.1016/j.clp.2010.01.003
50  Musiime GM, Seale AC, Moxon SG, Lawn JE. Risk of gentamicin toxicity in neonates treated for possible severe bacte-
rial infection in low- and middle-income countries: Systematic review. Trop Med Int Health. 2015;20:1593-606. Med-
line:26426298 doi:10.1111/tmi.12608
51  Gabrysch S, Civitelli G, Edmond KM, Mathai M, Ali M, Bhutta ZA, et al. New signal functions to measure the ability of 
health facilities to provide routine and emergency newborn care. PLoS Med. 2012;9:e1001340. Medline:23152724 
doi:10.1371/journal.pmed.1001340
52  UNFPA. Improving obstetric and neonatal care: implementation manual for developing a national network of referral 




Appendix P: PDF of published paper: Categorising interventions to levels of inpatient 
care for small and sick newborns: Findings from a global survey 
 
For licensing agreement see: https://journals.plos.org/plosone/s/licenses-and-copyright 
  
RESEARCH ARTICLE
Categorising interventions to levels of
inpatient care for small and sick newborns:
Findings from a global survey
Sarah G. MoxonID
1*, Hannah BlencoweID1, Patricia Bailey2, John Bradley1, Louise
Tina Day1, Pavani K. Ram3, Jean-Pierre Monet4, Allisyn C. Moran5, Willibald Zeck6, Joy
E. Lawn1
1 Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine,
London, United Kingdom, 2 Averting Maternal Death & Disability, Mailman School of Public Health, Columbia
University, New York, United States of America, 3 Office of Maternal and Child Health and Nutrition, US
Agency for International Development, Washington DC, United States of America, 4 Technical Division,
United Nations Population Fund (UNFPA), New York, United States of America, 5 Department of Maternal,
Newborn, Child and Adolescent Health, World Health Organisation, Geneva, Switzerland, 6 UNICEF Health




In 2017, 2.5 million newborns died, mainly from prematurity, infections, and intrapartum
events. Preventing these deaths requires health systems to provide routine and emergency
care at birth, and quality inpatient care for small and sick newborns. Defined levels of emer-
gency obstetric care (EmOC) and standardised measurement of “signal functions” has
improved tracking of maternal care in low- and middle-income countries (LMICs). Levels of
newborn care, particularly for small and sick newborns, and associated signal functions are
still not consistently defined or tracked.
Methods
Between November 2016-November 2017, we conducted an online survey of professionals
working in maternal and newborn health. We asked respondents to categorise 18 clinical
care interventions that could act as potential signal functions for small and sick newborns
to 3 levels of care they thought were appropriate for health systems in LMICs to provide:
“routine care at birth”, “special care” and “intensive care”. We calculated the percentage of
respondents that classified each intervention at each level of care and stratified responses
to look at variation by respondent characteristics.
Results
Six interventions were classified to specific levels by more than 50% of respondents as
“routine care at birth,” three interventions as “special care” and one as “intensive care”.
Eight interventions were borderline between these care levels. Responses were more con-
sistent for interventions with relevant WHO clinical care guidelines while more variation in
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respondents’ classification was observed in complex interventions that lack standards or
guidelines. Respondents with experience in lower-income settings were more likely to
assign a higher level of care for more complex interventions.
Conclusions
Results were consistent with known challenges of scaling up inpatient care in lower-income
settings and underline the importance of comprehensive guidelines and standards for inpa-
tient care. Further work is needed to develop a shortlist of newborn signal functions aligned
with emergency obstetric care levels to track universal health coverage for mothers and
their newborns.
Introduction
Each year an estimated 2.5 million newborns die in the 28 days after birth [1]. The main causes
of death are direct complications of prematurity (35%), infections (23%), and intrapartum
complications leading to birth injury (24%) [2]. Most of these deaths occur in low- and mid-
dle-income countries (LMICs) [3]. Many lives could be saved—and morbidity prevented—
through a health systems approach along the continuum of care [4]. Such an approach requires
delivery of quality packages of care including routine and emergency care for mothers and
newborns at birth, and inpatient care for small and sick newborns [4, 5].
In addition to routine essential newborn care, many low birth weight (LBW) newborns,
including both preterm infants, and those born small for gestational age, require additional
support to feed and to maintain their temperature [6, 7]. Preterm newborns face increased
risks of respiratory problems, infections, and jaundice [8]. Even amongst those born at full
term, significant numbers of newborns face complications including, systemic infections, neo-
natal encephalopathy, severe jaundice, and congenital disorders, with high mortality risk in
the absence of quality care [3, 7]. Many of these small and sick babies will require inpatient
care for them to survive and minimise chances of developing future morbidities and/or long-
term disability [9–13]. Access to appropriate level and quality care remains challenging, espe-
cially for mothers and newborns experiencing complications, and notably in LMICs [4, 7, 14].
Based on evidence from higher income settings, a rational approach to organising and
delivering quality services is through an integrated network of facilities providing increasing
levels of care, referred to as regionalisation of care [15–17]. Managing mothers and newborns
experiencing complications by more skilled staff working in specialised, better equipped facili-
ties than in lower level facilities or those staffed solely by generalists allows for an efficient use
of resources, and is an effective strategy to improve access to care for complications [14, 15,
17]. Higher levels of care build on the capabilities of lower level(s) with the additional infra-
structure, equipment, supplies and health providers to manage more complex levels of care
[15, 18]. For such an approach to work, synergy in institutional capabilities for mother and
newborns is needed with a functional communication and referral system [15, 19, 20]. Levels
of care need to be clearly defined with accompanying monitoring systems to identify issues in
availability, access and quality of care for services [16, 18, 21]. Defined levels of maternal and
newborn care are common in high-income settings [15, 16, 20, 22, 23], but there is a need for
such a delineation for newborns in LMICs [7].
In LMICs, maternal care has been categorised by United Nations (UN) agencies at two lev-
els referred to as basic emergency obstetric care (BEmOC) or comprehensive emergency
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obstetric care (CEmOC) [24]. These levels of care act as a proxy measure of the availability of
the human resources, infrastructure, equipment, and supplies needed to provide specific ser-
vices. This delineation allows Ministries of Health and technical partners to manage and moni-
tor emergency obstetric care services in LMICs through “signal functions”, a core list of life-
saving services that have been used to assess the provision of emergency obstetric care at either
a basic or comprehensive levels [24–26]. Currently, there are seven signal functions assessed
for BEmOC and two additional CEmOC signal functions; they mostly address the obstetric
complications that lead to maternal death and disability, including post-partum haemorrhage,
infections and hypertensive disorders [24].
Throughout this article, we will refer to the “Emergency Obstetric Care (EmOC) signal
functions” in recognition of the fact that these were primarily designed from an obstetric per-
spective and do not represent the full spectrum of interventions required for emergency new-
born care. More recently, the newborn has been more intentionally included and the term
Emergency Obstetric and Newborn Care (EmONC) has emerged, a change that has been wel-
comed by maternal and newborn health experts, policy makers and programme implementers.
We will use the term EmONC whenever we are referring to programmes, policies or indicators
that were designed with a view to include both obstetric and newborn care and/or when we
refer to the health facility assessments (EmONC assessments) that have been carried out with a
view to looking at both maternal and newborn health services.
For small and sick newborn care in LMICs, one newborn-specific signal function, newborn
resuscitation with bag and mask, was added to the core list of BEmOC signal functions nearly
a decade ago [24]. However, despite the addition of a resuscitation indicator, the signal func-
tions do not accurately represent the full package of interventions needed by the mother-baby
dyad, most notably care for small and sick newborns [14, 21, 26]. This gap was highlighted by
Gabrysch and colleagues in 2012, who proposed a new set of signal functions for routine and
emergency maternal and newborn care following a systematic review of newborn survival lit-
erature and a consultation with 39 experts [26]. Gabrysch and colleagues proposed additional
signal functions for routine and emergency care for mothers and newborns, however, this
work has yet to lead to the formal definition and adoption of levels of care and accompanying
newborn signal functions. Furthermore, this work did not focus intentionally on the levels of
care needed for those babies born small and sick.
Since 2012, there has been a significant increase in epidemiological data for newborns [3],
including better estimates of mortality, morbidity and outcomes beyond survival [8, 13, 27]. The
global Every Newborn Action Plan, launched in 2015, called for increased focus on the program-
matic and monitoring needs of newborns in order to end preventable maternal, newborn death,
disability and stillbirth [21, 28, 29]. Every Newborn highlighted the need to improve the quality
care for small and sick newborns and develop accompanying monitoring systems [3, 21]. Dur-
ing the past years increasingly efforts are being made by the global health community to tackle
the specific health problems of small and sick newborn babies though investment in quality neo-
natal care. This article builds on this platform and the previous work to develop levels of care
and associated signal functions [26] for small and sick newborns, in particular. The specific aim
of this article is to describe the findings of an online global survey undertaken to categorise a list
of newborn interventions, potential newborn signal functions, to different levels of care.
Methods
Study design and population
We designed an online survey to collect opinions from professionals working in maternal and
newborn health, including clinicians with neonatal and obstetric experience (midwives, nurses
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and doctors), researchers and programme managers or governmental officials (e.g. Ministry of
Health). Whilst LMIC health services for small and sick newborns was the focus, the survey
was not limited to respondents based in LMICs.
Questionnaire
We developed an online questionnaire to collect respondent characteristics (profession, cur-
rent country/region of practice/employment, experience (geography, length, private/public)
and type of experience (e.g. clinician, research, etc.).
We generated a list of 18 newborn services or interventions based on WHO guidelines,
previous work on the subject [26] and specific work carried out as part of the Every Newborn
process [4, 7, 30–33], including an expert focus group at an Every Newborn workshop where
participants discussed interventions for small and sick newborns and voted on a shortlist [34].
Interventions for the shortlist were prioritised based on potential contributions to mortality
reduction and LMIC health system feasibility [4, 32].
In the questionnaire, we asked respondents to assign the 18 interventions to one of 3 levels
of care appropriate for health systems in LMICs to provide: “routine care at birth”, “special
care”, “intensive inpatient care” as well as a classification category for services that would not
be appropriate as a signal function. Routine care at birth was included based on the rationale
that all newborns (including those born small and sick) will require these interventions before
they are admitted to inpatient care. To avoid biasing respondents, the questionnaire generated
the list of interventions/services in random order for each respondent.
The levels of inpatient care were described in the questionnaire as follows:
• Routine care at birth: This should be available at all facilities and for all babies including
those that need inpatient care because they are small and sick newborns.
• Special care: this service is part of inpatient care for small and sick newborns. In many set-
tings, this is referred to as special newborn care or level 2 care [16]. These inpatient care
signal functions are interventions for small and sick newborns that should be provided in
addition to routine care at birth.
• Intensive care: This service is part of inpatient care for very small and sick newborns. In
most settings this will only be available at the highest level of a referral hospital. In many set-
tings, this level is referred to as neonatal intensive care (NICU), or level 3 care [16]. These
services are for very small and sick newborns in addition to all the services provided at the
special care level.
We piloted the questionnaire for face validity among a group of 4 experienced public health
colleagues (not part of the study team) who pre-tested and provided feedback on the question
flow and wording. We then refined the wording of questionnaire based on this pilot. We trans-
lated the final version into French and Spanish, using native speakers with clinical or program-
matic experience in maternal and newborn health. The final version of the questionnaire is
available at http://doi.org/10.17037/DATA.00000902.
Recruitment
The survey was accessible online for 12 months from November 2016-November 2017 in
English, Spanish and French via the online platform Survey Monkey (www.surveymonkey.co.
uk). Respondents could only complete the survey after giving informed consent. Respondents
were given the option to exit the survey at any point. This study was granted ethical approval
Levels of inpatient care for small and sick newborns
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by the Research Ethics Committee of the London School of Hygiene &Tropical Medicine (ref-
erence number 11922).
Given that no sampling frame for this population exists, it was not possible to achieve a
probability sample. Therefore, we employed a multi-faceted approach to recruit participants
with diverse experience in maternal newborn health from a variety of settings, especially
LMICs. We made the survey available on a wide range of professional networks, including
Healthy Newborn Network https://www.healthynewbornnetwork.org/ and CHIFA http://
www.hifa.org/forums/chifa-child-health-and-rights to reach both professionals working in
international organisations and health professionals working on the ground. These platforms
were used with the aim of recruiting a wide range of both clinicians (including nurses, mid-
wives, doctors and allied professionals) and programme professionals with a breadth of experi-
ence. We encouraged snowball sampling by suggesting that respondents share the survey
widely amongst colleagues. In addition, we promoted the survey at international conferences
on newborn health: http://inkmc.net/index.php/11th-workshop-and-congress and midwifery
https://www.internationalmidwives.org/events/triennial-congress/toronto-2017/.
Statistical analyses
We calculated descriptive statistics for the respondents, including background characteristics
and respondent experience. We categorised respondent experience by age group (18–34, 35–
54, 55–74, 75 years or older), experience in LMICs and/or high income countries (HICs), clini-
cal and non-clinical experience, regional base (using World Bank regions https://datahelpdesk.
worldbank.org/knowledgebase/articles/906519-world-bank-country-and-lending-groups) and
experience in the public and the private sector.
For each signal function:
• We calculated the percentage of respondents that classified each intervention at each level of
care
• We stratified responses by respondent characteristics and looked at variation for each signal
function and respondent group using chi-squared tests to identify significant differences
between respondent groups and selected level of care.
Results
Respondent characteristics
A total of 372 individuals accessed the online survey, of which 110 (29.6%) were excluded as
after registering they did not answer any questions relating to interventions and levels of care.
The final sample included 262 respondents from 61 countries and 7 regions of the world (Fig
1). Data summary tables are available at http://doi.org/10.17037/DATA.00000902.
Levels of care
For the list of interventions selected as potential signal functions and the percentage of respon-
dents that categorised these at each level of care see Fig 2.
In the following sections, we present the results by levels of care; a service was described
under a specific level of care when it was selected at that level by >50% of respondents. This
threshold was defined as an iterative process, based on exploration of the data.
Routine care at birth. Six services were selected by >50% of respondents as “routine care
at birth”. Prevention of mother to child transmission of HIV (PMTCT) (83%), basic neonatal
resuscitation (86%), thermal protection (87%), immediate and exclusive breastfeeding (93%),
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and essential newborn care (93%) were all classified by over 80% of respondents as routine
care at birth. Prevention and treatment of hypoglycaemia was selected by over 60% of respon-
dents at this level.
Other than for prevention and treatment of hypoglycaemia, we found no significant varia-
tion by respondent characteristics of the six interventions that were classified as routine care at
birth. Classification of hypoglycaemia by clinicians and non-clinicians did vary significantly:
70% of clinicians classified this as care at birth compared with only 44% of non-clinicians
(p<0.01). Neonatal resuscitation, the only intervention in the list that is an existing EmOC sig-
nal function, was the option with the lowest number of responses identifying it as “not a poten-
tial signal function” (1%).
Special care. Three services were selected by>50% of respondents as “special care”: Intra-
venous (IV) fluids (59%), injectable antibiotics (57%) and phototherapy (51%). Respondents
with only experience in LMICs, were significantly more likely to classify IV fluids at a higher
level of care compared with those with experience in a high-income setting (p<0.05). For
injectable antibiotics, respondents based in high burden settings, such as South Asia, were
more likely to classify this option at higher levels of care whereas Latin American respondents
were more likely to classify it at a lower level (p<0.05). For phototherapy, there was some vari-
ation between non-clinicians and clinician respondents. Non-clinicians were more likely to
classify phototherapy at either “special care” or “intensive care” than clinicians; 28% of non-cli-
nicians categorised this as “intensive care” compared with only 12% of clinicians (p<0.05). A
larger percentage of respondents with experience in the private sector classified phototherapy
as “routine care at birth” (63%) than respondents with public (35%) or those with mixed pub-
lic-private experience (27%) (p<0.05).
Fig 1. Frequency of responses to global survey on levels of inpatient care by country. Respondent experience of working in maternal and newborn health
ranged from 1–49 years with a median of 19 years. The largest percentage of respondents was based in Europe and Central Asia (31%) and the smallest percentage
of respondents was based in the Middle East and North Africa (5%); thereon 14% based in North America, 11% based in Latin America & Caribbean, 8% were
based in South Asia, and 7% East Asia & Pacific. Over half of respondents (52%) had previous experience working in both HICs and LMICs, 13% of respondents
had experience from only a high-income country and 35% only LMIC experience. The majority of respondents were trained clinicians (75%). Of these the majority
were doctors (71%) followed by nurses (25%), midwives (2%) and allied health professionals (2%). Almost all clinicians had experience working in the public
sector; 65% with public sector experience only, 30% with a mix of private and public-sector experience and 6% with only private sector experience.
https://doi.org/10.1371/journal.pone.0218748.g001
Levels of inpatient care for small and sick newborns
PLOS ONE | https://doi.org/10.1371/journal.pone.0218748 July 11, 2019 6 / 15
Intensive care. Mechanical ventilation was the only intervention classified by >50% of
respondents as a service for “intensive care”. Respondents with experience in LMICs were
more likely to classify mechanical ventilation as “intensive care” than respondents who had
not worked in LMICs (66% vs. 41% respectively) (p<0.05).
Interventions/Services without clear categorisation (borderline). Borderline “routine
care at birth”/ “special care” refers to interventions not meeting the>50% threshold for any level
of care but categorised by close to 50% of respondents as “routine care at birth” or”special care”.
Three interventions were classified as borderline “routine care at birth”/ “special care”: safe
oxygen therapy (46%/41%), KMC (44%/47%) and assisted feeding (41%/49%), respectively.
For oxygen and assisted feeding, experience of working in LMICs, regional and experience
working in the public and private sector were significantly associated with variation. Those
with LMIC experience or from higher burden settings were more likely to classify these inter-
ventions at higher levels of care.
For KMC, there was no significant variation between levels of care and respondent
characteristics.
Borderline “special care”/ “intensive care” refers to interventions not meeting the>50%
threshold for any level of care but categorised by close to 50% of respondents as “special care” or
“intensive care”.
Five interventions were classified as borderline “special care”/ “intensive care”: specialised
follow up of high risk (41%/49%), continuous positive airway pressure (CPAP) (50%/34%), sei-
zure management (44%/30%), blood transfusion (36%/46%) and retinopathy of prematurity
(ROP) (29%/50%).
Fig 2. Bar graph showing list of interventions and percent of respondents for each level of care (n = 262). PMTCT = Prevention of mother to child
transmission of HIV, KMC = Kangaroo mother care, ABX = antibiotics, IV = intravenous, CPAP = Continuous positive airway pressure, ROP = retinopathy of
prematurity. �Only intervention classified by>50% of respondents as “intensive care”.
https://doi.org/10.1371/journal.pone.0218748.g002
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For management of seizures, blood transfusion and CPAP, clinicians were significantly
more likely to classify these interventions as special care while non-clinicians were more likely
to classify them as intensive care (p<0.05).
For blood transfusion, CPAP and screening and treatment of ROP, experience in a LMIC
was significantly associated with variation in the selected levels of care. Those with experience
in LMICs were significantly more likely to classify these interventions as “intensive care” and
while those with only experience in a high-income country more likely to classify them as “spe-
cial care” (p<0.05). For example, 71% of respondents with only HIC experience classified
CPAP as “special care” compared to only 33% of respondents with only LMIC experience;
respondents with only LMIC experience were significantly more likely to classify it as
“intensive care” (49%) (p =<0.05). For ROP, 16% of those who had only worked in LMICs
responded that ROP was not a signal function compared to no respondents with only HIC
experience and 7% of respondents with experience in both LMICs and HICs (p<0.05).
For specialised follow up of high risk, there was no significant variation in respondent char-
acteristics for the between levels of care selected.
Discussion
This article presents results from a global survey of 262 respondents from 61 countries to clas-
sify 18 newborn care interventions, into 3 levels of care. Applying the>50% threshold to 18
potential signal functions, 10 of these clearly aligned to specific levels of care: six for routine
care at birth, three for special care and one for intensive care. The remaining eight signal func-
tions did not meet the >50% threshold for a specific level of care. Previous work has encour-
aged the development of routine and emergency newborn signal functions [26], but levels of
newborn care have not yet been well-defined for LMICs, particularly for small and sick new-
borns. This work contributes new insights into levels of neonatal care in LMICs as a step
towards formally defined newborn care levels that could be aligned with EmOC.
Interpretation of categorisation of levels of inpatient care for small and
sick newborns from global survey
Consistency with existing guidelines. Out of the interventions that were clearly classified
as “routine care at birth” by more than 80% of respondents, four have existing WHO guide-
lines (PMTCT (83%)[35], neonatal resuscitation (86%)[36], immediate and exclusive breast-
feeding (93%)[37], and essential newborn care (93%) [38]). These interventions showed little
variation among respondents. For more complex interventions that do not have specific WHO
guidelines, level of care classification was less clear and there was greater respondent variation.
This may be related to individual respondents applying existing classification systems within
countries where they had worked. For example, in many settings the capacity to provide neo-
natal mechanical ventilation is the defining feature of an intensive care unit [39], as it requires
more complex health system capacity [18]. The wording of the intervention as injectable anti-
biotics may have led to ambiguity with respondents by differentiating intravenous from intra-
muscular antibiotics. Some respondents may have perceived that intravenous infusions of
antibiotics for treatment of infection may require special care capacity in contrast to intramus-
cular antibiotics that WHO recommends as feasible at low levels of the health system [40].
Low- and middle-income experience. Overall, experience in LMICs was most frequently
associated with variation in response as was the case with oxygen, assisted feeding, blood trans-
fusion, continuous positive airway pressure (CPAP) and screening and treatment for ROP.
There was a clear pattern for respondents with experience in lower income settings or those
based in LMICs to classify interventions more cautiously (at a higher level of care e.g. intensive
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care rather than special care). That respondents with LMIC experience were more comfortable
assigning a higher level of care for certain interventions may reflect the respondents’ percep-
tions of feasibility of introducing or scaling up interventions such as CPAP [41–43]. It may
also be indicative of a lack of experience delivering those interventions and/or the challenges
of scaling up inpatient care in these settings. Experience in the private sector may have driven
a more optimistic perception about interventions that could be provided at lower levels of
care, as was the case with phototherapy, despite the increase in availability of low-cost photo-
therapy devices that can safely be used in LMICs [7, 44].
Clinical experience and knowledge of interventions. For more complex interventions,
non-clinicians may not have been familiar with nomenclature, or have had less knowledge of
the clinical significance or the potential feasibility of these interventions. This may explain
some of the variation in responses for hypoglycaemia, treatment of seizures and phototherapy.
For example, clinicians may be more likely than non-clinicians to recognise the significance of
seizures in the neonatal period and the frequency of intrapartum injury in LMIC settings. The
majority of respondents were clinicians who had worked in a LMIC (197/262); very few non-
clinicians who had worked only in HICs (2/262) responded to the survey. However, arguably
programmatic or clinical experience in LMICs was a motivating factor to respond to the sur-
vey, which related directly to LMIC health programmes and was advertised through forums
relevant to these professional groups.
Transitional interventions. There is marked variation in the health system requirements
between different levels of care. For example, facilities may be able to provide high quality rou-
tine care at birth, but lack the infrastructure, equipment and human resources to provide spe-
cial care. Perceptions of the potential harm that can be caused by certain interventions if not
provided in a safe, enabling environment may have influenced respondents. The perception is
justified by epidemiological data showing long term consequences of poor-quality neonatal
care, a pattern that has been seen in countries where there has been rapid scale up without suf-
ficient attention to safety and monitoring systems [13, 45]. For example, countries in Asia and
Latin America are seeing an epidemic of childhood blindness caused by unregulated use of
oxygen in neonatal units, as well as poor screening and follow up services for survivors of neo-
natal care [11].
One interpretation of the results of this survey for potential signal functions that lacked
clear classification may be to consider them as “transitional”. This would refer to interven-
tions or services that bridge the nexus between two defined levels of care. This approach
allows facilities that are developing inpatient care capacity at either the special care or inten-
sive care level to go through a transitional phase whereby interventions are added in a step-
wise manner before moving up to the next level of care. Facilities offering newborn care
would need to offer all service category requirements at lower levels of the hierarchy before
adding transitional interventions linked to higher levels [46]. For example, facilities offering
routine care at birth may begin a transitional phase to building special care capacity by add-
ing interventions such as oxygen and assisted feeding (starting with cup feeding of expressed
breastmilk) in addition to or as part of stabilisation and referral. The progressive or stepwise
introduction of such interventions will also be influenced by context; hospitals with larger
catchment areas may need to cover a wider range of services than smaller ones. To move to
the next level, all transitional interventions would need to be available and provided to a
minimum standard [18].
In practice the introduction of transitional interventions would require policy and imple-
mentation discussions and further operational research, as settings differ widely [19]. Much of
the existing evidence and guidance on neonatal care pertains from high income countries [15,
16, 20, 23, 46], with the majority of implementation studies from LMICs being hospital level
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only with few from a health systems perspective [47]. Further research is needed to document
and develop quality evidence from LMICs on the organisation of neonatal care.
Next steps: Aligning levels of inpatient newborn care with routine and
emergency obstetric care measurement
Agreed levels of care are urgently needed for newborns, but further work is needed to align
these with existing EmOC levels and determine an appropriate integrated and dynamic
approach for monitoring. Fig 3 shows how the results of the survey could potentially align
with the existing emergency obstetric care signal functions and levels of care. Critically, this
figure places the mother and newborn together at the centre of the care.
Interventions in green are those which are existing signal functions. Starting from the bot-
tom of the figure, routine and preventive care interventions reduce the need for emergency
and inpatient care by preventing complications and there is a strong argument for their inclu-
sion in the list of signal functions. The special care level may align with existing comprehensive
signal functions as these are interventions that are only likely to be feasible to provide at a first
level referral facility or regional hospital that has the capacity to have a dedicated newborn
inpatient care ward and staff. A higher level, intensive care will likely only be available at a very
small number of CEmOC facilities (e.g. central hospitals). Intensive care would less likely to be
part of the existing EmOC framework that does not currently cover an intensive level of care
for women with severe obstetric complications. These findings are also consistent with
Fig 3. Interventions and levels of inpatient care for small and sick newborns aligned with Emergency Obstetric Care (EmOC) signal functions and levels of
care. Green = existing signal function. Grey = transitional interventions. PMTCT = Prevention of mother to child transmission of HIV, IV = intravenous,
IM = intramuscular, CPAP = continuous positive airway pressure.
https://doi.org/10.1371/journal.pone.0218748.g003
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previous work that promotes the inclusion of routine and preventive care signal functions for
EmoC monitoring [26]. However, one might argue that by including preventive, routine care
and inpatient care measures, the framework ceases to be an “emergency framework” and
becomes a framework for interventions for intrapartum and postnatal care.
Further discussion and consensus to formulate measurable newborn signal functions from
this list of interventions will be needed. As currently presented, the list of interventions are
potential signal functions not yet validated by being shown to link to improved outcomes,
although each of these interventions does have evidence of impact [4, 7]. As part of further for-
mative research, piloting and testing the measurement of a selection of these interventions in
existing LMIC inpatient care facilities would be important. Qualitative work may be needed to
look at the use of a selection of signal functions at the country and facility level in different set-
tings. In addition, these would need to be used alongside complementary indicators that could
be used for newborn care that reflect access, utilization and quality dimensions, aligned with
the WHO quality of care framework [48]. The availability and density of facilities capable of
providing both routine, emergency obstetric and small and sick newborn care as well as the
proportion of population at a defined travel time from such facilities are useful health system
tools for planning and monitoring the supply-side towards ensuring sufficient services for
both maternal and newborn care. Such guidance has been lacking for small and sick newborn
care, which faces major gaps in availability of and access to facilities.
This work is timely, as a revision of the EmONC monitoring handbook and associated indi-
cators is planned. Such a revision is intended to build on lessons learned from implementation
and better reflect the needs of the mother-baby dyad, including routine maternal and newborn
care and inpatient care for small and sick newborns. This work contributes part of the forma-
tive work for this wider revision.
Limitations
Since health system contexts in LMICs differ, we used an online approach to collect a wide
range of opinions from different settings and professional backgrounds. However, a number of
limitations of this approach must be noted. Firstly, our sample was not fully representative of
all regions. Whilst the sample was geographically diverse, selection bias is a limitation and
opinions of those who could not or did not access the survey due to limited internet connec-
tion, language or access issues is unknown. For example, few middle-income countries in sub-
Saharan Africa were represented in the sample. The findings may also be biased by the larger
frequency of respondents from Europe and the Americas, although the majority of respon-
dents reported experience in LMIC settings even if currently based in higher-income settings.
Secondly, survey fatigue may have occurred, although the list of interventions appeared in ran-
dom order to avoid biasing results through respondent attrition. Survey fatigue may partially
explain the number of individuals that accessed the survey but did not complete any informa-
tion on newborn interventions. There may also have been a number that accessed it and real-
ised they did not have the background knowledge to be able to answer the questions on the
interventions. Several factors may have influenced the classification of inpatient care interven-
tions, including knowledge of the intervention, perception of the importance of the interven-
tion (e.g. its potential impact on mortality and morbidity) and perceived feasibility. This may
have resulted in a conflict between perceived feasibility (can do) and perceived need (should
do) and respondents may have been strongly influenced by their own personal clinical or con-
textual programmatic experiences. Finally, for ease of interpretation, a threshold of >50% was
used to classify interventions into different levels. This was pragmatic, but entirely arbitrary
threshold and the findings would be slightly different if other thresholds were applied.
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This work was focused on inpatient care for small and sick newborns that occurs in the
postnatal period. It does not discuss community interventions or interventions that benefit
newborns but are delivered in the antenatal period. The use of antenatal corticosteroids for
mothers with threatened preterm labour [49] and antibiotics for preterm premature rupture of
membranes (P-PROM) [50] are two interventions for small and sick newborns that have an
evidence base, but that do not naturally fit into the inpatient newborn care package due to the
timing in the peripartum period.
Conclusions
This article has shown how practitioners categorised 18 newborn interventions that could act
as potential signal functions to different levels of care, including routine care at birth and inpa-
tient care for small and sick newborns. Findings were consistent with existing clinical guide-
lines and previous work on the subject, but also provided new insights on how newborn care
programmes, including more complex interventions for small and sick newborns, could be
organised and monitored. Future research should focus on refining the list to a small selection
of measurable signal functions and testing of these potential signal functions in existing inpa-
tient care units. Further work is needed to align these newborn signal functions to the existing
obstetric care levels to create a dynamic and integrated framework for maternal and newborn
care. Working towards universal health coverage, future adaptations, including improvements
to indicators of service availability, access and quality, should reflect the needs of health pro-
grammes for both mothers and their newborns.
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